{"idB": "906709_12_item1a_p10_s1", "idA": "906709_11_item1a_p0_s0", "sentA": "any degree of certainty the duration and completion costs of our research and development projects, anticipated completion dates or when and to what extent we will receive cash inflows from a collaboration arrangement or the commercialization of a drug candidate.", "sentB": "We intend to continue to seek partnerships with pharmaceutical and biotechnology partners to fund a portion of our research and development capital requirements.", "type": 2, "words": ["<tag1>", "any", "degree", "of", "certainty", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects,", "anticipated", "completion", "dates", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "a", "collaboration", "arrangement", "or", "the", "commercialization", "of", "a", "drug", "candidate.", "<tag2>", "We", "intend", "to", "continue", "to", "seek", "partnerships", "with", "pharmaceutical", "and", "biotechnology", "partners", "to", "fund", "a", "portion", "of", "our", "research", "and", "development", "capital", "requirements.", "<tag3>"], "wordsA": ["any", "degree", "of", "certainty", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects,", "anticipated", "completion", "dates", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "a", "collaboration", "arrangement", "or", "the", "commercialization", "of", "a", "drug", "candidate."], "wordsB": ["We", "intend", "to", "continue", "to", "seek", "partnerships", "with", "pharmaceutical", "and", "biotechnology", "partners", "to", "fund", "a", "portion", "of", "our", "research", "and", "development", "capital", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p13_s0", "idA": "906709_11_item1a_p0_s0", "sentA": "any degree of certainty the duration and completion costs of our research and development projects, anticipated completion dates or when and to what extent we will receive cash inflows from a collaboration arrangement or the commercialization of a drug candidate.", "sentB": "The commercial potential of a drug candidate in development is difficult to predict.", "type": 2, "words": ["<tag1>", "any", "degree", "of", "certainty", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects,", "anticipated", "completion", "dates", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "a", "collaboration", "arrangement", "or", "the", "commercialization", "of", "a", "drug", "candidate.", "<tag2>", "The", "commercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["any", "degree", "of", "certainty", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects,", "anticipated", "completion", "dates", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "a", "collaboration", "arrangement", "or", "the", "commercialization", "of", "a", "drug", "candidate."], "wordsB": ["The", "commercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s12", "idA": "906709_11_item1a_p0_s0", "sentA": "any degree of certainty the duration and completion costs of our research and development projects, anticipated completion dates or when and to what extent we will receive cash inflows from a collaboration arrangement or the commercialization of a drug candidate.", "sentB": "Our corporate headquarters, including a substantial portion of our research and development operations, are located in the San Francisco Bay Area, a region known for seismic activity and a potential terrorist target.", "type": 2, "words": ["<tag1>", "any", "degree", "of", "certainty", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects,", "anticipated", "completion", "dates", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "a", "collaboration", "arrangement", "or", "the", "commercialization", "of", "a", "drug", "candidate.", "<tag2>", "Our", "corporate", "headquarters,", "including", "a", "substantial", "portion", "of", "our", "research", "and", "development", "operations,", "are", "located", "in", "the", "San", "Francisco", "Bay", "Area,", "a", "region", "known", "for", "seismic", "activity", "and", "a", "potential", "terrorist", "target.", "<tag3>"], "wordsA": ["any", "degree", "of", "certainty", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects,", "anticipated", "completion", "dates", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "a", "collaboration", "arrangement", "or", "the", "commercialization", "of", "a", "drug", "candidate."], "wordsB": ["Our", "corporate", "headquarters,", "including", "a", "substantial", "portion", "of", "our", "research", "and", "development", "operations,", "are", "located", "in", "the", "San", "Francisco", "Bay", "Area,", "a", "region", "known", "for", "seismic", "activity", "and", "a", "potential", "terrorist", "target."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p5_s2", "idA": "906709_11_item1a_p11_s1", "sentA": "As of December 31, 2010, we had cash, cash equivalents and investments in marketable securities of $315.9 million and indebtedness of $240.4 million, including $215.0 million of convertible subordinated notes, $19.0 million in capital lease obligations and $6.4 million in other liabilities.", "sentB": "As of December 31, 2011, we had cash, cash equivalents, and investments in marketable securities valued at approximately $414.9 million and indebtedness of approximately $239.9 million, including approximately $215.0 million in convertible subordinated notes due September 2012, $17.0 million in capital lease obligations, and $7.9 million of other liabilities.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2010,", "we", "had", "cash,", "cash", "equivalents", "and", "investments", "in", "marketable", "securities", "of", "$315.9", "million", "and", "indebtedness", "of", "$240.4", "million,", "including", "$215.0", "million", "of", "convertible", "subordinated", "notes,", "$19.0", "million", "in", "capital", "lease", "obligations", "and", "$6.4", "million", "in", "other", "liabilities.", "<tag2>", "As", "of", "December", "31,", "2011,", "we", "had", "cash,", "cash", "equivalents,", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$414.9", "million", "and", "indebtedness", "of", "approximately", "$239.9", "million,", "including", "approximately", "$215.0", "million", "in", "convertible", "subordinated", "notes", "due", "September", "2012,", "$17.0", "million", "in", "capital", "lease", "obligations,", "and", "$7.9", "million", "of", "other", "liabilities.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2010,", "we", "had", "cash,", "cash", "equivalents", "and", "investments", "in", "marketable", "securities", "of", "$315.9", "million", "and", "indebtedness", "of", "$240.4", "million,", "including", "$215.0", "million", "of", "convertible", "subordinated", "notes,", "$19.0", "million", "in", "capital", "lease", "obligations", "and", "$6.4", "million", "in", "other", "liabilities."], "wordsB": ["As", "of", "December", "31,", "2011,", "we", "had", "cash,", "cash", "equivalents,", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$414.9", "million", "and", "indebtedness", "of", "approximately", "$239.9", "million,", "including", "approximately", "$215.0", "million", "in", "convertible", "subordinated", "notes", "due", "September", "2012,", "$17.0", "million", "in", "capital", "lease", "obligations,", "and", "$7.9", "million", "of", "other", "liabilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p51_s10", "idA": "906709_11_item1a_p11_s4", "sentA": "On January 24, 2011, we completed a public offering of our common stock with proceeds of approximately $220.4 million.", "sentB": "A variety of factors may have a significant effect on the market price of our common stock or notes, including:", "type": 2, "words": ["<tag1>", "On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "proceeds", "of", "approximately", "$220.4", "million.", "<tag2>", "A", "variety", "of", "factors", "may", "have", "a", "significant", "effect", "on", "the", "market", "price", "of", "our", "common", "stock", "or", "notes,", "including:", "<tag3>"], "wordsA": ["On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "proceeds", "of", "approximately", "$220.4", "million."], "wordsB": ["A", "variety", "of", "factors", "may", "have", "a", "significant", "effect", "on", "the", "market", "price", "of", "our", "common", "stock", "or", "notes,", "including:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p51_s5", "idA": "906709_11_item1a_p11_s4", "sentA": "On January 24, 2011, we completed a public offering of our common stock with proceeds of approximately $220.4 million.", "sentB": "The price of our common stock is expected to remain volatile.", "type": 2, "words": ["<tag1>", "On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "proceeds", "of", "approximately", "$220.4", "million.", "<tag2>", "The", "price", "of", "our", "common", "stock", "is", "expected", "to", "remain", "volatile.", "<tag3>"], "wordsA": ["On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "proceeds", "of", "approximately", "$220.4", "million."], "wordsB": ["The", "price", "of", "our", "common", "stock", "is", "expected", "to", "remain", "volatile."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p2_s1", "idA": "906709_11_item1a_p12_s0", "sentA": "We will likely not have sufficient capital to fund the development of the drug candidates in our current research and development pipeline, fund late stage clinical development of NKTR-102 and repay the $215.0 million convertible notes when they become due in September 2012.", "sentB": "We have a number of proprietary drug candidates and partnered drug candidates in research and development ranging from the early discovery research phase through preclinical testing and clinical trials.", "type": 2, "words": ["<tag1>", "We", "will", "likely", "not", "have", "sufficient", "capital", "to", "fund", "the", "development", "of", "the", "drug", "candidates", "in", "our", "current", "research", "and", "development", "pipeline,", "fund", "late", "stage", "clinical", "development", "of", "NKTR-102", "and", "repay", "the", "$215.0", "million", "convertible", "notes", "when", "they", "become", "due", "in", "September", "2012.", "<tag2>", "We", "have", "a", "number", "of", "proprietary", "drug", "candidates", "and", "partnered", "drug", "candidates", "in", "research", "and", "development", "ranging", "from", "the", "early", "discovery", "research", "phase", "through", "preclinical", "testing", "and", "clinical", "trials.", "<tag3>"], "wordsA": ["We", "will", "likely", "not", "have", "sufficient", "capital", "to", "fund", "the", "development", "of", "the", "drug", "candidates", "in", "our", "current", "research", "and", "development", "pipeline,", "fund", "late", "stage", "clinical", "development", "of", "NKTR-102", "and", "repay", "the", "$215.0", "million", "convertible", "notes", "when", "they", "become", "due", "in", "September", "2012."], "wordsB": ["We", "have", "a", "number", "of", "proprietary", "drug", "candidates", "and", "partnered", "drug", "candidates", "in", "research", "and", "development", "ranging", "from", "the", "early", "discovery", "research", "phase", "through", "preclinical", "testing", "and", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s14", "idA": "906709_11_item1a_p12_s0", "sentA": "We will likely not have sufficient capital to fund the development of the drug candidates in our current research and development pipeline, fund late stage clinical development of NKTR-102 and repay the $215.0 million convertible notes when they become due in September 2012.", "sentB": "If non-dilutive financing alternatives are not available to us on commercially reasonable terms or at all, in order to continue future operations as planned, we will be required to pursue dilutive equity-based financing alternatives such as the issuance of convertible debt or common stock to fund the remaining balance of the convertible notes and to provide sufficient capital to fund our future operations.", "type": 2, "words": ["<tag1>", "We", "will", "likely", "not", "have", "sufficient", "capital", "to", "fund", "the", "development", "of", "the", "drug", "candidates", "in", "our", "current", "research", "and", "development", "pipeline,", "fund", "late", "stage", "clinical", "development", "of", "NKTR-102", "and", "repay", "the", "$215.0", "million", "convertible", "notes", "when", "they", "become", "due", "in", "September", "2012.", "<tag2>", "If", "non-dilutive", "financing", "alternatives", "are", "not", "available", "to", "us", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "in", "order", "to", "continue", "future", "operations", "as", "planned,", "we", "will", "be", "required", "to", "pursue", "dilutive", "equity-based", "financing", "alternatives", "such", "as", "the", "issuance", "of", "convertible", "debt", "or", "common", "stock", "to", "fund", "the", "remaining", "balance", "of", "the", "convertible", "notes", "and", "to", "provide", "sufficient", "capital", "to", "fund", "our", "future", "operations.", "<tag3>"], "wordsA": ["We", "will", "likely", "not", "have", "sufficient", "capital", "to", "fund", "the", "development", "of", "the", "drug", "candidates", "in", "our", "current", "research", "and", "development", "pipeline,", "fund", "late", "stage", "clinical", "development", "of", "NKTR-102", "and", "repay", "the", "$215.0", "million", "convertible", "notes", "when", "they", "become", "due", "in", "September", "2012."], "wordsB": ["If", "non-dilutive", "financing", "alternatives", "are", "not", "available", "to", "us", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "in", "order", "to", "continue", "future", "operations", "as", "planned,", "we", "will", "be", "required", "to", "pursue", "dilutive", "equity-based", "financing", "alternatives", "such", "as", "the", "issuance", "of", "convertible", "debt", "or", "common", "stock", "to", "fund", "the", "remaining", "balance", "of", "the", "convertible", "notes", "and", "to", "provide", "sufficient", "capital", "to", "fund", "our", "future", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p36_s1", "idA": "906709_11_item1a_p12_s1", "sentA": "We have no material credit facility or other material committed sources of capital.", "sentB": "We currently have no sales, marketing or distribution capabilities.", "type": 2, "words": ["<tag1>", "We", "have", "no", "material", "credit", "facility", "or", "other", "material", "committed", "sources", "of", "capital.", "<tag2>", "We", "currently", "have", "no", "sales,", "marketing", "or", "distribution", "capabilities.", "<tag3>"], "wordsA": ["We", "have", "no", "material", "credit", "facility", "or", "other", "material", "committed", "sources", "of", "capital."], "wordsB": ["We", "currently", "have", "no", "sales,", "marketing", "or", "distribution", "capabilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p49_s7", "idA": "906709_11_item1a_p13_s0", "sentA": "resources because we anticipate bearing a majority or all of the development costs for that drug candidate.", "sentB": "Our decision to bear a majority or all of the clinical development costs of NKTR-102 substantially increases our future capital requirements.", "type": 2, "words": ["<tag1>", "resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate.", "<tag2>", "Our", "decision", "to", "bear", "a", "majority", "or", "all", "of", "the", "clinical", "development", "costs", "of", "NKTR-102", "substantially", "increases", "our", "future", "capital", "requirements.", "<tag3>"], "wordsA": ["resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate."], "wordsB": ["Our", "decision", "to", "bear", "a", "majority", "or", "all", "of", "the", "clinical", "development", "costs", "of", "NKTR-102", "substantially", "increases", "our", "future", "capital", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p34_s0", "idA": "906709_11_item1a_p14_s0", "sentA": "Prior to the maturity of the convertible notes, we plan to explore a number of alternatives to provide for the repayment of the convertible notes, including restructuring the convertible notes.", "sentB": "Our reliance on collaboration partners poses a number of risks to our business, including risks that:", "type": 2, "words": ["<tag1>", "Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes.", "<tag2>", "Our", "reliance", "on", "collaboration", "partners", "poses", "a", "number", "of", "risks", "to", "our", "business,", "including", "risks", "that:", "<tag3>"], "wordsA": ["Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes."], "wordsB": ["Our", "reliance", "on", "collaboration", "partners", "poses", "a", "number", "of", "risks", "to", "our", "business,", "including", "risks", "that:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p49_s5", "idA": "906709_11_item1a_p14_s0", "sentA": "Prior to the maturity of the convertible notes, we plan to explore a number of alternatives to provide for the repayment of the convertible notes, including restructuring the convertible notes.", "sentB": "Our business strategy requires us to manage our business to provide for the continued development and potential commercialization of our proprietary and partnered drug candidates.", "type": 2, "words": ["<tag1>", "Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes.", "<tag2>", "Our", "business", "strategy", "requires", "us", "to", "manage", "our", "business", "to", "provide", "for", "the", "continued", "development", "and", "potential", "commercialization", "of", "our", "proprietary", "and", "partnered", "drug", "candidates.", "<tag3>"], "wordsA": ["Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes."], "wordsB": ["Our", "business", "strategy", "requires", "us", "to", "manage", "our", "business", "to", "provide", "for", "the", "continued", "development", "and", "potential", "commercialization", "of", "our", "proprietary", "and", "partnered", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s1", "idA": "906709_11_item1a_p14_s0", "sentA": "Prior to the maturity of the convertible notes, we plan to explore a number of alternatives to provide for the repayment of the convertible notes, including restructuring the convertible notes.", "sentB": "This process generally takes a number of years and requires the expenditure of substantial resources.", "type": 2, "words": ["<tag1>", "Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes.", "<tag2>", "This", "process", "generally", "takes", "a", "number", "of", "years", "and", "requires", "the", "expenditure", "of", "substantial", "resources.", "<tag3>"], "wordsA": ["Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes."], "wordsB": ["This", "process", "generally", "takes", "a", "number", "of", "years", "and", "requires", "the", "expenditure", "of", "substantial", "resources."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p51_s9", "idA": "906709_11_item1a_p14_s0", "sentA": "Prior to the maturity of the convertible notes, we plan to explore a number of alternatives to provide for the repayment of the convertible notes, including restructuring the convertible notes.", "sentB": "Also, interest rate fluctuations can affect the price of our convertible notes.", "type": 2, "words": ["<tag1>", "Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes.", "<tag2>", "Also,", "interest", "rate", "fluctuations", "can", "affect", "the", "price", "of", "our", "convertible", "notes.", "<tag3>"], "wordsA": ["Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "convertible", "notes,", "including", "restructuring", "the", "convertible", "notes."], "wordsB": ["Also,", "interest", "rate", "fluctuations", "can", "affect", "the", "price", "of", "our", "convertible", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p14_s5", "idA": "906709_11_item1a_p14_s2", "sentA": "Please refer to Part I, Item 1A, Risk Factors, We will need to restructure our convertible notes or raise substantial additional capital to repay the notes and fund operations, and we may be unable to restructure the notes or raise such capital when needed and on acceptable terms.", "sentB": "If a license is not available on commercially reasonable terms or at all, our business, results of operations, and financial condition could be significantly harmed and we may be prevented from developing and selling the drug.", "type": 2, "words": ["<tag1>", "Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms.", "<tag2>", "If", "a", "license", "is", "not", "available", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "our", "business,", "results", "of", "operations,", "and", "financial", "condition", "could", "be", "significantly", "harmed", "and", "we", "may", "be", "prevented", "from", "developing", "and", "selling", "the", "drug.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms."], "wordsB": ["If", "a", "license", "is", "not", "available", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "our", "business,", "results", "of", "operations,", "and", "financial", "condition", "could", "be", "significantly", "harmed", "and", "we", "may", "be", "prevented", "from", "developing", "and", "selling", "the", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p37_s2", "idA": "906709_11_item1a_p14_s2", "sentA": "Please refer to Part I, Item 1A, Risk Factors, We will need to restructure our convertible notes or raise substantial additional capital to repay the notes and fund operations, and we may be unable to restructure the notes or raise such capital when needed and on acceptable terms.", "sentB": "To the extent we rely on other pharmaceutical or biotechnology companies with established sales, marketing and distribution systems to market our products, we will need to establish and maintain partnership arrangements, and we may not be able to enter into these arrangements on acceptable terms or at all.", "type": 2, "words": ["<tag1>", "Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms.", "<tag2>", "To", "the", "extent", "we", "rely", "on", "other", "pharmaceutical", "or", "biotechnology", "companies", "with", "established", "sales,", "marketing", "and", "distribution", "systems", "to", "market", "our", "products,", "we", "will", "need", "to", "establish", "and", "maintain", "partnership", "arrangements,", "and", "we", "may", "not", "be", "able", "to", "enter", "into", "these", "arrangements", "on", "acceptable", "terms", "or", "at", "all.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms."], "wordsB": ["To", "the", "extent", "we", "rely", "on", "other", "pharmaceutical", "or", "biotechnology", "companies", "with", "established", "sales,", "marketing", "and", "distribution", "systems", "to", "market", "our", "products,", "we", "will", "need", "to", "establish", "and", "maintain", "partnership", "arrangements,", "and", "we", "may", "not", "be", "able", "to", "enter", "into", "these", "arrangements", "on", "acceptable", "terms", "or", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s8", "idA": "906709_11_item1a_p14_s2", "sentA": "Please refer to Part I, Item 1A, Risk Factors, We will need to restructure our convertible notes or raise substantial additional capital to repay the notes and fund operations, and we may be unable to restructure the notes or raise such capital when needed and on acceptable terms.", "sentB": "We will need to raise substantial additional capital to repay the $215.0 million in convertible notes due in September 2012 and fund our planned future operations, and we may be unable to secure such capital without dilutive financing transactions.", "type": 2, "words": ["<tag1>", "Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms.", "<tag2>", "We", "will", "need", "to", "raise", "substantial", "additional", "capital", "to", "repay", "the", "$215.0", "million", "in", "convertible", "notes", "due", "in", "September", "2012", "and", "fund", "our", "planned", "future", "operations,", "and", "we", "may", "be", "unable", "to", "secure", "such", "capital", "without", "dilutive", "financing", "transactions.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "will", "need", "to", "restructure", "our", "convertible", "notes", "or", "raise", "substantial", "additional", "capital", "to", "repay", "the", "notes", "and", "fund", "operations,", "and", "we", "may", "be", "unable", "to", "restructure", "the", "notes", "or", "raise", "such", "capital", "when", "needed", "and", "on", "acceptable", "terms."], "wordsB": ["We", "will", "need", "to", "raise", "substantial", "additional", "capital", "to", "repay", "the", "$215.0", "million", "in", "convertible", "notes", "due", "in", "September", "2012", "and", "fund", "our", "planned", "future", "operations,", "and", "we", "may", "be", "unable", "to", "secure", "such", "capital", "without", "dilutive", "financing", "transactions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p37_s4", "idA": "906709_11_item1a_p15_s4", "sentA": "Based on our available cash and our expected operating cash requirements, we do not intend to sell these securities and it is more likely than not that we will not be required to sell these securities before we recover the amortized cost basis.", "sentB": "In the event that we market our products without a partner, we would be required to build a sales and marketing organization and infrastructure, which would require a significant investment and we may not be successful in building this organization and infrastructure in a timely or efficient manner.", "type": 2, "words": ["<tag1>", "Based", "on", "our", "available", "cash", "and", "our", "expected", "operating", "cash", "requirements,", "we", "do", "not", "intend", "to", "sell", "these", "securities", "and", "it", "is", "more", "likely", "than", "not", "that", "we", "will", "not", "be", "required", "to", "sell", "these", "securities", "before", "we", "recover", "the", "amortized", "cost", "basis.", "<tag2>", "In", "the", "event", "that", "we", "market", "our", "products", "without", "a", "partner,", "we", "would", "be", "required", "to", "build", "a", "sales", "and", "marketing", "organization", "and", "infrastructure,", "which", "would", "require", "a", "significant", "investment", "and", "we", "may", "not", "be", "successful", "in", "building", "this", "organization", "and", "infrastructure", "in", "a", "timely", "or", "efficient", "manner.", "<tag3>"], "wordsA": ["Based", "on", "our", "available", "cash", "and", "our", "expected", "operating", "cash", "requirements,", "we", "do", "not", "intend", "to", "sell", "these", "securities", "and", "it", "is", "more", "likely", "than", "not", "that", "we", "will", "not", "be", "required", "to", "sell", "these", "securities", "before", "we", "recover", "the", "amortized", "cost", "basis."], "wordsB": ["In", "the", "event", "that", "we", "market", "our", "products", "without", "a", "partner,", "we", "would", "be", "required", "to", "build", "a", "sales", "and", "marketing", "organization", "and", "infrastructure,", "which", "would", "require", "a", "significant", "investment", "and", "we", "may", "not", "be", "successful", "in", "building", "this", "organization", "and", "infrastructure", "in", "a", "timely", "or", "efficient", "manner."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p49_s10", "idA": "906709_11_item1a_p15_s5", "sentA": "To date we have not experienced any liquidity issues with respect to these securities, but should such issues arise, we may be required to hold some, or all, of these securities until maturity.", "sentB": "Furthermore, if adequate funds are not available, we may be required to obtain funds through arrangements with partners or other sources that may require us to relinquish rights to certain of our technologies, products or future economic rights that we would not otherwise relinquish or require us to enter into other financing arrangements on unfavorable terms.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "should", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity.", "<tag2>", "Furthermore,", "if", "adequate", "funds", "are", "not", "available,", "we", "may", "be", "required", "to", "obtain", "funds", "through", "arrangements", "with", "partners", "or", "other", "sources", "that", "may", "require", "us", "to", "relinquish", "rights", "to", "certain", "of", "our", "technologies,", "products", "or", "future", "economic", "rights", "that", "we", "would", "not", "otherwise", "relinquish", "or", "require", "us", "to", "enter", "into", "other", "financing", "arrangements", "on", "unfavorable", "terms.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "should", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity."], "wordsB": ["Furthermore,", "if", "adequate", "funds", "are", "not", "available,", "we", "may", "be", "required", "to", "obtain", "funds", "through", "arrangements", "with", "partners", "or", "other", "sources", "that", "may", "require", "us", "to", "relinquish", "rights", "to", "certain", "of", "our", "technologies,", "products", "or", "future", "economic", "rights", "that", "we", "would", "not", "otherwise", "relinquish", "or", "require", "us", "to", "enter", "into", "other", "financing", "arrangements", "on", "unfavorable", "terms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p5_s3", "idA": "906709_11_item1a_p15_s6", "sentA": "We believe that, even allowing for potential liquidity issues with respect to these securities, our remaining cash and cash equivalents and short-term investments will be sufficient to meet our anticipated cash needs for at least the next twelve months.", "sentB": "While we believe that our cash position will be sufficient to meet our liquidity requirements through at least the next 12 months, our future capital requirements will depend upon numerous unpredictable factors, including:", "type": 2, "words": ["<tag1>", "We", "believe", "that,", "even", "allowing", "for", "potential", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "our", "remaining", "cash", "and", "cash", "equivalents", "and", "short-term", "investments", "will", "be", "sufficient", "to", "meet", "our", "anticipated", "cash", "needs", "for", "at", "least", "the", "next", "twelve", "months.", "<tag2>", "While", "we", "believe", "that", "our", "cash", "position", "will", "be", "sufficient", "to", "meet", "our", "liquidity", "requirements", "through", "at", "least", "the", "next", "12", "months,", "our", "future", "capital", "requirements", "will", "depend", "upon", "numerous", "unpredictable", "factors,", "including:", "<tag3>"], "wordsA": ["We", "believe", "that,", "even", "allowing", "for", "potential", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "our", "remaining", "cash", "and", "cash", "equivalents", "and", "short-term", "investments", "will", "be", "sufficient", "to", "meet", "our", "anticipated", "cash", "needs", "for", "at", "least", "the", "next", "twelve", "months."], "wordsB": ["While", "we", "believe", "that", "our", "cash", "position", "will", "be", "sufficient", "to", "meet", "our", "liquidity", "requirements", "through", "at", "least", "the", "next", "12", "months,", "our", "future", "capital", "requirements", "will", "depend", "upon", "numerous", "unpredictable", "factors,", "including:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p6_s2", "idA": "906709_11_item1a_p16_s1", "sentA": "We expect that cash flows used in operating activities, excluding upfront payments received, if any, will increase in 2011 as a result of increased spending on our proprietary research and development programs.", "sentB": "If sufficient capital is not available to us or is not available on commercially reasonable terms, it could require us to delay or reduce one or more of our research and development programs.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "payments", "received,", "if", "any,", "will", "increase", "in", "2011", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs.", "<tag2>", "If", "sufficient", "capital", "is", "not", "available", "to", "us", "or", "is", "not", "available", "on", "commercially", "reasonable", "terms,", "it", "could", "require", "us", "to", "delay", "or", "reduce", "one", "or", "more", "of", "our", "research", "and", "development", "programs.", "<tag3>"], "wordsA": ["We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "payments", "received,", "if", "any,", "will", "increase", "in", "2011", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs."], "wordsB": ["If", "sufficient", "capital", "is", "not", "available", "to", "us", "or", "is", "not", "available", "on", "commercially", "reasonable", "terms,", "it", "could", "require", "us", "to", "delay", "or", "reduce", "one", "or", "more", "of", "our", "research", "and", "development", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p10_s2", "idA": "906709_11_item1a_p17_s0", "sentA": "During the year ended December 31, 2009, net cash provided by operating activities totaled $39.7 million, which included the $125.0 million upfront payment received from AstraZeneca under the license agreement we entered into for NKTR-118 and NKTR-119 and a $31.0 million license extension payment received from Roche in December 2009.", "sentB": "For example, in September 2009 we entered into a license agreement with AstraZeneca for NKTR-118 and NKTR-119 that included an upfront payment of $125.0 million.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2009,", "net", "cash", "provided", "by", "operating", "activities", "totaled", "$39.7", "million,", "which", "included", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "under", "the", "license", "agreement", "we", "entered", "into", "for", "NKTR-118", "and", "NKTR-119", "and", "a", "$31.0", "million", "license", "extension", "payment", "received", "from", "Roche", "in", "December", "2009.", "<tag2>", "For", "example,", "in", "September", "2009", "we", "entered", "into", "a", "license", "agreement", "with", "AstraZeneca", "for", "NKTR-118", "and", "NKTR-119", "that", "included", "an", "upfront", "payment", "of", "$125.0", "million.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2009,", "net", "cash", "provided", "by", "operating", "activities", "totaled", "$39.7", "million,", "which", "included", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "under", "the", "license", "agreement", "we", "entered", "into", "for", "NKTR-118", "and", "NKTR-119", "and", "a", "$31.0", "million", "license", "extension", "payment", "received", "from", "Roche", "in", "December", "2009."], "wordsB": ["For", "example,", "in", "September", "2009", "we", "entered", "into", "a", "license", "agreement", "with", "AstraZeneca", "for", "NKTR-118", "and", "NKTR-119", "that", "included", "an", "upfront", "payment", "of", "$125.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p17_s0", "idA": "906709_11_item1a_p17_s0", "sentA": "During the year ended December 31, 2009, net cash provided by operating activities totaled $39.7 million, which included the $125.0 million upfront payment received from AstraZeneca under the license agreement we entered into for NKTR-118 and NKTR-119 and a $31.0 million license extension payment received from Roche in December 2009.", "sentB": "On September 20, 2009, we entered into a worldwide exclusive license agreement with AstraZeneca for the further development and commercialization of NKTR-118 and NKTR-119.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2009,", "net", "cash", "provided", "by", "operating", "activities", "totaled", "$39.7", "million,", "which", "included", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "under", "the", "license", "agreement", "we", "entered", "into", "for", "NKTR-118", "and", "NKTR-119", "and", "a", "$31.0", "million", "license", "extension", "payment", "received", "from", "Roche", "in", "December", "2009.", "<tag2>", "On", "September", "20,", "2009,", "we", "entered", "into", "a", "worldwide", "exclusive", "license", "agreement", "with", "AstraZeneca", "for", "the", "further", "development", "and", "commercialization", "of", "NKTR-118", "and", "NKTR-119.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2009,", "net", "cash", "provided", "by", "operating", "activities", "totaled", "$39.7", "million,", "which", "included", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "under", "the", "license", "agreement", "we", "entered", "into", "for", "NKTR-118", "and", "NKTR-119", "and", "a", "$31.0", "million", "license", "extension", "payment", "received", "from", "Roche", "in", "December", "2009."], "wordsB": ["On", "September", "20,", "2009,", "we", "entered", "into", "a", "worldwide", "exclusive", "license", "agreement", "with", "AstraZeneca", "for", "the", "further", "development", "and", "commercialization", "of", "NKTR-118", "and", "NKTR-119."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p20_s6", "idA": "906709_11_item1a_p17_s0", "sentA": "During the year ended December 31, 2009, net cash provided by operating activities totaled $39.7 million, which included the $125.0 million upfront payment received from AstraZeneca under the license agreement we entered into for NKTR-118 and NKTR-119 and a $31.0 million license extension payment received from Roche in December 2009.", "sentB": "In October 2011, we entered into a settlement related to a trade secret and breach of contract litigation where we agreed to make an upfront payment of $2.7 million and a future contingent payment of $3.0 million if a certain drug candidate receives FDA approval.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2009,", "net", "cash", "provided", "by", "operating", "activities", "totaled", "$39.7", "million,", "which", "included", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "under", "the", "license", "agreement", "we", "entered", "into", "for", "NKTR-118", "and", "NKTR-119", "and", "a", "$31.0", "million", "license", "extension", "payment", "received", "from", "Roche", "in", "December", "2009.", "<tag2>", "In", "October", "2011,", "we", "entered", "into", "a", "settlement", "related", "to", "a", "trade", "secret", "and", "breach", "of", "contract", "litigation", "where", "we", "agreed", "to", "make", "an", "upfront", "payment", "of", "$2.7", "million", "and", "a", "future", "contingent", "payment", "of", "$3.0", "million", "if", "a", "certain", "drug", "candidate", "receives", "FDA", "approval.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2009,", "net", "cash", "provided", "by", "operating", "activities", "totaled", "$39.7", "million,", "which", "included", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "under", "the", "license", "agreement", "we", "entered", "into", "for", "NKTR-118", "and", "NKTR-119", "and", "a", "$31.0", "million", "license", "extension", "payment", "received", "from", "Roche", "in", "December", "2009."], "wordsB": ["In", "October", "2011,", "we", "entered", "into", "a", "settlement", "related", "to", "a", "trade", "secret", "and", "breach", "of", "contract", "litigation", "where", "we", "agreed", "to", "make", "an", "upfront", "payment", "of", "$2.7", "million", "and", "a", "future", "contingent", "payment", "of", "$3.0", "million", "if", "a", "certain", "drug", "candidate", "receives", "FDA", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s13", "idA": "906709_11_item1a_p19_s2", "sentA": "Our capital expenditures increased in 2010, as we constructed the leasehold improvements for the Mission Bay Facility and completed our research and development facility in Hyderabad, India.", "sentB": "In addition, we own facilities for the manufacture of products using our PEGylation and advanced polymer conjugate technologies in Huntsville, Alabama and own and lease offices in Hyderabad, India.", "type": 2, "words": ["<tag1>", "Our", "capital", "expenditures", "increased", "in", "2010,", "as", "we", "constructed", "the", "leasehold", "improvements", "for", "the", "Mission", "Bay", "Facility", "and", "completed", "our", "research", "and", "development", "facility", "in", "Hyderabad,", "India.", "<tag2>", "In", "addition,", "we", "own", "facilities", "for", "the", "manufacture", "of", "products", "using", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technologies", "in", "Huntsville,", "Alabama", "and", "own", "and", "lease", "offices", "in", "Hyderabad,", "India.", "<tag3>"], "wordsA": ["Our", "capital", "expenditures", "increased", "in", "2010,", "as", "we", "constructed", "the", "leasehold", "improvements", "for", "the", "Mission", "Bay", "Facility", "and", "completed", "our", "research", "and", "development", "facility", "in", "Hyderabad,", "India."], "wordsB": ["In", "addition,", "we", "own", "facilities", "for", "the", "manufacture", "of", "products", "using", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technologies", "in", "Huntsville,", "Alabama", "and", "own", "and", "lease", "offices", "in", "Hyderabad,", "India."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p51_s7", "idA": "906709_11_item1a_p19_s3", "sentA": "We expect our capital expenditures to decrease in 2011 compared to 2010.", "sentB": "We expect our stock price to remain volatile.", "type": 2, "words": ["<tag1>", "We", "expect", "our", "capital", "expenditures", "to", "decrease", "in", "2011", "compared", "to", "2010.", "<tag2>", "We", "expect", "our", "stock", "price", "to", "remain", "volatile.", "<tag3>"], "wordsA": ["We", "expect", "our", "capital", "expenditures", "to", "decrease", "in", "2011", "compared", "to", "2010."], "wordsB": ["We", "expect", "our", "stock", "price", "to", "remain", "volatile."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p17_s1", "idA": "906709_11_item1a_p20_s0", "sentA": "On December 31, 2008, we completed the sale of certain pulmonary assets to Novartis for a purchase price of $115.0 million.", "sentB": "In addition, we have also entered into complex commercial agreements with Novartis in connection with the sale of certain assets related to our pulmonary business, associated technology and intellectual property to Novartis (the Novartis Pulmonary Asset Sale), which was completed on December 31, 2008.", "type": 2, "words": ["<tag1>", "On", "December", "31,", "2008,", "we", "completed", "the", "sale", "of", "certain", "pulmonary", "assets", "to", "Novartis", "for", "a", "purchase", "price", "of", "$115.0", "million.", "<tag2>", "In", "addition,", "we", "have", "also", "entered", "into", "complex", "commercial", "agreements", "with", "Novartis", "in", "connection", "with", "the", "sale", "of", "certain", "assets", "related", "to", "our", "pulmonary", "business,", "associated", "technology", "and", "intellectual", "property", "to", "Novartis", "(the", "Novartis", "Pulmonary", "Asset", "Sale),", "which", "was", "completed", "on", "December", "31,", "2008.", "<tag3>"], "wordsA": ["On", "December", "31,", "2008,", "we", "completed", "the", "sale", "of", "certain", "pulmonary", "assets", "to", "Novartis", "for", "a", "purchase", "price", "of", "$115.0", "million."], "wordsB": ["In", "addition,", "we", "have", "also", "entered", "into", "complex", "commercial", "agreements", "with", "Novartis", "in", "connection", "with", "the", "sale", "of", "certain", "assets", "related", "to", "our", "pulmonary", "business,", "associated", "technology", "and", "intellectual", "property", "to", "Novartis", "(the", "Novartis", "Pulmonary", "Asset", "Sale),", "which", "was", "completed", "on", "December", "31,", "2008."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s12", "idA": "906709_11_item1a_p20_s0", "sentA": "On December 31, 2008, we completed the sale of certain pulmonary assets to Novartis for a purchase price of $115.0 million.", "sentB": "We are actively pursuing other non-dilutive financing alternatives such as the sale of additional royalty interests held by us or term loan arrangements.", "type": 2, "words": ["<tag1>", "On", "December", "31,", "2008,", "we", "completed", "the", "sale", "of", "certain", "pulmonary", "assets", "to", "Novartis", "for", "a", "purchase", "price", "of", "$115.0", "million.", "<tag2>", "We", "are", "actively", "pursuing", "other", "non-dilutive", "financing", "alternatives", "such", "as", "the", "sale", "of", "additional", "royalty", "interests", "held", "by", "us", "or", "term", "loan", "arrangements.", "<tag3>"], "wordsA": ["On", "December", "31,", "2008,", "we", "completed", "the", "sale", "of", "certain", "pulmonary", "assets", "to", "Novartis", "for", "a", "purchase", "price", "of", "$115.0", "million."], "wordsB": ["We", "are", "actively", "pursuing", "other", "non-dilutive", "financing", "alternatives", "such", "as", "the", "sale", "of", "additional", "royalty", "interests", "held", "by", "us", "or", "term", "loan", "arrangements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p20_s8", "idA": "906709_11_item1a_p20_s3", "sentA": "In 2007, we granted Pearl a limited field intellectual property license to certain of our proprietary pulmonary delivery technology.", "sentB": "If any of our pending patent applications do not issue, or are deemed invalid following issuance, we may lose valuable intellectual property protection.", "type": 2, "words": ["<tag1>", "In", "2007,", "we", "granted", "Pearl", "a", "limited", "field", "intellectual", "property", "license", "to", "certain", "of", "our", "proprietary", "pulmonary", "delivery", "technology.", "<tag2>", "If", "any", "of", "our", "pending", "patent", "applications", "do", "not", "issue,", "or", "are", "deemed", "invalid", "following", "issuance,", "we", "may", "lose", "valuable", "intellectual", "property", "protection.", "<tag3>"], "wordsA": ["In", "2007,", "we", "granted", "Pearl", "a", "limited", "field", "intellectual", "property", "license", "to", "certain", "of", "our", "proprietary", "pulmonary", "delivery", "technology."], "wordsB": ["If", "any", "of", "our", "pending", "patent", "applications", "do", "not", "issue,", "or", "are", "deemed", "invalid", "following", "issuance,", "we", "may", "lose", "valuable", "intellectual", "property", "protection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p38_s6", "idA": "906709_11_item1a_p23_s0", "sentA": "During the year ended December 31, 2008, we repurchased approximately $100.0 million in par value of our 3.25% convertible subordinated notes for an aggregate purchase price of $47.8 million.", "sentB": "For the year ended December 31, 2011, we reported a net loss of $134.0 million.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2008,", "we", "repurchased", "approximately", "$100.0", "million", "in", "par", "value", "of", "our", "3.25%", "convertible", "subordinated", "notes", "for", "an", "aggregate", "purchase", "price", "of", "$47.8", "million.", "<tag2>", "For", "the", "year", "ended", "December", "31,", "2011,", "we", "reported", "a", "net", "loss", "of", "$134.0", "million.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2008,", "we", "repurchased", "approximately", "$100.0", "million", "in", "par", "value", "of", "our", "3.25%", "convertible", "subordinated", "notes", "for", "an", "aggregate", "purchase", "price", "of", "$47.8", "million."], "wordsB": ["For", "the", "year", "ended", "December", "31,", "2011,", "we", "reported", "a", "net", "loss", "of", "$134.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s11", "idA": "906709_11_item1a_p23_s1", "sentA": "The $215.0 million of 3.25% convertible subordinated notes outstanding at December 31, 2010, are due in September 2012.", "sentB": "We plan to use the proceeds from this transaction towards the repayment of our $215.0 million in convertible subordinated notes due in September 2012.", "type": 2, "words": ["<tag1>", "The", "$215.0", "million", "of", "3.25%", "convertible", "subordinated", "notes", "outstanding", "at", "December", "31,", "2010,", "are", "due", "in", "September", "2012.", "<tag2>", "We", "plan", "to", "use", "the", "proceeds", "from", "this", "transaction", "towards", "the", "repayment", "of", "our", "$215.0", "million", "in", "convertible", "subordinated", "notes", "due", "in", "September", "2012.", "<tag3>"], "wordsA": ["The", "$215.0", "million", "of", "3.25%", "convertible", "subordinated", "notes", "outstanding", "at", "December", "31,", "2010,", "are", "due", "in", "September", "2012."], "wordsB": ["We", "plan", "to", "use", "the", "proceeds", "from", "this", "transaction", "towards", "the", "repayment", "of", "our", "$215.0", "million", "in", "convertible", "subordinated", "notes", "due", "in", "September", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s10", "idA": "906709_11_item1a_p24_s1", "sentA": "Additionally, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other offering expenses.", "sentB": "Additionally, we incurred approximately $4.5 million in transaction costs.", "type": 2, "words": ["<tag1>", "Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses.", "<tag2>", "Additionally,", "we", "incurred", "approximately", "$4.5", "million", "in", "transaction", "costs.", "<tag3>"], "wordsA": ["Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses."], "wordsB": ["Additionally,", "we", "incurred", "approximately", "$4.5", "million", "in", "transaction", "costs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p35_s2", "idA": "906709_11_item1a_p27_s1", "sentA": "Under the terms of the sublease we entered into with Pfizer Inc. on September 30, 2009 for the Mission Bay Facility, we will begin making non-cancelable lease payments in 2014.", "sentB": "We have entered into collaborations in the past that have been subsequently terminated, such as our collaboration with Pfizer for the development and commercialization of inhaled insulin that was terminated by Pfizer in November 2007.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "of", "the", "sublease", "we", "entered", "into", "with", "Pfizer", "Inc.", "on", "September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "will", "begin", "making", "non-cancelable", "lease", "payments", "in", "2014.", "<tag2>", "We", "have", "entered", "into", "collaborations", "in", "the", "past", "that", "have", "been", "subsequently", "terminated,", "such", "as", "our", "collaboration", "with", "Pfizer", "for", "the", "development", "and", "commercialization", "of", "inhaled", "insulin", "that", "was", "terminated", "by", "Pfizer", "in", "November", "2007.", "<tag3>"], "wordsA": ["Under", "the", "terms", "of", "the", "sublease", "we", "entered", "into", "with", "Pfizer", "Inc.", "on", "September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "will", "begin", "making", "non-cancelable", "lease", "payments", "in", "2014."], "wordsB": ["We", "have", "entered", "into", "collaborations", "in", "the", "past", "that", "have", "been", "subsequently", "terminated,", "such", "as", "our", "collaboration", "with", "Pfizer", "for", "the", "development", "and", "commercialization", "of", "inhaled", "insulin", "that", "was", "terminated", "by", "Pfizer", "in", "November", "2007."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p5_s0", "idA": "906709_11_item1a_p29_s0", "sentA": "Given our current cash requirements, we forecast that we will have sufficient cash to meet our net operating expense requirements and contractual obligations at least through December 31, 2011.", "sentB": "We have substantial future capital requirements and there is a risk we may not have access to sufficient capital to meet our current business plan.", "type": 2, "words": ["<tag1>", "Given", "our", "current", "cash", "requirements,", "we", "forecast", "that", "we", "will", "have", "sufficient", "cash", "to", "meet", "our", "net", "operating", "expense", "requirements", "and", "contractual", "obligations", "at", "least", "through", "December", "31,", "2011.", "<tag2>", "We", "have", "substantial", "future", "capital", "requirements", "and", "there", "is", "a", "risk", "we", "may", "not", "have", "access", "to", "sufficient", "capital", "to", "meet", "our", "current", "business", "plan.", "<tag3>"], "wordsA": ["Given", "our", "current", "cash", "requirements,", "we", "forecast", "that", "we", "will", "have", "sufficient", "cash", "to", "meet", "our", "net", "operating", "expense", "requirements", "and", "contractual", "obligations", "at", "least", "through", "December", "31,", "2011."], "wordsB": ["We", "have", "substantial", "future", "capital", "requirements", "and", "there", "is", "a", "risk", "we", "may", "not", "have", "access", "to", "sufficient", "capital", "to", "meet", "our", "current", "business", "plan."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p30_s0", "idA": "906709_11_item1a_p29_s1", "sentA": "We plan to continue to invest in our growth and our future cash requirements will depend upon the timing and results of these investments.", "sentB": "Our revenue is exclusively derived from our collaboration agreements, which can result in significant fluctuation in our revenue from period to period, and our past revenue is therefore not necessarily indicative of our future revenue.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "continue", "to", "invest", "in", "our", "growth", "and", "our", "future", "cash", "requirements", "will", "depend", "upon", "the", "timing", "and", "results", "of", "these", "investments.", "<tag2>", "Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "which", "can", "result", "in", "significant", "fluctuation", "in", "our", "revenue", "from", "period", "to", "period,", "and", "our", "past", "revenue", "is", "therefore", "not", "necessarily", "indicative", "of", "our", "future", "revenue.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "to", "invest", "in", "our", "growth", "and", "our", "future", "cash", "requirements", "will", "depend", "upon", "the", "timing", "and", "results", "of", "these", "investments."], "wordsB": ["Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "which", "can", "result", "in", "significant", "fluctuation", "in", "our", "revenue", "from", "period", "to", "period,", "and", "our", "past", "revenue", "is", "therefore", "not", "necessarily", "indicative", "of", "our", "future", "revenue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p37_s3", "idA": "906709_11_item1a_p29_s1", "sentA": "We plan to continue to invest in our growth and our future cash requirements will depend upon the timing and results of these investments.", "sentB": "To the extent that we enter into co-promotion or other arrangements, any revenues we receive will depend upon the efforts of third parties, which may not be successful and are only partially in our control.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "continue", "to", "invest", "in", "our", "growth", "and", "our", "future", "cash", "requirements", "will", "depend", "upon", "the", "timing", "and", "results", "of", "these", "investments.", "<tag2>", "To", "the", "extent", "that", "we", "enter", "into", "co-promotion", "or", "other", "arrangements,", "any", "revenues", "we", "receive", "will", "depend", "upon", "the", "efforts", "of", "third", "parties,", "which", "may", "not", "be", "successful", "and", "are", "only", "partially", "in", "our", "control.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "to", "invest", "in", "our", "growth", "and", "our", "future", "cash", "requirements", "will", "depend", "upon", "the", "timing", "and", "results", "of", "these", "investments."], "wordsB": ["To", "the", "extent", "that", "we", "enter", "into", "co-promotion", "or", "other", "arrangements,", "any", "revenues", "we", "receive", "will", "depend", "upon", "the", "efforts", "of", "third", "parties,", "which", "may", "not", "be", "successful", "and", "are", "only", "partially", "in", "our", "control."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p40_s4", "idA": "906709_11_item1a_p30_s0", "sentA": "filing, prosecuting, maintaining and enforcing patent claims, the need to acquire licenses to new technologies and the status of competitive products.", "sentB": "Therefore, significant uncertainty exists as to the pricing approvals for, and the payment or reimbursement status of, newly approved healthcare products.", "type": 2, "words": ["<tag1>", "filing,", "prosecuting,", "maintaining", "and", "enforcing", "patent", "claims,", "the", "need", "to", "acquire", "licenses", "to", "new", "technologies", "and", "the", "status", "of", "competitive", "products.", "<tag2>", "Therefore,", "significant", "uncertainty", "exists", "as", "to", "the", "pricing", "approvals", "for,", "and", "the", "payment", "or", "reimbursement", "status", "of,", "newly", "approved", "healthcare", "products.", "<tag3>"], "wordsA": ["filing,", "prosecuting,", "maintaining", "and", "enforcing", "patent", "claims,", "the", "need", "to", "acquire", "licenses", "to", "new", "technologies", "and", "the", "status", "of", "competitive", "products."], "wordsB": ["Therefore,", "significant", "uncertainty", "exists", "as", "to", "the", "pricing", "approvals", "for,", "and", "the", "payment", "or", "reimbursement", "status", "of,", "newly", "approved", "healthcare", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s15", "idA": "906709_11_item1a_p31_s0", "sentA": "To date we have incurred substantial debt as a result of our issuances of subordinated notes that are convertible into our common stock.", "sentB": "The issuance of convertible notes, common stock, preferred stock or securities convertible into or exchangeable for our securities would dilute the percentage ownership of our current common stock security holders and could significantly lower the market value of our common stock.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "incurred", "substantial", "debt", "as", "a", "result", "of", "our", "issuances", "of", "subordinated", "notes", "that", "are", "convertible", "into", "our", "common", "stock.", "<tag2>", "The", "issuance", "of", "convertible", "notes,", "common", "stock,", "preferred", "stock", "or", "securities", "convertible", "into", "or", "exchangeable", "for", "our", "securities", "would", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stock", "security", "holders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "incurred", "substantial", "debt", "as", "a", "result", "of", "our", "issuances", "of", "subordinated", "notes", "that", "are", "convertible", "into", "our", "common", "stock."], "wordsB": ["The", "issuance", "of", "convertible", "notes,", "common", "stock,", "preferred", "stock", "or", "securities", "convertible", "into", "or", "exchangeable", "for", "our", "securities", "would", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stock", "security", "holders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p51_s8", "idA": "906709_11_item1a_p31_s0", "sentA": "To date we have incurred substantial debt as a result of our issuances of subordinated notes that are convertible into our common stock.", "sentB": "In addition, as our convertible notes are convertible into shares of our common stock, volatility or depressed prices of our common stock could have a similar effect on the trading price of our notes.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "incurred", "substantial", "debt", "as", "a", "result", "of", "our", "issuances", "of", "subordinated", "notes", "that", "are", "convertible", "into", "our", "common", "stock.", "<tag2>", "In", "addition,", "as", "our", "convertible", "notes", "are", "convertible", "into", "shares", "of", "our", "common", "stock,", "volatility", "or", "depressed", "prices", "of", "our", "common", "stock", "could", "have", "a", "similar", "effect", "on", "the", "trading", "price", "of", "our", "notes.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "incurred", "substantial", "debt", "as", "a", "result", "of", "our", "issuances", "of", "subordinated", "notes", "that", "are", "convertible", "into", "our", "common", "stock."], "wordsB": ["In", "addition,", "as", "our", "convertible", "notes", "are", "convertible", "into", "shares", "of", "our", "common", "stock,", "volatility", "or", "depressed", "prices", "of", "our", "common", "stock", "could", "have", "a", "similar", "effect", "on", "the", "trading", "price", "of", "our", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p31_s0", "idA": "906709_11_item1a_p31_s2", "sentA": "Our ability to meet our ongoing operating expenses and repay our outstanding indebtedness is dependent upon our and our partners ability to successfully complete clinical development of, obtain regulatory approvals for and successfully commercialize new drugs.", "sentB": "If our partners, on which we depend to obtain regulatory approvals for and to commercialize our partnered drug candidates, are not successful, or if such collaborations fail, the development or commercialization of our partnered drug candidates may be delayed or unsuccessful.", "type": 2, "words": ["<tag1>", "Our", "ability", "to", "meet", "our", "ongoing", "operating", "expenses", "and", "repay", "our", "outstanding", "indebtedness", "is", "dependent", "upon", "our", "and", "our", "partners", "ability", "to", "successfully", "complete", "clinical", "development", "of,", "obtain", "regulatory", "approvals", "for", "and", "successfully", "commercialize", "new", "drugs.", "<tag2>", "If", "our", "partners,", "on", "which", "we", "depend", "to", "obtain", "regulatory", "approvals", "for", "and", "to", "commercialize", "our", "partnered", "drug", "candidates,", "are", "not", "successful,", "or", "if", "such", "collaborations", "fail,", "the", "development", "or", "commercialization", "of", "our", "partnered", "drug", "candidates", "may", "be", "delayed", "or", "unsuccessful.", "<tag3>"], "wordsA": ["Our", "ability", "to", "meet", "our", "ongoing", "operating", "expenses", "and", "repay", "our", "outstanding", "indebtedness", "is", "dependent", "upon", "our", "and", "our", "partners", "ability", "to", "successfully", "complete", "clinical", "development", "of,", "obtain", "regulatory", "approvals", "for", "and", "successfully", "commercialize", "new", "drugs."], "wordsB": ["If", "our", "partners,", "on", "which", "we", "depend", "to", "obtain", "regulatory", "approvals", "for", "and", "to", "commercialize", "our", "partnered", "drug", "candidates,", "are", "not", "successful,", "or", "if", "such", "collaborations", "fail,", "the", "development", "or", "commercialization", "of", "our", "partnered", "drug", "candidates", "may", "be", "delayed", "or", "unsuccessful."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s15", "idA": "906709_11_item1a_p31_s2", "sentA": "Our ability to meet our ongoing operating expenses and repay our outstanding indebtedness is dependent upon our and our partners ability to successfully complete clinical development of, obtain regulatory approvals for and successfully commercialize new drugs.", "sentB": "In the event of an earthquake or other natural disaster, political instability, or terrorist event in any of these locations, our ability to manufacture and supply materials for drug candidates in development and our ability to meet our manufacturing obligations to our customers would be significantly disrupted and our business, results of operations and financial condition would be harmed.", "type": 2, "words": ["<tag1>", "Our", "ability", "to", "meet", "our", "ongoing", "operating", "expenses", "and", "repay", "our", "outstanding", "indebtedness", "is", "dependent", "upon", "our", "and", "our", "partners", "ability", "to", "successfully", "complete", "clinical", "development", "of,", "obtain", "regulatory", "approvals", "for", "and", "successfully", "commercialize", "new", "drugs.", "<tag2>", "In", "the", "event", "of", "an", "earthquake", "or", "other", "natural", "disaster,", "political", "instability,", "or", "terrorist", "event", "in", "any", "of", "these", "locations,", "our", "ability", "to", "manufacture", "and", "supply", "materials", "for", "drug", "candidates", "in", "development", "and", "our", "ability", "to", "meet", "our", "manufacturing", "obligations", "to", "our", "customers", "would", "be", "significantly", "disrupted", "and", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "would", "be", "harmed.", "<tag3>"], "wordsA": ["Our", "ability", "to", "meet", "our", "ongoing", "operating", "expenses", "and", "repay", "our", "outstanding", "indebtedness", "is", "dependent", "upon", "our", "and", "our", "partners", "ability", "to", "successfully", "complete", "clinical", "development", "of,", "obtain", "regulatory", "approvals", "for", "and", "successfully", "commercialize", "new", "drugs."], "wordsB": ["In", "the", "event", "of", "an", "earthquake", "or", "other", "natural", "disaster,", "political", "instability,", "or", "terrorist", "event", "in", "any", "of", "these", "locations,", "our", "ability", "to", "manufacture", "and", "supply", "materials", "for", "drug", "candidates", "in", "development", "and", "our", "ability", "to", "meet", "our", "manufacturing", "obligations", "to", "our", "customers", "would", "be", "significantly", "disrupted", "and", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "would", "be", "harmed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p18_s1", "idA": "906709_11_item1a_p31_s3", "sentA": "Even if we or our partners are successful, we may require additional capital to continue to fund our operations and repay our debt obligations as they become due.", "sentB": "From time to time, third parties have asserted, and may in the future assert, that we or our partners infringe their proprietary rights, such as patents and trade secrets, or have otherwise breached our obligations to them.", "type": 2, "words": ["<tag1>", "Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due.", "<tag2>", "From", "time", "to", "time,", "third", "parties", "have", "asserted,", "and", "may", "in", "the", "future", "assert,", "that", "we", "or", "our", "partners", "infringe", "their", "proprietary", "rights,", "such", "as", "patents", "and", "trade", "secrets,", "or", "have", "otherwise", "breached", "our", "obligations", "to", "them.", "<tag3>"], "wordsA": ["Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due."], "wordsB": ["From", "time", "to", "time,", "third", "parties", "have", "asserted,", "and", "may", "in", "the", "future", "assert,", "that", "we", "or", "our", "partners", "infringe", "their", "proprietary", "rights,", "such", "as", "patents", "and", "trade", "secrets,", "or", "have", "otherwise", "breached", "our", "obligations", "to", "them."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p38_s5", "idA": "906709_11_item1a_p31_s3", "sentA": "Even if we or our partners are successful, we may require additional capital to continue to fund our operations and repay our debt obligations as they become due.", "sentB": "We expect to continue to incur substantial losses and negative cash flow from operations and may not achieve or sustain profitability in the future.", "type": 2, "words": ["<tag1>", "Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due.", "<tag2>", "We", "expect", "to", "continue", "to", "incur", "substantial", "losses", "and", "negative", "cash", "flow", "from", "operations", "and", "may", "not", "achieve", "or", "sustain", "profitability", "in", "the", "future.", "<tag3>"], "wordsA": ["Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due."], "wordsB": ["We", "expect", "to", "continue", "to", "incur", "substantial", "losses", "and", "negative", "cash", "flow", "from", "operations", "and", "may", "not", "achieve", "or", "sustain", "profitability", "in", "the", "future."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p3_s0", "idA": "906709_11_item1a_p31_s3", "sentA": "Even if we or our partners are successful, we may require additional capital to continue to fund our operations and repay our debt obligations as they become due.", "sentB": "If we or our partners do not obtain regulatory approval for our drug candidates on a timely basis, or at all, or if the terms of any approval impose significant restrictions or limitations on use, our business, results of operations and financial condition will be negatively affected.", "type": 2, "words": ["<tag1>", "Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due.", "<tag2>", "If", "we", "or", "our", "partners", "do", "not", "obtain", "regulatory", "approval", "for", "our", "drug", "candidates", "on", "a", "timely", "basis,", "or", "at", "all,", "or", "if", "the", "terms", "of", "any", "approval", "impose", "significant", "restrictions", "or", "limitations", "on", "use,", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "will", "be", "negatively", "affected.", "<tag3>"], "wordsA": ["Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due."], "wordsB": ["If", "we", "or", "our", "partners", "do", "not", "obtain", "regulatory", "approval", "for", "our", "drug", "candidates", "on", "a", "timely", "basis,", "or", "at", "all,", "or", "if", "the", "terms", "of", "any", "approval", "impose", "significant", "restrictions", "or", "limitations", "on", "use,", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "will", "be", "negatively", "affected."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s4", "idA": "906709_11_item1a_p31_s3", "sentA": "Even if we or our partners are successful, we may require additional capital to continue to fund our operations and repay our debt obligations as they become due.", "sentB": "Even if we or our partners receive regulatory approval of a product, the approval may limit the indicated uses for which the drug may be marketed.", "type": 2, "words": ["<tag1>", "Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due.", "<tag2>", "Even", "if", "we", "or", "our", "partners", "receive", "regulatory", "approval", "of", "a", "product,", "the", "approval", "may", "limit", "the", "indicated", "uses", "for", "which", "the", "drug", "may", "be", "marketed.", "<tag3>"], "wordsA": ["Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due."], "wordsB": ["Even", "if", "we", "or", "our", "partners", "receive", "regulatory", "approval", "of", "a", "product,", "the", "approval", "may", "limit", "the", "indicated", "uses", "for", "which", "the", "drug", "may", "be", "marketed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s3", "idA": "906709_11_item1a_p31_s3", "sentA": "Even if we or our partners are successful, we may require additional capital to continue to fund our operations and repay our debt obligations as they become due.", "sentB": "Because competition for highly qualified technical personnel is intense, we may not be able to attract and retain the personnel we need to support our operations and growth.", "type": 2, "words": ["<tag1>", "Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due.", "<tag2>", "Because", "competition", "for", "highly", "qualified", "technical", "personnel", "is", "intense,", "we", "may", "not", "be", "able", "to", "attract", "and", "retain", "the", "personnel", "we", "need", "to", "support", "our", "operations", "and", "growth.", "<tag3>"], "wordsA": ["Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due."], "wordsB": ["Because", "competition", "for", "highly", "qualified", "technical", "personnel", "is", "intense,", "we", "may", "not", "be", "able", "to", "attract", "and", "retain", "the", "personnel", "we", "need", "to", "support", "our", "operations", "and", "growth."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p13_s4", "idA": "906709_11_item1a_p31_s4", "sentA": "There can be no assurance that additional funds, if and when required, will be available to us on favorable terms, if at all.", "sentB": "We may not be able to obtain intellectual property licenses related to the development of our technology on a commercially reasonable basis, if at all.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "additional", "funds,", "if", "and", "when", "required,", "will", "be", "available", "to", "us", "on", "favorable", "terms,", "if", "at", "all.", "<tag2>", "We", "may", "not", "be", "able", "to", "obtain", "intellectual", "property", "licenses", "related", "to", "the", "development", "of", "our", "technology", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "additional", "funds,", "if", "and", "when", "required,", "will", "be", "available", "to", "us", "on", "favorable", "terms,", "if", "at", "all."], "wordsB": ["We", "may", "not", "be", "able", "to", "obtain", "intellectual", "property", "licenses", "related", "to", "the", "development", "of", "our", "technology", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p14_s3", "idA": "906709_11_item1a_p31_s4", "sentA": "There can be no assurance that additional funds, if and when required, will be available to us on favorable terms, if at all.", "sentB": "There can be no assurance that we can obtain a license to any technology that we determine we need on reasonable terms, if at all, or that we could develop or otherwise obtain alternate technology.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "additional", "funds,", "if", "and", "when", "required,", "will", "be", "available", "to", "us", "on", "favorable", "terms,", "if", "at", "all.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "we", "can", "obtain", "a", "license", "to", "any", "technology", "that", "we", "determine", "we", "need", "on", "reasonable", "terms,", "if", "at", "all,", "or", "that", "we", "could", "develop", "or", "otherwise", "obtain", "alternate", "technology.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "additional", "funds,", "if", "and", "when", "required,", "will", "be", "available", "to", "us", "on", "favorable", "terms,", "if", "at", "all."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "we", "can", "obtain", "a", "license", "to", "any", "technology", "that", "we", "determine", "we", "need", "on", "reasonable", "terms,", "if", "at", "all,", "or", "that", "we", "could", "develop", "or", "otherwise", "obtain", "alternate", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p21_s3", "idA": "906709_11_item1a_p31_s4", "sentA": "There can be no assurance that additional funds, if and when required, will be available to us on favorable terms, if at all.", "sentB": "There can be no assurance that patents that have issued will be valid and enforceable or that patents for which we apply will issue with broad coverage, if at all.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "additional", "funds,", "if", "and", "when", "required,", "will", "be", "available", "to", "us", "on", "favorable", "terms,", "if", "at", "all.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "patents", "that", "have", "issued", "will", "be", "valid", "and", "enforceable", "or", "that", "patents", "for", "which", "we", "apply", "will", "issue", "with", "broad", "coverage,", "if", "at", "all.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "additional", "funds,", "if", "and", "when", "required,", "will", "be", "available", "to", "us", "on", "favorable", "terms,", "if", "at", "all."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "patents", "that", "have", "issued", "will", "be", "valid", "and", "enforceable", "or", "that", "patents", "for", "which", "we", "apply", "will", "issue", "with", "broad", "coverage,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p48_s0", "idA": "906709_11_item1a_p31_s4", "sentA": "There can be no assurance that additional funds, if and when required, will be available to us on favorable terms, if at all.", "sentB": "There can be no assurance that we or our partners will successfully develop, obtain regulatory approvals for and commercialize next-generation or new products that will successfully compete with those of our competitors.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "additional", "funds,", "if", "and", "when", "required,", "will", "be", "available", "to", "us", "on", "favorable", "terms,", "if", "at", "all.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "we", "or", "our", "partners", "will", "successfully", "develop,", "obtain", "regulatory", "approvals", "for", "and", "commercialize", "next-generation", "or", "new", "products", "that", "will", "successfully", "compete", "with", "those", "of", "our", "competitors.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "additional", "funds,", "if", "and", "when", "required,", "will", "be", "available", "to", "us", "on", "favorable", "terms,", "if", "at", "all."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "we", "or", "our", "partners", "will", "successfully", "develop,", "obtain", "regulatory", "approvals", "for", "and", "commercialize", "next-generation", "or", "new", "products", "that", "will", "successfully", "compete", "with", "those", "of", "our", "competitors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s2", "idA": "906709_11_item1a_p32_s0", "sentA": "We do not utilize off-balance sheet financing arrangements as a source of liquidity or financing.", "sentB": "We do not have any post-employment noncompetition agreements with any of our employees and do not maintain key person life insurance policies on any of our executive officers or key employees.", "type": 2, "words": ["<tag1>", "We", "do", "not", "utilize", "off-balance", "sheet", "financing", "arrangements", "as", "a", "source", "of", "liquidity", "or", "financing.", "<tag2>", "We", "do", "not", "have", "any", "post-employment", "noncompetition", "agreements", "with", "any", "of", "our", "employees", "and", "do", "not", "maintain", "key", "person", "life", "insurance", "policies", "on", "any", "of", "our", "executive", "officers", "or", "key", "employees.", "<tag3>"], "wordsA": ["We", "do", "not", "utilize", "off-balance", "sheet", "financing", "arrangements", "as", "a", "source", "of", "liquidity", "or", "financing."], "wordsB": ["We", "do", "not", "have", "any", "post-employment", "noncompetition", "agreements", "with", "any", "of", "our", "employees", "and", "do", "not", "maintain", "key", "person", "life", "insurance", "policies", "on", "any", "of", "our", "executive", "officers", "or", "key", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p11_s1", "idA": "906709_11_item1a_p34_s2", "sentA": "We have determined that for the periods reported in this report, the following accounting policies and estimates are critical in understanding our financial condition and results of our operations.", "sentB": "If we are unable to find suitable partners or to negotiate collaboration arrangements with favorable commercial terms with respect to our existing and future drug candidates or the licensing of our intellectual property, or if any arrangements we negotiate, or have negotiated, are terminated, it could have a material adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations.", "<tag2>", "If", "we", "are", "unable", "to", "find", "suitable", "partners", "or", "to", "negotiate", "collaboration", "arrangements", "with", "favorable", "commercial", "terms", "with", "respect", "to", "our", "existing", "and", "future", "drug", "candidates", "or", "the", "licensing", "of", "our", "intellectual", "property,", "or", "if", "any", "arrangements", "we", "negotiate,", "or", "have", "negotiated,", "are", "terminated,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations."], "wordsB": ["If", "we", "are", "unable", "to", "find", "suitable", "partners", "or", "to", "negotiate", "collaboration", "arrangements", "with", "favorable", "commercial", "terms", "with", "respect", "to", "our", "existing", "and", "future", "drug", "candidates", "or", "the", "licensing", "of", "our", "intellectual", "property,", "or", "if", "any", "arrangements", "we", "negotiate,", "or", "have", "negotiated,", "are", "terminated,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p13_s3", "idA": "906709_11_item1a_p34_s2", "sentA": "We have determined that for the periods reported in this report, the following accounting policies and estimates are critical in understanding our financial condition and results of our operations.", "sentB": "If due to one or more of these risks the market potential for a drug candidate is lower than we anticipated, it could significantly and negatively impact the commercial terms of any collaboration partnership potential for such drug candidate or, if we have already entered into a collaboration for such drug candidate, the revenue potential from royalty and milestone payments could be significantly diminished and would negatively impact our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations.", "<tag2>", "If", "due", "to", "one", "or", "more", "of", "these", "risks", "the", "market", "potential", "for", "a", "drug", "candidate", "is", "lower", "than", "we", "anticipated,", "it", "could", "significantly", "and", "negatively", "impact", "the", "commercial", "terms", "of", "any", "collaboration", "partnership", "potential", "for", "such", "drug", "candidate", "or,", "if", "we", "have", "already", "entered", "into", "a", "collaboration", "for", "such", "drug", "candidate,", "the", "revenue", "potential", "from", "royalty", "and", "milestone", "payments", "could", "be", "significantly", "diminished", "and", "would", "negatively", "impact", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations."], "wordsB": ["If", "due", "to", "one", "or", "more", "of", "these", "risks", "the", "market", "potential", "for", "a", "drug", "candidate", "is", "lower", "than", "we", "anticipated,", "it", "could", "significantly", "and", "negatively", "impact", "the", "commercial", "terms", "of", "any", "collaboration", "partnership", "potential", "for", "such", "drug", "candidate", "or,", "if", "we", "have", "already", "entered", "into", "a", "collaboration", "for", "such", "drug", "candidate,", "the", "revenue", "potential", "from", "royalty", "and", "milestone", "payments", "could", "be", "significantly", "diminished", "and", "would", "negatively", "impact", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p18_s0", "idA": "906709_11_item1a_p34_s2", "sentA": "We have determined that for the periods reported in this report, the following accounting policies and estimates are critical in understanding our financial condition and results of our operations.", "sentB": "We could be involved in legal proceedings and may incur substantial litigation costs and liabilities that will adversely affect our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations.", "<tag2>", "We", "could", "be", "involved", "in", "legal", "proceedings", "and", "may", "incur", "substantial", "litigation", "costs", "and", "liabilities", "that", "will", "adversely", "affect", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations."], "wordsB": ["We", "could", "be", "involved", "in", "legal", "proceedings", "and", "may", "incur", "substantial", "litigation", "costs", "and", "liabilities", "that", "will", "adversely", "affect", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p24_s11", "idA": "906709_11_item1a_p34_s2", "sentA": "We have determined that for the periods reported in this report, the following accounting policies and estimates are critical in understanding our financial condition and results of our operations.", "sentB": "If we or our contract manufacturers are not able to manufacture drugs or drug substances in sufficient quantities that meet applicable quality standards, it could delay clinical studies, result in reduced sales or constitute a breach of our contractual obligations, any of which could significantly harm our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations.", "<tag2>", "If", "we", "or", "our", "contract", "manufacturers", "are", "not", "able", "to", "manufacture", "drugs", "or", "drug", "substances", "in", "sufficient", "quantities", "that", "meet", "applicable", "quality", "standards,", "it", "could", "delay", "clinical", "studies,", "result", "in", "reduced", "sales", "or", "constitute", "a", "breach", "of", "our", "contractual", "obligations,", "any", "of", "which", "could", "significantly", "harm", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations."], "wordsB": ["If", "we", "or", "our", "contract", "manufacturers", "are", "not", "able", "to", "manufacture", "drugs", "or", "drug", "substances", "in", "sufficient", "quantities", "that", "meet", "applicable", "quality", "standards,", "it", "could", "delay", "clinical", "studies,", "result", "in", "reduced", "sales", "or", "constitute", "a", "breach", "of", "our", "contractual", "obligations,", "any", "of", "which", "could", "significantly", "harm", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p2_s8", "idA": "906709_11_item1a_p34_s2", "sentA": "We have determined that for the periods reported in this report, the following accounting policies and estimates are critical in understanding our financial condition and results of our operations.", "sentB": "The failure of one or more of our drug candidates could have a material adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations.", "<tag2>", "The", "failure", "of", "one", "or", "more", "of", "our", "drug", "candidates", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations."], "wordsB": ["The", "failure", "of", "one", "or", "more", "of", "our", "drug", "candidates", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p49_s8", "idA": "906709_11_item1a_p34_s2", "sentA": "We have determined that for the periods reported in this report, the following accounting policies and estimates are critical in understanding our financial condition and results of our operations.", "sentB": "If we are unable to manage effectively our current operations and any growth we may experience, our business, financial condition and results of operations may be adversely affected.", "type": 2, "words": ["<tag1>", "We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations.", "<tag2>", "If", "we", "are", "unable", "to", "manage", "effectively", "our", "current", "operations", "and", "any", "growth", "we", "may", "experience,", "our", "business,", "financial", "condition", "and", "results", "of", "operations", "may", "be", "adversely", "affected.", "<tag3>"], "wordsA": ["We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations."], "wordsB": ["If", "we", "are", "unable", "to", "manage", "effectively", "our", "current", "operations", "and", "any", "growth", "we", "may", "experience,", "our", "business,", "financial", "condition", "and", "results", "of", "operations", "may", "be", "adversely", "affected."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p6_s3", "idA": "906709_11_item1a_p34_s2", "sentA": "We have determined that for the periods reported in this report, the following accounting policies and estimates are critical in understanding our financial condition and results of our operations.", "sentB": "If we are unable to sufficiently advance our research and development programs, it could substantially impair the value of such programs and result in a material adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations.", "<tag2>", "If", "we", "are", "unable", "to", "sufficiently", "advance", "our", "research", "and", "development", "programs,", "it", "could", "substantially", "impair", "the", "value", "of", "such", "programs", "and", "result", "in", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations."], "wordsB": ["If", "we", "are", "unable", "to", "sufficiently", "advance", "our", "research", "and", "development", "programs,", "it", "could", "substantially", "impair", "the", "value", "of", "such", "programs", "and", "result", "in", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p49_s12", "idA": "906709_11_item1a_p35_s0", "sentA": "License, collaboration and other research revenue is recognized based on the facts and circumstances of each contractual agreement and includes amortization of upfront fees.", "sentB": "Our success largely depends on the continued services of our executive officers and other key personnel.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "research", "revenue", "is", "recognized", "based", "on", "the", "facts", "and", "circumstances", "of", "each", "contractual", "agreement", "and", "includes", "amortization", "of", "upfront", "fees.", "<tag2>", "Our", "success", "largely", "depends", "on", "the", "continued", "services", "of", "our", "executive", "officers", "and", "other", "key", "personnel.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "research", "revenue", "is", "recognized", "based", "on", "the", "facts", "and", "circumstances", "of", "each", "contractual", "agreement", "and", "includes", "amortization", "of", "upfront", "fees."], "wordsB": ["Our", "success", "largely", "depends", "on", "the", "continued", "services", "of", "our", "executive", "officers", "and", "other", "key", "personnel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p6_s1", "idA": "906709_11_item1a_p37_s2", "sentA": "Given the complexities and uncertainties of research and development collaborations, significant judgment is required by management to determine the duration of the performance period.", "sentB": "A significant multi-year capital commitment is required to advance our drug candidates through the various stages of research and development in order to generate sufficient data to enable high value collaboration partnerships with significant up-front payments or to successfully achieve regulatory approval.", "type": 2, "words": ["<tag1>", "Given", "the", "complexities", "and", "uncertainties", "of", "research", "and", "development", "collaborations,", "significant", "judgment", "is", "required", "by", "management", "to", "determine", "the", "duration", "of", "the", "performance", "period.", "<tag2>", "A", "significant", "multi-year", "capital", "commitment", "is", "required", "to", "advance", "our", "drug", "candidates", "through", "the", "various", "stages", "of", "research", "and", "development", "in", "order", "to", "generate", "sufficient", "data", "to", "enable", "high", "value", "collaboration", "partnerships", "with", "significant", "up-front", "payments", "or", "to", "successfully", "achieve", "regulatory", "approval.", "<tag3>"], "wordsA": ["Given", "the", "complexities", "and", "uncertainties", "of", "research", "and", "development", "collaborations,", "significant", "judgment", "is", "required", "by", "management", "to", "determine", "the", "duration", "of", "the", "performance", "period."], "wordsB": ["A", "significant", "multi-year", "capital", "commitment", "is", "required", "to", "advance", "our", "drug", "candidates", "through", "the", "various", "stages", "of", "research", "and", "development", "in", "order", "to", "generate", "sufficient", "data", "to", "enable", "high", "value", "collaboration", "partnerships", "with", "significant", "up-front", "payments", "or", "to", "successfully", "achieve", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p17_s3", "idA": "906709_11_item1a_p3_s0", "sentA": "The decrease in general and administrative expenses for the year ended December 31, 2009 compared to the year ended December 31, 2008 is primarily attributable to decreased employee compensation costs of $4.1 million, decreased professional fees of $4.3 million, and decreased marketing costs of $1.5 million due to our election to terminate our co-promotion rights and obligations under the collaboration agreement with Bayer for Amikacin Inhale.", "sentB": "We also entered into a service agreement pursuant to which we have subcontracted to Novartis certain services to be performed related to our partner program for Amikacin Inhale.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "general", "and", "administrative", "expenses", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008", "is", "primarily", "attributable", "to", "decreased", "employee", "compensation", "costs", "of", "$4.1", "million,", "decreased", "professional", "fees", "of", "$4.3", "million,", "and", "decreased", "marketing", "costs", "of", "$1.5", "million", "due", "to", "our", "election", "to", "terminate", "our", "co-promotion", "rights", "and", "obligations", "under", "the", "collaboration", "agreement", "with", "Bayer", "for", "Amikacin", "Inhale.", "<tag2>", "We", "also", "entered", "into", "a", "service", "agreement", "pursuant", "to", "which", "we", "have", "subcontracted", "to", "Novartis", "certain", "services", "to", "be", "performed", "related", "to", "our", "partner", "program", "for", "Amikacin", "Inhale.", "<tag3>"], "wordsA": ["The", "decrease", "in", "general", "and", "administrative", "expenses", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008", "is", "primarily", "attributable", "to", "decreased", "employee", "compensation", "costs", "of", "$4.1", "million,", "decreased", "professional", "fees", "of", "$4.3", "million,", "and", "decreased", "marketing", "costs", "of", "$1.5", "million", "due", "to", "our", "election", "to", "terminate", "our", "co-promotion", "rights", "and", "obligations", "under", "the", "collaboration", "agreement", "with", "Bayer", "for", "Amikacin", "Inhale."], "wordsB": ["We", "also", "entered", "into", "a", "service", "agreement", "pursuant", "to", "which", "we", "have", "subcontracted", "to", "Novartis", "certain", "services", "to", "be", "performed", "related", "to", "our", "partner", "program", "for", "Amikacin", "Inhale."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p26_s1", "idA": "906709_11_item1a_p3_s0", "sentA": "The decrease in general and administrative expenses for the year ended December 31, 2009 compared to the year ended December 31, 2008 is primarily attributable to decreased employee compensation costs of $4.1 million, decreased professional fees of $4.3 million, and decreased marketing costs of $1.5 million due to our election to terminate our co-promotion rights and obligations under the collaboration agreement with Bayer for Amikacin Inhale.", "sentB": "For instance, we entered a service agreement with Novartis pursuant to which we subcontract to Novartis certain important services to be performed in relation to our partnered program for Amikacin Inhale with Bayer Healthcare LLC.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "general", "and", "administrative", "expenses", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008", "is", "primarily", "attributable", "to", "decreased", "employee", "compensation", "costs", "of", "$4.1", "million,", "decreased", "professional", "fees", "of", "$4.3", "million,", "and", "decreased", "marketing", "costs", "of", "$1.5", "million", "due", "to", "our", "election", "to", "terminate", "our", "co-promotion", "rights", "and", "obligations", "under", "the", "collaboration", "agreement", "with", "Bayer", "for", "Amikacin", "Inhale.", "<tag2>", "For", "instance,", "we", "entered", "a", "service", "agreement", "with", "Novartis", "pursuant", "to", "which", "we", "subcontract", "to", "Novartis", "certain", "important", "services", "to", "be", "performed", "in", "relation", "to", "our", "partnered", "program", "for", "Amikacin", "Inhale", "with", "Bayer", "Healthcare", "LLC.", "<tag3>"], "wordsA": ["The", "decrease", "in", "general", "and", "administrative", "expenses", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008", "is", "primarily", "attributable", "to", "decreased", "employee", "compensation", "costs", "of", "$4.1", "million,", "decreased", "professional", "fees", "of", "$4.3", "million,", "and", "decreased", "marketing", "costs", "of", "$1.5", "million", "due", "to", "our", "election", "to", "terminate", "our", "co-promotion", "rights", "and", "obligations", "under", "the", "collaboration", "agreement", "with", "Bayer", "for", "Amikacin", "Inhale."], "wordsB": ["For", "instance,", "we", "entered", "a", "service", "agreement", "with", "Novartis", "pursuant", "to", "which", "we", "subcontract", "to", "Novartis", "certain", "important", "services", "to", "be", "performed", "in", "relation", "to", "our", "partnered", "program", "for", "Amikacin", "Inhale", "with", "Bayer", "Healthcare", "LLC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p15_s2", "idA": "906709_11_item1a_p43_s0", "sentA": "either specified or is much shorter than research and collaboration agreements.", "sentB": "These collaboration agreements contain complex commercial terms, including:", "type": 2, "words": ["<tag1>", "either", "specified", "or", "is", "much", "shorter", "than", "research", "and", "collaboration", "agreements.", "<tag2>", "These", "collaboration", "agreements", "contain", "complex", "commercial", "terms,", "including:", "<tag3>"], "wordsA": ["either", "specified", "or", "is", "much", "shorter", "than", "research", "and", "collaboration", "agreements."], "wordsB": ["These", "collaboration", "agreements", "contain", "complex", "commercial", "terms,", "including:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p21_s4", "idA": "906709_11_item1a_p43_s1", "sentA": "We may experience delays in the execution of technology transfer plans, which may result in a longer amortization period for applicable agreements.", "sentB": "The coverage claimed in a patent application can be significantly reduced before the patent is issued and, as a consequence, our patent applications may result in patents with narrow coverage that may not prevent competition from similar drugs.", "type": 2, "words": ["<tag1>", "We", "may", "experience", "delays", "in", "the", "execution", "of", "technology", "transfer", "plans,", "which", "may", "result", "in", "a", "longer", "amortization", "period", "for", "applicable", "agreements.", "<tag2>", "The", "coverage", "claimed", "in", "a", "patent", "application", "can", "be", "significantly", "reduced", "before", "the", "patent", "is", "issued", "and,", "as", "a", "consequence,", "our", "patent", "applications", "may", "result", "in", "patents", "with", "narrow", "coverage", "that", "may", "not", "prevent", "competition", "from", "similar", "drugs.", "<tag3>"], "wordsA": ["We", "may", "experience", "delays", "in", "the", "execution", "of", "technology", "transfer", "plans,", "which", "may", "result", "in", "a", "longer", "amortization", "period", "for", "applicable", "agreements."], "wordsB": ["The", "coverage", "claimed", "in", "a", "patent", "application", "can", "be", "significantly", "reduced", "before", "the", "patent", "is", "issued", "and,", "as", "a", "consequence,", "our", "patent", "applications", "may", "result", "in", "patents", "with", "narrow", "coverage", "that", "may", "not", "prevent", "competition", "from", "similar", "drugs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p18_s3", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "Similar assertions of infringement could be based on future patents that may issue to third parties.", "type": 2, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "Similar", "assertions", "of", "infringement", "could", "be", "based", "on", "future", "patents", "that", "may", "issue", "to", "third", "parties.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["Similar", "assertions", "of", "infringement", "could", "be", "based", "on", "future", "patents", "that", "may", "issue", "to", "third", "parties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p37_s5", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "We purchase some of the starting material for drugs and drug candidates from a single source or a limited number of suppliers, and the partial or complete loss of one of these suppliers could cause production delays, clinical trial delays, substantial loss of revenue and contract liability to third parties.", "type": 2, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "We", "purchase", "some", "of", "the", "starting", "material", "for", "drugs", "and", "drug", "candidates", "from", "a", "single", "source", "or", "a", "limited", "number", "of", "suppliers,", "and", "the", "partial", "or", "complete", "loss", "of", "one", "of", "these", "suppliers", "could", "cause", "production", "delays,", "clinical", "trial", "delays,", "substantial", "loss", "of", "revenue", "and", "contract", "liability", "to", "third", "parties.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["We", "purchase", "some", "of", "the", "starting", "material", "for", "drugs", "and", "drug", "candidates", "from", "a", "single", "source", "or", "a", "limited", "number", "of", "suppliers,", "and", "the", "partial", "or", "complete", "loss", "of", "one", "of", "these", "suppliers", "could", "cause", "production", "delays,", "clinical", "trial", "delays,", "substantial", "loss", "of", "revenue", "and", "contract", "liability", "to", "third", "parties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p37_s6", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "We often face very limited supply of a critical raw material that can only be obtained from a single, or a limited number of, suppliers, which could cause production delays, clinical trial delays, substantial lost revenue opportunity or contract liability to third parties.", "type": 2, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "We", "often", "face", "very", "limited", "supply", "of", "a", "critical", "raw", "material", "that", "can", "only", "be", "obtained", "from", "a", "single,", "or", "a", "limited", "number", "of,", "suppliers,", "which", "could", "cause", "production", "delays,", "clinical", "trial", "delays,", "substantial", "lost", "revenue", "opportunity", "or", "contract", "liability", "to", "third", "parties.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["We", "often", "face", "very", "limited", "supply", "of", "a", "critical", "raw", "material", "that", "can", "only", "be", "obtained", "from", "a", "single,", "or", "a", "limited", "number", "of,", "suppliers,", "which", "could", "cause", "production", "delays,", "clinical", "trial", "delays,", "substantial", "lost", "revenue", "opportunity", "or", "contract", "liability", "to", "third", "parties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p41_s2", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "We rely heavily on these parties for successful execution of our clinical trials.", "type": 2, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "We", "rely", "heavily", "on", "these", "parties", "for", "successful", "execution", "of", "our", "clinical", "trials.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["We", "rely", "heavily", "on", "these", "parties", "for", "successful", "execution", "of", "our", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p41_s4", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "For example, we are responsible for ensuring that each of our clinical trials is conducted in accordance with the general investigational plan and protocols for the trial, but the independent clinical investigators may prioritize other projects over ours or communicate issues regarding our products to us in an untimely manner.", "type": 2, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "For", "example,", "we", "are", "responsible", "for", "ensuring", "that", "each", "of", "our", "clinical", "trials", "is", "conducted", "in", "accordance", "with", "the", "general", "investigational", "plan", "and", "protocols", "for", "the", "trial,", "but", "the", "independent", "clinical", "investigators", "may", "prioritize", "other", "projects", "over", "ours", "or", "communicate", "issues", "regarding", "our", "products", "to", "us", "in", "an", "untimely", "manner.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["For", "example,", "we", "are", "responsible", "for", "ensuring", "that", "each", "of", "our", "clinical", "trials", "is", "conducted", "in", "accordance", "with", "the", "general", "investigational", "plan", "and", "protocols", "for", "the", "trial,", "but", "the", "independent", "clinical", "investigators", "may", "prioritize", "other", "projects", "over", "ours", "or", "communicate", "issues", "regarding", "our", "products", "to", "us", "in", "an", "untimely", "manner."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p41_s6", "idA": "906709_11_item1a_p47_s0", "sentA": "We record accruals for the estimated costs of our clinical trial activities performed by third parties.", "sentB": "The early termination of any of our clinical trial arrangements, the failure of third parties to comply with the regulations and requirements governing clinical trials or our reliance on results of trials that we have not directly conducted or monitored could hinder or delay the development, approval and commercialization of our product candidates and would adversely affect our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties.", "<tag2>", "The", "early", "termination", "of", "any", "of", "our", "clinical", "trial", "arrangements,", "the", "failure", "of", "third", "parties", "to", "comply", "with", "the", "regulations", "and", "requirements", "governing", "clinical", "trials", "or", "our", "reliance", "on", "results", "of", "trials", "that", "we", "have", "not", "directly", "conducted", "or", "monitored", "could", "hinder", "or", "delay", "the", "development,", "approval", "and", "commercialization", "of", "our", "product", "candidates", "and", "would", "adversely", "affect", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "trial", "activities", "performed", "by", "third", "parties."], "wordsB": ["The", "early", "termination", "of", "any", "of", "our", "clinical", "trial", "arrangements,", "the", "failure", "of", "third", "parties", "to", "comply", "with", "the", "regulations", "and", "requirements", "governing", "clinical", "trials", "or", "our", "reliance", "on", "results", "of", "trials", "that", "we", "have", "not", "directly", "conducted", "or", "monitored", "could", "hinder", "or", "delay", "the", "development,", "approval", "and", "commercialization", "of", "our", "product", "candidates", "and", "would", "adversely", "affect", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p12_s2", "idA": "906709_11_item1a_p48_s0", "sentA": "We accrue costs associated with treatment phase of clinical trials based on the total estimated cost of the clinical trials and are expensed ratably based on patient enrollment in the trials.", "sentB": "Interim data is also subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data becomes available.", "type": 2, "words": ["<tag1>", "We", "accrue", "costs", "associated", "with", "treatment", "phase", "of", "clinical", "trials", "based", "on", "the", "total", "estimated", "cost", "of", "the", "clinical", "trials", "and", "are", "expensed", "ratably", "based", "on", "patient", "enrollment", "in", "the", "trials.", "<tag2>", "Interim", "data", "is", "also", "subject", "to", "the", "risk", "that", "one", "or", "more", "of", "the", "clinical", "outcomes", "may", "materially", "change", "as", "patient", "enrollment", "continues", "and", "more", "patient", "data", "becomes", "available.", "<tag3>"], "wordsA": ["We", "accrue", "costs", "associated", "with", "treatment", "phase", "of", "clinical", "trials", "based", "on", "the", "total", "estimated", "cost", "of", "the", "clinical", "trials", "and", "are", "expensed", "ratably", "based", "on", "patient", "enrollment", "in", "the", "trials."], "wordsB": ["Interim", "data", "is", "also", "subject", "to", "the", "risk", "that", "one", "or", "more", "of", "the", "clinical", "outcomes", "may", "materially", "change", "as", "patient", "enrollment", "continues", "and", "more", "patient", "data", "becomes", "available."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p30_s2", "idA": "906709_11_item1a_p48_s0", "sentA": "We accrue costs associated with treatment phase of clinical trials based on the total estimated cost of the clinical trials and are expensed ratably based on patient enrollment in the trials.", "sentB": "Significant variations in the timing of receipt of cash payments and our recognition of revenue can result from significant milestone payments based on the execution of new collaboration agreements, the timing of clinical outcomes, regulatory approval, commercial launch and the achievement of certain annual sales thresholds.", "type": 2, "words": ["<tag1>", "We", "accrue", "costs", "associated", "with", "treatment", "phase", "of", "clinical", "trials", "based", "on", "the", "total", "estimated", "cost", "of", "the", "clinical", "trials", "and", "are", "expensed", "ratably", "based", "on", "patient", "enrollment", "in", "the", "trials.", "<tag2>", "Significant", "variations", "in", "the", "timing", "of", "receipt", "of", "cash", "payments", "and", "our", "recognition", "of", "revenue", "can", "result", "from", "significant", "milestone", "payments", "based", "on", "the", "execution", "of", "new", "collaboration", "agreements,", "the", "timing", "of", "clinical", "outcomes,", "regulatory", "approval,", "commercial", "launch", "and", "the", "achievement", "of", "certain", "annual", "sales", "thresholds.", "<tag3>"], "wordsA": ["We", "accrue", "costs", "associated", "with", "treatment", "phase", "of", "clinical", "trials", "based", "on", "the", "total", "estimated", "cost", "of", "the", "clinical", "trials", "and", "are", "expensed", "ratably", "based", "on", "patient", "enrollment", "in", "the", "trials."], "wordsB": ["Significant", "variations", "in", "the", "timing", "of", "receipt", "of", "cash", "payments", "and", "our", "recognition", "of", "revenue", "can", "result", "from", "significant", "milestone", "payments", "based", "on", "the", "execution", "of", "new", "collaboration", "agreements,", "the", "timing", "of", "clinical", "outcomes,", "regulatory", "approval,", "commercial", "launch", "and", "the", "achievement", "of", "certain", "annual", "sales", "thresholds."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p51_s6", "idA": "906709_11_item1a_p4_s0", "sentA": "During the year ended December 31, 2010, we relocated all of our operations previously located in San Carlos, California, including our corporate headquarters, to our Mission Bay Facility in San Francisco, California.", "sentB": "During the year ended December 31, 2011, based on closing bid prices on The NASDAQ Global Select Market, our stock price ranged from $12.53 to $4.22 per share.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2010,", "we", "relocated", "all", "of", "our", "operations", "previously", "located", "in", "San", "Carlos,", "California,", "including", "our", "corporate", "headquarters,", "to", "our", "Mission", "Bay", "Facility", "in", "San", "Francisco,", "California.", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2011,", "based", "on", "closing", "bid", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$12.53", "to", "$4.22", "per", "share.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2010,", "we", "relocated", "all", "of", "our", "operations", "previously", "located", "in", "San", "Carlos,", "California,", "including", "our", "corporate", "headquarters,", "to", "our", "Mission", "Bay", "Facility", "in", "San", "Francisco,", "California."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2011,", "based", "on", "closing", "bid", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$12.53", "to", "$4.22", "per", "share."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p17_s6", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "One or more disputes may arise or escalate in the future regarding our collaboration agreements, transaction documents, or third-party license agreements that may ultimately result in costly litigation and unfavorable interpretation of contract terms, which would have a material adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "One", "or", "more", "disputes", "may", "arise", "or", "escalate", "in", "the", "future", "regarding", "our", "collaboration", "agreements,", "transaction", "documents,", "or", "third-party", "license", "agreements", "that", "may", "ultimately", "result", "in", "costly", "litigation", "and", "unfavorable", "interpretation", "of", "contract", "terms,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["One", "or", "more", "disputes", "may", "arise", "or", "escalate", "in", "the", "future", "regarding", "our", "collaboration", "agreements,", "transaction", "documents,", "or", "third-party", "license", "agreements", "that", "may", "ultimately", "result", "in", "costly", "litigation", "and", "unfavorable", "interpretation", "of", "contract", "terms,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p1_s5", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "New factors emerge from time to time and it is not possible to predict the impact of all of these factors on our business, financial condition or results of operations.", "type": 2, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "New", "factors", "emerge", "from", "time", "to", "time", "and", "it", "is", "not", "possible", "to", "predict", "the", "impact", "of", "all", "of", "these", "factors", "on", "our", "business,", "financial", "condition", "or", "results", "of", "operations.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["New", "factors", "emerge", "from", "time", "to", "time", "and", "it", "is", "not", "possible", "to", "predict", "the", "impact", "of", "all", "of", "these", "factors", "on", "our", "business,", "financial", "condition", "or", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p20_s3", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "Costs associated with such litigation, substantial damage claims, indemnification claims or royalties paid for licenses from third parties could have a material adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "Costs", "associated", "with", "such", "litigation,", "substantial", "damage", "claims,", "indemnification", "claims", "or", "royalties", "paid", "for", "licenses", "from", "third", "parties", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["Costs", "associated", "with", "such", "litigation,", "substantial", "damage", "claims,", "indemnification", "claims", "or", "royalties", "paid", "for", "licenses", "from", "third", "parties", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p24_s10", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "Manufacturing delays, for us or our contract manufacturers, pending resolution of regulatory deficiencies or suspensions would have a material adverse effect on our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "Manufacturing", "delays,", "for", "us", "or", "our", "contract", "manufacturers,", "pending", "resolution", "of", "regulatory", "deficiencies", "or", "suspensions", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["Manufacturing", "delays,", "for", "us", "or", "our", "contract", "manufacturers,", "pending", "resolution", "of", "regulatory", "deficiencies", "or", "suspensions", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p24_s4", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "Our manufacturing operations and those of our contract manufacturers are subject to governmental regulatory requirements, which, if not met, would have a material adverse effect on our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "Our", "manufacturing", "operations", "and", "those", "of", "our", "contract", "manufacturers", "are", "subject", "to", "governmental", "regulatory", "requirements,", "which,", "if", "not", "met,", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["Our", "manufacturing", "operations", "and", "those", "of", "our", "contract", "manufacturers", "are", "subject", "to", "governmental", "regulatory", "requirements,", "which,", "if", "not", "met,", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p2_s13", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "If one or more of these drug candidates fail in Phase 3 clinical studies, it would have a material adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "If", "one", "or", "more", "of", "these", "drug", "candidates", "fail", "in", "Phase", "3", "clinical", "studies,", "it", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["If", "one", "or", "more", "of", "these", "drug", "candidates", "fail", "in", "Phase", "3", "clinical", "studies,", "it", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p35_s1", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "Given these risks, the success of our current and future partnerships is highly unpredictable and can have a substantial negative or positive impact on our business.", "type": 2, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p40_s1", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "If government and private insurance programs do not provide payment or reimbursement for our partnered products or proprietary products, those products will not be widely accepted, which would have a negative impact on our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "If", "government", "and", "private", "insurance", "programs", "do", "not", "provide", "payment", "or", "reimbursement", "for", "our", "partnered", "products", "or", "proprietary", "products,", "those", "products", "will", "not", "be", "widely", "accepted,", "which", "would", "have", "a", "negative", "impact", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["If", "government", "and", "private", "insurance", "programs", "do", "not", "provide", "payment", "or", "reimbursement", "for", "our", "partnered", "products", "or", "proprietary", "products,", "those", "products", "will", "not", "be", "widely", "accepted,", "which", "would", "have", "a", "negative", "impact", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p49_s1", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "If product liability costs exceed our product liability insurance coverage, we may incur substantial liabilities that could have a severe negative impact on our financial position.", "type": 2, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "If", "product", "liability", "costs", "exceed", "our", "product", "liability", "insurance", "coverage,", "we", "may", "incur", "substantial", "liabilities", "that", "could", "have", "a", "severe", "negative", "impact", "on", "our", "financial", "position.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["If", "product", "liability", "costs", "exceed", "our", "product", "liability", "insurance", "coverage,", "we", "may", "incur", "substantial", "liabilities", "that", "could", "have", "a", "severe", "negative", "impact", "on", "our", "financial", "position."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s17", "idA": "906709_11_item1a_p50_s1", "sentA": "We do not expect this ASU will have a material impact on our financial position or results of operations when we adopt it on January 1, 2011.", "sentB": "We have not undertaken a systematic analysis of the potential consequences to our business, results of operations and financial condition from a major earthquake or other catastrophic event, such as a fire, sustained loss of power, terrorist activity or other disaster, and do not have a recovery plan for such disasters.", "type": 2, "words": ["<tag1>", "We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011.", "<tag2>", "We", "have", "not", "undertaken", "a", "systematic", "analysis", "of", "the", "potential", "consequences", "to", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "from", "a", "major", "earthquake", "or", "other", "catastrophic", "event,", "such", "as", "a", "fire,", "sustained", "loss", "of", "power,", "terrorist", "activity", "or", "other", "disaster,", "and", "do", "not", "have", "a", "recovery", "plan", "for", "such", "disasters.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "this", "ASU", "will", "have", "a", "material", "impact", "on", "our", "financial", "position", "or", "results", "of", "operations", "when", "we", "adopt", "it", "on", "January", "1,", "2011."], "wordsB": ["We", "have", "not", "undertaken", "a", "systematic", "analysis", "of", "the", "potential", "consequences", "to", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "from", "a", "major", "earthquake", "or", "other", "catastrophic", "event,", "such", "as", "a", "fire,", "sustained", "loss", "of", "power,", "terrorist", "activity", "or", "other", "disaster,", "and", "do", "not", "have", "a", "recovery", "plan", "for", "such", "disasters."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p12_s1", "idA": "906709_11_item1a_p50_s2", "sentA": "However, the adoption of this guidance may result in revenue recognition patterns for agreements entered into or modified after adoption that are materially different from those recognized under the existing multiple-element guidance.", "sentB": "Preliminary data remains subject to audit confirmation and verification procedures that may result in the final data being materially different from the preliminary data we previously published.", "type": 2, "words": ["<tag1>", "However,", "the", "adoption", "of", "this", "guidance", "may", "result", "in", "revenue", "recognition", "patterns", "for", "agreements", "entered", "into", "or", "modified", "after", "adoption", "that", "are", "materially", "different", "from", "those", "recognized", "under", "the", "existing", "multiple-element", "guidance.", "<tag2>", "Preliminary", "data", "remains", "subject", "to", "audit", "confirmation", "and", "verification", "procedures", "that", "may", "result", "in", "the", "final", "data", "being", "materially", "different", "from", "the", "preliminary", "data", "we", "previously", "published.", "<tag3>"], "wordsA": ["However,", "the", "adoption", "of", "this", "guidance", "may", "result", "in", "revenue", "recognition", "patterns", "for", "agreements", "entered", "into", "or", "modified", "after", "adoption", "that", "are", "materially", "different", "from", "those", "recognized", "under", "the", "existing", "multiple-element", "guidance."], "wordsB": ["Preliminary", "data", "remains", "subject", "to", "audit", "confirmation", "and", "verification", "procedures", "that", "may", "result", "in", "the", "final", "data", "being", "materially", "different", "from", "the", "preliminary", "data", "we", "previously", "published."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p50_s8", "idA": "906709_11_item1a_p5_s2", "sentA": "We determined the carrying value of the manufacturing equipment exceeded the fair value based on a discounted cash flow model.", "sentB": "Further, in making employment decisions, job candidates often consider the value of the stock options they are to receive in connection with their employment.", "type": 2, "words": ["<tag1>", "We", "determined", "the", "carrying", "value", "of", "the", "manufacturing", "equipment", "exceeded", "the", "fair", "value", "based", "on", "a", "discounted", "cash", "flow", "model.", "<tag2>", "Further,", "in", "making", "employment", "decisions,", "job", "candidates", "often", "consider", "the", "value", "of", "the", "stock", "options", "they", "are", "to", "receive", "in", "connection", "with", "their", "employment.", "<tag3>"], "wordsA": ["We", "determined", "the", "carrying", "value", "of", "the", "manufacturing", "equipment", "exceeded", "the", "fair", "value", "based", "on", "a", "discounted", "cash", "flow", "model."], "wordsB": ["Further,", "in", "making", "employment", "decisions,", "job", "candidates", "often", "consider", "the", "value", "of", "the", "stock", "options", "they", "are", "to", "receive", "in", "connection", "with", "their", "employment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p15_s1", "idA": "906709_11_item1a_p9_s0", "sentA": "We repurchased $100.0 million par value of our 3.25% convertible subordinated notes in the fourth quarter of 2008.", "sentB": "We currently derive, and expect to derive in the foreseeable future, all of our revenue from collaboration agreements with biotechnology and pharmaceutical companies.", "type": 2, "words": ["<tag1>", "We", "repurchased", "$100.0", "million", "par", "value", "of", "our", "3.25%", "convertible", "subordinated", "notes", "in", "the", "fourth", "quarter", "of", "2008.", "<tag2>", "We", "currently", "derive,", "and", "expect", "to", "derive", "in", "the", "foreseeable", "future,", "all", "of", "our", "revenue", "from", "collaboration", "agreements", "with", "biotechnology", "and", "pharmaceutical", "companies.", "<tag3>"], "wordsA": ["We", "repurchased", "$100.0", "million", "par", "value", "of", "our", "3.25%", "convertible", "subordinated", "notes", "in", "the", "fourth", "quarter", "of", "2008."], "wordsB": ["We", "currently", "derive,", "and", "expect", "to", "derive", "in", "the", "foreseeable", "future,", "all", "of", "our", "revenue", "from", "collaboration", "agreements", "with", "biotechnology", "and", "pharmaceutical", "companies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item1a_p4_s9", "idA": "906709_11_item1a_p9_s0", "sentA": "We repurchased $100.0 million par value of our 3.25% convertible subordinated notes in the fourth quarter of 2008.", "sentB": "On February 29, 2012, we received $124.0 million in gross proceeds from the sale of our royalty interest in the CIMZIA and MIRCERA drug products.", "type": 2, "words": ["<tag1>", "We", "repurchased", "$100.0", "million", "par", "value", "of", "our", "3.25%", "convertible", "subordinated", "notes", "in", "the", "fourth", "quarter", "of", "2008.", "<tag2>", "On", "February", "29,", "2012,", "we", "received", "$124.0", "million", "in", "gross", "proceeds", "from", "the", "sale", "of", "our", "royalty", "interest", "in", "the", "CIMZIA", "and", "MIRCERA", "drug", "products.", "<tag3>"], "wordsA": ["We", "repurchased", "$100.0", "million", "par", "value", "of", "our", "3.25%", "convertible", "subordinated", "notes", "in", "the", "fourth", "quarter", "of", "2008."], "wordsB": ["On", "February", "29,", "2012,", "we", "received", "$124.0", "million", "in", "gross", "proceeds", "from", "the", "sale", "of", "our", "royalty", "interest", "in", "the", "CIMZIA", "and", "MIRCERA", "drug", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p16_s2", "idA": "906709_12_item1a_p11_s0", "sentA": "approval processes, the definitive agreement negotiation process and numerous other unpredictable factors that can delay, impede or prevent significant transactions.", "sentB": "The timing of new collaboration partnerships is difficult to predict due to availability of clinical data, the outcomes from our clinical studies, the number of potential partners that need to complete due diligence and approval processes, the definitive agreement negotiation process and numerous other unpredictable factors that can delay, impede or prevent significant transactions.", "type": 2, "words": ["<tag1>", "approval", "processes,", "the", "definitive", "agreement", "negotiation", "process", "and", "numerous", "other", "unpredictable", "factors", "that", "can", "delay,", "impede", "or", "prevent", "significant", "transactions.", "<tag2>", "The", "timing", "of", "new", "collaboration", "partnerships", "is", "difficult", "to", "predict", "due", "to", "availability", "of", "clinical", "data,", "the", "outcomes", "from", "our", "clinical", "studies,", "the", "number", "of", "potential", "partners", "that", "need", "to", "complete", "due", "diligence", "and", "approval", "processes,", "the", "definitive", "agreement", "negotiation", "process", "and", "numerous", "other", "unpredictable", "factors", "that", "can", "delay,", "impede", "or", "prevent", "significant", "transactions.", "<tag3>"], "wordsA": ["approval", "processes,", "the", "definitive", "agreement", "negotiation", "process", "and", "numerous", "other", "unpredictable", "factors", "that", "can", "delay,", "impede", "or", "prevent", "significant", "transactions."], "wordsB": ["The", "timing", "of", "new", "collaboration", "partnerships", "is", "difficult", "to", "predict", "due", "to", "availability", "of", "clinical", "data,", "the", "outcomes", "from", "our", "clinical", "studies,", "the", "number", "of", "potential", "partners", "that", "need", "to", "complete", "due", "diligence", "and", "approval", "processes,", "the", "definitive", "agreement", "negotiation", "process", "and", "numerous", "other", "unpredictable", "factors", "that", "can", "delay,", "impede", "or", "prevent", "significant", "transactions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p3_s1", "idA": "906709_12_item1a_p13_s0", "sentA": "The commercial potential of a drug candidate in development is difficult to predict.", "sentB": "The time required for obtaining regulatory decisions is uncertain and difficult to predict.", "type": 2, "words": ["<tag1>", "The", "commercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict.", "<tag2>", "The", "time", "required", "for", "obtaining", "regulatory", "decisions", "is", "uncertain", "and", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["The", "commercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict."], "wordsB": ["The", "time", "required", "for", "obtaining", "regulatory", "decisions", "is", "uncertain", "and", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p3_s3", "idA": "906709_12_item1a_p13_s0", "sentA": "The commercial potential of a drug candidate in development is difficult to predict.", "sentB": "Further, health authorities have the discretion to analyze data using their own methodologies that may differ from those used by us or our partners which could lead such authorities to arrive at different conclusions regarding the safety or efficacy of a drug candidate.", "type": 2, "words": ["<tag1>", "The", "commercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict.", "<tag2>", "Further,", "health", "authorities", "have", "the", "discretion", "to", "analyze", "data", "using", "their", "own", "methodologies", "that", "may", "differ", "from", "those", "used", "by", "us", "or", "our", "partners", "which", "could", "lead", "such", "authorities", "to", "arrive", "at", "different", "conclusions", "regarding", "the", "safety", "or", "efficacy", "of", "a", "drug", "candidate.", "<tag3>"], "wordsA": ["The", "commercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict."], "wordsB": ["Further,", "health", "authorities", "have", "the", "discretion", "to", "analyze", "data", "using", "their", "own", "methodologies", "that", "may", "differ", "from", "those", "used", "by", "us", "or", "our", "partners", "which", "could", "lead", "such", "authorities", "to", "arrive", "at", "different", "conclusions", "regarding", "the", "safety", "or", "efficacy", "of", "a", "drug", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p17_s10", "idA": "906709_12_item1a_p13_s4", "sentA": "We may not be able to obtain intellectual property licenses related to the development of our technology on a commercially reasonable basis, if at all.", "sentB": "These and other of our planned clinical studies may not begin on time, have an effective design, enroll a sufficient number of patients or be completed on schedule, if at all.", "type": 2, "words": ["<tag1>", "We", "may", "not", "be", "able", "to", "obtain", "intellectual", "property", "licenses", "related", "to", "the", "development", "of", "our", "technology", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all.", "<tag2>", "These", "and", "other", "of", "our", "planned", "clinical", "studies", "may", "not", "begin", "on", "time,", "have", "an", "effective", "design,", "enroll", "a", "sufficient", "number", "of", "patients", "or", "be", "completed", "on", "schedule,", "if", "at", "all.", "<tag3>"], "wordsA": ["We", "may", "not", "be", "able", "to", "obtain", "intellectual", "property", "licenses", "related", "to", "the", "development", "of", "our", "technology", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all."], "wordsB": ["These", "and", "other", "of", "our", "planned", "clinical", "studies", "may", "not", "begin", "on", "time,", "have", "an", "effective", "design,", "enroll", "a", "sufficient", "number", "of", "patients", "or", "be", "completed", "on", "schedule,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p19_s4", "idA": "906709_12_item1a_p13_s4", "sentA": "We may not be able to obtain intellectual property licenses related to the development of our technology on a commercially reasonable basis, if at all.", "sentB": "We may not be able to obtain intellectual property licenses related to the development of our drug candidates on a commercially reasonable basis, if at all.", "type": 2, "words": ["<tag1>", "We", "may", "not", "be", "able", "to", "obtain", "intellectual", "property", "licenses", "related", "to", "the", "development", "of", "our", "technology", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all.", "<tag2>", "We", "may", "not", "be", "able", "to", "obtain", "intellectual", "property", "licenses", "related", "to", "the", "development", "of", "our", "drug", "candidates", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all.", "<tag3>"], "wordsA": ["We", "may", "not", "be", "able", "to", "obtain", "intellectual", "property", "licenses", "related", "to", "the", "development", "of", "our", "technology", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all."], "wordsB": ["We", "may", "not", "be", "able", "to", "obtain", "intellectual", "property", "licenses", "related", "to", "the", "development", "of", "our", "drug", "candidates", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p24_s3", "idA": "906709_12_item1a_p13_s4", "sentA": "We may not be able to obtain intellectual property licenses related to the development of our technology on a commercially reasonable basis, if at all.", "sentB": "In those instances where we seek an intellectual property license from another, we may not be able to obtain the license on a commercially reasonable basis, if at all, thereby raising concerns on our ability to freely commercialize our technologies and/or products.", "type": 2, "words": ["<tag1>", "We", "may", "not", "be", "able", "to", "obtain", "intellectual", "property", "licenses", "related", "to", "the", "development", "of", "our", "technology", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all.", "<tag2>", "In", "those", "instances", "where", "we", "seek", "an", "intellectual", "property", "license", "from", "another,", "we", "may", "not", "be", "able", "to", "obtain", "the", "license", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all,", "thereby", "raising", "concerns", "on", "our", "ability", "to", "freely", "commercialize", "our", "technologies", "and/or", "products.", "<tag3>"], "wordsA": ["We", "may", "not", "be", "able", "to", "obtain", "intellectual", "property", "licenses", "related", "to", "the", "development", "of", "our", "technology", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all."], "wordsB": ["In", "those", "instances", "where", "we", "seek", "an", "intellectual", "property", "license", "from", "another,", "we", "may", "not", "be", "able", "to", "obtain", "the", "license", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all,", "thereby", "raising", "concerns", "on", "our", "ability", "to", "freely", "commercialize", "our", "technologies", "and/or", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p20_s5", "idA": "906709_12_item1a_p14_s5", "sentA": "If a license is not available on commercially reasonable terms or at all, our business, results of operations, and financial condition could be significantly harmed and we may be prevented from developing and selling the drug.", "sentB": "If a license is not available on commercially reasonable terms or at all, we may be prevented from developing and selling the drug, which could significantly harm our business, results of operations, and financial condition.", "type": 2, "words": ["<tag1>", "If", "a", "license", "is", "not", "available", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "our", "business,", "results", "of", "operations,", "and", "financial", "condition", "could", "be", "significantly", "harmed", "and", "we", "may", "be", "prevented", "from", "developing", "and", "selling", "the", "drug.", "<tag2>", "If", "a", "license", "is", "not", "available", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "we", "may", "be", "prevented", "from", "developing", "and", "selling", "the", "drug,", "which", "could", "significantly", "harm", "our", "business,", "results", "of", "operations,", "and", "financial", "condition.", "<tag3>"], "wordsA": ["If", "a", "license", "is", "not", "available", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "our", "business,", "results", "of", "operations,", "and", "financial", "condition", "could", "be", "significantly", "harmed", "and", "we", "may", "be", "prevented", "from", "developing", "and", "selling", "the", "drug."], "wordsB": ["If", "a", "license", "is", "not", "available", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "we", "may", "be", "prevented", "from", "developing", "and", "selling", "the", "drug,", "which", "could", "significantly", "harm", "our", "business,", "results", "of", "operations,", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p6_s1", "idA": "906709_12_item1a_p17_s0", "sentA": "On September 20, 2009, we entered into a worldwide exclusive license agreement with AstraZeneca for the further development and commercialization of NKTR-118 and NKTR-119.", "sentB": "We are a party to certain significant agreements including an asset purchase agreement with Novartis pursuant to which we sold a significant portion of our pulmonary business at the end of 2008, the worldwide exclusive license agreement with AstraZeneca related to the further development and commercialization of naloxegol, and the purchase and sale agreement with RPI Finance Trust (RPI) related to the sale of our royalty interests in UCB s CIMZIA and Roche s MIRCERA that we completed in February 2012.", "type": 2, "words": ["<tag1>", "On", "September", "20,", "2009,", "we", "entered", "into", "a", "worldwide", "exclusive", "license", "agreement", "with", "AstraZeneca", "for", "the", "further", "development", "and", "commercialization", "of", "NKTR-118", "and", "NKTR-119.", "<tag2>", "We", "are", "a", "party", "to", "certain", "significant", "agreements", "including", "an", "asset", "purchase", "agreement", "with", "Novartis", "pursuant", "to", "which", "we", "sold", "a", "significant", "portion", "of", "our", "pulmonary", "business", "at", "the", "end", "of", "2008,", "the", "worldwide", "exclusive", "license", "agreement", "with", "AstraZeneca", "related", "to", "the", "further", "development", "and", "commercialization", "of", "naloxegol,", "and", "the", "purchase", "and", "sale", "agreement", "with", "RPI", "Finance", "Trust", "(RPI)", "related", "to", "the", "sale", "of", "our", "royalty", "interests", "in", "UCB", "s", "CIMZIA", "and", "Roche", "s", "MIRCERA", "that", "we", "completed", "in", "February", "2012.", "<tag3>"], "wordsA": ["On", "September", "20,", "2009,", "we", "entered", "into", "a", "worldwide", "exclusive", "license", "agreement", "with", "AstraZeneca", "for", "the", "further", "development", "and", "commercialization", "of", "NKTR-118", "and", "NKTR-119."], "wordsB": ["We", "are", "a", "party", "to", "certain", "significant", "agreements", "including", "an", "asset", "purchase", "agreement", "with", "Novartis", "pursuant", "to", "which", "we", "sold", "a", "significant", "portion", "of", "our", "pulmonary", "business", "at", "the", "end", "of", "2008,", "the", "worldwide", "exclusive", "license", "agreement", "with", "AstraZeneca", "related", "to", "the", "further", "development", "and", "commercialization", "of", "naloxegol,", "and", "the", "purchase", "and", "sale", "agreement", "with", "RPI", "Finance", "Trust", "(RPI)", "related", "to", "the", "sale", "of", "our", "royalty", "interests", "in", "UCB", "s", "CIMZIA", "and", "Roche", "s", "MIRCERA", "that", "we", "completed", "in", "February", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p8_s5", "idA": "906709_12_item1a_p17_s1", "sentA": "In addition, we have also entered into complex commercial agreements with Novartis in connection with the sale of certain assets related to our pulmonary business, associated technology and intellectual property to Novartis (the Novartis Pulmonary Asset Sale), which was completed on December 31, 2008.", "sentB": "In addition, at December 31, 2012, we had a $131.3 million liability related to the sale of future royalties.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "have", "also", "entered", "into", "complex", "commercial", "agreements", "with", "Novartis", "in", "connection", "with", "the", "sale", "of", "certain", "assets", "related", "to", "our", "pulmonary", "business,", "associated", "technology", "and", "intellectual", "property", "to", "Novartis", "(the", "Novartis", "Pulmonary", "Asset", "Sale),", "which", "was", "completed", "on", "December", "31,", "2008.", "<tag2>", "In", "addition,", "at", "December", "31,", "2012,", "we", "had", "a", "$131.3", "million", "liability", "related", "to", "the", "sale", "of", "future", "royalties.", "<tag3>"], "wordsA": ["In", "addition,", "we", "have", "also", "entered", "into", "complex", "commercial", "agreements", "with", "Novartis", "in", "connection", "with", "the", "sale", "of", "certain", "assets", "related", "to", "our", "pulmonary", "business,", "associated", "technology", "and", "intellectual", "property", "to", "Novartis", "(the", "Novartis", "Pulmonary", "Asset", "Sale),", "which", "was", "completed", "on", "December", "31,", "2008."], "wordsB": ["In", "addition,", "at", "December", "31,", "2012,", "we", "had", "a", "$131.3", "million", "liability", "related", "to", "the", "sale", "of", "future", "royalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p7_s0", "idA": "906709_12_item1a_p17_s4", "sentA": "Our agreements with AstraZeneca and Novartis contain complex representations and warranties, covenants and indemnification obligations that could result in substantial future liability and harm our financial condition if we breach any of our agreements with AstraZeneca or Novartis or any third party agreements impacted by these complex transactions.", "sentB": "could result in substantial future liability and harm our financial condition if we breach any of our agreements with Novartis, AstraZeneca, RPI or any third party agreements impacted by these complex transactions.", "type": 2, "words": ["<tag1>", "Our", "agreements", "with", "AstraZeneca", "and", "Novartis", "contain", "complex", "representations", "and", "warranties,", "covenants", "and", "indemnification", "obligations", "that", "could", "result", "in", "substantial", "future", "liability", "and", "harm", "our", "financial", "condition", "if", "we", "breach", "any", "of", "our", "agreements", "with", "AstraZeneca", "or", "Novartis", "or", "any", "third", "party", "agreements", "impacted", "by", "these", "complex", "transactions.", "<tag2>", "could", "result", "in", "substantial", "future", "liability", "and", "harm", "our", "financial", "condition", "if", "we", "breach", "any", "of", "our", "agreements", "with", "Novartis,", "AstraZeneca,", "RPI", "or", "any", "third", "party", "agreements", "impacted", "by", "these", "complex", "transactions.", "<tag3>"], "wordsA": ["Our", "agreements", "with", "AstraZeneca", "and", "Novartis", "contain", "complex", "representations", "and", "warranties,", "covenants", "and", "indemnification", "obligations", "that", "could", "result", "in", "substantial", "future", "liability", "and", "harm", "our", "financial", "condition", "if", "we", "breach", "any", "of", "our", "agreements", "with", "AstraZeneca", "or", "Novartis", "or", "any", "third", "party", "agreements", "impacted", "by", "these", "complex", "transactions."], "wordsB": ["could", "result", "in", "substantial", "future", "liability", "and", "harm", "our", "financial", "condition", "if", "we", "breach", "any", "of", "our", "agreements", "with", "Novartis,", "AstraZeneca,", "RPI", "or", "any", "third", "party", "agreements", "impacted", "by", "these", "complex", "transactions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p27_s1", "idA": "906709_12_item1a_p18_s1", "sentA": "From time to time, third parties have asserted, and may in the future assert, that we or our partners infringe their proprietary rights, such as patents and trade secrets, or have otherwise breached our obligations to them.", "sentB": "In addition, from time to time, we may in the future assert claims against third parties, based on infringement of our proprietary rights or otherwise.", "type": 2, "words": ["<tag1>", "From", "time", "to", "time,", "third", "parties", "have", "asserted,", "and", "may", "in", "the", "future", "assert,", "that", "we", "or", "our", "partners", "infringe", "their", "proprietary", "rights,", "such", "as", "patents", "and", "trade", "secrets,", "or", "have", "otherwise", "breached", "our", "obligations", "to", "them.", "<tag2>", "In", "addition,", "from", "time", "to", "time,", "we", "may", "in", "the", "future", "assert", "claims", "against", "third", "parties,", "based", "on", "infringement", "of", "our", "proprietary", "rights", "or", "otherwise.", "<tag3>"], "wordsA": ["From", "time", "to", "time,", "third", "parties", "have", "asserted,", "and", "may", "in", "the", "future", "assert,", "that", "we", "or", "our", "partners", "infringe", "their", "proprietary", "rights,", "such", "as", "patents", "and", "trade", "secrets,", "or", "have", "otherwise", "breached", "our", "obligations", "to", "them."], "wordsB": ["In", "addition,", "from", "time", "to", "time,", "we", "may", "in", "the", "future", "assert", "claims", "against", "third", "parties,", "based", "on", "infringement", "of", "our", "proprietary", "rights", "or", "otherwise."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p0_s0", "idA": "906709_12_item1a_p1_s0", "sentA": "These are factors that, individually or in the aggregate, we think could cause our actual results to differ materially from expected and historical results and our forward-looking statements.", "sentB": "we think could cause our actual results to differ materially from expected and historical results and our forward-looking statements.", "type": 2, "words": ["<tag1>", "These", "are", "factors", "that,", "individually", "or", "in", "the", "aggregate,", "we", "think", "could", "cause", "our", "actual", "results", "to", "differ", "materially", "from", "expected", "and", "historical", "results", "and", "our", "forward-looking", "statements.", "<tag2>", "we", "think", "could", "cause", "our", "actual", "results", "to", "differ", "materially", "from", "expected", "and", "historical", "results", "and", "our", "forward-looking", "statements.", "<tag3>"], "wordsA": ["These", "are", "factors", "that,", "individually", "or", "in", "the", "aggregate,", "we", "think", "could", "cause", "our", "actual", "results", "to", "differ", "materially", "from", "expected", "and", "historical", "results", "and", "our", "forward-looking", "statements."], "wordsB": ["we", "think", "could", "cause", "our", "actual", "results", "to", "differ", "materially", "from", "expected", "and", "historical", "results", "and", "our", "forward-looking", "statements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p27_s0", "idA": "906709_12_item1a_p20_s7", "sentA": "In 2006, we entered into a litigation settlement related to an intellectual property dispute with the University of Alabama in Huntsville pursuant to which we paid $11.0 million and agreed to pay an additional $10.0 million in equal $1.0 million installments over ten years ending with the last payment due on July 1, 2016.", "sentB": "pursuant to which we paid $11.0 million and agreed to pay an additional $10.0 million in equal $1.0 million installments over ten years ending with the last payment due on July 1, 2016.", "type": 2, "words": ["<tag1>", "In", "2006,", "we", "entered", "into", "a", "litigation", "settlement", "related", "to", "an", "intellectual", "property", "dispute", "with", "the", "University", "of", "Alabama", "in", "Huntsville", "pursuant", "to", "which", "we", "paid", "$11.0", "million", "and", "agreed", "to", "pay", "an", "additional", "$10.0", "million", "in", "equal", "$1.0", "million", "installments", "over", "ten", "years", "ending", "with", "the", "last", "payment", "due", "on", "July", "1,", "2016.", "<tag2>", "pursuant", "to", "which", "we", "paid", "$11.0", "million", "and", "agreed", "to", "pay", "an", "additional", "$10.0", "million", "in", "equal", "$1.0", "million", "installments", "over", "ten", "years", "ending", "with", "the", "last", "payment", "due", "on", "July", "1,", "2016.", "<tag3>"], "wordsA": ["In", "2006,", "we", "entered", "into", "a", "litigation", "settlement", "related", "to", "an", "intellectual", "property", "dispute", "with", "the", "University", "of", "Alabama", "in", "Huntsville", "pursuant", "to", "which", "we", "paid", "$11.0", "million", "and", "agreed", "to", "pay", "an", "additional", "$10.0", "million", "in", "equal", "$1.0", "million", "installments", "over", "ten", "years", "ending", "with", "the", "last", "payment", "due", "on", "July", "1,", "2016."], "wordsB": ["pursuant", "to", "which", "we", "paid", "$11.0", "million", "and", "agreed", "to", "pay", "an", "additional", "$10.0", "million", "in", "equal", "$1.0", "million", "installments", "over", "ten", "years", "ending", "with", "the", "last", "payment", "due", "on", "July", "1,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p21_s1", "idA": "906709_12_item1a_p21_s1", "sentA": "We own greater than 120 U.S. and 420 foreign patents and a number of pending patent applications that cover various aspects of our technologies.", "sentB": "We own more than 150 U.S. and 500 foreign patents and a number of pending patent applications that cover various aspects of our technologies.", "type": 2, "words": ["<tag1>", "We", "own", "greater", "than", "120", "U.S.", "and", "420", "foreign", "patents", "and", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies.", "<tag2>", "We", "own", "more", "than", "150", "U.S.", "and", "500", "foreign", "patents", "and", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies.", "<tag3>"], "wordsA": ["We", "own", "greater", "than", "120", "U.S.", "and", "420", "foreign", "patents", "and", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies."], "wordsB": ["We", "own", "more", "than", "150", "U.S.", "and", "500", "foreign", "patents", "and", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p21_s2", "idA": "906709_12_item1a_p21_s3", "sentA": "There can be no assurance that patents that have issued will be valid and enforceable or that patents for which we apply will issue with broad coverage, if at all.", "sentB": "There can be no assurance that patents that have issued will be held valid and enforceable in a court of law.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "patents", "that", "have", "issued", "will", "be", "valid", "and", "enforceable", "or", "that", "patents", "for", "which", "we", "apply", "will", "issue", "with", "broad", "coverage,", "if", "at", "all.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "patents", "that", "have", "issued", "will", "be", "held", "valid", "and", "enforceable", "in", "a", "court", "of", "law.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "patents", "that", "have", "issued", "will", "be", "valid", "and", "enforceable", "or", "that", "patents", "for", "which", "we", "apply", "will", "issue", "with", "broad", "coverage,", "if", "at", "all."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "patents", "that", "have", "issued", "will", "be", "held", "valid", "and", "enforceable", "in", "a", "court", "of", "law."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p22_s5", "idA": "906709_12_item1a_p21_s3", "sentA": "There can be no assurance that patents that have issued will be valid and enforceable or that patents for which we apply will issue with broad coverage, if at all.", "sentB": "There can be no assurance that the patent applications for which we apply would actually issue as a patents, or do so with commercially relevant and/or broad coverage.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "patents", "that", "have", "issued", "will", "be", "valid", "and", "enforceable", "or", "that", "patents", "for", "which", "we", "apply", "will", "issue", "with", "broad", "coverage,", "if", "at", "all.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "the", "patent", "applications", "for", "which", "we", "apply", "would", "actually", "issue", "as", "a", "patents,", "or", "do", "so", "with", "commercially", "relevant", "and/or", "broad", "coverage.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "patents", "that", "have", "issued", "will", "be", "valid", "and", "enforceable", "or", "that", "patents", "for", "which", "we", "apply", "will", "issue", "with", "broad", "coverage,", "if", "at", "all."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "the", "patent", "applications", "for", "which", "we", "apply", "would", "actually", "issue", "as", "a", "patents,", "or", "do", "so", "with", "commercially", "relevant", "and/or", "broad", "coverage."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p23_s0", "idA": "906709_12_item1a_p21_s4", "sentA": "The coverage claimed in a patent application can be significantly reduced before the patent is issued and, as a consequence, our patent applications may result in patents with narrow coverage that may not prevent competition from similar drugs.", "sentB": "The coverage claimed in a patent application can be significantly reduced before the patent is issued.", "type": 2, "words": ["<tag1>", "The", "coverage", "claimed", "in", "a", "patent", "application", "can", "be", "significantly", "reduced", "before", "the", "patent", "is", "issued", "and,", "as", "a", "consequence,", "our", "patent", "applications", "may", "result", "in", "patents", "with", "narrow", "coverage", "that", "may", "not", "prevent", "competition", "from", "similar", "drugs.", "<tag2>", "The", "coverage", "claimed", "in", "a", "patent", "application", "can", "be", "significantly", "reduced", "before", "the", "patent", "is", "issued.", "<tag3>"], "wordsA": ["The", "coverage", "claimed", "in", "a", "patent", "application", "can", "be", "significantly", "reduced", "before", "the", "patent", "is", "issued", "and,", "as", "a", "consequence,", "our", "patent", "applications", "may", "result", "in", "patents", "with", "narrow", "coverage", "that", "may", "not", "prevent", "competition", "from", "similar", "drugs."], "wordsB": ["The", "coverage", "claimed", "in", "a", "patent", "application", "can", "be", "significantly", "reduced", "before", "the", "patent", "is", "issued."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p23_s1", "idA": "906709_12_item1a_p21_s5", "sentA": "The scope of our patent claim coverage can be critical to our right to receive royalties from our collaboration partnerships.", "sentB": "The scope of our claim coverage can be critical to our ability to enter into licensing transactions with third parties and our right to receive royalties from our collaboration partnerships.", "type": 2, "words": ["<tag1>", "The", "scope", "of", "our", "patent", "claim", "coverage", "can", "be", "critical", "to", "our", "right", "to", "receive", "royalties", "from", "our", "collaboration", "partnerships.", "<tag2>", "The", "scope", "of", "our", "claim", "coverage", "can", "be", "critical", "to", "our", "ability", "to", "enter", "into", "licensing", "transactions", "with", "third", "parties", "and", "our", "right", "to", "receive", "royalties", "from", "our", "collaboration", "partnerships.", "<tag3>"], "wordsA": ["The", "scope", "of", "our", "patent", "claim", "coverage", "can", "be", "critical", "to", "our", "right", "to", "receive", "royalties", "from", "our", "collaboration", "partnerships."], "wordsB": ["The", "scope", "of", "our", "claim", "coverage", "can", "be", "critical", "to", "our", "ability", "to", "enter", "into", "licensing", "transactions", "with", "third", "parties", "and", "our", "right", "to", "receive", "royalties", "from", "our", "collaboration", "partnerships."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p21_s3", "idA": "906709_12_item1a_p22_s2", "sentA": "Any attempt to enforce our patents or patent application rights could be time consuming and costly.", "sentB": "Even for patents that are held valid and enforceable, the legal process associated with obtaining such a judgment is time consuming and costly.", "type": 2, "words": ["<tag1>", "Any", "attempt", "to", "enforce", "our", "patents", "or", "patent", "application", "rights", "could", "be", "time", "consuming", "and", "costly.", "<tag2>", "Even", "for", "patents", "that", "are", "held", "valid", "and", "enforceable,", "the", "legal", "process", "associated", "with", "obtaining", "such", "a", "judgment", "is", "time", "consuming", "and", "costly.", "<tag3>"], "wordsA": ["Any", "attempt", "to", "enforce", "our", "patents", "or", "patent", "application", "rights", "could", "be", "time", "consuming", "and", "costly."], "wordsB": ["Even", "for", "patents", "that", "are", "held", "valid", "and", "enforceable,", "the", "legal", "process", "associated", "with", "obtaining", "such", "a", "judgment", "is", "time", "consuming", "and", "costly."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p24_s2", "idA": "906709_12_item1a_p22_s3", "sentA": "An adverse outcome could subject us to significant liabilities to third parties, require disputed rights to be licensed from or to third parties or require us to cease using the technology in dispute.", "sentB": "An adverse outcome in any judicial proceeding involving intellectual property, including patents, could subject us to significant liabilities to third parties, require disputed rights to be licensed from or to third parties or require us to cease using the technology in dispute.", "type": 2, "words": ["<tag1>", "An", "adverse", "outcome", "could", "subject", "us", "to", "significant", "liabilities", "to", "third", "parties,", "require", "disputed", "rights", "to", "be", "licensed", "from", "or", "to", "third", "parties", "or", "require", "us", "to", "cease", "using", "the", "technology", "in", "dispute.", "<tag2>", "An", "adverse", "outcome", "in", "any", "judicial", "proceeding", "involving", "intellectual", "property,", "including", "patents,", "could", "subject", "us", "to", "significant", "liabilities", "to", "third", "parties,", "require", "disputed", "rights", "to", "be", "licensed", "from", "or", "to", "third", "parties", "or", "require", "us", "to", "cease", "using", "the", "technology", "in", "dispute.", "<tag3>"], "wordsA": ["An", "adverse", "outcome", "could", "subject", "us", "to", "significant", "liabilities", "to", "third", "parties,", "require", "disputed", "rights", "to", "be", "licensed", "from", "or", "to", "third", "parties", "or", "require", "us", "to", "cease", "using", "the", "technology", "in", "dispute."], "wordsB": ["An", "adverse", "outcome", "in", "any", "judicial", "proceeding", "involving", "intellectual", "property,", "including", "patents,", "could", "subject", "us", "to", "significant", "liabilities", "to", "third", "parties,", "require", "disputed", "rights", "to", "be", "licensed", "from", "or", "to", "third", "parties", "or", "require", "us", "to", "cease", "using", "the", "technology", "in", "dispute."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p22_s2", "idA": "906709_12_item1a_p23_s0", "sentA": "Even if a patent is issued and enforceable, because development and commercialization of pharmaceutical products can be subject to substantial delays, patents may expire early and provide only a short period of protection, if any, following commercialization of related products.", "sentB": "Even if a patent is issued and enforceable, because development and commercialization of pharmaceutical products can be subject to substantial delays, patents may expire early and provide only a short period of protection, if any, following the commercialization of a products encompassed by our patent(s).", "type": 2, "words": ["<tag1>", "Even", "if", "a", "patent", "is", "issued", "and", "enforceable,", "because", "development", "and", "commercialization", "of", "pharmaceutical", "products", "can", "be", "subject", "to", "substantial", "delays,", "patents", "may", "expire", "early", "and", "provide", "only", "a", "short", "period", "of", "protection,", "if", "any,", "following", "commercialization", "of", "related", "products.", "<tag2>", "Even", "if", "a", "patent", "is", "issued", "and", "enforceable,", "because", "development", "and", "commercialization", "of", "pharmaceutical", "products", "can", "be", "subject", "to", "substantial", "delays,", "patents", "may", "expire", "early", "and", "provide", "only", "a", "short", "period", "of", "protection,", "if", "any,", "following", "the", "commercialization", "of", "a", "products", "encompassed", "by", "our", "patent(s).", "<tag3>"], "wordsA": ["Even", "if", "a", "patent", "is", "issued", "and", "enforceable,", "because", "development", "and", "commercialization", "of", "pharmaceutical", "products", "can", "be", "subject", "to", "substantial", "delays,", "patents", "may", "expire", "early", "and", "provide", "only", "a", "short", "period", "of", "protection,", "if", "any,", "following", "commercialization", "of", "related", "products."], "wordsB": ["Even", "if", "a", "patent", "is", "issued", "and", "enforceable,", "because", "development", "and", "commercialization", "of", "pharmaceutical", "products", "can", "be", "subject", "to", "substantial", "delays,", "patents", "may", "expire", "early", "and", "provide", "only", "a", "short", "period", "of", "protection,", "if", "any,", "following", "the", "commercialization", "of", "a", "products", "encompassed", "by", "our", "patent(s)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p27_s3", "idA": "906709_12_item1a_p24_s4", "sentA": "Our manufacturing operations and those of our contract manufacturers are subject to governmental regulatory requirements, which, if not met, would have a material adverse effect on our business, results of operations and financial condition.", "sentB": "Our manufacturing operations and those of our contract manufacturers are subject to laws and other governmental regulatory requirements, which, if not met, would have a material adverse effect on our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "Our", "manufacturing", "operations", "and", "those", "of", "our", "contract", "manufacturers", "are", "subject", "to", "governmental", "regulatory", "requirements,", "which,", "if", "not", "met,", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Our", "manufacturing", "operations", "and", "those", "of", "our", "contract", "manufacturers", "are", "subject", "to", "laws", "and", "other", "governmental", "regulatory", "requirements,", "which,", "if", "not", "met,", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["Our", "manufacturing", "operations", "and", "those", "of", "our", "contract", "manufacturers", "are", "subject", "to", "governmental", "regulatory", "requirements,", "which,", "if", "not", "met,", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Our", "manufacturing", "operations", "and", "those", "of", "our", "contract", "manufacturers", "are", "subject", "to", "laws", "and", "other", "governmental", "regulatory", "requirements,", "which,", "if", "not", "met,", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p27_s4", "idA": "906709_12_item1a_p24_s5", "sentA": "We and our contract manufacturers are required in certain cases to maintain compliance with current good manufacturing practices (cGMP), including cGMP guidelines applicable to active pharmaceutical ingredients, and are subject to inspections by the FDA or comparable agencies in other jurisdictions to confirm such compliance.", "sentB": "We and our contract manufacturers are required in certain cases to maintain compliance with current good manufacturing practices (cGMP), including cGMP guidelines applicable to active pharmaceutical ingredients, and with laws and regulations governing manufacture and distribution of controlled substances, and are subject to inspections by the FDA, DEA or comparable agencies in other jurisdictions to confirm such compliance.", "type": 2, "words": ["<tag1>", "We", "and", "our", "contract", "manufacturers", "are", "required", "in", "certain", "cases", "to", "maintain", "compliance", "with", "current", "good", "manufacturing", "practices", "(cGMP),", "including", "cGMP", "guidelines", "applicable", "to", "active", "pharmaceutical", "ingredients,", "and", "are", "subject", "to", "inspections", "by", "the", "FDA", "or", "comparable", "agencies", "in", "other", "jurisdictions", "to", "confirm", "such", "compliance.", "<tag2>", "We", "and", "our", "contract", "manufacturers", "are", "required", "in", "certain", "cases", "to", "maintain", "compliance", "with", "current", "good", "manufacturing", "practices", "(cGMP),", "including", "cGMP", "guidelines", "applicable", "to", "active", "pharmaceutical", "ingredients,", "and", "with", "laws", "and", "regulations", "governing", "manufacture", "and", "distribution", "of", "controlled", "substances,", "and", "are", "subject", "to", "inspections", "by", "the", "FDA,", "DEA", "or", "comparable", "agencies", "in", "other", "jurisdictions", "to", "confirm", "such", "compliance.", "<tag3>"], "wordsA": ["We", "and", "our", "contract", "manufacturers", "are", "required", "in", "certain", "cases", "to", "maintain", "compliance", "with", "current", "good", "manufacturing", "practices", "(cGMP),", "including", "cGMP", "guidelines", "applicable", "to", "active", "pharmaceutical", "ingredients,", "and", "are", "subject", "to", "inspections", "by", "the", "FDA", "or", "comparable", "agencies", "in", "other", "jurisdictions", "to", "confirm", "such", "compliance."], "wordsB": ["We", "and", "our", "contract", "manufacturers", "are", "required", "in", "certain", "cases", "to", "maintain", "compliance", "with", "current", "good", "manufacturing", "practices", "(cGMP),", "including", "cGMP", "guidelines", "applicable", "to", "active", "pharmaceutical", "ingredients,", "and", "with", "laws", "and", "regulations", "governing", "manufacture", "and", "distribution", "of", "controlled", "substances,", "and", "are", "subject", "to", "inspections", "by", "the", "FDA,", "DEA", "or", "comparable", "agencies", "in", "other", "jurisdictions", "to", "confirm", "such", "compliance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p27_s6", "idA": "906709_12_item1a_p24_s7", "sentA": "Any failure to follow and document our or our contract manufacturers adherence to such cGMP regulations or satisfy other manufacturing and product release regulatory requirements may disrupt our ability to meet our manufacturing obligations to our customers, lead to significant delays in the availability of products for commercial use or clinical study, result in the termination or hold on a clinical study or delay or prevent filing or approval of marketing applications for our products.", "sentB": "Any failure to follow and document our or our contract manufacturers adherence to such cGMP and other laws and governmental regulations or satisfy other manufacturing and product release regulatory requirements may disrupt our ability to meet our manufacturing obligations to our customers, lead to significant delays in the availability of products for commercial use or clinical study, result in the termination or hold on a clinical study or delay or prevent filing or approval of marketing applications for our products.", "type": 2, "words": ["<tag1>", "Any", "failure", "to", "follow", "and", "document", "our", "or", "our", "contract", "manufacturers", "adherence", "to", "such", "cGMP", "regulations", "or", "satisfy", "other", "manufacturing", "and", "product", "release", "regulatory", "requirements", "may", "disrupt", "our", "ability", "to", "meet", "our", "manufacturing", "obligations", "to", "our", "customers,", "lead", "to", "significant", "delays", "in", "the", "availability", "of", "products", "for", "commercial", "use", "or", "clinical", "study,", "result", "in", "the", "termination", "or", "hold", "on", "a", "clinical", "study", "or", "delay", "or", "prevent", "filing", "or", "approval", "of", "marketing", "applications", "for", "our", "products.", "<tag2>", "Any", "failure", "to", "follow", "and", "document", "our", "or", "our", "contract", "manufacturers", "adherence", "to", "such", "cGMP", "and", "other", "laws", "and", "governmental", "regulations", "or", "satisfy", "other", "manufacturing", "and", "product", "release", "regulatory", "requirements", "may", "disrupt", "our", "ability", "to", "meet", "our", "manufacturing", "obligations", "to", "our", "customers,", "lead", "to", "significant", "delays", "in", "the", "availability", "of", "products", "for", "commercial", "use", "or", "clinical", "study,", "result", "in", "the", "termination", "or", "hold", "on", "a", "clinical", "study", "or", "delay", "or", "prevent", "filing", "or", "approval", "of", "marketing", "applications", "for", "our", "products.", "<tag3>"], "wordsA": ["Any", "failure", "to", "follow", "and", "document", "our", "or", "our", "contract", "manufacturers", "adherence", "to", "such", "cGMP", "regulations", "or", "satisfy", "other", "manufacturing", "and", "product", "release", "regulatory", "requirements", "may", "disrupt", "our", "ability", "to", "meet", "our", "manufacturing", "obligations", "to", "our", "customers,", "lead", "to", "significant", "delays", "in", "the", "availability", "of", "products", "for", "commercial", "use", "or", "clinical", "study,", "result", "in", "the", "termination", "or", "hold", "on", "a", "clinical", "study", "or", "delay", "or", "prevent", "filing", "or", "approval", "of", "marketing", "applications", "for", "our", "products."], "wordsB": ["Any", "failure", "to", "follow", "and", "document", "our", "or", "our", "contract", "manufacturers", "adherence", "to", "such", "cGMP", "and", "other", "laws", "and", "governmental", "regulations", "or", "satisfy", "other", "manufacturing", "and", "product", "release", "regulatory", "requirements", "may", "disrupt", "our", "ability", "to", "meet", "our", "manufacturing", "obligations", "to", "our", "customers,", "lead", "to", "significant", "delays", "in", "the", "availability", "of", "products", "for", "commercial", "use", "or", "clinical", "study,", "result", "in", "the", "termination", "or", "hold", "on", "a", "clinical", "study", "or", "delay", "or", "prevent", "filing", "or", "approval", "of", "marketing", "applications", "for", "our", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p27_s7", "idA": "906709_12_item1a_p24_s8", "sentA": "Failure to comply with applicable regulations may also result in sanctions being imposed on us, including fines, injunctions, civil penalties, failure of regulatory authorities to grant marketing approval of our products, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of products, operating restrictions and criminal prosecutions, any of which could harm our business.", "sentB": "Failure to comply with applicable laws and regulations may also result in sanctions being imposed on us, including fines, injunctions, civil penalties, failure of regulatory authorities to grant marketing approval of our products, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of products, operating restrictions and criminal prosecutions, any of which could harm our business.", "type": 2, "words": ["<tag1>", "Failure", "to", "comply", "with", "applicable", "regulations", "may", "also", "result", "in", "sanctions", "being", "imposed", "on", "us,", "including", "fines,", "injunctions,", "civil", "penalties,", "failure", "of", "regulatory", "authorities", "to", "grant", "marketing", "approval", "of", "our", "products,", "delays,", "suspension", "or", "withdrawal", "of", "approvals,", "license", "revocation,", "seizures", "or", "recalls", "of", "products,", "operating", "restrictions", "and", "criminal", "prosecutions,", "any", "of", "which", "could", "harm", "our", "business.", "<tag2>", "Failure", "to", "comply", "with", "applicable", "laws", "and", "regulations", "may", "also", "result", "in", "sanctions", "being", "imposed", "on", "us,", "including", "fines,", "injunctions,", "civil", "penalties,", "failure", "of", "regulatory", "authorities", "to", "grant", "marketing", "approval", "of", "our", "products,", "delays,", "suspension", "or", "withdrawal", "of", "approvals,", "license", "revocation,", "seizures", "or", "recalls", "of", "products,", "operating", "restrictions", "and", "criminal", "prosecutions,", "any", "of", "which", "could", "harm", "our", "business.", "<tag3>"], "wordsA": ["Failure", "to", "comply", "with", "applicable", "regulations", "may", "also", "result", "in", "sanctions", "being", "imposed", "on", "us,", "including", "fines,", "injunctions,", "civil", "penalties,", "failure", "of", "regulatory", "authorities", "to", "grant", "marketing", "approval", "of", "our", "products,", "delays,", "suspension", "or", "withdrawal", "of", "approvals,", "license", "revocation,", "seizures", "or", "recalls", "of", "products,", "operating", "restrictions", "and", "criminal", "prosecutions,", "any", "of", "which", "could", "harm", "our", "business."], "wordsB": ["Failure", "to", "comply", "with", "applicable", "laws", "and", "regulations", "may", "also", "result", "in", "sanctions", "being", "imposed", "on", "us,", "including", "fines,", "injunctions,", "civil", "penalties,", "failure", "of", "regulatory", "authorities", "to", "grant", "marketing", "approval", "of", "our", "products,", "delays,", "suspension", "or", "withdrawal", "of", "approvals,", "license", "revocation,", "seizures", "or", "recalls", "of", "products,", "operating", "restrictions", "and", "criminal", "prosecutions,", "any", "of", "which", "could", "harm", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p17_s6", "idA": "906709_12_item1a_p25_s2", "sentA": "Failure by us or our contract manufacturers to supply drug product in sufficient quantities that meet all applicable quality requirements could result in supply shortages for our clinical studies or the clinical studies and commercial activities of our collaboration partners.", "sentB": "Delays in clinical studies are common and have many causes, and any significant delay in clinical studies being conducted by us or our partners could result in delay in regulatory approvals and jeopardize the ability to proceed to commercialization.", "type": 2, "words": ["<tag1>", "Failure", "by", "us", "or", "our", "contract", "manufacturers", "to", "supply", "drug", "product", "in", "sufficient", "quantities", "that", "meet", "all", "applicable", "quality", "requirements", "could", "result", "in", "supply", "shortages", "for", "our", "clinical", "studies", "or", "the", "clinical", "studies", "and", "commercial", "activities", "of", "our", "collaboration", "partners.", "<tag2>", "Delays", "in", "clinical", "studies", "are", "common", "and", "have", "many", "causes,", "and", "any", "significant", "delay", "in", "clinical", "studies", "being", "conducted", "by", "us", "or", "our", "partners", "could", "result", "in", "delay", "in", "regulatory", "approvals", "and", "jeopardize", "the", "ability", "to", "proceed", "to", "commercialization.", "<tag3>"], "wordsA": ["Failure", "by", "us", "or", "our", "contract", "manufacturers", "to", "supply", "drug", "product", "in", "sufficient", "quantities", "that", "meet", "all", "applicable", "quality", "requirements", "could", "result", "in", "supply", "shortages", "for", "our", "clinical", "studies", "or", "the", "clinical", "studies", "and", "commercial", "activities", "of", "our", "collaboration", "partners."], "wordsB": ["Delays", "in", "clinical", "studies", "are", "common", "and", "have", "many", "causes,", "and", "any", "significant", "delay", "in", "clinical", "studies", "being", "conducted", "by", "us", "or", "our", "partners", "could", "result", "in", "delay", "in", "regulatory", "approvals", "and", "jeopardize", "the", "ability", "to", "proceed", "to", "commercialization."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p28_s0", "idA": "906709_12_item1a_p25_s2", "sentA": "Failure by us or our contract manufacturers to supply drug product in sufficient quantities that meet all applicable quality requirements could result in supply shortages for our clinical studies or the clinical studies and commercial activities of our collaboration partners.", "sentB": "In some cases, we rely on contract manufacturing organizations to manufacture and supply drug product for our clinical studies and those of our collaboration partners.", "type": 2, "words": ["<tag1>", "Failure", "by", "us", "or", "our", "contract", "manufacturers", "to", "supply", "drug", "product", "in", "sufficient", "quantities", "that", "meet", "all", "applicable", "quality", "requirements", "could", "result", "in", "supply", "shortages", "for", "our", "clinical", "studies", "or", "the", "clinical", "studies", "and", "commercial", "activities", "of", "our", "collaboration", "partners.", "<tag2>", "In", "some", "cases,", "we", "rely", "on", "contract", "manufacturing", "organizations", "to", "manufacture", "and", "supply", "drug", "product", "for", "our", "clinical", "studies", "and", "those", "of", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["Failure", "by", "us", "or", "our", "contract", "manufacturers", "to", "supply", "drug", "product", "in", "sufficient", "quantities", "that", "meet", "all", "applicable", "quality", "requirements", "could", "result", "in", "supply", "shortages", "for", "our", "clinical", "studies", "or", "the", "clinical", "studies", "and", "commercial", "activities", "of", "our", "collaboration", "partners."], "wordsB": ["In", "some", "cases,", "we", "rely", "on", "contract", "manufacturing", "organizations", "to", "manufacture", "and", "supply", "drug", "product", "for", "our", "clinical", "studies", "and", "those", "of", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p30_s0", "idA": "906709_12_item1a_p26_s0", "sentA": "Failures in device manufacturing has similar effects.", "sentB": "Failures in device manufacturing could have similar effects.", "type": 2, "words": ["<tag1>", "Failures", "in", "device", "manufacturing", "has", "similar", "effects.", "<tag2>", "Failures", "in", "device", "manufacturing", "could", "have", "similar", "effects.", "<tag3>"], "wordsA": ["Failures", "in", "device", "manufacturing", "has", "similar", "effects."], "wordsB": ["Failures", "in", "device", "manufacturing", "could", "have", "similar", "effects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p17_s8", "idA": "906709_12_item1a_p28_s1", "sentA": "We have experienced repeated significant delays in starting the Phase 3 clinical development program for Amikacin Inhale as we seek to finalize and validate the device design with a demonstrated capability to be manufactured at commercial scale.", "sentB": "Etirinotecan pegol and BAX 855 are currently in Phase 3 clinical studies and Bayer plans to advance Amikacin Inhale into Phase 3 clinical development in March 2013.", "type": 2, "words": ["<tag1>", "We", "have", "experienced", "repeated", "significant", "delays", "in", "starting", "the", "Phase", "3", "clinical", "development", "program", "for", "Amikacin", "Inhale", "as", "we", "seek", "to", "finalize", "and", "validate", "the", "device", "design", "with", "a", "demonstrated", "capability", "to", "be", "manufactured", "at", "commercial", "scale.", "<tag2>", "Etirinotecan", "pegol", "and", "BAX", "855", "are", "currently", "in", "Phase", "3", "clinical", "studies", "and", "Bayer", "plans", "to", "advance", "Amikacin", "Inhale", "into", "Phase", "3", "clinical", "development", "in", "March", "2013.", "<tag3>"], "wordsA": ["We", "have", "experienced", "repeated", "significant", "delays", "in", "starting", "the", "Phase", "3", "clinical", "development", "program", "for", "Amikacin", "Inhale", "as", "we", "seek", "to", "finalize", "and", "validate", "the", "device", "design", "with", "a", "demonstrated", "capability", "to", "be", "manufactured", "at", "commercial", "scale."], "wordsB": ["Etirinotecan", "pegol", "and", "BAX", "855", "are", "currently", "in", "Phase", "3", "clinical", "studies", "and", "Bayer", "plans", "to", "advance", "Amikacin", "Inhale", "into", "Phase", "3", "clinical", "development", "in", "March", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p4_s3", "idA": "906709_12_item1a_p2_s10", "sentA": "A number of companies have suffered significant unforeseen failures in late stage clinical studies due to factors such as inconclusive efficacy results and adverse medical events, even after achieving positive results in earlier clinical studies that were satisfactory both to them and to reviewing government health authorities.", "sentB": "A number of companies have suffered significant unforeseen failures in late stage clinical studies due to factors such as inconclusive efficacy or safety, even after achieving positive results in earlier clinical studies that were satisfactory both to them and to reviewing government health authorities.", "type": 2, "words": ["<tag1>", "A", "number", "of", "companies", "have", "suffered", "significant", "unforeseen", "failures", "in", "late", "stage", "clinical", "studies", "due", "to", "factors", "such", "as", "inconclusive", "efficacy", "results", "and", "adverse", "medical", "events,", "even", "after", "achieving", "positive", "results", "in", "earlier", "clinical", "studies", "that", "were", "satisfactory", "both", "to", "them", "and", "to", "reviewing", "government", "health", "authorities.", "<tag2>", "A", "number", "of", "companies", "have", "suffered", "significant", "unforeseen", "failures", "in", "late", "stage", "clinical", "studies", "due", "to", "factors", "such", "as", "inconclusive", "efficacy", "or", "safety,", "even", "after", "achieving", "positive", "results", "in", "earlier", "clinical", "studies", "that", "were", "satisfactory", "both", "to", "them", "and", "to", "reviewing", "government", "health", "authorities.", "<tag3>"], "wordsA": ["A", "number", "of", "companies", "have", "suffered", "significant", "unforeseen", "failures", "in", "late", "stage", "clinical", "studies", "due", "to", "factors", "such", "as", "inconclusive", "efficacy", "results", "and", "adverse", "medical", "events,", "even", "after", "achieving", "positive", "results", "in", "earlier", "clinical", "studies", "that", "were", "satisfactory", "both", "to", "them", "and", "to", "reviewing", "government", "health", "authorities."], "wordsB": ["A", "number", "of", "companies", "have", "suffered", "significant", "unforeseen", "failures", "in", "late", "stage", "clinical", "studies", "due", "to", "factors", "such", "as", "inconclusive", "efficacy", "or", "safety,", "even", "after", "achieving", "positive", "results", "in", "earlier", "clinical", "studies", "that", "were", "satisfactory", "both", "to", "them", "and", "to", "reviewing", "government", "health", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p4_s4", "idA": "906709_12_item1a_p2_s11", "sentA": "While the NKTR-118, NKTR-102, and Amikacin Inhale drug candidates have each demonstrated positive results from Phase 2 clinical studies, there is a substantial risk that Phase 3 clinical study outcomes from these drug candidates from larger patient populations will not demonstrate positive efficacy, safety or other clinical outcomes sufficient to support regulatory filings and achieve regulatory approval.", "sentB": "While etirinotecan pegol, Amikacin Inhale, and BAX 855 have each demonstrated positive results from Phase 1 and 2 clinical studies, there is a substantial risk that Phase 3 clinical study outcomes for these drug candidates from larger patient populations will not demonstrate positive efficacy, safety or other clinical outcomes sufficient to support regulatory filings and achieve regulatory approval.", "type": 2, "words": ["<tag1>", "While", "the", "NKTR-118,", "NKTR-102,", "and", "Amikacin", "Inhale", "drug", "candidates", "have", "each", "demonstrated", "positive", "results", "from", "Phase", "2", "clinical", "studies,", "there", "is", "a", "substantial", "risk", "that", "Phase", "3", "clinical", "study", "outcomes", "from", "these", "drug", "candidates", "from", "larger", "patient", "populations", "will", "not", "demonstrate", "positive", "efficacy,", "safety", "or", "other", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "filings", "and", "achieve", "regulatory", "approval.", "<tag2>", "While", "etirinotecan", "pegol,", "Amikacin", "Inhale,", "and", "BAX", "855", "have", "each", "demonstrated", "positive", "results", "from", "Phase", "1", "and", "2", "clinical", "studies,", "there", "is", "a", "substantial", "risk", "that", "Phase", "3", "clinical", "study", "outcomes", "for", "these", "drug", "candidates", "from", "larger", "patient", "populations", "will", "not", "demonstrate", "positive", "efficacy,", "safety", "or", "other", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "filings", "and", "achieve", "regulatory", "approval.", "<tag3>"], "wordsA": ["While", "the", "NKTR-118,", "NKTR-102,", "and", "Amikacin", "Inhale", "drug", "candidates", "have", "each", "demonstrated", "positive", "results", "from", "Phase", "2", "clinical", "studies,", "there", "is", "a", "substantial", "risk", "that", "Phase", "3", "clinical", "study", "outcomes", "from", "these", "drug", "candidates", "from", "larger", "patient", "populations", "will", "not", "demonstrate", "positive", "efficacy,", "safety", "or", "other", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "filings", "and", "achieve", "regulatory", "approval."], "wordsB": ["While", "etirinotecan", "pegol,", "Amikacin", "Inhale,", "and", "BAX", "855", "have", "each", "demonstrated", "positive", "results", "from", "Phase", "1", "and", "2", "clinical", "studies,", "there", "is", "a", "substantial", "risk", "that", "Phase", "3", "clinical", "study", "outcomes", "for", "these", "drug", "candidates", "from", "larger", "patient", "populations", "will", "not", "demonstrate", "positive", "efficacy,", "safety", "or", "other", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "filings", "and", "achieve", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p4_s5", "idA": "906709_12_item1a_p2_s12", "sentA": "Phase 3 clinical outcomes remain very unpredictable and it is possible that one or more of these Phase 3 clinical studies could fail at any time due to efficacy, safety or other important clinical findings or regulatory requirements.", "sentB": "Phase 3 clinical study outcomes remain very unpredictable and it is possible that one or more of these Phase 3 clinical studies could fail at any time due to efficacy, safety or other important clinical findings or regulatory requirements.", "type": 2, "words": ["<tag1>", "Phase", "3", "clinical", "outcomes", "remain", "very", "unpredictable", "and", "it", "is", "possible", "that", "one", "or", "more", "of", "these", "Phase", "3", "clinical", "studies", "could", "fail", "at", "any", "time", "due", "to", "efficacy,", "safety", "or", "other", "important", "clinical", "findings", "or", "regulatory", "requirements.", "<tag2>", "Phase", "3", "clinical", "study", "outcomes", "remain", "very", "unpredictable", "and", "it", "is", "possible", "that", "one", "or", "more", "of", "these", "Phase", "3", "clinical", "studies", "could", "fail", "at", "any", "time", "due", "to", "efficacy,", "safety", "or", "other", "important", "clinical", "findings", "or", "regulatory", "requirements.", "<tag3>"], "wordsA": ["Phase", "3", "clinical", "outcomes", "remain", "very", "unpredictable", "and", "it", "is", "possible", "that", "one", "or", "more", "of", "these", "Phase", "3", "clinical", "studies", "could", "fail", "at", "any", "time", "due", "to", "efficacy,", "safety", "or", "other", "important", "clinical", "findings", "or", "regulatory", "requirements."], "wordsB": ["Phase", "3", "clinical", "study", "outcomes", "remain", "very", "unpredictable", "and", "it", "is", "possible", "that", "one", "or", "more", "of", "these", "Phase", "3", "clinical", "studies", "could", "fail", "at", "any", "time", "due", "to", "efficacy,", "safety", "or", "other", "important", "clinical", "findings", "or", "regulatory", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p2_s4", "idA": "906709_12_item1a_p2_s4", "sentA": "The start or end of a clinical study is often delayed or halted due to changing regulatory requirements, manufacturing challenges, required clinical trial administrative actions, slower than anticipated patient enrollment, changing standards of care, availability or prevalence of use of a comparator drug or required prior therapy, clinical outcomes, or our own financial constraints.", "sentB": "The start or end of a clinical study is often delayed or halted due to changing regulatory requirements, manufacturing challenges, required clinical trial administrative actions, slower than anticipated patient enrollment, changing standards of care, availability or prevalence of use of a comparator drug or required prior therapy, clinical outcomes, or our and our partners financial constraints.", "type": 2, "words": ["<tag1>", "The", "start", "or", "end", "of", "a", "clinical", "study", "is", "often", "delayed", "or", "halted", "due", "to", "changing", "regulatory", "requirements,", "manufacturing", "challenges,", "required", "clinical", "trial", "administrative", "actions,", "slower", "than", "anticipated", "patient", "enrollment,", "changing", "standards", "of", "care,", "availability", "or", "prevalence", "of", "use", "of", "a", "comparator", "drug", "or", "required", "prior", "therapy,", "clinical", "outcomes,", "or", "our", "own", "financial", "constraints.", "<tag2>", "The", "start", "or", "end", "of", "a", "clinical", "study", "is", "often", "delayed", "or", "halted", "due", "to", "changing", "regulatory", "requirements,", "manufacturing", "challenges,", "required", "clinical", "trial", "administrative", "actions,", "slower", "than", "anticipated", "patient", "enrollment,", "changing", "standards", "of", "care,", "availability", "or", "prevalence", "of", "use", "of", "a", "comparator", "drug", "or", "required", "prior", "therapy,", "clinical", "outcomes,", "or", "our", "and", "our", "partners", "financial", "constraints.", "<tag3>"], "wordsA": ["The", "start", "or", "end", "of", "a", "clinical", "study", "is", "often", "delayed", "or", "halted", "due", "to", "changing", "regulatory", "requirements,", "manufacturing", "challenges,", "required", "clinical", "trial", "administrative", "actions,", "slower", "than", "anticipated", "patient", "enrollment,", "changing", "standards", "of", "care,", "availability", "or", "prevalence", "of", "use", "of", "a", "comparator", "drug", "or", "required", "prior", "therapy,", "clinical", "outcomes,", "or", "our", "own", "financial", "constraints."], "wordsB": ["The", "start", "or", "end", "of", "a", "clinical", "study", "is", "often", "delayed", "or", "halted", "due", "to", "changing", "regulatory", "requirements,", "manufacturing", "challenges,", "required", "clinical", "trial", "administrative", "actions,", "slower", "than", "anticipated", "patient", "enrollment,", "changing", "standards", "of", "care,", "availability", "or", "prevalence", "of", "use", "of", "a", "comparator", "drug", "or", "required", "prior", "therapy,", "clinical", "outcomes,", "or", "our", "and", "our", "partners", "financial", "constraints."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p2_s7", "idA": "906709_12_item1a_p2_s7", "sentA": "The risk of failure is increased for our drug candidates that are based on new technologies, such as the application of our advanced polymer conjugate technology to small molecules, including NKTR-118, NKTR-119, NKTR-102, NKTR-181, NKTR-192 and other drug candidates currently in discovery research or preclinical development.", "sentB": "The risk of failure increases for our drug candidates that are based on new technologies, such as the application of our advanced polymer conjugate technology to small molecules, including naloxegol, etirinotecan pegol, NKTR-181, NKTR-192, NKTR-171 and other drug candidates currently in discovery research or preclinical development.", "type": 2, "words": ["<tag1>", "The", "risk", "of", "failure", "is", "increased", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "small", "molecules,", "including", "NKTR-118,", "NKTR-119,", "NKTR-102,", "NKTR-181,", "NKTR-192", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development.", "<tag2>", "The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "small", "molecules,", "including", "naloxegol,", "etirinotecan", "pegol,", "NKTR-181,", "NKTR-192,", "NKTR-171", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development.", "<tag3>"], "wordsA": ["The", "risk", "of", "failure", "is", "increased", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "small", "molecules,", "including", "NKTR-118,", "NKTR-119,", "NKTR-102,", "NKTR-181,", "NKTR-192", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development."], "wordsB": ["The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "small", "molecules,", "including", "naloxegol,", "etirinotecan", "pegol,", "NKTR-181,", "NKTR-192,", "NKTR-171", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p18_s0", "idA": "906709_12_item1a_p2_s8", "sentA": "The failure of one or more of our drug candidates could have a material adverse effect on our business, financial condition and results of operations.", "sentB": "any change in health authorities policies or guidances applicable to our drug candidates.", "type": 2, "words": ["<tag1>", "The", "failure", "of", "one", "or", "more", "of", "our", "drug", "candidates", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "any", "change", "in", "health", "authorities", "policies", "or", "guidances", "applicable", "to", "our", "drug", "candidates.", "<tag3>"], "wordsA": ["The", "failure", "of", "one", "or", "more", "of", "our", "drug", "candidates", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["any", "change", "in", "health", "authorities", "policies", "or", "guidances", "applicable", "to", "our", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p18_s1", "idA": "906709_12_item1a_p2_s8", "sentA": "The failure of one or more of our drug candidates could have a material adverse effect on our business, financial condition and results of operations.", "sentB": "If initiation or completion of any of the planned clinical studies are delayed for our drug candidates for any of the above reasons or otherwise, the approval process could be delayed and the ability to commercialize and commence sales of these drug candidates could be materially harmed, which could have a material adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "The", "failure", "of", "one", "or", "more", "of", "our", "drug", "candidates", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "If", "initiation", "or", "completion", "of", "any", "of", "the", "planned", "clinical", "studies", "are", "delayed", "for", "our", "drug", "candidates", "for", "any", "of", "the", "above", "reasons", "or", "otherwise,", "the", "approval", "process", "could", "be", "delayed", "and", "the", "ability", "to", "commercialize", "and", "commence", "sales", "of", "these", "drug", "candidates", "could", "be", "materially", "harmed,", "which", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["The", "failure", "of", "one", "or", "more", "of", "our", "drug", "candidates", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["If", "initiation", "or", "completion", "of", "any", "of", "the", "planned", "clinical", "studies", "are", "delayed", "for", "our", "drug", "candidates", "for", "any", "of", "the", "above", "reasons", "or", "otherwise,", "the", "approval", "process", "could", "be", "delayed", "and", "the", "ability", "to", "commercialize", "and", "commence", "sales", "of", "these", "drug", "candidates", "could", "be", "materially", "harmed,", "which", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p4_s2", "idA": "906709_12_item1a_p2_s9", "sentA": "Even with success in preclinical testing and previously completed clinical trials, the risk of clinical failure for any drug candidate remains high prior to regulatory approval.", "sentB": "Even with success in previously completed clinical trials, the risk of clinical failure for any drug candidate remains high prior to regulatory approval.", "type": 2, "words": ["<tag1>", "Even", "with", "success", "in", "preclinical", "testing", "and", "previously", "completed", "clinical", "trials,", "the", "risk", "of", "clinical", "failure", "for", "any", "drug", "candidate", "remains", "high", "prior", "to", "regulatory", "approval.", "<tag2>", "Even", "with", "success", "in", "previously", "completed", "clinical", "trials,", "the", "risk", "of", "clinical", "failure", "for", "any", "drug", "candidate", "remains", "high", "prior", "to", "regulatory", "approval.", "<tag3>"], "wordsA": ["Even", "with", "success", "in", "preclinical", "testing", "and", "previously", "completed", "clinical", "trials,", "the", "risk", "of", "clinical", "failure", "for", "any", "drug", "candidate", "remains", "high", "prior", "to", "regulatory", "approval."], "wordsB": ["Even", "with", "success", "in", "previously", "completed", "clinical", "trials,", "the", "risk", "of", "clinical", "failure", "for", "any", "drug", "candidate", "remains", "high", "prior", "to", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p17_s11", "idA": "906709_12_item1a_p35_s4", "sentA": "If our collaborations fail, our product development or commercialization of product candidates could be delayed or cancelled, which would negatively impact our business, results of operations and financial condition.", "sentB": "Our clinical trials for any of our product candidates could be delayed for a variety of reasons, including:", "type": 2, "words": ["<tag1>", "If", "our", "collaborations", "fail,", "our", "product", "development", "or", "commercialization", "of", "product", "candidates", "could", "be", "delayed", "or", "cancelled,", "which", "would", "negatively", "impact", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Our", "clinical", "trials", "for", "any", "of", "our", "product", "candidates", "could", "be", "delayed", "for", "a", "variety", "of", "reasons,", "including:", "<tag3>"], "wordsA": ["If", "our", "collaborations", "fail,", "our", "product", "development", "or", "commercialization", "of", "product", "candidates", "could", "be", "delayed", "or", "cancelled,", "which", "would", "negatively", "impact", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Our", "clinical", "trials", "for", "any", "of", "our", "product", "candidates", "could", "be", "delayed", "for", "a", "variety", "of", "reasons,", "including:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p39_s13", "idA": "906709_12_item1a_p38_s6", "sentA": "For the year ended December 31, 2011, we reported a net loss of $134.0 million.", "sentB": "For the year ended December 31, 2012, we reported a net loss of $171.9 million.", "type": 2, "words": ["<tag1>", "For", "the", "year", "ended", "December", "31,", "2011,", "we", "reported", "a", "net", "loss", "of", "$134.0", "million.", "<tag2>", "For", "the", "year", "ended", "December", "31,", "2012,", "we", "reported", "a", "net", "loss", "of", "$171.9", "million.", "<tag3>"], "wordsA": ["For", "the", "year", "ended", "December", "31,", "2011,", "we", "reported", "a", "net", "loss", "of", "$134.0", "million."], "wordsB": ["For", "the", "year", "ended", "December", "31,", "2012,", "we", "reported", "a", "net", "loss", "of", "$171.9", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p9_s0", "idA": "906709_12_item1a_p39_s0", "sentA": "If and when we achieve profitability depends upon a number of factors, including the timing and recognition of milestone payments and royalties received, the timing of revenue under our collaboration agreements, the amount of investments we make in our proprietary product candidates and the regulatory approval and market success of our product candidates.", "sentB": "if and when we receive potential milestone payments and royalties from our existing collaborations if the drug candidates subject to those collaborations achieve clinical, regulatory or commercial success.", "type": 2, "words": ["<tag1>", "If", "and", "when", "we", "achieve", "profitability", "depends", "upon", "a", "number", "of", "factors,", "including", "the", "timing", "and", "recognition", "of", "milestone", "payments", "and", "royalties", "received,", "the", "timing", "of", "revenue", "under", "our", "collaboration", "agreements,", "the", "amount", "of", "investments", "we", "make", "in", "our", "proprietary", "product", "candidates", "and", "the", "regulatory", "approval", "and", "market", "success", "of", "our", "product", "candidates.", "<tag2>", "if", "and", "when", "we", "receive", "potential", "milestone", "payments", "and", "royalties", "from", "our", "existing", "collaborations", "if", "the", "drug", "candidates", "subject", "to", "those", "collaborations", "achieve", "clinical,", "regulatory", "or", "commercial", "success.", "<tag3>"], "wordsA": ["If", "and", "when", "we", "achieve", "profitability", "depends", "upon", "a", "number", "of", "factors,", "including", "the", "timing", "and", "recognition", "of", "milestone", "payments", "and", "royalties", "received,", "the", "timing", "of", "revenue", "under", "our", "collaboration", "agreements,", "the", "amount", "of", "investments", "we", "make", "in", "our", "proprietary", "product", "candidates", "and", "the", "regulatory", "approval", "and", "market", "success", "of", "our", "product", "candidates."], "wordsB": ["if", "and", "when", "we", "receive", "potential", "milestone", "payments", "and", "royalties", "from", "our", "existing", "collaborations", "if", "the", "drug", "candidates", "subject", "to", "those", "collaborations", "achieve", "clinical,", "regulatory", "or", "commercial", "success."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p22_s1", "idA": "906709_12_item1a_p39_s1", "sentA": "We may not be able to achieve and sustain profitability.", "sentB": "Further, our competitors may be able to circumvent and otherwise design around our patents.", "type": 2, "words": ["<tag1>", "We", "may", "not", "be", "able", "to", "achieve", "and", "sustain", "profitability.", "<tag2>", "Further,", "our", "competitors", "may", "be", "able", "to", "circumvent", "and", "otherwise", "design", "around", "our", "patents.", "<tag3>"], "wordsA": ["We", "may", "not", "be", "able", "to", "achieve", "and", "sustain", "profitability."], "wordsB": ["Further,", "our", "competitors", "may", "be", "able", "to", "circumvent", "and", "otherwise", "design", "around", "our", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p17_s7", "idA": "906709_12_item1a_p3_s1", "sentA": "We or our partners may not obtain regulatory approval for drug candidates on a timely basis, or at all, or the terms of any approval (which in some countries includes pricing approval) may impose significant restrictions or limitations on use.", "sentB": "We or our partners may experience delays in clinical trials of drug candidates.", "type": 2, "words": ["<tag1>", "We", "or", "our", "partners", "may", "not", "obtain", "regulatory", "approval", "for", "drug", "candidates", "on", "a", "timely", "basis,", "or", "at", "all,", "or", "the", "terms", "of", "any", "approval", "(which", "in", "some", "countries", "includes", "pricing", "approval)", "may", "impose", "significant", "restrictions", "or", "limitations", "on", "use.", "<tag2>", "We", "or", "our", "partners", "may", "experience", "delays", "in", "clinical", "trials", "of", "drug", "candidates.", "<tag3>"], "wordsA": ["We", "or", "our", "partners", "may", "not", "obtain", "regulatory", "approval", "for", "drug", "candidates", "on", "a", "timely", "basis,", "or", "at", "all,", "or", "the", "terms", "of", "any", "approval", "(which", "in", "some", "countries", "includes", "pricing", "approval)", "may", "impose", "significant", "restrictions", "or", "limitations", "on", "use."], "wordsB": ["We", "or", "our", "partners", "may", "experience", "delays", "in", "clinical", "trials", "of", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p45_s1", "idA": "906709_12_item1a_p44_s1", "sentA": "For NKTR-118, there are currently several alternative therapies used to address opioid-induced constipation (OIC) and opioid-induced bowel dysfunction (OBD), including subcutaneous Relistor (methylnaltrexone bromide) and oral and rectal over-the-counter laxatives and stool softeners such as docusate sodium, senna and milk of magnesia.", "sentB": "For naloxegol, there are currently several alternative therapies used to address opioid-induced constipation (OIC) and opioid-induced bowel dysfunction (OBD), including subcutaneous Relistor (methylnaltrexone bromide) and oral and rectal over-the-counter laxatives and stool softeners such as docusate sodium, senna and milk of magnesia.", "type": 2, "words": ["<tag1>", "For", "NKTR-118,", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "subcutaneous", "Relistor", "(methylnaltrexone", "bromide)", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia.", "<tag2>", "For", "naloxegol,", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "subcutaneous", "Relistor", "(methylnaltrexone", "bromide)", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia.", "<tag3>"], "wordsA": ["For", "NKTR-118,", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "subcutaneous", "Relistor", "(methylnaltrexone", "bromide)", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia."], "wordsB": ["For", "naloxegol,", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "subcutaneous", "Relistor", "(methylnaltrexone", "bromide)", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p45_s2", "idA": "906709_12_item1a_p44_s2", "sentA": "In addition, there are a number of companies developing potential products which are in various stages of clinical development and are being evaluated for the treatment of OIC and OBD in different patient populations, including Adolor Corporation, Progenics Pharmaceuticals, Inc. in collaboration with Salix Pharmaceuticals, Ltd., Mundipharma Int.", "sentB": "In addition, there are a number of companies developing potential products which are in various stages of clinical development and are being evaluated for the treatment of OIC and OBD in different patient populations, including Cubist Pharmaceuticals , Progenics Pharmaceuticals, Inc. in collaboration with Salix Pharmaceuticals, Ltd., Mundipharma Int.", "type": 2, "words": ["<tag1>", "In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Adolor", "Corporation,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Mundipharma", "Int.", "<tag2>", "In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Cubist", "Pharmaceuticals", ",", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Mundipharma", "Int.", "<tag3>"], "wordsA": ["In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Adolor", "Corporation,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Mundipharma", "Int."], "wordsB": ["In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Cubist", "Pharmaceuticals", ",", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Mundipharma", "Int."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p45_s3", "idA": "906709_12_item1a_p44_s3", "sentA": "Limited, Sucampo Pharmaceuticals, Alkermes, Inc. and Takeda Pharmaceutical Company Limited.", "sentB": "Limited, Sucampo Pharmaceuticals and Takeda Pharmaceutical Company Limited.", "type": 2, "words": ["<tag1>", "Limited,", "Sucampo", "Pharmaceuticals,", "Alkermes,", "Inc.", "and", "Takeda", "Pharmaceutical", "Company", "Limited.", "<tag2>", "Limited,", "Sucampo", "Pharmaceuticals", "and", "Takeda", "Pharmaceutical", "Company", "Limited.", "<tag3>"], "wordsA": ["Limited,", "Sucampo", "Pharmaceuticals,", "Alkermes,", "Inc.", "and", "Takeda", "Pharmaceutical", "Company", "Limited."], "wordsB": ["Limited,", "Sucampo", "Pharmaceuticals", "and", "Takeda", "Pharmaceutical", "Company", "Limited."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p46_s0", "idA": "906709_12_item1a_p45_s0", "sentA": "For NKTR-102, there are a number of chemotherapies and cancer therapies approved today and in various stages of clinical development for ovarian and breast cancers including but not limited to: Avastin (bevacizumab), Camptosar (irinotecan), Doxil (doxorubicin HCl), Ellence (epirubicin), Gemzar (gemcitabine), Herceptin (trastuzumab), Hycamtin (topotecan), Iniparib, Paraplatin (carboplatin), and Taxol (paclitaxel).", "sentB": "For etirinotecan pegol, there are a number of chemotherapies and cancer therapies approved today and in various stages of clinical development for breast and ovarian cancers including but not limited to: Abraxane (paclitaxel protein-bound particles for injectable suspension (albumin bound)), Afinitor (everolimus), Doxil (doxorubicin HCl), Ellence (epirubicin), Gemzar (gemcitabine), Halaven (eribulin), Herceptin (trastuzumab), Hycamtin (topotecan), Ixempra (ixabepilone), Navelbine (vinolrebine), Iniparib, Paraplatin (carboplatin), Taxol (paclitaxel) and Taxotere (docetaxel).", "type": 2, "words": ["<tag1>", "For", "NKTR-102,", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "ovarian", "and", "breast", "cancers", "including", "but", "not", "limited", "to:", "Avastin", "(bevacizumab),", "Camptosar", "(irinotecan),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Iniparib,", "Paraplatin", "(carboplatin),", "and", "Taxol", "(paclitaxel).", "<tag2>", "For", "etirinotecan", "pegol,", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "and", "ovarian", "cancers", "including", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel).", "<tag3>"], "wordsA": ["For", "NKTR-102,", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "ovarian", "and", "breast", "cancers", "including", "but", "not", "limited", "to:", "Avastin", "(bevacizumab),", "Camptosar", "(irinotecan),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Iniparib,", "Paraplatin", "(carboplatin),", "and", "Taxol", "(paclitaxel)."], "wordsB": ["For", "etirinotecan", "pegol,", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "and", "ovarian", "cancers", "including", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p46_s1", "idA": "906709_12_item1a_p45_s1", "sentA": "Major pharmaceutical or biotechnology companies with approved drugs or drugs in development for these cancers include Bristol-Meyers Squibb, Eli Lilly Co., Roche, GlaxoSmithKline plc, Johnson and Johnson, Pfizer, Inc., Sanofi Aventis, and many others.", "sentB": "Major pharmaceutical or biotechnology companies with approved drugs or drugs in development for these cancers include, but are not limited to, Bristol-Meyers Squibb, Eli Lilly Co., Roche, GlaxoSmithKline plc, Johnson and Johnson, Pfizer, Inc.and Sanofi Aventis.", "type": 2, "words": ["<tag1>", "Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "these", "cancers", "include", "Bristol-Meyers", "Squibb,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer,", "Inc.,", "Sanofi", "Aventis,", "and", "many", "others.", "<tag2>", "Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "these", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Meyers", "Squibb,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer,", "Inc.and", "Sanofi", "Aventis.", "<tag3>"], "wordsA": ["Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "these", "cancers", "include", "Bristol-Meyers", "Squibb,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer,", "Inc.,", "Sanofi", "Aventis,", "and", "many", "others."], "wordsB": ["Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "these", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Meyers", "Squibb,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer,", "Inc.and", "Sanofi", "Aventis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p47_s0", "idA": "906709_12_item1a_p46_s0", "sentA": "There are approved therapies for the treatment of colorectal cancer, including Eloxatin (oxaliplatin), Camptosar (irinotecan), Avastin (bevacizumab), Erbitux (cetuximab), Vectibix (panitumumab), Xeloda (capecitabine), Adrucil (fluorouracil), and Wellcovorin (leucovorin).", "sentB": "There are approved therapies for the treatment of colorectal cancer, including Eloxatin (oxaliplatin), Camptosar (irinotecan), Avastin (bevacizumab), Zaltrap (Ziv-afilbercept), Stivarga (regorafenib), Erbitux (cetuximab), Vectibix (panitumumab), Xeloda (capecitabine), Adrucil (fluorouracil) and Wellcovorin (leucovorin).", "type": 2, "words": ["<tag1>", "There", "are", "approved", "therapies", "for", "the", "treatment", "of", "colorectal", "cancer,", "including", "Eloxatin", "(oxaliplatin),", "Camptosar", "(irinotecan),", "Avastin", "(bevacizumab),", "Erbitux", "(cetuximab),", "Vectibix", "(panitumumab),", "Xeloda", "(capecitabine),", "Adrucil", "(fluorouracil),", "and", "Wellcovorin", "(leucovorin).", "<tag2>", "There", "are", "approved", "therapies", "for", "the", "treatment", "of", "colorectal", "cancer,", "including", "Eloxatin", "(oxaliplatin),", "Camptosar", "(irinotecan),", "Avastin", "(bevacizumab),", "Zaltrap", "(Ziv-afilbercept),", "Stivarga", "(regorafenib),", "Erbitux", "(cetuximab),", "Vectibix", "(panitumumab),", "Xeloda", "(capecitabine),", "Adrucil", "(fluorouracil)", "and", "Wellcovorin", "(leucovorin).", "<tag3>"], "wordsA": ["There", "are", "approved", "therapies", "for", "the", "treatment", "of", "colorectal", "cancer,", "including", "Eloxatin", "(oxaliplatin),", "Camptosar", "(irinotecan),", "Avastin", "(bevacizumab),", "Erbitux", "(cetuximab),", "Vectibix", "(panitumumab),", "Xeloda", "(capecitabine),", "Adrucil", "(fluorouracil),", "and", "Wellcovorin", "(leucovorin)."], "wordsB": ["There", "are", "approved", "therapies", "for", "the", "treatment", "of", "colorectal", "cancer,", "including", "Eloxatin", "(oxaliplatin),", "Camptosar", "(irinotecan),", "Avastin", "(bevacizumab),", "Zaltrap", "(Ziv-afilbercept),", "Stivarga", "(regorafenib),", "Erbitux", "(cetuximab),", "Vectibix", "(panitumumab),", "Xeloda", "(capecitabine),", "Adrucil", "(fluorouracil)", "and", "Wellcovorin", "(leucovorin)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p47_s1", "idA": "906709_12_item1a_p47_s0", "sentA": "agents to potentially treat colorectal cancer, including, but not limited to, products in development from Bristol-Myers Squibb Company, Pfizer, Inc., GlaxoSmithKline plc, Antigenics, Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Cell Therapeutics, Inc., Neopharm Inc., Meditech Research Ltd, Alchemia Limited, Enzon Pharmaceuticals, Inc. and others.", "sentB": "In addition, there are a number of drugs in various stages of preclinical and clinical development from companies exploring cancer therapies or improved chemotherapeutic agents to potentially treat colorectal cancer, including, but not limited to, products in development from Bristol-Myers Squibb Company, Pfizer, Inc., GlaxoSmithKline plc, Antigenics, Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Cell Therapeutics, Inc., Neopharm Inc., Meditech Research Ltd, Alchemia Limited, and Enzon Pharmaceuticals, Inc.", "type": 2, "words": ["<tag1>", "agents", "to", "potentially", "treat", "colorectal", "cancer,", "including,", "but", "not", "limited", "to,", "products", "in", "development", "from", "Bristol-Myers", "Squibb", "Company,", "Pfizer,", "Inc.,", "GlaxoSmithKline", "plc,", "Antigenics,", "Inc.,", "F.", "Hoffmann-La", "Roche", "Ltd,", "Novartis", "AG,", "Cell", "Therapeutics,", "Inc.,", "Neopharm", "Inc.,", "Meditech", "Research", "Ltd,", "Alchemia", "Limited,", "Enzon", "Pharmaceuticals,", "Inc.", "and", "others.", "<tag2>", "In", "addition,", "there", "are", "a", "number", "of", "drugs", "in", "various", "stages", "of", "preclinical", "and", "clinical", "development", "from", "companies", "exploring", "cancer", "therapies", "or", "improved", "chemotherapeutic", "agents", "to", "potentially", "treat", "colorectal", "cancer,", "including,", "but", "not", "limited", "to,", "products", "in", "development", "from", "Bristol-Myers", "Squibb", "Company,", "Pfizer,", "Inc.,", "GlaxoSmithKline", "plc,", "Antigenics,", "Inc.,", "F.", "Hoffmann-La", "Roche", "Ltd,", "Novartis", "AG,", "Cell", "Therapeutics,", "Inc.,", "Neopharm", "Inc.,", "Meditech", "Research", "Ltd,", "Alchemia", "Limited,", "and", "Enzon", "Pharmaceuticals,", "Inc.", "<tag3>"], "wordsA": ["agents", "to", "potentially", "treat", "colorectal", "cancer,", "including,", "but", "not", "limited", "to,", "products", "in", "development", "from", "Bristol-Myers", "Squibb", "Company,", "Pfizer,", "Inc.,", "GlaxoSmithKline", "plc,", "Antigenics,", "Inc.,", "F.", "Hoffmann-La", "Roche", "Ltd,", "Novartis", "AG,", "Cell", "Therapeutics,", "Inc.,", "Neopharm", "Inc.,", "Meditech", "Research", "Ltd,", "Alchemia", "Limited,", "Enzon", "Pharmaceuticals,", "Inc.", "and", "others."], "wordsB": ["In", "addition,", "there", "are", "a", "number", "of", "drugs", "in", "various", "stages", "of", "preclinical", "and", "clinical", "development", "from", "companies", "exploring", "cancer", "therapies", "or", "improved", "chemotherapeutic", "agents", "to", "potentially", "treat", "colorectal", "cancer,", "including,", "but", "not", "limited", "to,", "products", "in", "development", "from", "Bristol-Myers", "Squibb", "Company,", "Pfizer,", "Inc.,", "GlaxoSmithKline", "plc,", "Antigenics,", "Inc.,", "F.", "Hoffmann-La", "Roche", "Ltd,", "Novartis", "AG,", "Cell", "Therapeutics,", "Inc.,", "Neopharm", "Inc.,", "Meditech", "Research", "Ltd,", "Alchemia", "Limited,", "and", "Enzon", "Pharmaceuticals,", "Inc."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p27_s2", "idA": "906709_12_item1a_p48_s5", "sentA": "If product liability lawsuits are brought against us, we may incur substantial liabilities.", "sentB": "Any such claims may not ultimately be successful, and we may incur substantial costs and liabilities in pursuing them.", "type": 2, "words": ["<tag1>", "If", "product", "liability", "lawsuits", "are", "brought", "against", "us,", "we", "may", "incur", "substantial", "liabilities.", "<tag2>", "Any", "such", "claims", "may", "not", "ultimately", "be", "successful,", "and", "we", "may", "incur", "substantial", "costs", "and", "liabilities", "in", "pursuing", "them.", "<tag3>"], "wordsA": ["If", "product", "liability", "lawsuits", "are", "brought", "against", "us,", "we", "may", "incur", "substantial", "liabilities."], "wordsB": ["Any", "such", "claims", "may", "not", "ultimately", "be", "successful,", "and", "we", "may", "incur", "substantial", "costs", "and", "liabilities", "in", "pursuing", "them."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p8_s6", "idA": "906709_12_item1a_p49_s10", "sentA": "Furthermore, if adequate funds are not available, we may be required to obtain funds through arrangements with partners or other sources that may require us to relinquish rights to certain of our technologies, products or future economic rights that we would not otherwise relinquish or require us to enter into other financing arrangements on unfavorable terms.", "sentB": "While this royalty obligation liability will not be settled in cash, we may be required to make a payment of up to $7.0 million in 2014 if the worldwide net sales thresholds of MIRCERA in 2013 are not met.", "type": 2, "words": ["<tag1>", "Furthermore,", "if", "adequate", "funds", "are", "not", "available,", "we", "may", "be", "required", "to", "obtain", "funds", "through", "arrangements", "with", "partners", "or", "other", "sources", "that", "may", "require", "us", "to", "relinquish", "rights", "to", "certain", "of", "our", "technologies,", "products", "or", "future", "economic", "rights", "that", "we", "would", "not", "otherwise", "relinquish", "or", "require", "us", "to", "enter", "into", "other", "financing", "arrangements", "on", "unfavorable", "terms.", "<tag2>", "While", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash,", "we", "may", "be", "required", "to", "make", "a", "payment", "of", "up", "to", "$7.0", "million", "in", "2014", "if", "the", "worldwide", "net", "sales", "thresholds", "of", "MIRCERA", "in", "2013", "are", "not", "met.", "<tag3>"], "wordsA": ["Furthermore,", "if", "adequate", "funds", "are", "not", "available,", "we", "may", "be", "required", "to", "obtain", "funds", "through", "arrangements", "with", "partners", "or", "other", "sources", "that", "may", "require", "us", "to", "relinquish", "rights", "to", "certain", "of", "our", "technologies,", "products", "or", "future", "economic", "rights", "that", "we", "would", "not", "otherwise", "relinquish", "or", "require", "us", "to", "enter", "into", "other", "financing", "arrangements", "on", "unfavorable", "terms."], "wordsB": ["While", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash,", "we", "may", "be", "required", "to", "make", "a", "payment", "of", "up", "to", "$7.0", "million", "in", "2014", "if", "the", "worldwide", "net", "sales", "thresholds", "of", "MIRCERA", "in", "2013", "are", "not", "met."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p50_s3", "idA": "906709_12_item1a_p49_s7", "sentA": "Our decision to bear a majority or all of the clinical development costs of NKTR-102 substantially increases our future capital requirements.", "sentB": "Our decision to bear a majority or all of the clinical development costs of etirinotecan pegol substantially increases our future capital requirements.", "type": 2, "words": ["<tag1>", "Our", "decision", "to", "bear", "a", "majority", "or", "all", "of", "the", "clinical", "development", "costs", "of", "NKTR-102", "substantially", "increases", "our", "future", "capital", "requirements.", "<tag2>", "Our", "decision", "to", "bear", "a", "majority", "or", "all", "of", "the", "clinical", "development", "costs", "of", "etirinotecan", "pegol", "substantially", "increases", "our", "future", "capital", "requirements.", "<tag3>"], "wordsA": ["Our", "decision", "to", "bear", "a", "majority", "or", "all", "of", "the", "clinical", "development", "costs", "of", "NKTR-102", "substantially", "increases", "our", "future", "capital", "requirements."], "wordsB": ["Our", "decision", "to", "bear", "a", "majority", "or", "all", "of", "the", "clinical", "development", "costs", "of", "etirinotecan", "pegol", "substantially", "increases", "our", "future", "capital", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p11_s1", "idA": "906709_12_item1a_p4_s15", "sentA": "The issuance of convertible notes, common stock, preferred stock or securities convertible into or exchangeable for our securities would dilute the percentage ownership of our current common stock security holders and could significantly lower the market value of our common stock.", "sentB": "In the event we do not enter into any new collaboration partnerships with significant up-front payments and we choose to continue our main research and development programs, we may need to pursue financing alternatives, including dilutive equity-based financings, such as an offering of convertible debt or common stock, which would dilute the percentage ownership of our current common stockholders and could significantly lower the market value of our common stock.", "type": 2, "words": ["<tag1>", "The", "issuance", "of", "convertible", "notes,", "common", "stock,", "preferred", "stock", "or", "securities", "convertible", "into", "or", "exchangeable", "for", "our", "securities", "would", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stock", "security", "holders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock.", "<tag2>", "In", "the", "event", "we", "do", "not", "enter", "into", "any", "new", "collaboration", "partnerships", "with", "significant", "up-front", "payments", "and", "we", "choose", "to", "continue", "our", "main", "research", "and", "development", "programs,", "we", "may", "need", "to", "pursue", "financing", "alternatives,", "including", "dilutive", "equity-based", "financings,", "such", "as", "an", "offering", "of", "convertible", "debt", "or", "common", "stock,", "which", "would", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stockholders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["The", "issuance", "of", "convertible", "notes,", "common", "stock,", "preferred", "stock", "or", "securities", "convertible", "into", "or", "exchangeable", "for", "our", "securities", "would", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stock", "security", "holders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock."], "wordsB": ["In", "the", "event", "we", "do", "not", "enter", "into", "any", "new", "collaboration", "partnerships", "with", "significant", "up-front", "payments", "and", "we", "choose", "to", "continue", "our", "main", "research", "and", "development", "programs,", "we", "may", "need", "to", "pursue", "financing", "alternatives,", "including", "dilutive", "equity-based", "financings,", "such", "as", "an", "offering", "of", "convertible", "debt", "or", "common", "stock,", "which", "would", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stockholders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p22_s3", "idA": "906709_12_item1a_p4_s16", "sentA": "In addition, a financing could result in the issuance of new securities that may have rights, preferences or privileges senior to those of our existing stockholders.", "sentB": "We may have to participate in interference proceedings declared by the U.S. Patent and Trademark Office, which could result in a loss of the patent and/or substantial cost to us.", "type": 2, "words": ["<tag1>", "In", "addition,", "a", "financing", "could", "result", "in", "the", "issuance", "of", "new", "securities", "that", "may", "have", "rights,", "preferences", "or", "privileges", "senior", "to", "those", "of", "our", "existing", "stockholders.", "<tag2>", "We", "may", "have", "to", "participate", "in", "interference", "proceedings", "declared", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "which", "could", "result", "in", "a", "loss", "of", "the", "patent", "and/or", "substantial", "cost", "to", "us.", "<tag3>"], "wordsA": ["In", "addition,", "a", "financing", "could", "result", "in", "the", "issuance", "of", "new", "securities", "that", "may", "have", "rights,", "preferences", "or", "privileges", "senior", "to", "those", "of", "our", "existing", "stockholders."], "wordsB": ["We", "may", "have", "to", "participate", "in", "interference", "proceedings", "declared", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "which", "could", "result", "in", "a", "loss", "of", "the", "patent", "and/or", "substantial", "cost", "to", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p54_s4", "idA": "906709_12_item1a_p4_s16", "sentA": "In addition, a financing could result in the issuance of new securities that may have rights, preferences or privileges senior to those of our existing stockholders.", "sentB": "Our failure to comply with our debt-related obligations could result in an event of default under our other indebtedness and the acceleration of our other indebtedness, in whole or in part, could result in an event of default under the indenture governing the senior secured notes.", "type": 2, "words": ["<tag1>", "In", "addition,", "a", "financing", "could", "result", "in", "the", "issuance", "of", "new", "securities", "that", "may", "have", "rights,", "preferences", "or", "privileges", "senior", "to", "those", "of", "our", "existing", "stockholders.", "<tag2>", "Our", "failure", "to", "comply", "with", "our", "debt-related", "obligations", "could", "result", "in", "an", "event", "of", "default", "under", "our", "other", "indebtedness", "and", "the", "acceleration", "of", "our", "other", "indebtedness,", "in", "whole", "or", "in", "part,", "could", "result", "in", "an", "event", "of", "default", "under", "the", "indenture", "governing", "the", "senior", "secured", "notes.", "<tag3>"], "wordsA": ["In", "addition,", "a", "financing", "could", "result", "in", "the", "issuance", "of", "new", "securities", "that", "may", "have", "rights,", "preferences", "or", "privileges", "senior", "to", "those", "of", "our", "existing", "stockholders."], "wordsB": ["Our", "failure", "to", "comply", "with", "our", "debt-related", "obligations", "could", "result", "in", "an", "event", "of", "default", "under", "our", "other", "indebtedness", "and", "the", "acceleration", "of", "our", "other", "indebtedness,", "in", "whole", "or", "in", "part,", "could", "result", "in", "an", "event", "of", "default", "under", "the", "indenture", "governing", "the", "senior", "secured", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p53_s0", "idA": "906709_12_item1a_p4_s17", "sentA": "If we issue convertible notes or enter into a term loan arrangement, the payment of principal and interest on such indebtedness may limit funds available for our business activities such as the continued advancement of our research and development pipeline, and such indebtedness could impose covenants that restrict our ability to operate our business.", "sentB": "The indenture governing the senior secured notes imposes significant operating and financial restrictions on us and our subsidiaries that may prevent us from pursuing certain business opportunities and restrict our ability to operate our business.", "type": 2, "words": ["<tag1>", "If", "we", "issue", "convertible", "notes", "or", "enter", "into", "a", "term", "loan", "arrangement,", "the", "payment", "of", "principal", "and", "interest", "on", "such", "indebtedness", "may", "limit", "funds", "available", "for", "our", "business", "activities", "such", "as", "the", "continued", "advancement", "of", "our", "research", "and", "development", "pipeline,", "and", "such", "indebtedness", "could", "impose", "covenants", "that", "restrict", "our", "ability", "to", "operate", "our", "business.", "<tag2>", "The", "indenture", "governing", "the", "senior", "secured", "notes", "imposes", "significant", "operating", "and", "financial", "restrictions", "on", "us", "and", "our", "subsidiaries", "that", "may", "prevent", "us", "from", "pursuing", "certain", "business", "opportunities", "and", "restrict", "our", "ability", "to", "operate", "our", "business.", "<tag3>"], "wordsA": ["If", "we", "issue", "convertible", "notes", "or", "enter", "into", "a", "term", "loan", "arrangement,", "the", "payment", "of", "principal", "and", "interest", "on", "such", "indebtedness", "may", "limit", "funds", "available", "for", "our", "business", "activities", "such", "as", "the", "continued", "advancement", "of", "our", "research", "and", "development", "pipeline,", "and", "such", "indebtedness", "could", "impose", "covenants", "that", "restrict", "our", "ability", "to", "operate", "our", "business."], "wordsB": ["The", "indenture", "governing", "the", "senior", "secured", "notes", "imposes", "significant", "operating", "and", "financial", "restrictions", "on", "us", "and", "our", "subsidiaries", "that", "may", "prevent", "us", "from", "pursuing", "certain", "business", "opportunities", "and", "restrict", "our", "ability", "to", "operate", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p53_s1", "idA": "906709_12_item1a_p4_s17", "sentA": "If we issue convertible notes or enter into a term loan arrangement, the payment of principal and interest on such indebtedness may limit funds available for our business activities such as the continued advancement of our research and development pipeline, and such indebtedness could impose covenants that restrict our ability to operate our business.", "sentB": "The indenture governing the senior secured notes contains covenants that restrict our and our subsidiaries ability to take various actions, such as:", "type": 2, "words": ["<tag1>", "If", "we", "issue", "convertible", "notes", "or", "enter", "into", "a", "term", "loan", "arrangement,", "the", "payment", "of", "principal", "and", "interest", "on", "such", "indebtedness", "may", "limit", "funds", "available", "for", "our", "business", "activities", "such", "as", "the", "continued", "advancement", "of", "our", "research", "and", "development", "pipeline,", "and", "such", "indebtedness", "could", "impose", "covenants", "that", "restrict", "our", "ability", "to", "operate", "our", "business.", "<tag2>", "The", "indenture", "governing", "the", "senior", "secured", "notes", "contains", "covenants", "that", "restrict", "our", "and", "our", "subsidiaries", "ability", "to", "take", "various", "actions,", "such", "as:", "<tag3>"], "wordsA": ["If", "we", "issue", "convertible", "notes", "or", "enter", "into", "a", "term", "loan", "arrangement,", "the", "payment", "of", "principal", "and", "interest", "on", "such", "indebtedness", "may", "limit", "funds", "available", "for", "our", "business", "activities", "such", "as", "the", "continued", "advancement", "of", "our", "research", "and", "development", "pipeline,", "and", "such", "indebtedness", "could", "impose", "covenants", "that", "restrict", "our", "ability", "to", "operate", "our", "business."], "wordsB": ["The", "indenture", "governing", "the", "senior", "secured", "notes", "contains", "covenants", "that", "restrict", "our", "and", "our", "subsidiaries", "ability", "to", "take", "various", "actions,", "such", "as:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p3_s2", "idA": "906709_12_item1a_p4_s2", "sentA": "The time required for completing testing and obtaining approvals is uncertain, and the FDA and other U.S. and foreign regulatory agencies have substantial discretion, at any phase of development, to terminate clinical studies, require additional clinical development or other testing, delay or withhold registration and marketing approval and mandate product withdrawals, including recalls.", "sentB": "The FDA and other U.S. and foreign health authorities have substantial discretion, at any phase of development, to terminate clinical studies, require additional clinical development or other testing, delay or withhold registration and marketing approval and mandate product withdrawals, including recalls.", "type": 2, "words": ["<tag1>", "The", "time", "required", "for", "completing", "testing", "and", "obtaining", "approvals", "is", "uncertain,", "and", "the", "FDA", "and", "other", "U.S.", "and", "foreign", "regulatory", "agencies", "have", "substantial", "discretion,", "at", "any", "phase", "of", "development,", "to", "terminate", "clinical", "studies,", "require", "additional", "clinical", "development", "or", "other", "testing,", "delay", "or", "withhold", "registration", "and", "marketing", "approval", "and", "mandate", "product", "withdrawals,", "including", "recalls.", "<tag2>", "The", "FDA", "and", "other", "U.S.", "and", "foreign", "health", "authorities", "have", "substantial", "discretion,", "at", "any", "phase", "of", "development,", "to", "terminate", "clinical", "studies,", "require", "additional", "clinical", "development", "or", "other", "testing,", "delay", "or", "withhold", "registration", "and", "marketing", "approval", "and", "mandate", "product", "withdrawals,", "including", "recalls.", "<tag3>"], "wordsA": ["The", "time", "required", "for", "completing", "testing", "and", "obtaining", "approvals", "is", "uncertain,", "and", "the", "FDA", "and", "other", "U.S.", "and", "foreign", "regulatory", "agencies", "have", "substantial", "discretion,", "at", "any", "phase", "of", "development,", "to", "terminate", "clinical", "studies,", "require", "additional", "clinical", "development", "or", "other", "testing,", "delay", "or", "withhold", "registration", "and", "marketing", "approval", "and", "mandate", "product", "withdrawals,", "including", "recalls."], "wordsB": ["The", "FDA", "and", "other", "U.S.", "and", "foreign", "health", "authorities", "have", "substantial", "discretion,", "at", "any", "phase", "of", "development,", "to", "terminate", "clinical", "studies,", "require", "additional", "clinical", "development", "or", "other", "testing,", "delay", "or", "withhold", "registration", "and", "marketing", "approval", "and", "mandate", "product", "withdrawals,", "including", "recalls."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p50_s11", "idA": "906709_12_item1a_p50_s0", "sentA": "products and the regulatory approval process.", "sentB": "We are also dependent on the continued services of our technical personnel because of the highly technical nature of our products and the regulatory approval process.", "type": 2, "words": ["<tag1>", "products", "and", "the", "regulatory", "approval", "process.", "<tag2>", "We", "are", "also", "dependent", "on", "the", "continued", "services", "of", "our", "technical", "personnel", "because", "of", "the", "highly", "technical", "nature", "of", "our", "products", "and", "the", "regulatory", "approval", "process.", "<tag3>"], "wordsA": ["products", "and", "the", "regulatory", "approval", "process."], "wordsB": ["We", "are", "also", "dependent", "on", "the", "continued", "services", "of", "our", "technical", "personnel", "because", "of", "the", "highly", "technical", "nature", "of", "our", "products", "and", "the", "regulatory", "approval", "process."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p51_s0", "idA": "906709_12_item1a_p50_s14", "sentA": "There are no backup facilities for our manufacturing operations located in Huntsville, Alabama.", "sentB": "backup facilities for our manufacturing operations located in Huntsville, Alabama.", "type": 2, "words": ["<tag1>", "There", "are", "no", "backup", "facilities", "for", "our", "manufacturing", "operations", "located", "in", "Huntsville,", "Alabama.", "<tag2>", "backup", "facilities", "for", "our", "manufacturing", "operations", "located", "in", "Huntsville,", "Alabama.", "<tag3>"], "wordsA": ["There", "are", "no", "backup", "facilities", "for", "our", "manufacturing", "operations", "located", "in", "Huntsville,", "Alabama."], "wordsB": ["backup", "facilities", "for", "our", "manufacturing", "operations", "located", "in", "Huntsville,", "Alabama."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p51_s2", "idA": "906709_12_item1a_p50_s16", "sentA": "Our collaborative partners may also be subject to catastrophic events, such as hurricanes and tornadoes, any of which could harm our business, results of operations and financial condition.", "sentB": "Our collaborative partners may also be subject to catastrophic events, such as earthquakes, floods, hurricanes and tornadoes, any of which could harm our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "Our", "collaborative", "partners", "may", "also", "be", "subject", "to", "catastrophic", "events,", "such", "as", "hurricanes", "and", "tornadoes,", "any", "of", "which", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Our", "collaborative", "partners", "may", "also", "be", "subject", "to", "catastrophic", "events,", "such", "as", "earthquakes,", "floods,", "hurricanes", "and", "tornadoes,", "any", "of", "which", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["Our", "collaborative", "partners", "may", "also", "be", "subject", "to", "catastrophic", "events,", "such", "as", "hurricanes", "and", "tornadoes,", "any", "of", "which", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Our", "collaborative", "partners", "may", "also", "be", "subject", "to", "catastrophic", "events,", "such", "as", "earthquakes,", "floods,", "hurricanes", "and", "tornadoes,", "any", "of", "which", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p50_s15", "idA": "906709_12_item1a_p50_s4", "sentA": "We must attract and retain experts in the areas of clinical testing, manufacturing, regulatory, finance, marketing and distribution and develop additional expertise in our existing personnel.", "sentB": "We must attract and retain experts in the areas of clinical testing, manufacturing, research, regulatory and finance, and may need to attract and retain marketing and distribution experts and develop additional expertise in our existing personnel.", "type": 2, "words": ["<tag1>", "We", "must", "attract", "and", "retain", "experts", "in", "the", "areas", "of", "clinical", "testing,", "manufacturing,", "regulatory,", "finance,", "marketing", "and", "distribution", "and", "develop", "additional", "expertise", "in", "our", "existing", "personnel.", "<tag2>", "We", "must", "attract", "and", "retain", "experts", "in", "the", "areas", "of", "clinical", "testing,", "manufacturing,", "research,", "regulatory", "and", "finance,", "and", "may", "need", "to", "attract", "and", "retain", "marketing", "and", "distribution", "experts", "and", "develop", "additional", "expertise", "in", "our", "existing", "personnel.", "<tag3>"], "wordsA": ["We", "must", "attract", "and", "retain", "experts", "in", "the", "areas", "of", "clinical", "testing,", "manufacturing,", "regulatory,", "finance,", "marketing", "and", "distribution", "and", "develop", "additional", "expertise", "in", "our", "existing", "personnel."], "wordsB": ["We", "must", "attract", "and", "retain", "experts", "in", "the", "areas", "of", "clinical", "testing,", "manufacturing,", "research,", "regulatory", "and", "finance,", "and", "may", "need", "to", "attract", "and", "retain", "marketing", "and", "distribution", "experts", "and", "develop", "additional", "expertise", "in", "our", "existing", "personnel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p55_s0", "idA": "906709_12_item1a_p50_s9", "sentA": "Our equity incentive plan and employee benefit plans may not be effective in motivating or retaining our employees or attracting new employees, and significant volatility in the price of our stock may adversely affect our ability to attract or retain qualified personnel.", "sentB": "The restrictions contained in the indenture governing the senior secured notes could also limit our ability to plan for or react to market conditions, meet capital needs or otherwise restrict our activities or business plans and adversely affect our ability to finance our operations, enter into acquisitions or to engage in other business activities that would be in our interest.", "type": 2, "words": ["<tag1>", "Our", "equity", "incentive", "plan", "and", "employee", "benefit", "plans", "may", "not", "be", "effective", "in", "motivating", "or", "retaining", "our", "employees", "or", "attracting", "new", "employees,", "and", "significant", "volatility", "in", "the", "price", "of", "our", "stock", "may", "adversely", "affect", "our", "ability", "to", "attract", "or", "retain", "qualified", "personnel.", "<tag2>", "The", "restrictions", "contained", "in", "the", "indenture", "governing", "the", "senior", "secured", "notes", "could", "also", "limit", "our", "ability", "to", "plan", "for", "or", "react", "to", "market", "conditions,", "meet", "capital", "needs", "or", "otherwise", "restrict", "our", "activities", "or", "business", "plans", "and", "adversely", "affect", "our", "ability", "to", "finance", "our", "operations,", "enter", "into", "acquisitions", "or", "to", "engage", "in", "other", "business", "activities", "that", "would", "be", "in", "our", "interest.", "<tag3>"], "wordsA": ["Our", "equity", "incentive", "plan", "and", "employee", "benefit", "plans", "may", "not", "be", "effective", "in", "motivating", "or", "retaining", "our", "employees", "or", "attracting", "new", "employees,", "and", "significant", "volatility", "in", "the", "price", "of", "our", "stock", "may", "adversely", "affect", "our", "ability", "to", "attract", "or", "retain", "qualified", "personnel."], "wordsB": ["The", "restrictions", "contained", "in", "the", "indenture", "governing", "the", "senior", "secured", "notes", "could", "also", "limit", "our", "ability", "to", "plan", "for", "or", "react", "to", "market", "conditions,", "meet", "capital", "needs", "or", "otherwise", "restrict", "our", "activities", "or", "business", "plans", "and", "adversely", "affect", "our", "ability", "to", "finance", "our", "operations,", "enter", "into", "acquisitions", "or", "to", "engage", "in", "other", "business", "activities", "that", "would", "be", "in", "our", "interest."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p52_s6", "idA": "906709_12_item1a_p51_s6", "sentA": "During the year ended December 31, 2011, based on closing bid prices on The NASDAQ Global Select Market, our stock price ranged from $12.53 to $4.22 per share.", "sentB": "During the year ended December 31, 2012, based on closing bid prices on The NASDAQ Global Select Market, our stock price ranged from $10.83 to $5.68 per share.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2011,", "based", "on", "closing", "bid", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$12.53", "to", "$4.22", "per", "share.", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2012,", "based", "on", "closing", "bid", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$10.83", "to", "$5.68", "per", "share.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2011,", "based", "on", "closing", "bid", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$12.53", "to", "$4.22", "per", "share."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2012,", "based", "on", "closing", "bid", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$10.83", "to", "$5.68", "per", "share."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p8_s4", "idA": "906709_12_item1a_p5_s2", "sentA": "As of December 31, 2011, we had cash, cash equivalents, and investments in marketable securities valued at approximately $414.9 million and indebtedness of approximately $239.9 million, including approximately $215.0 million in convertible subordinated notes due September 2012, $17.0 million in capital lease obligations, and $7.9 million of other liabilities.", "sentB": "As of December 31, 2012, we had cash, cash equivalents, and investments in marketable securities valued at approximately $302.2 million and indebtedness of approximately $149.0 million, including approximately $125.0 million in senior secured notes due July 2017, $14.6 million in capital lease obligations, and $9.4 million of other liabilities.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2011,", "we", "had", "cash,", "cash", "equivalents,", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$414.9", "million", "and", "indebtedness", "of", "approximately", "$239.9", "million,", "including", "approximately", "$215.0", "million", "in", "convertible", "subordinated", "notes", "due", "September", "2012,", "$17.0", "million", "in", "capital", "lease", "obligations,", "and", "$7.9", "million", "of", "other", "liabilities.", "<tag2>", "As", "of", "December", "31,", "2012,", "we", "had", "cash,", "cash", "equivalents,", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$302.2", "million", "and", "indebtedness", "of", "approximately", "$149.0", "million,", "including", "approximately", "$125.0", "million", "in", "senior", "secured", "notes", "due", "July", "2017,", "$14.6", "million", "in", "capital", "lease", "obligations,", "and", "$9.4", "million", "of", "other", "liabilities.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2011,", "we", "had", "cash,", "cash", "equivalents,", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$414.9", "million", "and", "indebtedness", "of", "approximately", "$239.9", "million,", "including", "approximately", "$215.0", "million", "in", "convertible", "subordinated", "notes", "due", "September", "2012,", "$17.0", "million", "in", "capital", "lease", "obligations,", "and", "$7.9", "million", "of", "other", "liabilities."], "wordsB": ["As", "of", "December", "31,", "2012,", "we", "had", "cash,", "cash", "equivalents,", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$302.2", "million", "and", "indebtedness", "of", "approximately", "$149.0", "million,", "including", "approximately", "$125.0", "million", "in", "senior", "secured", "notes", "due", "July", "2017,", "$14.6", "million", "in", "capital", "lease", "obligations,", "and", "$9.4", "million", "of", "other", "liabilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p12_s0", "idA": "906709_12_item1a_p7_s0", "sentA": "The results from the expanded Phase 2 clinical study for NKTR-102 in women with platinum-resistant/refractory ovarian cancer are unlikely to result in a review or an approval of a new drug application (NDA) by the United States Food and Drug Administration (FDA), and the future results from this trial are difficult to predict.", "sentB": "The results from the expanded Phase 2 clinical study for etirinotecan pegol in women with platinum-resistant/refractory ovarian cancer are unlikely to result in a review or an approval of a NDA by the FDA.", "type": 2, "words": ["<tag1>", "The", "results", "from", "the", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "are", "unlikely", "to", "result", "in", "a", "review", "or", "an", "approval", "of", "a", "new", "drug", "application", "(NDA)", "by", "the", "United", "States", "Food", "and", "Drug", "Administration", "(FDA),", "and", "the", "future", "results", "from", "this", "trial", "are", "difficult", "to", "predict.", "<tag2>", "The", "results", "from", "the", "expanded", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "are", "unlikely", "to", "result", "in", "a", "review", "or", "an", "approval", "of", "a", "NDA", "by", "the", "FDA.", "<tag3>"], "wordsA": ["The", "results", "from", "the", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "are", "unlikely", "to", "result", "in", "a", "review", "or", "an", "approval", "of", "a", "new", "drug", "application", "(NDA)", "by", "the", "United", "States", "Food", "and", "Drug", "Administration", "(FDA),", "and", "the", "future", "results", "from", "this", "trial", "are", "difficult", "to", "predict."], "wordsB": ["The", "results", "from", "the", "expanded", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "are", "unlikely", "to", "result", "in", "a", "review", "or", "an", "approval", "of", "a", "NDA", "by", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p17_s1", "idA": "906709_12_item1a_p7_s0", "sentA": "The results from the expanded Phase 2 clinical study for NKTR-102 in women with platinum-resistant/refractory ovarian cancer are unlikely to result in a review or an approval of a new drug application (NDA) by the United States Food and Drug Administration (FDA), and the future results from this trial are difficult to predict.", "sentB": "For example, we have announced preliminary tumor response rate data from our expanded Phase 2 clinical study for etirinotecan pegol in platinum resistant/refractory ovarian cancer.", "type": 2, "words": ["<tag1>", "The", "results", "from", "the", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "are", "unlikely", "to", "result", "in", "a", "review", "or", "an", "approval", "of", "a", "new", "drug", "application", "(NDA)", "by", "the", "United", "States", "Food", "and", "Drug", "Administration", "(FDA),", "and", "the", "future", "results", "from", "this", "trial", "are", "difficult", "to", "predict.", "<tag2>", "For", "example,", "we", "have", "announced", "preliminary", "tumor", "response", "rate", "data", "from", "our", "expanded", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "platinum", "resistant/refractory", "ovarian", "cancer.", "<tag3>"], "wordsA": ["The", "results", "from", "the", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "are", "unlikely", "to", "result", "in", "a", "review", "or", "an", "approval", "of", "a", "new", "drug", "application", "(NDA)", "by", "the", "United", "States", "Food", "and", "Drug", "Administration", "(FDA),", "and", "the", "future", "results", "from", "this", "trial", "are", "difficult", "to", "predict."], "wordsB": ["For", "example,", "we", "have", "announced", "preliminary", "tumor", "response", "rate", "data", "from", "our", "expanded", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "platinum", "resistant/refractory", "ovarian", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p12_s1", "idA": "906709_12_item1a_p7_s1", "sentA": "We expanded the NKTR-102 Phase 2 study by 110 patients in women with platinum-resistant/refractory ovarian cancer that had received prior Doxil therapy with the potential for us to consider an early NDA submission after we evaluate these expanded study results.", "sentB": "We expanded the etirinotecan pegol Phase 2 study by 110 patients in women with platinum-resistant/refractory ovarian cancer that had received prior Doxil therapy with the potential for us to consider an early NDA submission after we evaluate these expanded study results.", "type": 2, "words": ["<tag1>", "We", "expanded", "the", "NKTR-102", "Phase", "2", "study", "by", "110", "patients", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "that", "had", "received", "prior", "Doxil", "therapy", "with", "the", "potential", "for", "us", "to", "consider", "an", "early", "NDA", "submission", "after", "we", "evaluate", "these", "expanded", "study", "results.", "<tag2>", "We", "expanded", "the", "etirinotecan", "pegol", "Phase", "2", "study", "by", "110", "patients", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "that", "had", "received", "prior", "Doxil", "therapy", "with", "the", "potential", "for", "us", "to", "consider", "an", "early", "NDA", "submission", "after", "we", "evaluate", "these", "expanded", "study", "results.", "<tag3>"], "wordsA": ["We", "expanded", "the", "NKTR-102", "Phase", "2", "study", "by", "110", "patients", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "that", "had", "received", "prior", "Doxil", "therapy", "with", "the", "potential", "for", "us", "to", "consider", "an", "early", "NDA", "submission", "after", "we", "evaluate", "these", "expanded", "study", "results."], "wordsB": ["We", "expanded", "the", "etirinotecan", "pegol", "Phase", "2", "study", "by", "110", "patients", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "that", "had", "received", "prior", "Doxil", "therapy", "with", "the", "potential", "for", "us", "to", "consider", "an", "early", "NDA", "submission", "after", "we", "evaluate", "these", "expanded", "study", "results."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p12_s2", "idA": "906709_12_item1a_p7_s4", "sentA": "We are currently in the process of compiling and performing verification procedures on preliminary interim results from the patients.", "sentB": "We are currently in the process of compiling and performing verification procedures on the data from this study.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "in", "the", "process", "of", "compiling", "and", "performing", "verification", "procedures", "on", "preliminary", "interim", "results", "from", "the", "patients.", "<tag2>", "We", "are", "currently", "in", "the", "process", "of", "compiling", "and", "performing", "verification", "procedures", "on", "the", "data", "from", "this", "study.", "<tag3>"], "wordsA": ["We", "are", "currently", "in", "the", "process", "of", "compiling", "and", "performing", "verification", "procedures", "on", "preliminary", "interim", "results", "from", "the", "patients."], "wordsB": ["We", "are", "currently", "in", "the", "process", "of", "compiling", "and", "performing", "verification", "procedures", "on", "the", "data", "from", "this", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p13_s2", "idA": "906709_12_item1a_p8_s2", "sentA": "Therefore we do not expect the FDA to accept or approve an accelerated NDA based on this Phase 2 clinical study.", "sentB": "Therefore we do not expect the FDA to accept or approve a NDA based on this Phase 2 clinical study.", "type": 2, "words": ["<tag1>", "Therefore", "we", "do", "not", "expect", "the", "FDA", "to", "accept", "or", "approve", "an", "accelerated", "NDA", "based", "on", "this", "Phase", "2", "clinical", "study.", "<tag2>", "Therefore", "we", "do", "not", "expect", "the", "FDA", "to", "accept", "or", "approve", "a", "NDA", "based", "on", "this", "Phase", "2", "clinical", "study.", "<tag3>"], "wordsA": ["Therefore", "we", "do", "not", "expect", "the", "FDA", "to", "accept", "or", "approve", "an", "accelerated", "NDA", "based", "on", "this", "Phase", "2", "clinical", "study."], "wordsB": ["Therefore", "we", "do", "not", "expect", "the", "FDA", "to", "accept", "or", "approve", "a", "NDA", "based", "on", "this", "Phase", "2", "clinical", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p13_s4", "idA": "906709_12_item1a_p8_s4", "sentA": "One or more of such judgments and determinations by the FDA could impair our ability to submit an accelerated NDA for platinum resistant/refractory ovarian cancer patients, and even if submitted, whether the FDA would accept it for review and/or approve the NDA.", "sentB": "One or more of such judgments and determinations by the FDA could impair our ability to submit an NDA for platinum resistant/refractory ovarian cancer patients, and even if submitted, whether the FDA would accept it for review or approve the NDA.", "type": 2, "words": ["<tag1>", "One", "or", "more", "of", "such", "judgments", "and", "determinations", "by", "the", "FDA", "could", "impair", "our", "ability", "to", "submit", "an", "accelerated", "NDA", "for", "platinum", "resistant/refractory", "ovarian", "cancer", "patients,", "and", "even", "if", "submitted,", "whether", "the", "FDA", "would", "accept", "it", "for", "review", "and/or", "approve", "the", "NDA.", "<tag2>", "One", "or", "more", "of", "such", "judgments", "and", "determinations", "by", "the", "FDA", "could", "impair", "our", "ability", "to", "submit", "an", "NDA", "for", "platinum", "resistant/refractory", "ovarian", "cancer", "patients,", "and", "even", "if", "submitted,", "whether", "the", "FDA", "would", "accept", "it", "for", "review", "or", "approve", "the", "NDA.", "<tag3>"], "wordsA": ["One", "or", "more", "of", "such", "judgments", "and", "determinations", "by", "the", "FDA", "could", "impair", "our", "ability", "to", "submit", "an", "accelerated", "NDA", "for", "platinum", "resistant/refractory", "ovarian", "cancer", "patients,", "and", "even", "if", "submitted,", "whether", "the", "FDA", "would", "accept", "it", "for", "review", "and/or", "approve", "the", "NDA."], "wordsB": ["One", "or", "more", "of", "such", "judgments", "and", "determinations", "by", "the", "FDA", "could", "impair", "our", "ability", "to", "submit", "an", "NDA", "for", "platinum", "resistant/refractory", "ovarian", "cancer", "patients,", "and", "even", "if", "submitted,", "whether", "the", "FDA", "would", "accept", "it", "for", "review", "or", "approve", "the", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p13_s5", "idA": "906709_12_item1a_p8_s5", "sentA": "Further, this expansion of our Phase 2 study in platinum resistant/refractory ovarian cancer will necessarily change the final efficacy (e.g., overall response rates, progression-free survival, overall survival) and safety (i.e., frequency and severity of serious adverse events) results, and, accordingly, the final results in this study remain subject to substantial change and could be materially and adversely different from previously announced results.", "sentB": "Further, this expansion of our Phase 2 clinical study in platinum resistant/refractory ovarian cancer will necessarily change the final efficacy (e.g., overall response rates, progression-free survival, overall survival) and safety (i.e., frequency and severity of serious adverse events) results, and, accordingly, the final results in this study remain subject to substantial change and could be materially and adversely different from previously announced results.", "type": 2, "words": ["<tag1>", "Further,", "this", "expansion", "of", "our", "Phase", "2", "study", "in", "platinum", "resistant/refractory", "ovarian", "cancer", "will", "necessarily", "change", "the", "final", "efficacy", "(e.g.,", "overall", "response", "rates,", "progression-free", "survival,", "overall", "survival)", "and", "safety", "(i.e.,", "frequency", "and", "severity", "of", "serious", "adverse", "events)", "results,", "and,", "accordingly,", "the", "final", "results", "in", "this", "study", "remain", "subject", "to", "substantial", "change", "and", "could", "be", "materially", "and", "adversely", "different", "from", "previously", "announced", "results.", "<tag2>", "Further,", "this", "expansion", "of", "our", "Phase", "2", "clinical", "study", "in", "platinum", "resistant/refractory", "ovarian", "cancer", "will", "necessarily", "change", "the", "final", "efficacy", "(e.g.,", "overall", "response", "rates,", "progression-free", "survival,", "overall", "survival)", "and", "safety", "(i.e.,", "frequency", "and", "severity", "of", "serious", "adverse", "events)", "results,", "and,", "accordingly,", "the", "final", "results", "in", "this", "study", "remain", "subject", "to", "substantial", "change", "and", "could", "be", "materially", "and", "adversely", "different", "from", "previously", "announced", "results.", "<tag3>"], "wordsA": ["Further,", "this", "expansion", "of", "our", "Phase", "2", "study", "in", "platinum", "resistant/refractory", "ovarian", "cancer", "will", "necessarily", "change", "the", "final", "efficacy", "(e.g.,", "overall", "response", "rates,", "progression-free", "survival,", "overall", "survival)", "and", "safety", "(i.e.,", "frequency", "and", "severity", "of", "serious", "adverse", "events)", "results,", "and,", "accordingly,", "the", "final", "results", "in", "this", "study", "remain", "subject", "to", "substantial", "change", "and", "could", "be", "materially", "and", "adversely", "different", "from", "previously", "announced", "results."], "wordsB": ["Further,", "this", "expansion", "of", "our", "Phase", "2", "clinical", "study", "in", "platinum", "resistant/refractory", "ovarian", "cancer", "will", "necessarily", "change", "the", "final", "efficacy", "(e.g.,", "overall", "response", "rates,", "progression-free", "survival,", "overall", "survival)", "and", "safety", "(i.e.,", "frequency", "and", "severity", "of", "serious", "adverse", "events)", "results,", "and,", "accordingly,", "the", "final", "results", "in", "this", "study", "remain", "subject", "to", "substantial", "change", "and", "could", "be", "materially", "and", "adversely", "different", "from", "previously", "announced", "results."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p14_s0", "idA": "906709_12_item1a_p9_s0", "sentA": "If the clinical studies for NKTR-102 ovarian cancer are not successful, it could significantly harm our business, results of operations and financial condition.", "sentB": "If the clinical studies for etirinotecan pegol ovarian cancer are not successful, it could significantly harm our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "If", "the", "clinical", "studies", "for", "NKTR-102", "ovarian", "cancer", "are", "not", "successful,", "it", "could", "significantly", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "If", "the", "clinical", "studies", "for", "etirinotecan", "pegol", "ovarian", "cancer", "are", "not", "successful,", "it", "could", "significantly", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["If", "the", "clinical", "studies", "for", "NKTR-102", "ovarian", "cancer", "are", "not", "successful,", "it", "could", "significantly", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["If", "the", "clinical", "studies", "for", "etirinotecan", "pegol", "ovarian", "cancer", "are", "not", "successful,", "it", "could", "significantly", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item1a_p15_s0", "idA": "906709_12_item1a_p9_s4", "sentA": "In the future, an alternative chemistry technique, process or method of administration, or combination thereof, may be discovered to enable the conversion of NKTR-181 into a more abusable opioid which could significantly and negatively impact the potential of NKTR-181.", "sentB": "or combination thereof, may be discovered to enable the conversion of NKTR-181 into a more abusable opioid which could significantly and negatively impact the potential of NKTR-181.", "type": 2, "words": ["<tag1>", "In", "the", "future,", "an", "alternative", "chemistry", "technique,", "process", "or", "method", "of", "administration,", "or", "combination", "thereof,", "may", "be", "discovered", "to", "enable", "the", "conversion", "of", "NKTR-181", "into", "a", "more", "abusable", "opioid", "which", "could", "significantly", "and", "negatively", "impact", "the", "potential", "of", "NKTR-181.", "<tag2>", "or", "combination", "thereof,", "may", "be", "discovered", "to", "enable", "the", "conversion", "of", "NKTR-181", "into", "a", "more", "abusable", "opioid", "which", "could", "significantly", "and", "negatively", "impact", "the", "potential", "of", "NKTR-181.", "<tag3>"], "wordsA": ["In", "the", "future,", "an", "alternative", "chemistry", "technique,", "process", "or", "method", "of", "administration,", "or", "combination", "thereof,", "may", "be", "discovered", "to", "enable", "the", "conversion", "of", "NKTR-181", "into", "a", "more", "abusable", "opioid", "which", "could", "significantly", "and", "negatively", "impact", "the", "potential", "of", "NKTR-181."], "wordsB": ["or", "combination", "thereof,", "may", "be", "discovered", "to", "enable", "the", "conversion", "of", "NKTR-181", "into", "a", "more", "abusable", "opioid", "which", "could", "significantly", "and", "negatively", "impact", "the", "potential", "of", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p10_s1", "idA": "906709_13_item1a_p11_s0", "sentA": "A significant multi-year capital commitment is required to advance our drug candidates through the various stages of research and development in order to generate sufficient data to enable high value collaboration partnerships with significant up-front payments or to successfully achieve regulatory approval.", "sentB": "A significant multi-year capital commitment is required to advance our drug candidates through the various stages of research and development in order to generate sufficient data to enable high value collaboration partnerships with significant upfront payments or to successfully achieve regulatory approval.", "type": 2, "words": ["<tag1>", "A", "significant", "multi-year", "capital", "commitment", "is", "required", "to", "advance", "our", "drug", "candidates", "through", "the", "various", "stages", "of", "research", "and", "development", "in", "order", "to", "generate", "sufficient", "data", "to", "enable", "high", "value", "collaboration", "partnerships", "with", "significant", "up-front", "payments", "or", "to", "successfully", "achieve", "regulatory", "approval.", "<tag2>", "A", "significant", "multi-year", "capital", "commitment", "is", "required", "to", "advance", "our", "drug", "candidates", "through", "the", "various", "stages", "of", "research", "and", "development", "in", "order", "to", "generate", "sufficient", "data", "to", "enable", "high", "value", "collaboration", "partnerships", "with", "significant", "upfront", "payments", "or", "to", "successfully", "achieve", "regulatory", "approval.", "<tag3>"], "wordsA": ["A", "significant", "multi-year", "capital", "commitment", "is", "required", "to", "advance", "our", "drug", "candidates", "through", "the", "various", "stages", "of", "research", "and", "development", "in", "order", "to", "generate", "sufficient", "data", "to", "enable", "high", "value", "collaboration", "partnerships", "with", "significant", "up-front", "payments", "or", "to", "successfully", "achieve", "regulatory", "approval."], "wordsB": ["A", "significant", "multi-year", "capital", "commitment", "is", "required", "to", "advance", "our", "drug", "candidates", "through", "the", "various", "stages", "of", "research", "and", "development", "in", "order", "to", "generate", "sufficient", "data", "to", "enable", "high", "value", "collaboration", "partnerships", "with", "significant", "upfront", "payments", "or", "to", "successfully", "achieve", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p10_s2", "idA": "906709_13_item1a_p11_s1", "sentA": "In the event we do not enter into any new collaboration partnerships with significant up-front payments and we choose to continue our main research and development programs, we may need to pursue financing alternatives, including dilutive equity-based financings, such as an offering of convertible debt or common stock, which would dilute the percentage ownership of our current common stockholders and could significantly lower the market value of our common stock.", "sentB": "In the event we do not enter into any new collaboration partnerships with significant upfront payments and we choose to continue our later stage research and development programs, we may need to pursue financing alternatives, including dilutive equity-based financings, such as an offering of convertible debt or common stock, which would dilute the percentage ownership of our current common stockholders and could significantly lower the market value of our common stock.", "type": 2, "words": ["<tag1>", "In", "the", "event", "we", "do", "not", "enter", "into", "any", "new", "collaboration", "partnerships", "with", "significant", "up-front", "payments", "and", "we", "choose", "to", "continue", "our", "main", "research", "and", "development", "programs,", "we", "may", "need", "to", "pursue", "financing", "alternatives,", "including", "dilutive", "equity-based", "financings,", "such", "as", "an", "offering", "of", "convertible", "debt", "or", "common", "stock,", "which", "would", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stockholders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock.", "<tag2>", "In", "the", "event", "we", "do", "not", "enter", "into", "any", "new", "collaboration", "partnerships", "with", "significant", "upfront", "payments", "and", "we", "choose", "to", "continue", "our", "later", "stage", "research", "and", "development", "programs,", "we", "may", "need", "to", "pursue", "financing", "alternatives,", "including", "dilutive", "equity-based", "financings,", "such", "as", "an", "offering", "of", "convertible", "debt", "or", "common", "stock,", "which", "would", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stockholders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["In", "the", "event", "we", "do", "not", "enter", "into", "any", "new", "collaboration", "partnerships", "with", "significant", "up-front", "payments", "and", "we", "choose", "to", "continue", "our", "main", "research", "and", "development", "programs,", "we", "may", "need", "to", "pursue", "financing", "alternatives,", "including", "dilutive", "equity-based", "financings,", "such", "as", "an", "offering", "of", "convertible", "debt", "or", "common", "stock,", "which", "would", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stockholders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock."], "wordsB": ["In", "the", "event", "we", "do", "not", "enter", "into", "any", "new", "collaboration", "partnerships", "with", "significant", "upfront", "payments", "and", "we", "choose", "to", "continue", "our", "later", "stage", "research", "and", "development", "programs,", "we", "may", "need", "to", "pursue", "financing", "alternatives,", "including", "dilutive", "equity-based", "financings,", "such", "as", "an", "offering", "of", "convertible", "debt", "or", "common", "stock,", "which", "would", "dilute", "the", "percentage", "ownership", "of", "our", "current", "common", "stockholders", "and", "could", "significantly", "lower", "the", "market", "value", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p13_s10", "idA": "906709_13_item1a_p12_s0", "sentA": "The results from the expanded Phase 2 clinical study for etirinotecan pegol in women with platinum-resistant/refractory ovarian cancer are unlikely to result in a review or an approval of a NDA by the FDA.", "sentB": "We are currently evaluating the recently announced results from our Phase 2 efficacy clinical study for NKTR-181 and are in the planning stage for a Phase 3 clinical study for NKTR-181 including continuing consultations with leaders in the pain clinical trial field and interactions with the FDA.", "type": 2, "words": ["<tag1>", "The", "results", "from", "the", "expanded", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "are", "unlikely", "to", "result", "in", "a", "review", "or", "an", "approval", "of", "a", "NDA", "by", "the", "FDA.", "<tag2>", "We", "are", "currently", "evaluating", "the", "recently", "announced", "results", "from", "our", "Phase", "2", "efficacy", "clinical", "study", "for", "NKTR-181", "and", "are", "in", "the", "planning", "stage", "for", "a", "Phase", "3", "clinical", "study", "for", "NKTR-181", "including", "continuing", "consultations", "with", "leaders", "in", "the", "pain", "clinical", "trial", "field", "and", "interactions", "with", "the", "FDA.", "<tag3>"], "wordsA": ["The", "results", "from", "the", "expanded", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "women", "with", "platinum-resistant/refractory", "ovarian", "cancer", "are", "unlikely", "to", "result", "in", "a", "review", "or", "an", "approval", "of", "a", "NDA", "by", "the", "FDA."], "wordsB": ["We", "are", "currently", "evaluating", "the", "recently", "announced", "results", "from", "our", "Phase", "2", "efficacy", "clinical", "study", "for", "NKTR-181", "and", "are", "in", "the", "planning", "stage", "for", "a", "Phase", "3", "clinical", "study", "for", "NKTR-181", "including", "continuing", "consultations", "with", "leaders", "in", "the", "pain", "clinical", "trial", "field", "and", "interactions", "with", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p5_s1", "idA": "906709_13_item1a_p13_s1", "sentA": "As a result, acceptance for review or approval of an accelerated NDA submitted to the FDA based on overall response rate from our single-arm Phase 2 study in platinum-resistant/refractory ovarian cancer would be unusual and is highly unlikely.", "sentB": "The amendment provides that if the FDA requires a cardiovascular safety study as a condition to approval of naloxegol and, as a result, AstraZeneca terminates its agreement with us in its entirety, we would be required to repay AstraZeneca the $70.0 million we received upon the FDA s acceptance for review of the naloxegol NDA plus accrued interest at 4.5% compounded annually.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "acceptance", "for", "review", "or", "approval", "of", "an", "accelerated", "NDA", "submitted", "to", "the", "FDA", "based", "on", "overall", "response", "rate", "from", "our", "single-arm", "Phase", "2", "study", "in", "platinum-resistant/refractory", "ovarian", "cancer", "would", "be", "unusual", "and", "is", "highly", "unlikely.", "<tag2>", "The", "amendment", "provides", "that", "if", "the", "FDA", "requires", "a", "cardiovascular", "safety", "study", "as", "a", "condition", "to", "approval", "of", "naloxegol", "and,", "as", "a", "result,", "AstraZeneca", "terminates", "its", "agreement", "with", "us", "in", "its", "entirety,", "we", "would", "be", "required", "to", "repay", "AstraZeneca", "the", "$70.0", "million", "we", "received", "upon", "the", "FDA", "s", "acceptance", "for", "review", "of", "the", "naloxegol", "NDA", "plus", "accrued", "interest", "at", "4.5%", "compounded", "annually.", "<tag3>"], "wordsA": ["As", "a", "result,", "acceptance", "for", "review", "or", "approval", "of", "an", "accelerated", "NDA", "submitted", "to", "the", "FDA", "based", "on", "overall", "response", "rate", "from", "our", "single-arm", "Phase", "2", "study", "in", "platinum-resistant/refractory", "ovarian", "cancer", "would", "be", "unusual", "and", "is", "highly", "unlikely."], "wordsB": ["The", "amendment", "provides", "that", "if", "the", "FDA", "requires", "a", "cardiovascular", "safety", "study", "as", "a", "condition", "to", "approval", "of", "naloxegol", "and,", "as", "a", "result,", "AstraZeneca", "terminates", "its", "agreement", "with", "us", "in", "its", "entirety,", "we", "would", "be", "required", "to", "repay", "AstraZeneca", "the", "$70.0", "million", "we", "received", "upon", "the", "FDA", "s", "acceptance", "for", "review", "of", "the", "naloxegol", "NDA", "plus", "accrued", "interest", "at", "4.5%", "compounded", "annually."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p11_s3", "idA": "906709_13_item1a_p15_s0", "sentA": "or combination thereof, may be discovered to enable the conversion of NKTR-181 into a more abusable opioid which could significantly and negatively impact the potential of NKTR-181.", "sentB": "In the future, an alternative chemistry technique, process or method of administration, or combination thereof, may be discovered to enable the conversion of NKTR-181 into a more abusable opioid, which could significantly and negatively impact the potential of NKTR-181.", "type": 2, "words": ["<tag1>", "or", "combination", "thereof,", "may", "be", "discovered", "to", "enable", "the", "conversion", "of", "NKTR-181", "into", "a", "more", "abusable", "opioid", "which", "could", "significantly", "and", "negatively", "impact", "the", "potential", "of", "NKTR-181.", "<tag2>", "In", "the", "future,", "an", "alternative", "chemistry", "technique,", "process", "or", "method", "of", "administration,", "or", "combination", "thereof,", "may", "be", "discovered", "to", "enable", "the", "conversion", "of", "NKTR-181", "into", "a", "more", "abusable", "opioid,", "which", "could", "significantly", "and", "negatively", "impact", "the", "potential", "of", "NKTR-181.", "<tag3>"], "wordsA": ["or", "combination", "thereof,", "may", "be", "discovered", "to", "enable", "the", "conversion", "of", "NKTR-181", "into", "a", "more", "abusable", "opioid", "which", "could", "significantly", "and", "negatively", "impact", "the", "potential", "of", "NKTR-181."], "wordsB": ["In", "the", "future,", "an", "alternative", "chemistry", "technique,", "process", "or", "method", "of", "administration,", "or", "combination", "thereof,", "may", "be", "discovered", "to", "enable", "the", "conversion", "of", "NKTR-181", "into", "a", "more", "abusable", "opioid,", "which", "could", "significantly", "and", "negatively", "impact", "the", "potential", "of", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p13_s1", "idA": "906709_13_item1a_p17_s1", "sentA": "For example, we have announced preliminary tumor response rate data from our expanded Phase 2 clinical study for etirinotecan pegol in platinum resistant/refractory ovarian cancer.", "sentB": "For example, we have announced preliminary topline data from our Phase 2 clinical study for NKTR-181.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "have", "announced", "preliminary", "tumor", "response", "rate", "data", "from", "our", "expanded", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "platinum", "resistant/refractory", "ovarian", "cancer.", "<tag2>", "For", "example,", "we", "have", "announced", "preliminary", "topline", "data", "from", "our", "Phase", "2", "clinical", "study", "for", "NKTR-181.", "<tag3>"], "wordsA": ["For", "example,", "we", "have", "announced", "preliminary", "tumor", "response", "rate", "data", "from", "our", "expanded", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "platinum", "resistant/refractory", "ovarian", "cancer."], "wordsB": ["For", "example,", "we", "have", "announced", "preliminary", "topline", "data", "from", "our", "Phase", "2", "clinical", "study", "for", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p13_s9", "idA": "906709_13_item1a_p17_s1", "sentA": "For example, we have announced preliminary tumor response rate data from our expanded Phase 2 clinical study for etirinotecan pegol in platinum resistant/refractory ovarian cancer.", "sentB": "A Phase 2 clinical study for etirinotecan pegol in patients with metastatic colorectal cancer is still open for enrollment.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "have", "announced", "preliminary", "tumor", "response", "rate", "data", "from", "our", "expanded", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "platinum", "resistant/refractory", "ovarian", "cancer.", "<tag2>", "A", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "patients", "with", "metastatic", "colorectal", "cancer", "is", "still", "open", "for", "enrollment.", "<tag3>"], "wordsA": ["For", "example,", "we", "have", "announced", "preliminary", "tumor", "response", "rate", "data", "from", "our", "expanded", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "platinum", "resistant/refractory", "ovarian", "cancer."], "wordsB": ["A", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "patients", "with", "metastatic", "colorectal", "cancer", "is", "still", "open", "for", "enrollment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p14_s0", "idA": "906709_13_item1a_p17_s10", "sentA": "These and other of our planned clinical studies may not begin on time, have an effective design, enroll a sufficient number of patients or be completed on schedule, if at all.", "sentB": "and other of our planned clinical studies may not begin on time, have an effective design, enroll a sufficient number of patients or be completed on schedule, if at all.", "type": 2, "words": ["<tag1>", "These", "and", "other", "of", "our", "planned", "clinical", "studies", "may", "not", "begin", "on", "time,", "have", "an", "effective", "design,", "enroll", "a", "sufficient", "number", "of", "patients", "or", "be", "completed", "on", "schedule,", "if", "at", "all.", "<tag2>", "and", "other", "of", "our", "planned", "clinical", "studies", "may", "not", "begin", "on", "time,", "have", "an", "effective", "design,", "enroll", "a", "sufficient", "number", "of", "patients", "or", "be", "completed", "on", "schedule,", "if", "at", "all.", "<tag3>"], "wordsA": ["These", "and", "other", "of", "our", "planned", "clinical", "studies", "may", "not", "begin", "on", "time,", "have", "an", "effective", "design,", "enroll", "a", "sufficient", "number", "of", "patients", "or", "be", "completed", "on", "schedule,", "if", "at", "all."], "wordsB": ["and", "other", "of", "our", "planned", "clinical", "studies", "may", "not", "begin", "on", "time,", "have", "an", "effective", "design,", "enroll", "a", "sufficient", "number", "of", "patients", "or", "be", "completed", "on", "schedule,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p13_s8", "idA": "906709_13_item1a_p17_s8", "sentA": "Etirinotecan pegol and BAX 855 are currently in Phase 3 clinical studies and Bayer plans to advance Amikacin Inhale into Phase 3 clinical development in March 2013.", "sentB": "Etirinotecan pegol in patients with metastatic breast cancer and BAX 855 are currently in Phase 3 clinical studies, and Bayer has initiated Phase 3 clinical development of BAY41-6551 with the first patient enrolled in April 2013.", "type": 2, "words": ["<tag1>", "Etirinotecan", "pegol", "and", "BAX", "855", "are", "currently", "in", "Phase", "3", "clinical", "studies", "and", "Bayer", "plans", "to", "advance", "Amikacin", "Inhale", "into", "Phase", "3", "clinical", "development", "in", "March", "2013.", "<tag2>", "Etirinotecan", "pegol", "in", "patients", "with", "metastatic", "breast", "cancer", "and", "BAX", "855", "are", "currently", "in", "Phase", "3", "clinical", "studies,", "and", "Bayer", "has", "initiated", "Phase", "3", "clinical", "development", "of", "BAY41-6551", "with", "the", "first", "patient", "enrolled", "in", "April", "2013.", "<tag3>"], "wordsA": ["Etirinotecan", "pegol", "and", "BAX", "855", "are", "currently", "in", "Phase", "3", "clinical", "studies", "and", "Bayer", "plans", "to", "advance", "Amikacin", "Inhale", "into", "Phase", "3", "clinical", "development", "in", "March", "2013."], "wordsB": ["Etirinotecan", "pegol", "in", "patients", "with", "metastatic", "breast", "cancer", "and", "BAX", "855", "are", "currently", "in", "Phase", "3", "clinical", "studies,", "and", "Bayer", "has", "initiated", "Phase", "3", "clinical", "development", "of", "BAY41-6551", "with", "the", "first", "patient", "enrolled", "in", "April", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p13_s11", "idA": "906709_13_item1a_p17_s9", "sentA": "In addition, we are conducting a Phase 2 study for NKTR-181 that we estimate will be completed in mid-2013 and we also plan to start a human abuse liability study for NKTR-181 during the first half of 2013.", "sentB": "Because it is unlikely that we will be able to identify a single cause for the NKTR-181 Phase 2 study not meeting its primary efficacy endpoint, there is increased risk in effectively designing a Phase 3 clinical study to demonstrate the efficacy of NKTR-181.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "are", "conducting", "a", "Phase", "2", "study", "for", "NKTR-181", "that", "we", "estimate", "will", "be", "completed", "in", "mid-2013", "and", "we", "also", "plan", "to", "start", "a", "human", "abuse", "liability", "study", "for", "NKTR-181", "during", "the", "first", "half", "of", "2013.", "<tag2>", "Because", "it", "is", "unlikely", "that", "we", "will", "be", "able", "to", "identify", "a", "single", "cause", "for", "the", "NKTR-181", "Phase", "2", "study", "not", "meeting", "its", "primary", "efficacy", "endpoint,", "there", "is", "increased", "risk", "in", "effectively", "designing", "a", "Phase", "3", "clinical", "study", "to", "demonstrate", "the", "efficacy", "of", "NKTR-181.", "<tag3>"], "wordsA": ["In", "addition,", "we", "are", "conducting", "a", "Phase", "2", "study", "for", "NKTR-181", "that", "we", "estimate", "will", "be", "completed", "in", "mid-2013", "and", "we", "also", "plan", "to", "start", "a", "human", "abuse", "liability", "study", "for", "NKTR-181", "during", "the", "first", "half", "of", "2013."], "wordsB": ["Because", "it", "is", "unlikely", "that", "we", "will", "be", "able", "to", "identify", "a", "single", "cause", "for", "the", "NKTR-181", "Phase", "2", "study", "not", "meeting", "its", "primary", "efficacy", "endpoint,", "there", "is", "increased", "risk", "in", "effectively", "designing", "a", "Phase", "3", "clinical", "study", "to", "demonstrate", "the", "efficacy", "of", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p15_s0", "idA": "906709_13_item1a_p18_s0", "sentA": "any change in health authorities policies or guidances applicable to our drug candidates.", "sentB": "changes in health authorities policies or guidance applicable to our drug candidates.", "type": 2, "words": ["<tag1>", "any", "change", "in", "health", "authorities", "policies", "or", "guidances", "applicable", "to", "our", "drug", "candidates.", "<tag2>", "changes", "in", "health", "authorities", "policies", "or", "guidance", "applicable", "to", "our", "drug", "candidates.", "<tag3>"], "wordsA": ["any", "change", "in", "health", "authorities", "policies", "or", "guidances", "applicable", "to", "our", "drug", "candidates."], "wordsB": ["changes", "in", "health", "authorities", "policies", "or", "guidance", "applicable", "to", "our", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p17_s0", "idA": "906709_13_item1a_p19_s2", "sentA": "It is very difficult to estimate the commercial potential of product candidates due to important factors such as safety and efficacy compared to other available treatments, including potential generic drug alternatives with similar efficacy profiles, changing standards of care, third party payer reimbursement standards, patient and physician preferences, the availability of competitive alternatives that may emerge either during the long drug development process or after commercial introduction, and the availability of generic versions of our successful product candidates following approval by government health authorities based on the expiration of regulatory exclusivity or our inability to prevent generic versions from coming to market by asserting our patents.", "sentB": "It is very difficult to estimate the commercial potential of product candidates due to important factors such as safety and efficacy compared to other available treatments, including potential generic drug alternatives with similar efficacy profiles, changing standards of care, third party payer reimbursement standards, patient and physician preferences, drug scheduling status, the availability of competitive alternatives that may emerge either during the long drug development process or after commercial introduction, and the availability of generic versions of our successful product candidates following approval by government health authorities based on the expiration of regulatory exclusivity or our inability to prevent generic versions from coming to market by asserting our patents.", "type": 2, "words": ["<tag1>", "It", "is", "very", "difficult", "to", "estimate", "the", "commercial", "potential", "of", "product", "candidates", "due", "to", "important", "factors", "such", "as", "safety", "and", "efficacy", "compared", "to", "other", "available", "treatments,", "including", "potential", "generic", "drug", "alternatives", "with", "similar", "efficacy", "profiles,", "changing", "standards", "of", "care,", "third", "party", "payer", "reimbursement", "standards,", "patient", "and", "physician", "preferences,", "the", "availability", "of", "competitive", "alternatives", "that", "may", "emerge", "either", "during", "the", "long", "drug", "development", "process", "or", "after", "commercial", "introduction,", "and", "the", "availability", "of", "generic", "versions", "of", "our", "successful", "product", "candidates", "following", "approval", "by", "government", "health", "authorities", "based", "on", "the", "expiration", "of", "regulatory", "exclusivity", "or", "our", "inability", "to", "prevent", "generic", "versions", "from", "coming", "to", "market", "by", "asserting", "our", "patents.", "<tag2>", "It", "is", "very", "difficult", "to", "estimate", "the", "commercial", "potential", "of", "product", "candidates", "due", "to", "important", "factors", "such", "as", "safety", "and", "efficacy", "compared", "to", "other", "available", "treatments,", "including", "potential", "generic", "drug", "alternatives", "with", "similar", "efficacy", "profiles,", "changing", "standards", "of", "care,", "third", "party", "payer", "reimbursement", "standards,", "patient", "and", "physician", "preferences,", "drug", "scheduling", "status,", "the", "availability", "of", "competitive", "alternatives", "that", "may", "emerge", "either", "during", "the", "long", "drug", "development", "process", "or", "after", "commercial", "introduction,", "and", "the", "availability", "of", "generic", "versions", "of", "our", "successful", "product", "candidates", "following", "approval", "by", "government", "health", "authorities", "based", "on", "the", "expiration", "of", "regulatory", "exclusivity", "or", "our", "inability", "to", "prevent", "generic", "versions", "from", "coming", "to", "market", "by", "asserting", "our", "patents.", "<tag3>"], "wordsA": ["It", "is", "very", "difficult", "to", "estimate", "the", "commercial", "potential", "of", "product", "candidates", "due", "to", "important", "factors", "such", "as", "safety", "and", "efficacy", "compared", "to", "other", "available", "treatments,", "including", "potential", "generic", "drug", "alternatives", "with", "similar", "efficacy", "profiles,", "changing", "standards", "of", "care,", "third", "party", "payer", "reimbursement", "standards,", "patient", "and", "physician", "preferences,", "the", "availability", "of", "competitive", "alternatives", "that", "may", "emerge", "either", "during", "the", "long", "drug", "development", "process", "or", "after", "commercial", "introduction,", "and", "the", "availability", "of", "generic", "versions", "of", "our", "successful", "product", "candidates", "following", "approval", "by", "government", "health", "authorities", "based", "on", "the", "expiration", "of", "regulatory", "exclusivity", "or", "our", "inability", "to", "prevent", "generic", "versions", "from", "coming", "to", "market", "by", "asserting", "our", "patents."], "wordsB": ["It", "is", "very", "difficult", "to", "estimate", "the", "commercial", "potential", "of", "product", "candidates", "due", "to", "important", "factors", "such", "as", "safety", "and", "efficacy", "compared", "to", "other", "available", "treatments,", "including", "potential", "generic", "drug", "alternatives", "with", "similar", "efficacy", "profiles,", "changing", "standards", "of", "care,", "third", "party", "payer", "reimbursement", "standards,", "patient", "and", "physician", "preferences,", "drug", "scheduling", "status,", "the", "availability", "of", "competitive", "alternatives", "that", "may", "emerge", "either", "during", "the", "long", "drug", "development", "process", "or", "after", "commercial", "introduction,", "and", "the", "availability", "of", "generic", "versions", "of", "our", "successful", "product", "candidates", "following", "approval", "by", "government", "health", "authorities", "based", "on", "the", "expiration", "of", "regulatory", "exclusivity", "or", "our", "inability", "to", "prevent", "generic", "versions", "from", "coming", "to", "market", "by", "asserting", "our", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p19_s0", "idA": "906709_13_item1a_p20_s2", "sentA": "In certain cases, we have existing licenses or cross-licenses with third parties, however the scope and adequacy of these licenses is very uncertain and can change substantially during long development and commercialization cycles for biotechnology and pharmaceutical products.", "sentB": "long development and commercialization cycles for biotechnology and pharmaceutical products.", "type": 2, "words": ["<tag1>", "In", "certain", "cases,", "we", "have", "existing", "licenses", "or", "cross-licenses", "with", "third", "parties,", "however", "the", "scope", "and", "adequacy", "of", "these", "licenses", "is", "very", "uncertain", "and", "can", "change", "substantially", "during", "long", "development", "and", "commercialization", "cycles", "for", "biotechnology", "and", "pharmaceutical", "products.", "<tag2>", "long", "development", "and", "commercialization", "cycles", "for", "biotechnology", "and", "pharmaceutical", "products.", "<tag3>"], "wordsA": ["In", "certain", "cases,", "we", "have", "existing", "licenses", "or", "cross-licenses", "with", "third", "parties,", "however", "the", "scope", "and", "adequacy", "of", "these", "licenses", "is", "very", "uncertain", "and", "can", "change", "substantially", "during", "long", "development", "and", "commercialization", "cycles", "for", "biotechnology", "and", "pharmaceutical", "products."], "wordsB": ["long", "development", "and", "commercialization", "cycles", "for", "biotechnology", "and", "pharmaceutical", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p5_s0", "idA": "906709_13_item1a_p20_s4", "sentA": "If we are required to enter into a license with a third party, our potential economic benefit for the products subject to the license will be diminished.", "sentB": "We amended our license agreement with AstraZeneca to enter into a risk sharing arrangement in the event that pre-approval or post-approval cardiovascular safety studies are required by the FDA for naloxegol.", "type": 2, "words": ["<tag1>", "If", "we", "are", "required", "to", "enter", "into", "a", "license", "with", "a", "third", "party,", "our", "potential", "economic", "benefit", "for", "the", "products", "subject", "to", "the", "license", "will", "be", "diminished.", "<tag2>", "We", "amended", "our", "license", "agreement", "with", "AstraZeneca", "to", "enter", "into", "a", "risk", "sharing", "arrangement", "in", "the", "event", "that", "pre-approval", "or", "post-approval", "cardiovascular", "safety", "studies", "are", "required", "by", "the", "FDA", "for", "naloxegol.", "<tag3>"], "wordsA": ["If", "we", "are", "required", "to", "enter", "into", "a", "license", "with", "a", "third", "party,", "our", "potential", "economic", "benefit", "for", "the", "products", "subject", "to", "the", "license", "will", "be", "diminished."], "wordsB": ["We", "amended", "our", "license", "agreement", "with", "AstraZeneca", "to", "enter", "into", "a", "risk", "sharing", "arrangement", "in", "the", "event", "that", "pre-approval", "or", "post-approval", "cardiovascular", "safety", "studies", "are", "required", "by", "the", "FDA", "for", "naloxegol."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p21_s1", "idA": "906709_13_item1a_p21_s1", "sentA": "We own more than 150 U.S. and 500 foreign patents and a number of pending patent applications that cover various aspects of our technologies.", "sentB": "We own more than 175 U.S. and 500 foreign patents and a number of pending patent applications that cover various aspects of our technologies.", "type": 2, "words": ["<tag1>", "We", "own", "more", "than", "150", "U.S.", "and", "500", "foreign", "patents", "and", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies.", "<tag2>", "We", "own", "more", "than", "175", "U.S.", "and", "500", "foreign", "patents", "and", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies.", "<tag3>"], "wordsA": ["We", "own", "more", "than", "150", "U.S.", "and", "500", "foreign", "patents", "and", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies."], "wordsB": ["We", "own", "more", "than", "175", "U.S.", "and", "500", "foreign", "patents", "and", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p21_s4", "idA": "906709_13_item1a_p22_s0", "sentA": "revocation of the patent or maintenance of the patent in amended form (and potentially in a form that renders the patent without commercially relevant and/or broad coverage).", "sentB": "Additionally, issued patents can be subject to opposition or other proceedings that can result in the revocation of the patent or maintenance of the patent in amended form (and potentially in a form that renders the patent without commercially relevant and/or broad coverage).", "type": 2, "words": ["<tag1>", "revocation", "of", "the", "patent", "or", "maintenance", "of", "the", "patent", "in", "amended", "form", "(and", "potentially", "in", "a", "form", "that", "renders", "the", "patent", "without", "commercially", "relevant", "and/or", "broad", "coverage).", "<tag2>", "Additionally,", "issued", "patents", "can", "be", "subject", "to", "opposition", "or", "other", "proceedings", "that", "can", "result", "in", "the", "revocation", "of", "the", "patent", "or", "maintenance", "of", "the", "patent", "in", "amended", "form", "(and", "potentially", "in", "a", "form", "that", "renders", "the", "patent", "without", "commercially", "relevant", "and/or", "broad", "coverage).", "<tag3>"], "wordsA": ["revocation", "of", "the", "patent", "or", "maintenance", "of", "the", "patent", "in", "amended", "form", "(and", "potentially", "in", "a", "form", "that", "renders", "the", "patent", "without", "commercially", "relevant", "and/or", "broad", "coverage)."], "wordsB": ["Additionally,", "issued", "patents", "can", "be", "subject", "to", "opposition", "or", "other", "proceedings", "that", "can", "result", "in", "the", "revocation", "of", "the", "patent", "or", "maintenance", "of", "the", "patent", "in", "amended", "form", "(and", "potentially", "in", "a", "form", "that", "renders", "the", "patent", "without", "commercially", "relevant", "and/or", "broad", "coverage)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p43_s1", "idA": "906709_13_item1a_p22_s4", "sentA": "We have filed patent applications, and plan to file additional patent applications, covering various aspects of our PEGylation and advanced polymer conjugate technologies and our proprietary product candidates.", "sentB": "Competitors of our PEGylation and polymer conjugate chemistry technologies include Biogen Idec Inc., Savient Pharmaceuticals, Inc., Dr. Reddy s Laboratories Ltd., Enzon Pharmaceuticals, Inc., SunBio Corporation, Mountain View Pharmaceuticals, Inc., Novo Nordisk A/S (formerly assets held by Neose Technologies, Inc.), and NOF Corporation.", "type": 2, "words": ["<tag1>", "We", "have", "filed", "patent", "applications,", "and", "plan", "to", "file", "additional", "patent", "applications,", "covering", "various", "aspects", "of", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technologies", "and", "our", "proprietary", "product", "candidates.", "<tag2>", "Competitors", "of", "our", "PEGylation", "and", "polymer", "conjugate", "chemistry", "technologies", "include", "Biogen", "Idec", "Inc.,", "Savient", "Pharmaceuticals,", "Inc.,", "Dr.", "Reddy", "s", "Laboratories", "Ltd.,", "Enzon", "Pharmaceuticals,", "Inc.,", "SunBio", "Corporation,", "Mountain", "View", "Pharmaceuticals,", "Inc.,", "Novo", "Nordisk", "A/S", "(formerly", "assets", "held", "by", "Neose", "Technologies,", "Inc.),", "and", "NOF", "Corporation.", "<tag3>"], "wordsA": ["We", "have", "filed", "patent", "applications,", "and", "plan", "to", "file", "additional", "patent", "applications,", "covering", "various", "aspects", "of", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technologies", "and", "our", "proprietary", "product", "candidates."], "wordsB": ["Competitors", "of", "our", "PEGylation", "and", "polymer", "conjugate", "chemistry", "technologies", "include", "Biogen", "Idec", "Inc.,", "Savient", "Pharmaceuticals,", "Inc.,", "Dr.", "Reddy", "s", "Laboratories", "Ltd.,", "Enzon", "Pharmaceuticals,", "Inc.,", "SunBio", "Corporation,", "Mountain", "View", "Pharmaceuticals,", "Inc.,", "Novo", "Nordisk", "A/S", "(formerly", "assets", "held", "by", "Neose", "Technologies,", "Inc.),", "and", "NOF", "Corporation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p23_s4", "idA": "906709_13_item1a_p24_s4", "sentA": "We could be involved in legal proceedings and may incur substantial litigation costs and liabilities that will adversely affect our business, financial condition and results of operations.", "sentB": "We are involved in legal proceedings and may incur substantial litigation costs and liabilities that will adversely affect our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "We", "could", "be", "involved", "in", "legal", "proceedings", "and", "may", "incur", "substantial", "litigation", "costs", "and", "liabilities", "that", "will", "adversely", "affect", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "We", "are", "involved", "in", "legal", "proceedings", "and", "may", "incur", "substantial", "litigation", "costs", "and", "liabilities", "that", "will", "adversely", "affect", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["We", "could", "be", "involved", "in", "legal", "proceedings", "and", "may", "incur", "substantial", "litigation", "costs", "and", "liabilities", "that", "will", "adversely", "affect", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["We", "are", "involved", "in", "legal", "proceedings", "and", "may", "incur", "substantial", "litigation", "costs", "and", "liabilities", "that", "will", "adversely", "affect", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p25_s0", "idA": "906709_13_item1a_p25_s1", "sentA": "If a third party obtains injunctive or other equitable relief against us or our partners, they could effectively prevent us, or our partners, from developing or commercializing, or deriving revenue from, certain drugs or drug candidates in the U.S. and abroad.", "sentB": "from developing or commercializing, or deriving revenue from, certain drugs or drug candidates in the U.S. and abroad.", "type": 2, "words": ["<tag1>", "If", "a", "third", "party", "obtains", "injunctive", "or", "other", "equitable", "relief", "against", "us", "or", "our", "partners,", "they", "could", "effectively", "prevent", "us,", "or", "our", "partners,", "from", "developing", "or", "commercializing,", "or", "deriving", "revenue", "from,", "certain", "drugs", "or", "drug", "candidates", "in", "the", "U.S.", "and", "abroad.", "<tag2>", "from", "developing", "or", "commercializing,", "or", "deriving", "revenue", "from,", "certain", "drugs", "or", "drug", "candidates", "in", "the", "U.S.", "and", "abroad.", "<tag3>"], "wordsA": ["If", "a", "third", "party", "obtains", "injunctive", "or", "other", "equitable", "relief", "against", "us", "or", "our", "partners,", "they", "could", "effectively", "prevent", "us,", "or", "our", "partners,", "from", "developing", "or", "commercializing,", "or", "deriving", "revenue", "from,", "certain", "drugs", "or", "drug", "candidates", "in", "the", "U.S.", "and", "abroad."], "wordsB": ["from", "developing", "or", "commercializing,", "or", "deriving", "revenue", "from,", "certain", "drugs", "or", "drug", "candidates", "in", "the", "U.S.", "and", "abroad."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p25_s4", "idA": "906709_13_item1a_p26_s0", "sentA": "Currently, the Research Foundation of the State University of New York (SUNY) seeks to recover amounts it alleges it is owed pursuant to a technology licensing contract between SUNY and us.", "sentB": "In December 2013, we entered into a litigation settlement with the Research Foundation of the State University of New York (SUNY) pursuant to which we agree to the payment of a total of $12 million in future installments and certain other terms and conditions in exchange for the full release of certain breach of contract claims by SUNY.", "type": 2, "words": ["<tag1>", "Currently,", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "seeks", "to", "recover", "amounts", "it", "alleges", "it", "is", "owed", "pursuant", "to", "a", "technology", "licensing", "contract", "between", "SUNY", "and", "us.", "<tag2>", "In", "December", "2013,", "we", "entered", "into", "a", "litigation", "settlement", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "pursuant", "to", "which", "we", "agree", "to", "the", "payment", "of", "a", "total", "of", "$12", "million", "in", "future", "installments", "and", "certain", "other", "terms", "and", "conditions", "in", "exchange", "for", "the", "full", "release", "of", "certain", "breach", "of", "contract", "claims", "by", "SUNY.", "<tag3>"], "wordsA": ["Currently,", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "seeks", "to", "recover", "amounts", "it", "alleges", "it", "is", "owed", "pursuant", "to", "a", "technology", "licensing", "contract", "between", "SUNY", "and", "us."], "wordsB": ["In", "December", "2013,", "we", "entered", "into", "a", "litigation", "settlement", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "pursuant", "to", "which", "we", "agree", "to", "the", "payment", "of", "a", "total", "of", "$12", "million", "in", "future", "installments", "and", "certain", "other", "terms", "and", "conditions", "in", "exchange", "for", "the", "full", "release", "of", "certain", "breach", "of", "contract", "claims", "by", "SUNY."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p25_s1", "idA": "906709_13_item1a_p26_s3", "sentA": "Costs associated with such litigation, substantial damage claims, indemnification claims or royalties paid for licenses from third parties could have a material adverse effect on our business, financial condition and results of operations.", "sentB": "Costs associated with litigation, substantial damage claims, indemnification claims or royalties paid for licenses from third parties could have a material adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "Costs", "associated", "with", "such", "litigation,", "substantial", "damage", "claims,", "indemnification", "claims", "or", "royalties", "paid", "for", "licenses", "from", "third", "parties", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "Costs", "associated", "with", "litigation,", "substantial", "damage", "claims,", "indemnification", "claims", "or", "royalties", "paid", "for", "licenses", "from", "third", "parties", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["Costs", "associated", "with", "such", "litigation,", "substantial", "damage", "claims,", "indemnification", "claims", "or", "royalties", "paid", "for", "licenses", "from", "third", "parties", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["Costs", "associated", "with", "litigation,", "substantial", "damage", "claims,", "indemnification", "claims", "or", "royalties", "paid", "for", "licenses", "from", "third", "parties", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p25_s6", "idA": "906709_13_item1a_p27_s0", "sentA": "pursuant to which we paid $11.0 million and agreed to pay an additional $10.0 million in equal $1.0 million installments over ten years ending with the last payment due on July 1, 2016.", "sentB": "In 2006, we entered into a litigation settlement related to an intellectual property dispute with the University of Alabama in Huntsville pursuant to which we paid $11.0 million and agreed to pay an additional $10.0 million in equal $1.0 million installments over ten years ending with the last payment due on July 1, 2016.", "type": 2, "words": ["<tag1>", "pursuant", "to", "which", "we", "paid", "$11.0", "million", "and", "agreed", "to", "pay", "an", "additional", "$10.0", "million", "in", "equal", "$1.0", "million", "installments", "over", "ten", "years", "ending", "with", "the", "last", "payment", "due", "on", "July", "1,", "2016.", "<tag2>", "In", "2006,", "we", "entered", "into", "a", "litigation", "settlement", "related", "to", "an", "intellectual", "property", "dispute", "with", "the", "University", "of", "Alabama", "in", "Huntsville", "pursuant", "to", "which", "we", "paid", "$11.0", "million", "and", "agreed", "to", "pay", "an", "additional", "$10.0", "million", "in", "equal", "$1.0", "million", "installments", "over", "ten", "years", "ending", "with", "the", "last", "payment", "due", "on", "July", "1,", "2016.", "<tag3>"], "wordsA": ["pursuant", "to", "which", "we", "paid", "$11.0", "million", "and", "agreed", "to", "pay", "an", "additional", "$10.0", "million", "in", "equal", "$1.0", "million", "installments", "over", "ten", "years", "ending", "with", "the", "last", "payment", "due", "on", "July", "1,", "2016."], "wordsB": ["In", "2006,", "we", "entered", "into", "a", "litigation", "settlement", "related", "to", "an", "intellectual", "property", "dispute", "with", "the", "University", "of", "Alabama", "in", "Huntsville", "pursuant", "to", "which", "we", "paid", "$11.0", "million", "and", "agreed", "to", "pay", "an", "additional", "$10.0", "million", "in", "equal", "$1.0", "million", "installments", "over", "ten", "years", "ending", "with", "the", "last", "payment", "due", "on", "July", "1,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p5_s3", "idA": "906709_13_item1a_p27_s0", "sentA": "pursuant to which we paid $11.0 million and agreed to pay an additional $10.0 million in equal $1.0 million installments over ten years ending with the last payment due on July 1, 2016.", "sentB": "On the other hand, if the FDA determines a pre-approval cardiovascular safety study of naloxegol is not required, AstraZeneca is obligated to pay us an additional $35.0 million milestone payment.", "type": 2, "words": ["<tag1>", "pursuant", "to", "which", "we", "paid", "$11.0", "million", "and", "agreed", "to", "pay", "an", "additional", "$10.0", "million", "in", "equal", "$1.0", "million", "installments", "over", "ten", "years", "ending", "with", "the", "last", "payment", "due", "on", "July", "1,", "2016.", "<tag2>", "On", "the", "other", "hand,", "if", "the", "FDA", "determines", "a", "pre-approval", "cardiovascular", "safety", "study", "of", "naloxegol", "is", "not", "required,", "AstraZeneca", "is", "obligated", "to", "pay", "us", "an", "additional", "$35.0", "million", "milestone", "payment.", "<tag3>"], "wordsA": ["pursuant", "to", "which", "we", "paid", "$11.0", "million", "and", "agreed", "to", "pay", "an", "additional", "$10.0", "million", "in", "equal", "$1.0", "million", "installments", "over", "ten", "years", "ending", "with", "the", "last", "payment", "due", "on", "July", "1,", "2016."], "wordsB": ["On", "the", "other", "hand,", "if", "the", "FDA", "determines", "a", "pre-approval", "cardiovascular", "safety", "study", "of", "naloxegol", "is", "not", "required,", "AstraZeneca", "is", "obligated", "to", "pay", "us", "an", "additional", "$35.0", "million", "milestone", "payment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p26_s0", "idA": "906709_13_item1a_p27_s11", "sentA": "If we or our contract manufacturers are not able to manufacture and supply sufficient drug quantities meeting applicable quality standards required to support large clinical studies or commercial manufacturing in a timely manner, we risk delaying our clinical studies or those of our collaboration partners, reducing drug sales by our collaboration partners or breaching contractual obligations.", "sentB": "timely manner, we risk delaying our clinical studies or those of our collaboration partners, reducing drug sales by our collaboration partners or breaching contractual obligations.", "type": 2, "words": ["<tag1>", "If", "we", "or", "our", "contract", "manufacturers", "are", "not", "able", "to", "manufacture", "and", "supply", "sufficient", "drug", "quantities", "meeting", "applicable", "quality", "standards", "required", "to", "support", "large", "clinical", "studies", "or", "commercial", "manufacturing", "in", "a", "timely", "manner,", "we", "risk", "delaying", "our", "clinical", "studies", "or", "those", "of", "our", "collaboration", "partners,", "reducing", "drug", "sales", "by", "our", "collaboration", "partners", "or", "breaching", "contractual", "obligations.", "<tag2>", "timely", "manner,", "we", "risk", "delaying", "our", "clinical", "studies", "or", "those", "of", "our", "collaboration", "partners,", "reducing", "drug", "sales", "by", "our", "collaboration", "partners", "or", "breaching", "contractual", "obligations.", "<tag3>"], "wordsA": ["If", "we", "or", "our", "contract", "manufacturers", "are", "not", "able", "to", "manufacture", "and", "supply", "sufficient", "drug", "quantities", "meeting", "applicable", "quality", "standards", "required", "to", "support", "large", "clinical", "studies", "or", "commercial", "manufacturing", "in", "a", "timely", "manner,", "we", "risk", "delaying", "our", "clinical", "studies", "or", "those", "of", "our", "collaboration", "partners,", "reducing", "drug", "sales", "by", "our", "collaboration", "partners", "or", "breaching", "contractual", "obligations."], "wordsB": ["timely", "manner,", "we", "risk", "delaying", "our", "clinical", "studies", "or", "those", "of", "our", "collaboration", "partners,", "reducing", "drug", "sales", "by", "our", "collaboration", "partners", "or", "breaching", "contractual", "obligations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p3_s1", "idA": "906709_13_item1a_p27_s4", "sentA": "We and our contract manufacturers are required in certain cases to maintain compliance with current good manufacturing practices (cGMP), including cGMP guidelines applicable to active pharmaceutical ingredients, and with laws and regulations governing manufacture and distribution of controlled substances, and are subject to inspections by the FDA, DEA or comparable agencies in other jurisdictions to confirm such compliance.", "sentB": "Our partnered drugs that have obtained regulatory approval, and the manufacturing processes for these products, are subject to continued review and periodic inspections by the FDA and other regulatory authorities.", "type": 2, "words": ["<tag1>", "We", "and", "our", "contract", "manufacturers", "are", "required", "in", "certain", "cases", "to", "maintain", "compliance", "with", "current", "good", "manufacturing", "practices", "(cGMP),", "including", "cGMP", "guidelines", "applicable", "to", "active", "pharmaceutical", "ingredients,", "and", "with", "laws", "and", "regulations", "governing", "manufacture", "and", "distribution", "of", "controlled", "substances,", "and", "are", "subject", "to", "inspections", "by", "the", "FDA,", "DEA", "or", "comparable", "agencies", "in", "other", "jurisdictions", "to", "confirm", "such", "compliance.", "<tag2>", "Our", "partnered", "drugs", "that", "have", "obtained", "regulatory", "approval,", "and", "the", "manufacturing", "processes", "for", "these", "products,", "are", "subject", "to", "continued", "review", "and", "periodic", "inspections", "by", "the", "FDA", "and", "other", "regulatory", "authorities.", "<tag3>"], "wordsA": ["We", "and", "our", "contract", "manufacturers", "are", "required", "in", "certain", "cases", "to", "maintain", "compliance", "with", "current", "good", "manufacturing", "practices", "(cGMP),", "including", "cGMP", "guidelines", "applicable", "to", "active", "pharmaceutical", "ingredients,", "and", "with", "laws", "and", "regulations", "governing", "manufacture", "and", "distribution", "of", "controlled", "substances,", "and", "are", "subject", "to", "inspections", "by", "the", "FDA,", "DEA", "or", "comparable", "agencies", "in", "other", "jurisdictions", "to", "confirm", "such", "compliance."], "wordsB": ["Our", "partnered", "drugs", "that", "have", "obtained", "regulatory", "approval,", "and", "the", "manufacturing", "processes", "for", "these", "products,", "are", "subject", "to", "continued", "review", "and", "periodic", "inspections", "by", "the", "FDA", "and", "other", "regulatory", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p3_s4", "idA": "906709_13_item1a_p27_s9", "sentA": "Manufacturing delays, for us or our contract manufacturers, pending resolution of regulatory deficiencies or suspensions would have a material adverse effect on our business, results of operations and financial condition.", "sentB": "If the FDA requires a cardiovascular safety study for naloxegol, it could have a material adverse impact on the naloxegol program and our business prospects and financial condition.", "type": 2, "words": ["<tag1>", "Manufacturing", "delays,", "for", "us", "or", "our", "contract", "manufacturers,", "pending", "resolution", "of", "regulatory", "deficiencies", "or", "suspensions", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "If", "the", "FDA", "requires", "a", "cardiovascular", "safety", "study", "for", "naloxegol,", "it", "could", "have", "a", "material", "adverse", "impact", "on", "the", "naloxegol", "program", "and", "our", "business", "prospects", "and", "financial", "condition.", "<tag3>"], "wordsA": ["Manufacturing", "delays,", "for", "us", "or", "our", "contract", "manufacturers,", "pending", "resolution", "of", "regulatory", "deficiencies", "or", "suspensions", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["If", "the", "FDA", "requires", "a", "cardiovascular", "safety", "study", "for", "naloxegol,", "it", "could", "have", "a", "material", "adverse", "impact", "on", "the", "naloxegol", "program", "and", "our", "business", "prospects", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p28_s0", "idA": "906709_13_item1a_p29_s0", "sentA": "Pharmaceutical manufacturing involves significant risks and uncertainties related to the demonstration of adequate stability, sufficient purification of the drug substance and drug product, the identification and elimination of impurities, optimal formulations, process validation, and challenges in controlling for all of these variables.", "sentB": "Pharmaceutical manufacturing of drugs and devices involves significant risks and uncertainties related to the demonstration of adequate stability, sufficient purification of the drug substance and drug product, the identification and elimination of impurities, optimal formulations, process and analytical methods validations, device performance and challenges in controlling for all of these variables.", "type": 2, "words": ["<tag1>", "Pharmaceutical", "manufacturing", "involves", "significant", "risks", "and", "uncertainties", "related", "to", "the", "demonstration", "of", "adequate", "stability,", "sufficient", "purification", "of", "the", "drug", "substance", "and", "drug", "product,", "the", "identification", "and", "elimination", "of", "impurities,", "optimal", "formulations,", "process", "validation,", "and", "challenges", "in", "controlling", "for", "all", "of", "these", "variables.", "<tag2>", "Pharmaceutical", "manufacturing", "of", "drugs", "and", "devices", "involves", "significant", "risks", "and", "uncertainties", "related", "to", "the", "demonstration", "of", "adequate", "stability,", "sufficient", "purification", "of", "the", "drug", "substance", "and", "drug", "product,", "the", "identification", "and", "elimination", "of", "impurities,", "optimal", "formulations,", "process", "and", "analytical", "methods", "validations,", "device", "performance", "and", "challenges", "in", "controlling", "for", "all", "of", "these", "variables.", "<tag3>"], "wordsA": ["Pharmaceutical", "manufacturing", "involves", "significant", "risks", "and", "uncertainties", "related", "to", "the", "demonstration", "of", "adequate", "stability,", "sufficient", "purification", "of", "the", "drug", "substance", "and", "drug", "product,", "the", "identification", "and", "elimination", "of", "impurities,", "optimal", "formulations,", "process", "validation,", "and", "challenges", "in", "controlling", "for", "all", "of", "these", "variables."], "wordsB": ["Pharmaceutical", "manufacturing", "of", "drugs", "and", "devices", "involves", "significant", "risks", "and", "uncertainties", "related", "to", "the", "demonstration", "of", "adequate", "stability,", "sufficient", "purification", "of", "the", "drug", "substance", "and", "drug", "product,", "the", "identification", "and", "elimination", "of", "impurities,", "optimal", "formulations,", "process", "and", "analytical", "methods", "validations,", "device", "performance", "and", "challenges", "in", "controlling", "for", "all", "of", "these", "variables."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p28_s1", "idA": "906709_13_item1a_p29_s1", "sentA": "We have faced and may in the future face significant difficulties, delays and unexpected expenses as we validate third party contract manufacturers required for drug supply to support our clinical studies and the clinical studies and products of our collaboration partners.", "sentB": "We have faced and may in the future face significant difficulties, delays and unexpected expenses as we validate third party contract manufacturers required for drug and device supply to support our clinical studies and the clinical studies and products of our collaboration partners.", "type": 2, "words": ["<tag1>", "We", "have", "faced", "and", "may", "in", "the", "future", "face", "significant", "difficulties,", "delays", "and", "unexpected", "expenses", "as", "we", "validate", "third", "party", "contract", "manufacturers", "required", "for", "drug", "supply", "to", "support", "our", "clinical", "studies", "and", "the", "clinical", "studies", "and", "products", "of", "our", "collaboration", "partners.", "<tag2>", "We", "have", "faced", "and", "may", "in", "the", "future", "face", "significant", "difficulties,", "delays", "and", "unexpected", "expenses", "as", "we", "validate", "third", "party", "contract", "manufacturers", "required", "for", "drug", "and", "device", "supply", "to", "support", "our", "clinical", "studies", "and", "the", "clinical", "studies", "and", "products", "of", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["We", "have", "faced", "and", "may", "in", "the", "future", "face", "significant", "difficulties,", "delays", "and", "unexpected", "expenses", "as", "we", "validate", "third", "party", "contract", "manufacturers", "required", "for", "drug", "supply", "to", "support", "our", "clinical", "studies", "and", "the", "clinical", "studies", "and", "products", "of", "our", "collaboration", "partners."], "wordsB": ["We", "have", "faced", "and", "may", "in", "the", "future", "face", "significant", "difficulties,", "delays", "and", "unexpected", "expenses", "as", "we", "validate", "third", "party", "contract", "manufacturers", "required", "for", "drug", "and", "device", "supply", "to", "support", "our", "clinical", "studies", "and", "the", "clinical", "studies", "and", "products", "of", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p28_s2", "idA": "906709_13_item1a_p29_s2", "sentA": "Failure by us or our contract manufacturers to supply drug product in sufficient quantities that meet all applicable quality requirements could result in supply shortages for our clinical studies or the clinical studies and commercial activities of our collaboration partners.", "sentB": "Failure by us or our contract manufacturers to supply drug product or devices in sufficient quantities that meet all applicable quality requirements could result in supply shortages for our clinical studies or the clinical studies and commercial activities of our collaboration partners.", "type": 2, "words": ["<tag1>", "Failure", "by", "us", "or", "our", "contract", "manufacturers", "to", "supply", "drug", "product", "in", "sufficient", "quantities", "that", "meet", "all", "applicable", "quality", "requirements", "could", "result", "in", "supply", "shortages", "for", "our", "clinical", "studies", "or", "the", "clinical", "studies", "and", "commercial", "activities", "of", "our", "collaboration", "partners.", "<tag2>", "Failure", "by", "us", "or", "our", "contract", "manufacturers", "to", "supply", "drug", "product", "or", "devices", "in", "sufficient", "quantities", "that", "meet", "all", "applicable", "quality", "requirements", "could", "result", "in", "supply", "shortages", "for", "our", "clinical", "studies", "or", "the", "clinical", "studies", "and", "commercial", "activities", "of", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["Failure", "by", "us", "or", "our", "contract", "manufacturers", "to", "supply", "drug", "product", "in", "sufficient", "quantities", "that", "meet", "all", "applicable", "quality", "requirements", "could", "result", "in", "supply", "shortages", "for", "our", "clinical", "studies", "or", "the", "clinical", "studies", "and", "commercial", "activities", "of", "our", "collaboration", "partners."], "wordsB": ["Failure", "by", "us", "or", "our", "contract", "manufacturers", "to", "supply", "drug", "product", "or", "devices", "in", "sufficient", "quantities", "that", "meet", "all", "applicable", "quality", "requirements", "could", "result", "in", "supply", "shortages", "for", "our", "clinical", "studies", "or", "the", "clinical", "studies", "and", "commercial", "activities", "of", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p1_s5", "idA": "906709_13_item1a_p2_s5", "sentA": "Drug development is a highly uncertain scientific and medical endeavor, and failure can unexpectedly occur at any stage of clinical development.", "sentB": "Drug development is a highly uncertain scientific and medical endeavor, and failure can unexpectedly occur at any stage of preclinical and clinical development.", "type": 2, "words": ["<tag1>", "Drug", "development", "is", "a", "highly", "uncertain", "scientific", "and", "medical", "endeavor,", "and", "failure", "can", "unexpectedly", "occur", "at", "any", "stage", "of", "clinical", "development.", "<tag2>", "Drug", "development", "is", "a", "highly", "uncertain", "scientific", "and", "medical", "endeavor,", "and", "failure", "can", "unexpectedly", "occur", "at", "any", "stage", "of", "preclinical", "and", "clinical", "development.", "<tag3>"], "wordsA": ["Drug", "development", "is", "a", "highly", "uncertain", "scientific", "and", "medical", "endeavor,", "and", "failure", "can", "unexpectedly", "occur", "at", "any", "stage", "of", "clinical", "development."], "wordsB": ["Drug", "development", "is", "a", "highly", "uncertain", "scientific", "and", "medical", "endeavor,", "and", "failure", "can", "unexpectedly", "occur", "at", "any", "stage", "of", "preclinical", "and", "clinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p1_s7", "idA": "906709_13_item1a_p2_s7", "sentA": "The risk of failure increases for our drug candidates that are based on new technologies, such as the application of our advanced polymer conjugate technology to small molecules, including naloxegol, etirinotecan pegol, NKTR-181, NKTR-192, NKTR-171 and other drug candidates currently in discovery research or preclinical development.", "sentB": "The risk of failure increases for our drug candidates that are based on new technologies, such as the application of our advanced polymer conjugate technology to small molecules, including naloxegol, etirinotecan pegol (also known as NKTR-102), NKTR-181, NKTR-192, NKTR-171 and other drug candidates currently in discovery research or preclinical development.", "type": 2, "words": ["<tag1>", "The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "small", "molecules,", "including", "naloxegol,", "etirinotecan", "pegol,", "NKTR-181,", "NKTR-192,", "NKTR-171", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development.", "<tag2>", "The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "small", "molecules,", "including", "naloxegol,", "etirinotecan", "pegol", "(also", "known", "as", "NKTR-102),", "NKTR-181,", "NKTR-192,", "NKTR-171", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development.", "<tag3>"], "wordsA": ["The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "small", "molecules,", "including", "naloxegol,", "etirinotecan", "pegol,", "NKTR-181,", "NKTR-192,", "NKTR-171", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development."], "wordsB": ["The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "small", "molecules,", "including", "naloxegol,", "etirinotecan", "pegol", "(also", "known", "as", "NKTR-102),", "NKTR-181,", "NKTR-192,", "NKTR-171", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p31_s4", "idA": "906709_13_item1a_p33_s0", "sentA": "Our revenue is exclusively derived from our collaboration agreements, which can result in significant fluctuation in our revenue from period to period, and our past revenue is therefore not necessarily indicative of our future revenue.", "sentB": "Our past revenue generated from collaboration agreements is not necessarily indicative of our future revenue.", "type": 2, "words": ["<tag1>", "Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "which", "can", "result", "in", "significant", "fluctuation", "in", "our", "revenue", "from", "period", "to", "period,", "and", "our", "past", "revenue", "is", "therefore", "not", "necessarily", "indicative", "of", "our", "future", "revenue.", "<tag2>", "Our", "past", "revenue", "generated", "from", "collaboration", "agreements", "is", "not", "necessarily", "indicative", "of", "our", "future", "revenue.", "<tag3>"], "wordsA": ["Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "which", "can", "result", "in", "significant", "fluctuation", "in", "our", "revenue", "from", "period", "to", "period,", "and", "our", "past", "revenue", "is", "therefore", "not", "necessarily", "indicative", "of", "our", "future", "revenue."], "wordsB": ["Our", "past", "revenue", "generated", "from", "collaboration", "agreements", "is", "not", "necessarily", "indicative", "of", "our", "future", "revenue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p36_s2", "idA": "906709_13_item1a_p37_s2", "sentA": "We have entered into collaborations in the past that have been subsequently terminated, such as our collaboration with Pfizer for the development and commercialization of inhaled insulin that was terminated by Pfizer in November 2007.", "sentB": "We have entered into collaboration agreements in the past that have been subsequently terminated, such as our collaboration agreement with Pfizer, Inc. for the development and commercialization of inhaled insulin that was terminated by Pfizer, Inc. in November 2007.", "type": 2, "words": ["<tag1>", "We", "have", "entered", "into", "collaborations", "in", "the", "past", "that", "have", "been", "subsequently", "terminated,", "such", "as", "our", "collaboration", "with", "Pfizer", "for", "the", "development", "and", "commercialization", "of", "inhaled", "insulin", "that", "was", "terminated", "by", "Pfizer", "in", "November", "2007.", "<tag2>", "We", "have", "entered", "into", "collaboration", "agreements", "in", "the", "past", "that", "have", "been", "subsequently", "terminated,", "such", "as", "our", "collaboration", "agreement", "with", "Pfizer,", "Inc.", "for", "the", "development", "and", "commercialization", "of", "inhaled", "insulin", "that", "was", "terminated", "by", "Pfizer,", "Inc.", "in", "November", "2007.", "<tag3>"], "wordsA": ["We", "have", "entered", "into", "collaborations", "in", "the", "past", "that", "have", "been", "subsequently", "terminated,", "such", "as", "our", "collaboration", "with", "Pfizer", "for", "the", "development", "and", "commercialization", "of", "inhaled", "insulin", "that", "was", "terminated", "by", "Pfizer", "in", "November", "2007."], "wordsB": ["We", "have", "entered", "into", "collaboration", "agreements", "in", "the", "past", "that", "have", "been", "subsequently", "terminated,", "such", "as", "our", "collaboration", "agreement", "with", "Pfizer,", "Inc.", "for", "the", "development", "and", "commercialization", "of", "inhaled", "insulin", "that", "was", "terminated", "by", "Pfizer,", "Inc.", "in", "November", "2007."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p36_s3", "idA": "906709_13_item1a_p37_s3", "sentA": "If other collaborations are suspended or terminated, our ability to commercialize certain other proposed product candidates could also be negatively impacted.", "sentB": "If other collaboration agreements are suspended or terminated, our ability to commercialize certain other proposed product candidates could also be negatively impacted.", "type": 2, "words": ["<tag1>", "If", "other", "collaborations", "are", "suspended", "or", "terminated,", "our", "ability", "to", "commercialize", "certain", "other", "proposed", "product", "candidates", "could", "also", "be", "negatively", "impacted.", "<tag2>", "If", "other", "collaboration", "agreements", "are", "suspended", "or", "terminated,", "our", "ability", "to", "commercialize", "certain", "other", "proposed", "product", "candidates", "could", "also", "be", "negatively", "impacted.", "<tag3>"], "wordsA": ["If", "other", "collaborations", "are", "suspended", "or", "terminated,", "our", "ability", "to", "commercialize", "certain", "other", "proposed", "product", "candidates", "could", "also", "be", "negatively", "impacted."], "wordsB": ["If", "other", "collaboration", "agreements", "are", "suspended", "or", "terminated,", "our", "ability", "to", "commercialize", "certain", "other", "proposed", "product", "candidates", "could", "also", "be", "negatively", "impacted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p39_s0", "idA": "906709_13_item1a_p39_s10", "sentA": "In addition, unpatented proprietary rights, including trade secrets and know-how, can be difficult to protect and may lose their value if they are independently developed by a third party or if their secrecy is lost.", "sentB": "protect and may lose their value if they are independently developed by a third party or if their secrecy is lost.", "type": 2, "words": ["<tag1>", "In", "addition,", "unpatented", "proprietary", "rights,", "including", "trade", "secrets", "and", "know-how,", "can", "be", "difficult", "to", "protect", "and", "may", "lose", "their", "value", "if", "they", "are", "independently", "developed", "by", "a", "third", "party", "or", "if", "their", "secrecy", "is", "lost.", "<tag2>", "protect", "and", "may", "lose", "their", "value", "if", "they", "are", "independently", "developed", "by", "a", "third", "party", "or", "if", "their", "secrecy", "is", "lost.", "<tag3>"], "wordsA": ["In", "addition,", "unpatented", "proprietary", "rights,", "including", "trade", "secrets", "and", "know-how,", "can", "be", "difficult", "to", "protect", "and", "may", "lose", "their", "value", "if", "they", "are", "independently", "developed", "by", "a", "third", "party", "or", "if", "their", "secrecy", "is", "lost."], "wordsB": ["protect", "and", "may", "lose", "their", "value", "if", "they", "are", "independently", "developed", "by", "a", "third", "party", "or", "if", "their", "secrecy", "is", "lost."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p39_s3", "idA": "906709_13_item1a_p39_s13", "sentA": "For the year ended December 31, 2012, we reported a net loss of $171.9 million.", "sentB": "For the year ended December 31, 2013, we reported a net loss of $162.0 million.", "type": 2, "words": ["<tag1>", "For", "the", "year", "ended", "December", "31,", "2012,", "we", "reported", "a", "net", "loss", "of", "$171.9", "million.", "<tag2>", "For", "the", "year", "ended", "December", "31,", "2013,", "we", "reported", "a", "net", "loss", "of", "$162.0", "million.", "<tag3>"], "wordsA": ["For", "the", "year", "ended", "December", "31,", "2012,", "we", "reported", "a", "net", "loss", "of", "$171.9", "million."], "wordsB": ["For", "the", "year", "ended", "December", "31,", "2013,", "we", "reported", "a", "net", "loss", "of", "$162.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p38_s7", "idA": "906709_13_item1a_p39_s6", "sentA": "For example, there are only a limited number of qualified suppliers, and in some cases single source suppliers, for the raw materials included in our PEGylation and advanced polymer conjugate drug formulations, and any interruption in supply or failure to procure such raw materials on commercially feasible terms could harm our business by delaying our clinical trials, impeding commercialization of approved drugs or increasing our costs to the extent we cannot pass on increased costs to a manufacturing customer.", "sentB": "For example, there are only a limited number of qualified suppliers, and in some cases single source suppliers, for the raw materials included in our PEGylation and advanced polymer conjugate drug formulations.", "type": 2, "words": ["<tag1>", "For", "example,", "there", "are", "only", "a", "limited", "number", "of", "qualified", "suppliers,", "and", "in", "some", "cases", "single", "source", "suppliers,", "for", "the", "raw", "materials", "included", "in", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "drug", "formulations,", "and", "any", "interruption", "in", "supply", "or", "failure", "to", "procure", "such", "raw", "materials", "on", "commercially", "feasible", "terms", "could", "harm", "our", "business", "by", "delaying", "our", "clinical", "trials,", "impeding", "commercialization", "of", "approved", "drugs", "or", "increasing", "our", "costs", "to", "the", "extent", "we", "cannot", "pass", "on", "increased", "costs", "to", "a", "manufacturing", "customer.", "<tag2>", "For", "example,", "there", "are", "only", "a", "limited", "number", "of", "qualified", "suppliers,", "and", "in", "some", "cases", "single", "source", "suppliers,", "for", "the", "raw", "materials", "included", "in", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "drug", "formulations.", "<tag3>"], "wordsA": ["For", "example,", "there", "are", "only", "a", "limited", "number", "of", "qualified", "suppliers,", "and", "in", "some", "cases", "single", "source", "suppliers,", "for", "the", "raw", "materials", "included", "in", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "drug", "formulations,", "and", "any", "interruption", "in", "supply", "or", "failure", "to", "procure", "such", "raw", "materials", "on", "commercially", "feasible", "terms", "could", "harm", "our", "business", "by", "delaying", "our", "clinical", "trials,", "impeding", "commercialization", "of", "approved", "drugs", "or", "increasing", "our", "costs", "to", "the", "extent", "we", "cannot", "pass", "on", "increased", "costs", "to", "a", "manufacturing", "customer."], "wordsB": ["For", "example,", "there", "are", "only", "a", "limited", "number", "of", "qualified", "suppliers,", "and", "in", "some", "cases", "single", "source", "suppliers,", "for", "the", "raw", "materials", "included", "in", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "drug", "formulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p38_s8", "idA": "906709_13_item1a_p39_s6", "sentA": "For example, there are only a limited number of qualified suppliers, and in some cases single source suppliers, for the raw materials included in our PEGylation and advanced polymer conjugate drug formulations, and any interruption in supply or failure to procure such raw materials on commercially feasible terms could harm our business by delaying our clinical trials, impeding commercialization of approved drugs or increasing our costs to the extent we cannot pass on increased costs to a manufacturing customer.", "sentB": "Any interruption in supply or failure to procure such raw materials on commercially feasible terms could harm our business by delaying our clinical trials, impeding commercialization of approved drugs or increasing our costs.", "type": 2, "words": ["<tag1>", "For", "example,", "there", "are", "only", "a", "limited", "number", "of", "qualified", "suppliers,", "and", "in", "some", "cases", "single", "source", "suppliers,", "for", "the", "raw", "materials", "included", "in", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "drug", "formulations,", "and", "any", "interruption", "in", "supply", "or", "failure", "to", "procure", "such", "raw", "materials", "on", "commercially", "feasible", "terms", "could", "harm", "our", "business", "by", "delaying", "our", "clinical", "trials,", "impeding", "commercialization", "of", "approved", "drugs", "or", "increasing", "our", "costs", "to", "the", "extent", "we", "cannot", "pass", "on", "increased", "costs", "to", "a", "manufacturing", "customer.", "<tag2>", "Any", "interruption", "in", "supply", "or", "failure", "to", "procure", "such", "raw", "materials", "on", "commercially", "feasible", "terms", "could", "harm", "our", "business", "by", "delaying", "our", "clinical", "trials,", "impeding", "commercialization", "of", "approved", "drugs", "or", "increasing", "our", "costs.", "<tag3>"], "wordsA": ["For", "example,", "there", "are", "only", "a", "limited", "number", "of", "qualified", "suppliers,", "and", "in", "some", "cases", "single", "source", "suppliers,", "for", "the", "raw", "materials", "included", "in", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "drug", "formulations,", "and", "any", "interruption", "in", "supply", "or", "failure", "to", "procure", "such", "raw", "materials", "on", "commercially", "feasible", "terms", "could", "harm", "our", "business", "by", "delaying", "our", "clinical", "trials,", "impeding", "commercialization", "of", "approved", "drugs", "or", "increasing", "our", "costs", "to", "the", "extent", "we", "cannot", "pass", "on", "increased", "costs", "to", "a", "manufacturing", "customer."], "wordsB": ["Any", "interruption", "in", "supply", "or", "failure", "to", "procure", "such", "raw", "materials", "on", "commercially", "feasible", "terms", "could", "harm", "our", "business", "by", "delaying", "our", "clinical", "trials,", "impeding", "commercialization", "of", "approved", "drugs", "or", "increasing", "our", "costs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p2_s0", "idA": "906709_13_item1a_p3_s0", "sentA": "Drug candidates must undergo rigorous animal and human testing and an extensive FDA mandated or equivalent foreign government health authority review process for safety and efficacy.", "sentB": "Drug candidates must undergo rigorous animal and human testing and an extensive review process for safety and efficacy by the U.S. Food and Drug Administration (FDA) and equivalent foreign government health authorities.", "type": 2, "words": ["<tag1>", "Drug", "candidates", "must", "undergo", "rigorous", "animal", "and", "human", "testing", "and", "an", "extensive", "FDA", "mandated", "or", "equivalent", "foreign", "government", "health", "authority", "review", "process", "for", "safety", "and", "efficacy.", "<tag2>", "Drug", "candidates", "must", "undergo", "rigorous", "animal", "and", "human", "testing", "and", "an", "extensive", "review", "process", "for", "safety", "and", "efficacy", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "and", "equivalent", "foreign", "government", "health", "authorities.", "<tag3>"], "wordsA": ["Drug", "candidates", "must", "undergo", "rigorous", "animal", "and", "human", "testing", "and", "an", "extensive", "FDA", "mandated", "or", "equivalent", "foreign", "government", "health", "authority", "review", "process", "for", "safety", "and", "efficacy."], "wordsB": ["Drug", "candidates", "must", "undergo", "rigorous", "animal", "and", "human", "testing", "and", "an", "extensive", "review", "process", "for", "safety", "and", "efficacy", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "and", "equivalent", "foreign", "government", "health", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p3_s5", "idA": "906709_13_item1a_p3_s5", "sentA": "For example, we understand that the FDA is exploring whether there is any evidence of a potential cardiovascular class effect related to opioid withdrawal associated with mu-opioid antagonists and naloxegol is a mu-opioid antagonist.", "sentB": "The FDA is exploring whether there is any evidence of potential elevated cardiovascular risk possibly related to the class of mu-opioid antagonist drugs and naloxegol is a mu-opioid antagonist.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "understand", "that", "the", "FDA", "is", "exploring", "whether", "there", "is", "any", "evidence", "of", "a", "potential", "cardiovascular", "class", "effect", "related", "to", "opioid", "withdrawal", "associated", "with", "mu-opioid", "antagonists", "and", "naloxegol", "is", "a", "mu-opioid", "antagonist.", "<tag2>", "The", "FDA", "is", "exploring", "whether", "there", "is", "any", "evidence", "of", "potential", "elevated", "cardiovascular", "risk", "possibly", "related", "to", "the", "class", "of", "mu-opioid", "antagonist", "drugs", "and", "naloxegol", "is", "a", "mu-opioid", "antagonist.", "<tag3>"], "wordsA": ["For", "example,", "we", "understand", "that", "the", "FDA", "is", "exploring", "whether", "there", "is", "any", "evidence", "of", "a", "potential", "cardiovascular", "class", "effect", "related", "to", "opioid", "withdrawal", "associated", "with", "mu-opioid", "antagonists", "and", "naloxegol", "is", "a", "mu-opioid", "antagonist."], "wordsB": ["The", "FDA", "is", "exploring", "whether", "there", "is", "any", "evidence", "of", "potential", "elevated", "cardiovascular", "risk", "possibly", "related", "to", "the", "class", "of", "mu-opioid", "antagonist", "drugs", "and", "naloxegol", "is", "a", "mu-opioid", "antagonist."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p4_s1", "idA": "906709_13_item1a_p3_s5", "sentA": "For example, we understand that the FDA is exploring whether there is any evidence of a potential cardiovascular class effect related to opioid withdrawal associated with mu-opioid antagonists and naloxegol is a mu-opioid antagonist.", "sentB": "The FDA s general safety concern is based on data from other mu-opioid antagonist programs that may indicate increased cardiovascular risk associated with opioid withdrawal or the antagonism of the delta subtype of the opioid receptor, for which the FDA has not yet made a causal connection between these mechanisms and elevated cardiovascular risk.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "understand", "that", "the", "FDA", "is", "exploring", "whether", "there", "is", "any", "evidence", "of", "a", "potential", "cardiovascular", "class", "effect", "related", "to", "opioid", "withdrawal", "associated", "with", "mu-opioid", "antagonists", "and", "naloxegol", "is", "a", "mu-opioid", "antagonist.", "<tag2>", "The", "FDA", "s", "general", "safety", "concern", "is", "based", "on", "data", "from", "other", "mu-opioid", "antagonist", "programs", "that", "may", "indicate", "increased", "cardiovascular", "risk", "associated", "with", "opioid", "withdrawal", "or", "the", "antagonism", "of", "the", "delta", "subtype", "of", "the", "opioid", "receptor,", "for", "which", "the", "FDA", "has", "not", "yet", "made", "a", "causal", "connection", "between", "these", "mechanisms", "and", "elevated", "cardiovascular", "risk.", "<tag3>"], "wordsA": ["For", "example,", "we", "understand", "that", "the", "FDA", "is", "exploring", "whether", "there", "is", "any", "evidence", "of", "a", "potential", "cardiovascular", "class", "effect", "related", "to", "opioid", "withdrawal", "associated", "with", "mu-opioid", "antagonists", "and", "naloxegol", "is", "a", "mu-opioid", "antagonist."], "wordsB": ["The", "FDA", "s", "general", "safety", "concern", "is", "based", "on", "data", "from", "other", "mu-opioid", "antagonist", "programs", "that", "may", "indicate", "increased", "cardiovascular", "risk", "associated", "with", "opioid", "withdrawal", "or", "the", "antagonism", "of", "the", "delta", "subtype", "of", "the", "opioid", "receptor,", "for", "which", "the", "FDA", "has", "not", "yet", "made", "a", "causal", "connection", "between", "these", "mechanisms", "and", "elevated", "cardiovascular", "risk."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p4_s0", "idA": "906709_13_item1a_p3_s6", "sentA": "Although AstraZeneca has completed comprehensive safety studies for naloxegol as part of the KODIAC development program and the results from these studies are positive, the health authorities retain significant discretion over regulatory requirements which remain very uncertain and difficult to predict prior to obtaining approval.", "sentB": "AstraZeneca completed a 52-week, long-term controlled safety trial of naloxegol as part of the Phase 3 naloxegol development program.", "type": 2, "words": ["<tag1>", "Although", "AstraZeneca", "has", "completed", "comprehensive", "safety", "studies", "for", "naloxegol", "as", "part", "of", "the", "KODIAC", "development", "program", "and", "the", "results", "from", "these", "studies", "are", "positive,", "the", "health", "authorities", "retain", "significant", "discretion", "over", "regulatory", "requirements", "which", "remain", "very", "uncertain", "and", "difficult", "to", "predict", "prior", "to", "obtaining", "approval.", "<tag2>", "AstraZeneca", "completed", "a", "52-week,", "long-term", "controlled", "safety", "trial", "of", "naloxegol", "as", "part", "of", "the", "Phase", "3", "naloxegol", "development", "program.", "<tag3>"], "wordsA": ["Although", "AstraZeneca", "has", "completed", "comprehensive", "safety", "studies", "for", "naloxegol", "as", "part", "of", "the", "KODIAC", "development", "program", "and", "the", "results", "from", "these", "studies", "are", "positive,", "the", "health", "authorities", "retain", "significant", "discretion", "over", "regulatory", "requirements", "which", "remain", "very", "uncertain", "and", "difficult", "to", "predict", "prior", "to", "obtaining", "approval."], "wordsB": ["AstraZeneca", "completed", "a", "52-week,", "long-term", "controlled", "safety", "trial", "of", "naloxegol", "as", "part", "of", "the", "Phase", "3", "naloxegol", "development", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p42_s0", "idA": "906709_13_item1a_p41_s10", "sentA": "Though we are ultimately responsible for the results of their activities, many aspects of their activities are beyond our control.", "sentB": "activities, many aspects of their activities are beyond our control.", "type": 2, "words": ["<tag1>", "Though", "we", "are", "ultimately", "responsible", "for", "the", "results", "of", "their", "activities,", "many", "aspects", "of", "their", "activities", "are", "beyond", "our", "control.", "<tag2>", "activities,", "many", "aspects", "of", "their", "activities", "are", "beyond", "our", "control.", "<tag3>"], "wordsA": ["Though", "we", "are", "ultimately", "responsible", "for", "the", "results", "of", "their", "activities,", "many", "aspects", "of", "their", "activities", "are", "beyond", "our", "control."], "wordsB": ["activities,", "many", "aspects", "of", "their", "activities", "are", "beyond", "our", "control."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p45_s1", "idA": "906709_13_item1a_p45_s1", "sentA": "For naloxegol, there are currently several alternative therapies used to address opioid-induced constipation (OIC) and opioid-induced bowel dysfunction (OBD), including subcutaneous Relistor (methylnaltrexone bromide) and oral and rectal over-the-counter laxatives and stool softeners such as docusate sodium, senna and milk of magnesia.", "sentB": "For naloxegol, there are currently several alternative therapies used to address opioid-induced constipation (OIC) and opioid-induced bowel dysfunction (OBD), including subcutaneous Relistor (methylnaltrexone bromide), oral Amitizia (lubiprostone), and oral and rectal over-the-counter laxatives and stool softeners such as docusate sodium, senna and milk of magnesia.", "type": 2, "words": ["<tag1>", "For", "naloxegol,", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "subcutaneous", "Relistor", "(methylnaltrexone", "bromide)", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia.", "<tag2>", "For", "naloxegol,", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "subcutaneous", "Relistor", "(methylnaltrexone", "bromide),", "oral", "Amitizia", "(lubiprostone),", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia.", "<tag3>"], "wordsA": ["For", "naloxegol,", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "subcutaneous", "Relistor", "(methylnaltrexone", "bromide)", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia."], "wordsB": ["For", "naloxegol,", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "subcutaneous", "Relistor", "(methylnaltrexone", "bromide),", "oral", "Amitizia", "(lubiprostone),", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p45_s3", "idA": "906709_13_item1a_p45_s3", "sentA": "Limited, Sucampo Pharmaceuticals and Takeda Pharmaceutical Company Limited.", "sentB": "Limited, Sucampo Pharmaceuticals, Inc., Develco Pharma, Alkermes, Inc., GlaxoSmithKline plc, Theravance, Inc., and Takeda Pharmaceutical Company Limited.", "type": 2, "words": ["<tag1>", "Limited,", "Sucampo", "Pharmaceuticals", "and", "Takeda", "Pharmaceutical", "Company", "Limited.", "<tag2>", "Limited,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Develco", "Pharma,", "Alkermes,", "Inc.,", "GlaxoSmithKline", "plc,", "Theravance,", "Inc.,", "and", "Takeda", "Pharmaceutical", "Company", "Limited.", "<tag3>"], "wordsA": ["Limited,", "Sucampo", "Pharmaceuticals", "and", "Takeda", "Pharmaceutical", "Company", "Limited."], "wordsB": ["Limited,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Develco", "Pharma,", "Alkermes,", "Inc.,", "GlaxoSmithKline", "plc,", "Theravance,", "Inc.,", "and", "Takeda", "Pharmaceutical", "Company", "Limited."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p46_s0", "idA": "906709_13_item1a_p46_s0", "sentA": "For etirinotecan pegol, there are a number of chemotherapies and cancer therapies approved today and in various stages of clinical development for breast and ovarian cancers including but not limited to: Abraxane (paclitaxel protein-bound particles for injectable suspension (albumin bound)), Afinitor (everolimus), Doxil (doxorubicin HCl), Ellence (epirubicin), Gemzar (gemcitabine), Halaven (eribulin), Herceptin (trastuzumab), Hycamtin (topotecan), Ixempra (ixabepilone), Navelbine (vinolrebine), Iniparib, Paraplatin (carboplatin), Taxol (paclitaxel) and Taxotere (docetaxel).", "sentB": "For etirinotecan pegol, there are a number of chemotherapies and cancer therapies approved today and in various stages of clinical development for breast and ovarian cancers, including, but not limited to: Abraxane (paclitaxel protein-bound particles for injectable suspension (albumin bound)), Afinitor (everolimus), Doxil (doxorubicin HCl), Ellence (epirubicin), Gemzar (gemcitabine), Halaven (eribulin), Herceptin (trastuzumab), Hycamtin (topotecan), Ixempra (ixabepilone), Navelbine (vinolrebine), Iniparib, Paraplatin (carboplatin), Taxol (paclitaxel) and Taxotere (docetaxel).", "type": 2, "words": ["<tag1>", "For", "etirinotecan", "pegol,", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "and", "ovarian", "cancers", "including", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel).", "<tag2>", "For", "etirinotecan", "pegol,", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "and", "ovarian", "cancers,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel).", "<tag3>"], "wordsA": ["For", "etirinotecan", "pegol,", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "and", "ovarian", "cancers", "including", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel)."], "wordsB": ["For", "etirinotecan", "pegol,", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "and", "ovarian", "cancers,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p46_s1", "idA": "906709_13_item1a_p46_s1", "sentA": "Major pharmaceutical or biotechnology companies with approved drugs or drugs in development for these cancers include, but are not limited to, Bristol-Meyers Squibb, Eli Lilly Co., Roche, GlaxoSmithKline plc, Johnson and Johnson, Pfizer, Inc.and Sanofi Aventis.", "sentB": "Major pharmaceutical or biotechnology companies with approved drugs or drugs in development for these cancers include, but are not limited to, Bristol-Meyers Squibb Company, Eli Lilly Co., Roche, GlaxoSmithKline plc, Johnson and Johnson, Pfizer, Inc.", "type": 2, "words": ["<tag1>", "Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "these", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Meyers", "Squibb,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer,", "Inc.and", "Sanofi", "Aventis.", "<tag2>", "Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "these", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Meyers", "Squibb", "Company,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer,", "Inc.", "<tag3>"], "wordsA": ["Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "these", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Meyers", "Squibb,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer,", "Inc.and", "Sanofi", "Aventis."], "wordsB": ["Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "these", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Meyers", "Squibb", "Company,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer,", "Inc."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p5_s7", "idA": "906709_13_item1a_p4_s4", "sentA": "While etirinotecan pegol, Amikacin Inhale, and BAX 855 have each demonstrated positive results from Phase 1 and 2 clinical studies, there is a substantial risk that Phase 3 clinical study outcomes for these drug candidates from larger patient populations will not demonstrate positive efficacy, safety or other clinical outcomes sufficient to support regulatory filings and achieve regulatory approval.", "sentB": "While etirinotecan pegol, Amikacin Inhale, and BAX 855 have each demonstrated positive results from earlier clinical studies, there is a substantial risk that Phase 3 clinical study outcomes for these drug candidates from larger patient populations will not demonstrate positive efficacy, safety or other clinical outcomes sufficient to support regulatory filings and achieve regulatory approval.", "type": 2, "words": ["<tag1>", "While", "etirinotecan", "pegol,", "Amikacin", "Inhale,", "and", "BAX", "855", "have", "each", "demonstrated", "positive", "results", "from", "Phase", "1", "and", "2", "clinical", "studies,", "there", "is", "a", "substantial", "risk", "that", "Phase", "3", "clinical", "study", "outcomes", "for", "these", "drug", "candidates", "from", "larger", "patient", "populations", "will", "not", "demonstrate", "positive", "efficacy,", "safety", "or", "other", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "filings", "and", "achieve", "regulatory", "approval.", "<tag2>", "While", "etirinotecan", "pegol,", "Amikacin", "Inhale,", "and", "BAX", "855", "have", "each", "demonstrated", "positive", "results", "from", "earlier", "clinical", "studies,", "there", "is", "a", "substantial", "risk", "that", "Phase", "3", "clinical", "study", "outcomes", "for", "these", "drug", "candidates", "from", "larger", "patient", "populations", "will", "not", "demonstrate", "positive", "efficacy,", "safety", "or", "other", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "filings", "and", "achieve", "regulatory", "approval.", "<tag3>"], "wordsA": ["While", "etirinotecan", "pegol,", "Amikacin", "Inhale,", "and", "BAX", "855", "have", "each", "demonstrated", "positive", "results", "from", "Phase", "1", "and", "2", "clinical", "studies,", "there", "is", "a", "substantial", "risk", "that", "Phase", "3", "clinical", "study", "outcomes", "for", "these", "drug", "candidates", "from", "larger", "patient", "populations", "will", "not", "demonstrate", "positive", "efficacy,", "safety", "or", "other", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "filings", "and", "achieve", "regulatory", "approval."], "wordsB": ["While", "etirinotecan", "pegol,", "Amikacin", "Inhale,", "and", "BAX", "855", "have", "each", "demonstrated", "positive", "results", "from", "earlier", "clinical", "studies,", "there", "is", "a", "substantial", "risk", "that", "Phase", "3", "clinical", "study", "outcomes", "for", "these", "drug", "candidates", "from", "larger", "patient", "populations", "will", "not", "demonstrate", "positive", "efficacy,", "safety", "or", "other", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "filings", "and", "achieve", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p31_s5", "idA": "906709_13_item1a_p50_s4", "sentA": "If we are unable to manage effectively our current operations and any growth we may experience, our business, financial condition and results of operations may be adversely affected.", "sentB": "If any of our existing or future collaboration partners fails to develop, obtain regulatory approval for, manufacture or ultimately commercialize any product candidate under our collaboration agreement, our business, financial condition, results of operations and prospectus could be materially and adversely affected.", "type": 2, "words": ["<tag1>", "If", "we", "are", "unable", "to", "manage", "effectively", "our", "current", "operations", "and", "any", "growth", "we", "may", "experience,", "our", "business,", "financial", "condition", "and", "results", "of", "operations", "may", "be", "adversely", "affected.", "<tag2>", "If", "any", "of", "our", "existing", "or", "future", "collaboration", "partners", "fails", "to", "develop,", "obtain", "regulatory", "approval", "for,", "manufacture", "or", "ultimately", "commercialize", "any", "product", "candidate", "under", "our", "collaboration", "agreement,", "our", "business,", "financial", "condition,", "results", "of", "operations", "and", "prospectus", "could", "be", "materially", "and", "adversely", "affected.", "<tag3>"], "wordsA": ["If", "we", "are", "unable", "to", "manage", "effectively", "our", "current", "operations", "and", "any", "growth", "we", "may", "experience,", "our", "business,", "financial", "condition", "and", "results", "of", "operations", "may", "be", "adversely", "affected."], "wordsB": ["If", "any", "of", "our", "existing", "or", "future", "collaboration", "partners", "fails", "to", "develop,", "obtain", "regulatory", "approval", "for,", "manufacture", "or", "ultimately", "commercialize", "any", "product", "candidate", "under", "our", "collaboration", "agreement,", "our", "business,", "financial", "condition,", "results", "of", "operations", "and", "prospectus", "could", "be", "materially", "and", "adversely", "affected."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p50_s11", "idA": "906709_13_item1a_p51_s0", "sentA": "backup facilities for our manufacturing operations located in Huntsville, Alabama.", "sentB": "There are no backup facilities for our manufacturing operations located in Huntsville, Alabama.", "type": 2, "words": ["<tag1>", "backup", "facilities", "for", "our", "manufacturing", "operations", "located", "in", "Huntsville,", "Alabama.", "<tag2>", "There", "are", "no", "backup", "facilities", "for", "our", "manufacturing", "operations", "located", "in", "Huntsville,", "Alabama.", "<tag3>"], "wordsA": ["backup", "facilities", "for", "our", "manufacturing", "operations", "located", "in", "Huntsville,", "Alabama."], "wordsB": ["There", "are", "no", "backup", "facilities", "for", "our", "manufacturing", "operations", "located", "in", "Huntsville,", "Alabama."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p52_s7", "idA": "906709_13_item1a_p52_s5", "sentA": "The price of our common stock is expected to remain volatile.", "sentB": "A variety of factors may have a significant effect on the market price of our common stock, including:", "type": 2, "words": ["<tag1>", "The", "price", "of", "our", "common", "stock", "is", "expected", "to", "remain", "volatile.", "<tag2>", "A", "variety", "of", "factors", "may", "have", "a", "significant", "effect", "on", "the", "market", "price", "of", "our", "common", "stock,", "including:", "<tag3>"], "wordsA": ["The", "price", "of", "our", "common", "stock", "is", "expected", "to", "remain", "volatile."], "wordsB": ["A", "variety", "of", "factors", "may", "have", "a", "significant", "effect", "on", "the", "market", "price", "of", "our", "common", "stock,", "including:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p52_s5", "idA": "906709_13_item1a_p52_s6", "sentA": "During the year ended December 31, 2012, based on closing bid prices on The NASDAQ Global Select Market, our stock price ranged from $10.83 to $5.68 per share.", "sentB": "During the year ended December 31, 2013, based on closing prices on The NASDAQ Global Select Market, our stock price ranged from $13.96 to $7.54 per share.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2012,", "based", "on", "closing", "bid", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$10.83", "to", "$5.68", "per", "share.", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2013,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$13.96", "to", "$7.54", "per", "share.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2012,", "based", "on", "closing", "bid", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$10.83", "to", "$5.68", "per", "share."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2013,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$13.96", "to", "$7.54", "per", "share."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p7_s3", "idA": "906709_13_item1a_p7_s0", "sentA": "could result in substantial future liability and harm our financial condition if we breach any of our agreements with Novartis, AstraZeneca, RPI or any third party agreements impacted by these complex transactions.", "sentB": "If we breach any of our agreements with Novartis, AstraZeneca, RPI or any third party agreements impacted by these complex transactions, such a breach could result in substantial future liability and harm our financial condition.", "type": 2, "words": ["<tag1>", "could", "result", "in", "substantial", "future", "liability", "and", "harm", "our", "financial", "condition", "if", "we", "breach", "any", "of", "our", "agreements", "with", "Novartis,", "AstraZeneca,", "RPI", "or", "any", "third", "party", "agreements", "impacted", "by", "these", "complex", "transactions.", "<tag2>", "If", "we", "breach", "any", "of", "our", "agreements", "with", "Novartis,", "AstraZeneca,", "RPI", "or", "any", "third", "party", "agreements", "impacted", "by", "these", "complex", "transactions,", "such", "a", "breach", "could", "result", "in", "substantial", "future", "liability", "and", "harm", "our", "financial", "condition.", "<tag3>"], "wordsA": ["could", "result", "in", "substantial", "future", "liability", "and", "harm", "our", "financial", "condition", "if", "we", "breach", "any", "of", "our", "agreements", "with", "Novartis,", "AstraZeneca,", "RPI", "or", "any", "third", "party", "agreements", "impacted", "by", "these", "complex", "transactions."], "wordsB": ["If", "we", "breach", "any", "of", "our", "agreements", "with", "Novartis,", "AstraZeneca,", "RPI", "or", "any", "third", "party", "agreements", "impacted", "by", "these", "complex", "transactions,", "such", "a", "breach", "could", "result", "in", "substantial", "future", "liability", "and", "harm", "our", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p9_s2", "idA": "906709_13_item1a_p8_s4", "sentA": "As of December 31, 2012, we had cash, cash equivalents, and investments in marketable securities valued at approximately $302.2 million and indebtedness of approximately $149.0 million, including approximately $125.0 million in senior secured notes due July 2017, $14.6 million in capital lease obligations, and $9.4 million of other liabilities.", "sentB": "As of December 31, 2013, we had cash and investments in marketable securities valued at approximately $262.0 million, of which $25.0 million was restricted in relation to our 12.0% senior secured notes, and indebtedness of approximately $160.8 million.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2012,", "we", "had", "cash,", "cash", "equivalents,", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$302.2", "million", "and", "indebtedness", "of", "approximately", "$149.0", "million,", "including", "approximately", "$125.0", "million", "in", "senior", "secured", "notes", "due", "July", "2017,", "$14.6", "million", "in", "capital", "lease", "obligations,", "and", "$9.4", "million", "of", "other", "liabilities.", "<tag2>", "As", "of", "December", "31,", "2013,", "we", "had", "cash", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$262.0", "million,", "of", "which", "$25.0", "million", "was", "restricted", "in", "relation", "to", "our", "12.0%", "senior", "secured", "notes,", "and", "indebtedness", "of", "approximately", "$160.8", "million.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2012,", "we", "had", "cash,", "cash", "equivalents,", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$302.2", "million", "and", "indebtedness", "of", "approximately", "$149.0", "million,", "including", "approximately", "$125.0", "million", "in", "senior", "secured", "notes", "due", "July", "2017,", "$14.6", "million", "in", "capital", "lease", "obligations,", "and", "$9.4", "million", "of", "other", "liabilities."], "wordsB": ["As", "of", "December", "31,", "2013,", "we", "had", "cash", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$262.0", "million,", "of", "which", "$25.0", "million", "was", "restricted", "in", "relation", "to", "our", "12.0%", "senior", "secured", "notes,", "and", "indebtedness", "of", "approximately", "$160.8", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p9_s3", "idA": "906709_13_item1a_p8_s5", "sentA": "In addition, at December 31, 2012, we had a $131.3 million liability related to the sale of future royalties.", "sentB": "The indebtedness includes approximately $125.0 million in senior secured notes due July 2017, but excludes our long-term liability relating to the sale of future royalties.", "type": 2, "words": ["<tag1>", "In", "addition,", "at", "December", "31,", "2012,", "we", "had", "a", "$131.3", "million", "liability", "related", "to", "the", "sale", "of", "future", "royalties.", "<tag2>", "The", "indebtedness", "includes", "approximately", "$125.0", "million", "in", "senior", "secured", "notes", "due", "July", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties.", "<tag3>"], "wordsA": ["In", "addition,", "at", "December", "31,", "2012,", "we", "had", "a", "$131.3", "million", "liability", "related", "to", "the", "sale", "of", "future", "royalties."], "wordsB": ["The", "indebtedness", "includes", "approximately", "$125.0", "million", "in", "senior", "secured", "notes", "due", "July", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item1a_p9_s4", "idA": "906709_13_item1a_p8_s6", "sentA": "While this royalty obligation liability will not be settled in cash, we may be required to make a payment of up to $7.0 million in 2014 if the worldwide net sales thresholds of MIRCERA in 2013 are not met.", "sentB": "While this royalty obligation liability will not generally be settled in cash, we expect to be required to make a cash payment of $7.0 million in 2014, as a certain performance target is not expected to be met.", "type": 2, "words": ["<tag1>", "While", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash,", "we", "may", "be", "required", "to", "make", "a", "payment", "of", "up", "to", "$7.0", "million", "in", "2014", "if", "the", "worldwide", "net", "sales", "thresholds", "of", "MIRCERA", "in", "2013", "are", "not", "met.", "<tag2>", "While", "this", "royalty", "obligation", "liability", "will", "not", "generally", "be", "settled", "in", "cash,", "we", "expect", "to", "be", "required", "to", "make", "a", "cash", "payment", "of", "$7.0", "million", "in", "2014,", "as", "a", "certain", "performance", "target", "is", "not", "expected", "to", "be", "met.", "<tag3>"], "wordsA": ["While", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash,", "we", "may", "be", "required", "to", "make", "a", "payment", "of", "up", "to", "$7.0", "million", "in", "2014", "if", "the", "worldwide", "net", "sales", "thresholds", "of", "MIRCERA", "in", "2013", "are", "not", "met."], "wordsB": ["While", "this", "royalty", "obligation", "liability", "will", "not", "generally", "be", "settled", "in", "cash,", "we", "expect", "to", "be", "required", "to", "make", "a", "cash", "payment", "of", "$7.0", "million", "in", "2014,", "as", "a", "certain", "performance", "target", "is", "not", "expected", "to", "be", "met."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p1_s0", "idA": "906709_14_item1a_p0_s3", "sentA": "Consequently, you should not consider this section to be a complete discussion of all potential risks or uncertainties that may substantially impact our business.", "sentB": "you should not consider this section to be a complete discussion of all potential risks or uncertainties that may substantially impact our business.", "type": 2, "words": ["<tag1>", "Consequently,", "you", "should", "not", "consider", "this", "section", "to", "be", "a", "complete", "discussion", "of", "all", "potential", "risks", "or", "uncertainties", "that", "may", "substantially", "impact", "our", "business.", "<tag2>", "you", "should", "not", "consider", "this", "section", "to", "be", "a", "complete", "discussion", "of", "all", "potential", "risks", "or", "uncertainties", "that", "may", "substantially", "impact", "our", "business.", "<tag3>"], "wordsA": ["Consequently,", "you", "should", "not", "consider", "this", "section", "to", "be", "a", "complete", "discussion", "of", "all", "potential", "risks", "or", "uncertainties", "that", "may", "substantially", "impact", "our", "business."], "wordsB": ["you", "should", "not", "consider", "this", "section", "to", "be", "a", "complete", "discussion", "of", "all", "potential", "risks", "or", "uncertainties", "that", "may", "substantially", "impact", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p29_s5", "idA": "906709_14_item1a_p10_s4", "sentA": "If we are unable to sufficiently advance our research and development programs, it could substantially impair the value of such programs and result in a material adverse effect on our business, financial condition and results of operations.", "sentB": "Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could delay our research and development efforts or result in financial implications either in terms of seeking license arrangements or payment of damages or royalties.", "type": 2, "words": ["<tag1>", "If", "we", "are", "unable", "to", "sufficiently", "advance", "our", "research", "and", "development", "programs,", "it", "could", "substantially", "impair", "the", "value", "of", "such", "programs", "and", "result", "in", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "Uncertainties", "resulting", "from", "the", "initiation", "and", "continuation", "of", "patent", "litigation", "or", "other", "proceedings", "could", "delay", "our", "research", "and", "development", "efforts", "or", "result", "in", "financial", "implications", "either", "in", "terms", "of", "seeking", "license", "arrangements", "or", "payment", "of", "damages", "or", "royalties.", "<tag3>"], "wordsA": ["If", "we", "are", "unable", "to", "sufficiently", "advance", "our", "research", "and", "development", "programs,", "it", "could", "substantially", "impair", "the", "value", "of", "such", "programs", "and", "result", "in", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["Uncertainties", "resulting", "from", "the", "initiation", "and", "continuation", "of", "patent", "litigation", "or", "other", "proceedings", "could", "delay", "our", "research", "and", "development", "efforts", "or", "result", "in", "financial", "implications", "either", "in", "terms", "of", "seeking", "license", "arrangements", "or", "payment", "of", "damages", "or", "royalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p17_s7", "idA": "906709_14_item1a_p11_s3", "sentA": "In the future, an alternative chemistry technique, process or method of administration, or combination thereof, may be discovered to enable the conversion of NKTR-181 into a more abusable opioid, which could significantly and negatively impact the potential of NKTR-181.", "sentB": "In the future, an alternative chemistry technique, process or method of administration, or combination thereof, may be discovered to enable the conversion of NKTR-181 into a more abusable opioid, which could significantly and negatively impact the commercial potential or diminish the value of NKTR-181.", "type": 2, "words": ["<tag1>", "In", "the", "future,", "an", "alternative", "chemistry", "technique,", "process", "or", "method", "of", "administration,", "or", "combination", "thereof,", "may", "be", "discovered", "to", "enable", "the", "conversion", "of", "NKTR-181", "into", "a", "more", "abusable", "opioid,", "which", "could", "significantly", "and", "negatively", "impact", "the", "potential", "of", "NKTR-181.", "<tag2>", "In", "the", "future,", "an", "alternative", "chemistry", "technique,", "process", "or", "method", "of", "administration,", "or", "combination", "thereof,", "may", "be", "discovered", "to", "enable", "the", "conversion", "of", "NKTR-181", "into", "a", "more", "abusable", "opioid,", "which", "could", "significantly", "and", "negatively", "impact", "the", "commercial", "potential", "or", "diminish", "the", "value", "of", "NKTR-181.", "<tag3>"], "wordsA": ["In", "the", "future,", "an", "alternative", "chemistry", "technique,", "process", "or", "method", "of", "administration,", "or", "combination", "thereof,", "may", "be", "discovered", "to", "enable", "the", "conversion", "of", "NKTR-181", "into", "a", "more", "abusable", "opioid,", "which", "could", "significantly", "and", "negatively", "impact", "the", "potential", "of", "NKTR-181."], "wordsB": ["In", "the", "future,", "an", "alternative", "chemistry", "technique,", "process", "or", "method", "of", "administration,", "or", "combination", "thereof,", "may", "be", "discovered", "to", "enable", "the", "conversion", "of", "NKTR-181", "into", "a", "more", "abusable", "opioid,", "which", "could", "significantly", "and", "negatively", "impact", "the", "commercial", "potential", "or", "diminish", "the", "value", "of", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p6_s3", "idA": "906709_14_item1a_p12_s0", "sentA": "If we are unable to establish and maintain collaboration partnerships on attractive commercial terms, our business, results of operations and financial condition could suffer.", "sentB": "If we are unable to obtain sufficient capital resources to advance our drug candidate pipeline, it would negatively impact the value of our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "If", "we", "are", "unable", "to", "establish", "and", "maintain", "collaboration", "partnerships", "on", "attractive", "commercial", "terms,", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "could", "suffer.", "<tag2>", "If", "we", "are", "unable", "to", "obtain", "sufficient", "capital", "resources", "to", "advance", "our", "drug", "candidate", "pipeline,", "it", "would", "negatively", "impact", "the", "value", "of", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["If", "we", "are", "unable", "to", "establish", "and", "maintain", "collaboration", "partnerships", "on", "attractive", "commercial", "terms,", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "could", "suffer."], "wordsB": ["If", "we", "are", "unable", "to", "obtain", "sufficient", "capital", "resources", "to", "advance", "our", "drug", "candidate", "pipeline,", "it", "would", "negatively", "impact", "the", "value", "of", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p2_s8", "idA": "906709_14_item1a_p13_s11", "sentA": "Because it is unlikely that we will be able to identify a single cause for the NKTR-181 Phase 2 study not meeting its primary efficacy endpoint, there is increased risk in effectively designing a Phase 3 clinical study to demonstrate the efficacy of NKTR-181.", "sentB": "For example, while we recently started a Phase 3 clinical program for NKTR-181 which we believe employs the most appropriate clinical trial design, we were unable to identify a single cause for the Phase 2 study for NKTR-181 not meeting its primary efficacy endpoint, and therefore there is increased risk in effectively designing a Phase 3 clinical program for NKTR-181.", "type": 2, "words": ["<tag1>", "Because", "it", "is", "unlikely", "that", "we", "will", "be", "able", "to", "identify", "a", "single", "cause", "for", "the", "NKTR-181", "Phase", "2", "study", "not", "meeting", "its", "primary", "efficacy", "endpoint,", "there", "is", "increased", "risk", "in", "effectively", "designing", "a", "Phase", "3", "clinical", "study", "to", "demonstrate", "the", "efficacy", "of", "NKTR-181.", "<tag2>", "For", "example,", "while", "we", "recently", "started", "a", "Phase", "3", "clinical", "program", "for", "NKTR-181", "which", "we", "believe", "employs", "the", "most", "appropriate", "clinical", "trial", "design,", "we", "were", "unable", "to", "identify", "a", "single", "cause", "for", "the", "Phase", "2", "study", "for", "NKTR-181", "not", "meeting", "its", "primary", "efficacy", "endpoint,", "and", "therefore", "there", "is", "increased", "risk", "in", "effectively", "designing", "a", "Phase", "3", "clinical", "program", "for", "NKTR-181.", "<tag3>"], "wordsA": ["Because", "it", "is", "unlikely", "that", "we", "will", "be", "able", "to", "identify", "a", "single", "cause", "for", "the", "NKTR-181", "Phase", "2", "study", "not", "meeting", "its", "primary", "efficacy", "endpoint,", "there", "is", "increased", "risk", "in", "effectively", "designing", "a", "Phase", "3", "clinical", "study", "to", "demonstrate", "the", "efficacy", "of", "NKTR-181."], "wordsB": ["For", "example,", "while", "we", "recently", "started", "a", "Phase", "3", "clinical", "program", "for", "NKTR-181", "which", "we", "believe", "employs", "the", "most", "appropriate", "clinical", "trial", "design,", "we", "were", "unable", "to", "identify", "a", "single", "cause", "for", "the", "Phase", "2", "study", "for", "NKTR-181", "not", "meeting", "its", "primary", "efficacy", "endpoint,", "and", "therefore", "there", "is", "increased", "risk", "in", "effectively", "designing", "a", "Phase", "3", "clinical", "program", "for", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p19_s1", "idA": "906709_14_item1a_p13_s2", "sentA": "Preliminary data remains subject to audit confirmation and verification procedures that may result in the final data being materially different from the preliminary data we previously published.", "sentB": "Preliminary data remain subject to audit confirmation and verification procedures that may result in the final data being materially different from the preliminary data we previously published.", "type": 2, "words": ["<tag1>", "Preliminary", "data", "remains", "subject", "to", "audit", "confirmation", "and", "verification", "procedures", "that", "may", "result", "in", "the", "final", "data", "being", "materially", "different", "from", "the", "preliminary", "data", "we", "previously", "published.", "<tag2>", "Preliminary", "data", "remain", "subject", "to", "audit", "confirmation", "and", "verification", "procedures", "that", "may", "result", "in", "the", "final", "data", "being", "materially", "different", "from", "the", "preliminary", "data", "we", "previously", "published.", "<tag3>"], "wordsA": ["Preliminary", "data", "remains", "subject", "to", "audit", "confirmation", "and", "verification", "procedures", "that", "may", "result", "in", "the", "final", "data", "being", "materially", "different", "from", "the", "preliminary", "data", "we", "previously", "published."], "wordsB": ["Preliminary", "data", "remain", "subject", "to", "audit", "confirmation", "and", "verification", "procedures", "that", "may", "result", "in", "the", "final", "data", "being", "materially", "different", "from", "the", "preliminary", "data", "we", "previously", "published."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p20_s2", "idA": "906709_14_item1a_p13_s9", "sentA": "A Phase 2 clinical study for etirinotecan pegol in patients with metastatic colorectal cancer is still open for enrollment.", "sentB": "We currently have ongoing Phase 3 studies for etirinotecan pegol in patients with metastatic breast cancer and NKTR-181 in patients with chronic lower back pain.", "type": 2, "words": ["<tag1>", "A", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "patients", "with", "metastatic", "colorectal", "cancer", "is", "still", "open", "for", "enrollment.", "<tag2>", "We", "currently", "have", "ongoing", "Phase", "3", "studies", "for", "etirinotecan", "pegol", "in", "patients", "with", "metastatic", "breast", "cancer", "and", "NKTR-181", "in", "patients", "with", "chronic", "lower", "back", "pain.", "<tag3>"], "wordsA": ["A", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "patients", "with", "metastatic", "colorectal", "cancer", "is", "still", "open", "for", "enrollment."], "wordsB": ["We", "currently", "have", "ongoing", "Phase", "3", "studies", "for", "etirinotecan", "pegol", "in", "patients", "with", "metastatic", "breast", "cancer", "and", "NKTR-181", "in", "patients", "with", "chronic", "lower", "back", "pain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p20_s4", "idA": "906709_14_item1a_p14_s0", "sentA": "and other of our planned clinical studies may not begin on time, have an effective design, enroll a sufficient number of patients or be completed on schedule, if at all.", "sentB": "These and other clinical studies may not begin on time, enroll a sufficient number of patients or be completed on schedule, if at all.", "type": 2, "words": ["<tag1>", "and", "other", "of", "our", "planned", "clinical", "studies", "may", "not", "begin", "on", "time,", "have", "an", "effective", "design,", "enroll", "a", "sufficient", "number", "of", "patients", "or", "be", "completed", "on", "schedule,", "if", "at", "all.", "<tag2>", "These", "and", "other", "clinical", "studies", "may", "not", "begin", "on", "time,", "enroll", "a", "sufficient", "number", "of", "patients", "or", "be", "completed", "on", "schedule,", "if", "at", "all.", "<tag3>"], "wordsA": ["and", "other", "of", "our", "planned", "clinical", "studies", "may", "not", "begin", "on", "time,", "have", "an", "effective", "design,", "enroll", "a", "sufficient", "number", "of", "patients", "or", "be", "completed", "on", "schedule,", "if", "at", "all."], "wordsB": ["These", "and", "other", "clinical", "studies", "may", "not", "begin", "on", "time,", "enroll", "a", "sufficient", "number", "of", "patients", "or", "be", "completed", "on", "schedule,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p21_s1", "idA": "906709_14_item1a_p15_s1", "sentA": "If initiation or completion of any of the planned clinical studies are delayed for our drug candidates for any of the above reasons or otherwise, the approval process could be delayed and the ability to commercialize and commence sales of these drug candidates could be materially harmed, which could have a material adverse effect on our business, financial condition and results of operations.", "sentB": "If the initiation or completion of any of the planned clinical studies for our drug candidates is delayed for any of the above or other reasons, the regulatory approval process would be delayed and the ability to commercialize and commence sales of these drug candidates could be materially harmed, which could have a material adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "If", "initiation", "or", "completion", "of", "any", "of", "the", "planned", "clinical", "studies", "are", "delayed", "for", "our", "drug", "candidates", "for", "any", "of", "the", "above", "reasons", "or", "otherwise,", "the", "approval", "process", "could", "be", "delayed", "and", "the", "ability", "to", "commercialize", "and", "commence", "sales", "of", "these", "drug", "candidates", "could", "be", "materially", "harmed,", "which", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "If", "the", "initiation", "or", "completion", "of", "any", "of", "the", "planned", "clinical", "studies", "for", "our", "drug", "candidates", "is", "delayed", "for", "any", "of", "the", "above", "or", "other", "reasons,", "the", "regulatory", "approval", "process", "would", "be", "delayed", "and", "the", "ability", "to", "commercialize", "and", "commence", "sales", "of", "these", "drug", "candidates", "could", "be", "materially", "harmed,", "which", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["If", "initiation", "or", "completion", "of", "any", "of", "the", "planned", "clinical", "studies", "are", "delayed", "for", "our", "drug", "candidates", "for", "any", "of", "the", "above", "reasons", "or", "otherwise,", "the", "approval", "process", "could", "be", "delayed", "and", "the", "ability", "to", "commercialize", "and", "commence", "sales", "of", "these", "drug", "candidates", "could", "be", "materially", "harmed,", "which", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["If", "the", "initiation", "or", "completion", "of", "any", "of", "the", "planned", "clinical", "studies", "for", "our", "drug", "candidates", "is", "delayed", "for", "any", "of", "the", "above", "or", "other", "reasons,", "the", "regulatory", "approval", "process", "would", "be", "delayed", "and", "the", "ability", "to", "commercialize", "and", "commence", "sales", "of", "these", "drug", "candidates", "could", "be", "materially", "harmed,", "which", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p22_s2", "idA": "906709_14_item1a_p19_s0", "sentA": "long development and commercialization cycles for biotechnology and pharmaceutical products.", "sentB": "In certain cases, we have existing licenses or cross-licenses with third parties; however, the scope and adequacy of these licenses is very uncertain and can change substantially during long development and commercialization cycles for biotechnology and pharmaceutical products.", "type": 2, "words": ["<tag1>", "long", "development", "and", "commercialization", "cycles", "for", "biotechnology", "and", "pharmaceutical", "products.", "<tag2>", "In", "certain", "cases,", "we", "have", "existing", "licenses", "or", "cross-licenses", "with", "third", "parties;", "however,", "the", "scope", "and", "adequacy", "of", "these", "licenses", "is", "very", "uncertain", "and", "can", "change", "substantially", "during", "long", "development", "and", "commercialization", "cycles", "for", "biotechnology", "and", "pharmaceutical", "products.", "<tag3>"], "wordsA": ["long", "development", "and", "commercialization", "cycles", "for", "biotechnology", "and", "pharmaceutical", "products."], "wordsB": ["In", "certain", "cases,", "we", "have", "existing", "licenses", "or", "cross-licenses", "with", "third", "parties;", "however,", "the", "scope", "and", "adequacy", "of", "these", "licenses", "is", "very", "uncertain", "and", "can", "change", "substantially", "during", "long", "development", "and", "commercialization", "cycles", "for", "biotechnology", "and", "pharmaceutical", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p2_s7", "idA": "906709_14_item1a_p1_s7", "sentA": "The risk of failure increases for our drug candidates that are based on new technologies, such as the application of our advanced polymer conjugate technology to small molecules, including naloxegol, etirinotecan pegol (also known as NKTR-102), NKTR-181, NKTR-192, NKTR-171 and other drug candidates currently in discovery research or preclinical development.", "sentB": "The risk of failure increases for our drug candidates that are based on new technologies, such as the application of our advanced polymer conjugate technology to etirinotecan pegol, NKTR-181, NKTR-171, NKTR-214 and other drug candidates currently in discovery research or preclinical development.", "type": 2, "words": ["<tag1>", "The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "small", "molecules,", "including", "naloxegol,", "etirinotecan", "pegol", "(also", "known", "as", "NKTR-102),", "NKTR-181,", "NKTR-192,", "NKTR-171", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development.", "<tag2>", "The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "etirinotecan", "pegol,", "NKTR-181,", "NKTR-171,", "NKTR-214", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development.", "<tag3>"], "wordsA": ["The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "small", "molecules,", "including", "naloxegol,", "etirinotecan", "pegol", "(also", "known", "as", "NKTR-102),", "NKTR-181,", "NKTR-192,", "NKTR-171", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development."], "wordsB": ["The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "etirinotecan", "pegol,", "NKTR-181,", "NKTR-171,", "NKTR-214", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p24_s1", "idA": "906709_14_item1a_p21_s1", "sentA": "We own more than 175 U.S. and 500 foreign patents and a number of pending patent applications that cover various aspects of our technologies.", "sentB": "We own more than 215 U.S. and 750 foreign patents and a number of pending patent applications that cover various aspects of our technologies.", "type": 2, "words": ["<tag1>", "We", "own", "more", "than", "175", "U.S.", "and", "500", "foreign", "patents", "and", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies.", "<tag2>", "We", "own", "more", "than", "215", "U.S.", "and", "750", "foreign", "patents", "and", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies.", "<tag3>"], "wordsA": ["We", "own", "more", "than", "175", "U.S.", "and", "500", "foreign", "patents", "and", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies."], "wordsB": ["We", "own", "more", "than", "215", "U.S.", "and", "750", "foreign", "patents", "and", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p27_s1", "idA": "906709_14_item1a_p25_s0", "sentA": "from developing or commercializing, or deriving revenue from, certain drugs or drug candidates in the U.S. and abroad.", "sentB": "If a third party obtains injunctive or other equitable relief against us or our partners, they could effectively prevent us, or our partners, from developing or commercializing, or deriving revenue from, certain drugs or drug candidates in the U.S. and abroad.", "type": 2, "words": ["<tag1>", "from", "developing", "or", "commercializing,", "or", "deriving", "revenue", "from,", "certain", "drugs", "or", "drug", "candidates", "in", "the", "U.S.", "and", "abroad.", "<tag2>", "If", "a", "third", "party", "obtains", "injunctive", "or", "other", "equitable", "relief", "against", "us", "or", "our", "partners,", "they", "could", "effectively", "prevent", "us,", "or", "our", "partners,", "from", "developing", "or", "commercializing,", "or", "deriving", "revenue", "from,", "certain", "drugs", "or", "drug", "candidates", "in", "the", "U.S.", "and", "abroad.", "<tag3>"], "wordsA": ["from", "developing", "or", "commercializing,", "or", "deriving", "revenue", "from,", "certain", "drugs", "or", "drug", "candidates", "in", "the", "U.S.", "and", "abroad."], "wordsB": ["If", "a", "third", "party", "obtains", "injunctive", "or", "other", "equitable", "relief", "against", "us", "or", "our", "partners,", "they", "could", "effectively", "prevent", "us,", "or", "our", "partners,", "from", "developing", "or", "commercializing,", "or", "deriving", "revenue", "from,", "certain", "drugs", "or", "drug", "candidates", "in", "the", "U.S.", "and", "abroad."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p29_s7", "idA": "906709_14_item1a_p25_s10", "sentA": "We and our contract manufacturers are required in certain cases to maintain compliance with current good manufacturing practices (cGMP), including cGMP guidelines applicable to active pharmaceutical ingredients, and with laws and regulations governing manufacture and distribution of controlled substances, and are subject to inspections by the FDA, DEA or comparable agencies in other jurisdictions to confirm such compliance.", "sentB": "We and our contract manufacturers are required in certain cases to maintain compliance with current good manufacturing practices (cGMP), including cGMP guidelines applicable to active pharmaceutical ingredients, and with laws and regulations governing manufacture and distribution of controlled substances, and are subject to inspections by the FDA, the Drug Enforcement Administration or comparable agencies in other jurisdictions administering such compliance.", "type": 2, "words": ["<tag1>", "We", "and", "our", "contract", "manufacturers", "are", "required", "in", "certain", "cases", "to", "maintain", "compliance", "with", "current", "good", "manufacturing", "practices", "(cGMP),", "including", "cGMP", "guidelines", "applicable", "to", "active", "pharmaceutical", "ingredients,", "and", "with", "laws", "and", "regulations", "governing", "manufacture", "and", "distribution", "of", "controlled", "substances,", "and", "are", "subject", "to", "inspections", "by", "the", "FDA,", "DEA", "or", "comparable", "agencies", "in", "other", "jurisdictions", "to", "confirm", "such", "compliance.", "<tag2>", "We", "and", "our", "contract", "manufacturers", "are", "required", "in", "certain", "cases", "to", "maintain", "compliance", "with", "current", "good", "manufacturing", "practices", "(cGMP),", "including", "cGMP", "guidelines", "applicable", "to", "active", "pharmaceutical", "ingredients,", "and", "with", "laws", "and", "regulations", "governing", "manufacture", "and", "distribution", "of", "controlled", "substances,", "and", "are", "subject", "to", "inspections", "by", "the", "FDA,", "the", "Drug", "Enforcement", "Administration", "or", "comparable", "agencies", "in", "other", "jurisdictions", "administering", "such", "compliance.", "<tag3>"], "wordsA": ["We", "and", "our", "contract", "manufacturers", "are", "required", "in", "certain", "cases", "to", "maintain", "compliance", "with", "current", "good", "manufacturing", "practices", "(cGMP),", "including", "cGMP", "guidelines", "applicable", "to", "active", "pharmaceutical", "ingredients,", "and", "with", "laws", "and", "regulations", "governing", "manufacture", "and", "distribution", "of", "controlled", "substances,", "and", "are", "subject", "to", "inspections", "by", "the", "FDA,", "DEA", "or", "comparable", "agencies", "in", "other", "jurisdictions", "to", "confirm", "such", "compliance."], "wordsB": ["We", "and", "our", "contract", "manufacturers", "are", "required", "in", "certain", "cases", "to", "maintain", "compliance", "with", "current", "good", "manufacturing", "practices", "(cGMP),", "including", "cGMP", "guidelines", "applicable", "to", "active", "pharmaceutical", "ingredients,", "and", "with", "laws", "and", "regulations", "governing", "manufacture", "and", "distribution", "of", "controlled", "substances,", "and", "are", "subject", "to", "inspections", "by", "the", "FDA,", "the", "Drug", "Enforcement", "Administration", "or", "comparable", "agencies", "in", "other", "jurisdictions", "administering", "such", "compliance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p30_s1", "idA": "906709_14_item1a_p25_s16", "sentA": "If we or our contract manufacturers are not able to manufacture drugs or drug substances in sufficient quantities that meet applicable quality standards, it could delay clinical studies, result in reduced sales or constitute a breach of our contractual obligations, any of which could significantly harm our business, financial condition and results of operations.", "sentB": "If we or our contract manufacturers are not able to manufacture and supply sufficient drug quantities meeting applicable quality standards required to support large clinical studies or commercial manufacturing in a timely manner, it could delay our or our collaboration partners clinical studies or result in a breach of our contractual obligations, which could in turn reduce the potential commercial sales of our or our collaboration partners products.", "type": 2, "words": ["<tag1>", "If", "we", "or", "our", "contract", "manufacturers", "are", "not", "able", "to", "manufacture", "drugs", "or", "drug", "substances", "in", "sufficient", "quantities", "that", "meet", "applicable", "quality", "standards,", "it", "could", "delay", "clinical", "studies,", "result", "in", "reduced", "sales", "or", "constitute", "a", "breach", "of", "our", "contractual", "obligations,", "any", "of", "which", "could", "significantly", "harm", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "If", "we", "or", "our", "contract", "manufacturers", "are", "not", "able", "to", "manufacture", "and", "supply", "sufficient", "drug", "quantities", "meeting", "applicable", "quality", "standards", "required", "to", "support", "large", "clinical", "studies", "or", "commercial", "manufacturing", "in", "a", "timely", "manner,", "it", "could", "delay", "our", "or", "our", "collaboration", "partners", "clinical", "studies", "or", "result", "in", "a", "breach", "of", "our", "contractual", "obligations,", "which", "could", "in", "turn", "reduce", "the", "potential", "commercial", "sales", "of", "our", "or", "our", "collaboration", "partners", "products.", "<tag3>"], "wordsA": ["If", "we", "or", "our", "contract", "manufacturers", "are", "not", "able", "to", "manufacture", "drugs", "or", "drug", "substances", "in", "sufficient", "quantities", "that", "meet", "applicable", "quality", "standards,", "it", "could", "delay", "clinical", "studies,", "result", "in", "reduced", "sales", "or", "constitute", "a", "breach", "of", "our", "contractual", "obligations,", "any", "of", "which", "could", "significantly", "harm", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["If", "we", "or", "our", "contract", "manufacturers", "are", "not", "able", "to", "manufacture", "and", "supply", "sufficient", "drug", "quantities", "meeting", "applicable", "quality", "standards", "required", "to", "support", "large", "clinical", "studies", "or", "commercial", "manufacturing", "in", "a", "timely", "manner,", "it", "could", "delay", "our", "or", "our", "collaboration", "partners", "clinical", "studies", "or", "result", "in", "a", "breach", "of", "our", "contractual", "obligations,", "which", "could", "in", "turn", "reduce", "the", "potential", "commercial", "sales", "of", "our", "or", "our", "collaboration", "partners", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p28_s3", "idA": "906709_14_item1a_p25_s7", "sentA": "In addition, from time to time, we may in the future assert claims against third parties, based on infringement of our proprietary rights or otherwise.", "sentB": "In addition, from time to time, we are involved in legal proceedings where we or other third parties are enforcing or seeking intellectual property rights, invalidating or limiting patent rights that have already been allowed or issued, or otherwise asserting proprietary rights through one or more potential legal remedies.", "type": 2, "words": ["<tag1>", "In", "addition,", "from", "time", "to", "time,", "we", "may", "in", "the", "future", "assert", "claims", "against", "third", "parties,", "based", "on", "infringement", "of", "our", "proprietary", "rights", "or", "otherwise.", "<tag2>", "In", "addition,", "from", "time", "to", "time,", "we", "are", "involved", "in", "legal", "proceedings", "where", "we", "or", "other", "third", "parties", "are", "enforcing", "or", "seeking", "intellectual", "property", "rights,", "invalidating", "or", "limiting", "patent", "rights", "that", "have", "already", "been", "allowed", "or", "issued,", "or", "otherwise", "asserting", "proprietary", "rights", "through", "one", "or", "more", "potential", "legal", "remedies.", "<tag3>"], "wordsA": ["In", "addition,", "from", "time", "to", "time,", "we", "may", "in", "the", "future", "assert", "claims", "against", "third", "parties,", "based", "on", "infringement", "of", "our", "proprietary", "rights", "or", "otherwise."], "wordsB": ["In", "addition,", "from", "time", "to", "time,", "we", "are", "involved", "in", "legal", "proceedings", "where", "we", "or", "other", "third", "parties", "are", "enforcing", "or", "seeking", "intellectual", "property", "rights,", "invalidating", "or", "limiting", "patent", "rights", "that", "have", "already", "been", "allowed", "or", "issued,", "or", "otherwise", "asserting", "proprietary", "rights", "through", "one", "or", "more", "potential", "legal", "remedies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p30_s2", "idA": "906709_14_item1a_p26_s1", "sentA": "As a result, we could incur substantial costs and damages, and reduce or even eliminate product or royalty revenue.", "sentB": "As a result, we could incur substantial costs and damages and any product sales or royalty revenue that we would otherwise be entitled to receive could be reduced, delayed or eliminated.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "we", "could", "incur", "substantial", "costs", "and", "damages,", "and", "reduce", "or", "even", "eliminate", "product", "or", "royalty", "revenue.", "<tag2>", "As", "a", "result,", "we", "could", "incur", "substantial", "costs", "and", "damages", "and", "any", "product", "sales", "or", "royalty", "revenue", "that", "we", "would", "otherwise", "be", "entitled", "to", "receive", "could", "be", "reduced,", "delayed", "or", "eliminated.", "<tag3>"], "wordsA": ["As", "a", "result,", "we", "could", "incur", "substantial", "costs", "and", "damages,", "and", "reduce", "or", "even", "eliminate", "product", "or", "royalty", "revenue."], "wordsB": ["As", "a", "result,", "we", "could", "incur", "substantial", "costs", "and", "damages", "and", "any", "product", "sales", "or", "royalty", "revenue", "that", "we", "would", "otherwise", "be", "entitled", "to", "receive", "could", "be", "reduced,", "delayed", "or", "eliminated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p13_s0", "idA": "906709_14_item1a_p2_s0", "sentA": "Drug candidates must undergo rigorous animal and human testing and an extensive review process for safety and efficacy by the U.S. Food and Drug Administration (FDA) and equivalent foreign government health authorities.", "sentB": "Drug candidates must undergo rigorous animal and human testing and an extensive review process for safety and efficacy by the FDA and equivalent foreign government health authorities.", "type": 2, "words": ["<tag1>", "Drug", "candidates", "must", "undergo", "rigorous", "animal", "and", "human", "testing", "and", "an", "extensive", "review", "process", "for", "safety", "and", "efficacy", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "and", "equivalent", "foreign", "government", "health", "authorities.", "<tag2>", "Drug", "candidates", "must", "undergo", "rigorous", "animal", "and", "human", "testing", "and", "an", "extensive", "review", "process", "for", "safety", "and", "efficacy", "by", "the", "FDA", "and", "equivalent", "foreign", "government", "health", "authorities.", "<tag3>"], "wordsA": ["Drug", "candidates", "must", "undergo", "rigorous", "animal", "and", "human", "testing", "and", "an", "extensive", "review", "process", "for", "safety", "and", "efficacy", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "and", "equivalent", "foreign", "government", "health", "authorities."], "wordsB": ["Drug", "candidates", "must", "undergo", "rigorous", "animal", "and", "human", "testing", "and", "an", "extensive", "review", "process", "for", "safety", "and", "efficacy", "by", "the", "FDA", "and", "equivalent", "foreign", "government", "health", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p14_s0", "idA": "906709_14_item1a_p2_s4", "sentA": "In addition, undesirable side effects caused by our drug candidates could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restricted label or the delay or denial of regulatory approval by regulatory authorities.", "sentB": "undesirable side effects caused by our drug candidates could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restricted label or the delay or denial of regulatory approval by regulatory authorities.", "type": 2, "words": ["<tag1>", "In", "addition,", "undesirable", "side", "effects", "caused", "by", "our", "drug", "candidates", "could", "cause", "us", "or", "regulatory", "authorities", "to", "interrupt,", "delay", "or", "halt", "clinical", "trials", "and", "could", "result", "in", "a", "more", "restricted", "label", "or", "the", "delay", "or", "denial", "of", "regulatory", "approval", "by", "regulatory", "authorities.", "<tag2>", "undesirable", "side", "effects", "caused", "by", "our", "drug", "candidates", "could", "cause", "us", "or", "regulatory", "authorities", "to", "interrupt,", "delay", "or", "halt", "clinical", "trials", "and", "could", "result", "in", "a", "more", "restricted", "label", "or", "the", "delay", "or", "denial", "of", "regulatory", "approval", "by", "regulatory", "authorities.", "<tag3>"], "wordsA": ["In", "addition,", "undesirable", "side", "effects", "caused", "by", "our", "drug", "candidates", "could", "cause", "us", "or", "regulatory", "authorities", "to", "interrupt,", "delay", "or", "halt", "clinical", "trials", "and", "could", "result", "in", "a", "more", "restricted", "label", "or", "the", "delay", "or", "denial", "of", "regulatory", "approval", "by", "regulatory", "authorities."], "wordsB": ["undesirable", "side", "effects", "caused", "by", "our", "drug", "candidates", "could", "cause", "us", "or", "regulatory", "authorities", "to", "interrupt,", "delay", "or", "halt", "clinical", "trials", "and", "could", "result", "in", "a", "more", "restricted", "label", "or", "the", "delay", "or", "denial", "of", "regulatory", "approval", "by", "regulatory", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p20_s3", "idA": "906709_14_item1a_p30_s1", "sentA": "We experienced repeated significant delays in starting the Phase 3 clinical development program for Amikacin Inhale as we sought to finalize and validate the device design with a demonstrated capability to be manufactured at commercial scale.", "sentB": "In addition, our collaboration partners have several ongoing Phase 3 clinical programs including Baxter for BAX 855, Bayer for Amikacin Inhale and CIPRO Inhale, and Ophthotech for Fovista .", "type": 2, "words": ["<tag1>", "We", "experienced", "repeated", "significant", "delays", "in", "starting", "the", "Phase", "3", "clinical", "development", "program", "for", "Amikacin", "Inhale", "as", "we", "sought", "to", "finalize", "and", "validate", "the", "device", "design", "with", "a", "demonstrated", "capability", "to", "be", "manufactured", "at", "commercial", "scale.", "<tag2>", "In", "addition,", "our", "collaboration", "partners", "have", "several", "ongoing", "Phase", "3", "clinical", "programs", "including", "Baxter", "for", "BAX", "855,", "Bayer", "for", "Amikacin", "Inhale", "and", "CIPRO", "Inhale,", "and", "Ophthotech", "for", "Fovista", ".", "<tag3>"], "wordsA": ["We", "experienced", "repeated", "significant", "delays", "in", "starting", "the", "Phase", "3", "clinical", "development", "program", "for", "Amikacin", "Inhale", "as", "we", "sought", "to", "finalize", "and", "validate", "the", "device", "design", "with", "a", "demonstrated", "capability", "to", "be", "manufactured", "at", "commercial", "scale."], "wordsB": ["In", "addition,", "our", "collaboration", "partners", "have", "several", "ongoing", "Phase", "3", "clinical", "programs", "including", "Baxter", "for", "BAX", "855,", "Bayer", "for", "Amikacin", "Inhale", "and", "CIPRO", "Inhale,", "and", "Ophthotech", "for", "Fovista", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p35_s1", "idA": "906709_14_item1a_p31_s1", "sentA": "Our revenue is derived from our collaboration agreements, from which we receive contract research payments, milestone payments based on clinical progress, regulatory progress or net sales achievements, royalties and manufacturing revenue.", "sentB": "Our revenue is exclusively derived from our collaboration agreements, from which we receive contract research payments, milestone payments based on clinical progress, regulatory progress or net sales achievements, royalties and manufacturing revenue.", "type": 2, "words": ["<tag1>", "Our", "revenue", "is", "derived", "from", "our", "collaboration", "agreements,", "from", "which", "we", "receive", "contract", "research", "payments,", "milestone", "payments", "based", "on", "clinical", "progress,", "regulatory", "progress", "or", "net", "sales", "achievements,", "royalties", "and", "manufacturing", "revenue.", "<tag2>", "Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "from", "which", "we", "receive", "contract", "research", "payments,", "milestone", "payments", "based", "on", "clinical", "progress,", "regulatory", "progress", "or", "net", "sales", "achievements,", "royalties", "and", "manufacturing", "revenue.", "<tag3>"], "wordsA": ["Our", "revenue", "is", "derived", "from", "our", "collaboration", "agreements,", "from", "which", "we", "receive", "contract", "research", "payments,", "milestone", "payments", "based", "on", "clinical", "progress,", "regulatory", "progress", "or", "net", "sales", "achievements,", "royalties", "and", "manufacturing", "revenue."], "wordsB": ["Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "from", "which", "we", "receive", "contract", "research", "payments,", "milestone", "payments", "based", "on", "clinical", "progress,", "regulatory", "progress", "or", "net", "sales", "achievements,", "royalties", "and", "manufacturing", "revenue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p5_s0", "idA": "906709_14_item1a_p35_s0", "sentA": "Our reliance on collaboration partners poses a number of risks to our business, including risks that:", "sentB": "Our reliance on collaboration partners poses a number of significant risks to our business, including risks that:", "type": 2, "words": ["<tag1>", "Our", "reliance", "on", "collaboration", "partners", "poses", "a", "number", "of", "risks", "to", "our", "business,", "including", "risks", "that:", "<tag2>", "Our", "reliance", "on", "collaboration", "partners", "poses", "a", "number", "of", "significant", "risks", "to", "our", "business,", "including", "risks", "that:", "<tag3>"], "wordsA": ["Our", "reliance", "on", "collaboration", "partners", "poses", "a", "number", "of", "risks", "to", "our", "business,", "including", "risks", "that:"], "wordsB": ["Our", "reliance", "on", "collaboration", "partners", "poses", "a", "number", "of", "significant", "risks", "to", "our", "business,", "including", "risks", "that:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p6_s1", "idA": "906709_14_item1a_p36_s1", "sentA": "Given these risks, the success of our current and future partnerships is highly unpredictable and can have a substantial negative or positive impact on our business.", "sentB": "Given these risks, the success of our current and future collaboration partnerships is highly unpredictable and can have a substantial negative or positive impact on our business in particular, we expect the commercial outcomes of MOVANTIK , and if approved, BAX 855, to have a particularly significant impact on our near to mid- term financial results and financial condition.", "type": 2, "words": ["<tag1>", "Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business.", "<tag2>", "Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business", "in", "particular,", "we", "expect", "the", "commercial", "outcomes", "of", "MOVANTIK", ",", "and", "if", "approved,", "BAX", "855,", "to", "have", "a", "particularly", "significant", "impact", "on", "our", "near", "to", "mid-", "term", "financial", "results", "and", "financial", "condition.", "<tag3>"], "wordsA": ["Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business."], "wordsB": ["Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business", "in", "particular,", "we", "expect", "the", "commercial", "outcomes", "of", "MOVANTIK", ",", "and", "if", "approved,", "BAX", "855,", "to", "have", "a", "particularly", "significant", "impact", "on", "our", "near", "to", "mid-", "term", "financial", "results", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p6_s2", "idA": "906709_14_item1a_p36_s4", "sentA": "If our collaborations fail, our product development or commercialization of product candidates could be delayed or cancelled, which would negatively impact our business, results of operations and financial condition.", "sentB": "If our collaboration arrangements underperform or fail, our drug development efforts for our proprietary drug candidate pipeline could be delayed or reduced unless we can secure capital funding from other sources.", "type": 2, "words": ["<tag1>", "If", "our", "collaborations", "fail,", "our", "product", "development", "or", "commercialization", "of", "product", "candidates", "could", "be", "delayed", "or", "cancelled,", "which", "would", "negatively", "impact", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "If", "our", "collaboration", "arrangements", "underperform", "or", "fail,", "our", "drug", "development", "efforts", "for", "our", "proprietary", "drug", "candidate", "pipeline", "could", "be", "delayed", "or", "reduced", "unless", "we", "can", "secure", "capital", "funding", "from", "other", "sources.", "<tag3>"], "wordsA": ["If", "our", "collaborations", "fail,", "our", "product", "development", "or", "commercialization", "of", "product", "candidates", "could", "be", "delayed", "or", "cancelled,", "which", "would", "negatively", "impact", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["If", "our", "collaboration", "arrangements", "underperform", "or", "fail,", "our", "drug", "development", "efforts", "for", "our", "proprietary", "drug", "candidate", "pipeline", "could", "be", "delayed", "or", "reduced", "unless", "we", "can", "secure", "capital", "funding", "from", "other", "sources."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p37_s3", "idA": "906709_14_item1a_p38_s3", "sentA": "To the extent that we enter into co-promotion or other arrangements, any revenues we receive will depend upon the efforts of third parties, which may not be successful and are only partially in our control.", "sentB": "To the extent that we enter into co-promotion or other arrangements, any revenue we receive will depend upon the efforts of third parties, which may not be successful and are only partially in our control important examples of this risk include MOVANTIK partnered with AstraZeneca and BAX 855 partnered with Baxter.", "type": 2, "words": ["<tag1>", "To", "the", "extent", "that", "we", "enter", "into", "co-promotion", "or", "other", "arrangements,", "any", "revenues", "we", "receive", "will", "depend", "upon", "the", "efforts", "of", "third", "parties,", "which", "may", "not", "be", "successful", "and", "are", "only", "partially", "in", "our", "control.", "<tag2>", "To", "the", "extent", "that", "we", "enter", "into", "co-promotion", "or", "other", "arrangements,", "any", "revenue", "we", "receive", "will", "depend", "upon", "the", "efforts", "of", "third", "parties,", "which", "may", "not", "be", "successful", "and", "are", "only", "partially", "in", "our", "control", "important", "examples", "of", "this", "risk", "include", "MOVANTIK", "partnered", "with", "AstraZeneca", "and", "BAX", "855", "partnered", "with", "Baxter.", "<tag3>"], "wordsA": ["To", "the", "extent", "that", "we", "enter", "into", "co-promotion", "or", "other", "arrangements,", "any", "revenues", "we", "receive", "will", "depend", "upon", "the", "efforts", "of", "third", "parties,", "which", "may", "not", "be", "successful", "and", "are", "only", "partially", "in", "our", "control."], "wordsB": ["To", "the", "extent", "that", "we", "enter", "into", "co-promotion", "or", "other", "arrangements,", "any", "revenue", "we", "receive", "will", "depend", "upon", "the", "efforts", "of", "third", "parties,", "which", "may", "not", "be", "successful", "and", "are", "only", "partially", "in", "our", "control", "important", "examples", "of", "this", "risk", "include", "MOVANTIK", "partnered", "with", "AstraZeneca", "and", "BAX", "855", "partnered", "with", "Baxter."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p38_s3", "idA": "906709_14_item1a_p39_s0", "sentA": "protect and may lose their value if they are independently developed by a third party or if their secrecy is lost.", "sentB": "In addition, unpatented proprietary rights, including trade secrets and know-how, can be difficult to protect and may lose their value if they are independently developed by a third party or if their secrecy is lost.", "type": 2, "words": ["<tag1>", "protect", "and", "may", "lose", "their", "value", "if", "they", "are", "independently", "developed", "by", "a", "third", "party", "or", "if", "their", "secrecy", "is", "lost.", "<tag2>", "In", "addition,", "unpatented", "proprietary", "rights,", "including", "trade", "secrets", "and", "know-how,", "can", "be", "difficult", "to", "protect", "and", "may", "lose", "their", "value", "if", "they", "are", "independently", "developed", "by", "a", "third", "party", "or", "if", "their", "secrecy", "is", "lost.", "<tag3>"], "wordsA": ["protect", "and", "may", "lose", "their", "value", "if", "they", "are", "independently", "developed", "by", "a", "third", "party", "or", "if", "their", "secrecy", "is", "lost."], "wordsB": ["In", "addition,", "unpatented", "proprietary", "rights,", "including", "trade", "secrets", "and", "know-how,", "can", "be", "difficult", "to", "protect", "and", "may", "lose", "their", "value", "if", "they", "are", "independently", "developed", "by", "a", "third", "party", "or", "if", "their", "secrecy", "is", "lost."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p2_s15", "idA": "906709_14_item1a_p39_s1", "sentA": "Any loss of trade secret protection or other unpatented proprietary rights could harm our business, results of operations and financial condition.", "sentB": "Our results of operations and financial condition depend significantly on the ability of our collaboration partners to successfully develop and market drugs and they may fail to do so.", "type": 2, "words": ["<tag1>", "Any", "loss", "of", "trade", "secret", "protection", "or", "other", "unpatented", "proprietary", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Our", "results", "of", "operations", "and", "financial", "condition", "depend", "significantly", "on", "the", "ability", "of", "our", "collaboration", "partners", "to", "successfully", "develop", "and", "market", "drugs", "and", "they", "may", "fail", "to", "do", "so.", "<tag3>"], "wordsA": ["Any", "loss", "of", "trade", "secret", "protection", "or", "other", "unpatented", "proprietary", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Our", "results", "of", "operations", "and", "financial", "condition", "depend", "significantly", "on", "the", "ability", "of", "our", "collaboration", "partners", "to", "successfully", "develop", "and", "market", "drugs", "and", "they", "may", "fail", "to", "do", "so."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p38_s6", "idA": "906709_14_item1a_p39_s3", "sentA": "For the year ended December 31, 2013, we reported a net loss of $162.0 million.", "sentB": "For the year ended December 31, 2014, we reported a net loss of $53.9 million.", "type": 2, "words": ["<tag1>", "For", "the", "year", "ended", "December", "31,", "2013,", "we", "reported", "a", "net", "loss", "of", "$162.0", "million.", "<tag2>", "For", "the", "year", "ended", "December", "31,", "2014,", "we", "reported", "a", "net", "loss", "of", "$53.9", "million.", "<tag3>"], "wordsA": ["For", "the", "year", "ended", "December", "31,", "2013,", "we", "reported", "a", "net", "loss", "of", "$162.0", "million."], "wordsB": ["For", "the", "year", "ended", "December", "31,", "2014,", "we", "reported", "a", "net", "loss", "of", "$53.9", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p41_s3", "idA": "906709_14_item1a_p42_s0", "sentA": "activities, many aspects of their activities are beyond our control.", "sentB": "Though we are ultimately responsible for the results of their activities, many aspects of their activities are beyond our control.", "type": 2, "words": ["<tag1>", "activities,", "many", "aspects", "of", "their", "activities", "are", "beyond", "our", "control.", "<tag2>", "Though", "we", "are", "ultimately", "responsible", "for", "the", "results", "of", "their", "activities,", "many", "aspects", "of", "their", "activities", "are", "beyond", "our", "control.", "<tag3>"], "wordsA": ["activities,", "many", "aspects", "of", "their", "activities", "are", "beyond", "our", "control."], "wordsB": ["Though", "we", "are", "ultimately", "responsible", "for", "the", "results", "of", "their", "activities,", "many", "aspects", "of", "their", "activities", "are", "beyond", "our", "control."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p44_s1", "idA": "906709_14_item1a_p45_s1", "sentA": "For naloxegol, there are currently several alternative therapies used to address opioid-induced constipation (OIC) and opioid-induced bowel dysfunction (OBD), including subcutaneous Relistor (methylnaltrexone bromide), oral Amitizia (lubiprostone), and oral and rectal over-the-counter laxatives and stool softeners such as docusate sodium, senna and milk of magnesia.", "sentB": "Subcutaneous Injection, oral Amitizia (lubiprostone), and oral and rectal over-the-counter laxatives and stool softeners such as docusate sodium, senna and milk of magnesia.", "type": 2, "words": ["<tag1>", "For", "naloxegol,", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "subcutaneous", "Relistor", "(methylnaltrexone", "bromide),", "oral", "Amitizia", "(lubiprostone),", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia.", "<tag2>", "Subcutaneous", "Injection,", "oral", "Amitizia", "(lubiprostone),", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia.", "<tag3>"], "wordsA": ["For", "naloxegol,", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "subcutaneous", "Relistor", "(methylnaltrexone", "bromide),", "oral", "Amitizia", "(lubiprostone),", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia."], "wordsB": ["Subcutaneous", "Injection,", "oral", "Amitizia", "(lubiprostone),", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p45_s1", "idA": "906709_14_item1a_p45_s3", "sentA": "Limited, Sucampo Pharmaceuticals, Inc., Develco Pharma, Alkermes, Inc., GlaxoSmithKline plc, Theravance, Inc., and Takeda Pharmaceutical Company Limited.", "sentB": "Limited, Sucampo Pharmaceuticals, Inc., Develco Pharma GmbH, Alkermes, Inc., GlaxoSmithKline plc, Theravance, Inc., and Takeda Pharmaceutical Company Limited.", "type": 2, "words": ["<tag1>", "Limited,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Develco", "Pharma,", "Alkermes,", "Inc.,", "GlaxoSmithKline", "plc,", "Theravance,", "Inc.,", "and", "Takeda", "Pharmaceutical", "Company", "Limited.", "<tag2>", "Limited,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Develco", "Pharma", "GmbH,", "Alkermes,", "Inc.,", "GlaxoSmithKline", "plc,", "Theravance,", "Inc.,", "and", "Takeda", "Pharmaceutical", "Company", "Limited.", "<tag3>"], "wordsA": ["Limited,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Develco", "Pharma,", "Alkermes,", "Inc.,", "GlaxoSmithKline", "plc,", "Theravance,", "Inc.,", "and", "Takeda", "Pharmaceutical", "Company", "Limited."], "wordsB": ["Limited,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Develco", "Pharma", "GmbH,", "Alkermes,", "Inc.,", "GlaxoSmithKline", "plc,", "Theravance,", "Inc.,", "and", "Takeda", "Pharmaceutical", "Company", "Limited."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p46_s0", "idA": "906709_14_item1a_p46_s0", "sentA": "For etirinotecan pegol, there are a number of chemotherapies and cancer therapies approved today and in various stages of clinical development for breast and ovarian cancers, including, but not limited to: Abraxane (paclitaxel protein-bound particles for injectable suspension (albumin bound)), Afinitor (everolimus), Doxil (doxorubicin HCl), Ellence (epirubicin), Gemzar (gemcitabine), Halaven (eribulin), Herceptin (trastuzumab), Hycamtin (topotecan), Ixempra (ixabepilone), Navelbine (vinolrebine), Iniparib, Paraplatin (carboplatin), Taxol (paclitaxel) and Taxotere (docetaxel).", "sentB": "For etirinotecan pegol, there are a number of chemotherapies and cancer therapies approved today and in various stages of clinical development for breast and ovarian cancers, including, but not limited to: Abraxane (paclitaxel protein-bound particles for injectable suspension (albumin bound)), Xeloda (capecitabine), Afinitor (everolimus), Doxil (doxorubicin HCl), Ellence (epirubicin), Gemzar (gemcitabine), Halaven (eribulin), Herceptin (trastuzumab), Hycamtin (topotecan), Ibrance (palbociclib), Ixempra (ixabepilone), Navelbine (vinolrebine), Iniparib, Paraplatin (carboplatin), Taxol (paclitaxel) and Taxotere (docetaxel).", "type": 2, "words": ["<tag1>", "For", "etirinotecan", "pegol,", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "and", "ovarian", "cancers,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel).", "<tag2>", "For", "etirinotecan", "pegol,", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "and", "ovarian", "cancers,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Xeloda", "(capecitabine),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ibrance", "(palbociclib),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel).", "<tag3>"], "wordsA": ["For", "etirinotecan", "pegol,", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "and", "ovarian", "cancers,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel)."], "wordsB": ["For", "etirinotecan", "pegol,", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "and", "ovarian", "cancers,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Xeloda", "(capecitabine),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ibrance", "(palbociclib),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p47_s0", "idA": "906709_14_item1a_p47_s0", "sentA": "There are approved therapies for the treatment of colorectal cancer, including Eloxatin (oxaliplatin), Camptosar (irinotecan), Avastin (bevacizumab), Zaltrap (Ziv-afilbercept), Stivarga (regorafenib), Erbitux (cetuximab), Vectibix (panitumumab), Xeloda (capecitabine), Adrucil (fluorouracil) and Wellcovorin (leucovorin).", "sentB": "Camptosar (irinotecan), Avastin (bevacizumab), Zaltrap (Ziv-afilbercept), Stivarga (regorafenib), Erbitux (cetuximab), Vectibix (panitumumab), Xeloda (capecitabine), Adrucil (fluorouracil) and Wellcovorin (leucovorin).", "type": 2, "words": ["<tag1>", "There", "are", "approved", "therapies", "for", "the", "treatment", "of", "colorectal", "cancer,", "including", "Eloxatin", "(oxaliplatin),", "Camptosar", "(irinotecan),", "Avastin", "(bevacizumab),", "Zaltrap", "(Ziv-afilbercept),", "Stivarga", "(regorafenib),", "Erbitux", "(cetuximab),", "Vectibix", "(panitumumab),", "Xeloda", "(capecitabine),", "Adrucil", "(fluorouracil)", "and", "Wellcovorin", "(leucovorin).", "<tag2>", "Camptosar", "(irinotecan),", "Avastin", "(bevacizumab),", "Zaltrap", "(Ziv-afilbercept),", "Stivarga", "(regorafenib),", "Erbitux", "(cetuximab),", "Vectibix", "(panitumumab),", "Xeloda", "(capecitabine),", "Adrucil", "(fluorouracil)", "and", "Wellcovorin", "(leucovorin).", "<tag3>"], "wordsA": ["There", "are", "approved", "therapies", "for", "the", "treatment", "of", "colorectal", "cancer,", "including", "Eloxatin", "(oxaliplatin),", "Camptosar", "(irinotecan),", "Avastin", "(bevacizumab),", "Zaltrap", "(Ziv-afilbercept),", "Stivarga", "(regorafenib),", "Erbitux", "(cetuximab),", "Vectibix", "(panitumumab),", "Xeloda", "(capecitabine),", "Adrucil", "(fluorouracil)", "and", "Wellcovorin", "(leucovorin)."], "wordsB": ["Camptosar", "(irinotecan),", "Avastin", "(bevacizumab),", "Zaltrap", "(Ziv-afilbercept),", "Stivarga", "(regorafenib),", "Erbitux", "(cetuximab),", "Vectibix", "(panitumumab),", "Xeloda", "(capecitabine),", "Adrucil", "(fluorouracil)", "and", "Wellcovorin", "(leucovorin)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p47_s1", "idA": "906709_14_item1a_p47_s1", "sentA": "In addition, there are a number of drugs in various stages of preclinical and clinical development from companies exploring cancer therapies or improved chemotherapeutic agents to potentially treat colorectal cancer, including, but not limited to, products in development from Bristol-Myers Squibb Company, Pfizer, Inc., GlaxoSmithKline plc, Antigenics, Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Cell Therapeutics, Inc., Neopharm Inc., Meditech Research Ltd, Alchemia Limited, and Enzon Pharmaceuticals, Inc.", "sentB": "In addition, there are a number of drugs in various stages of preclinical and clinical development from companies exploring cancer therapies or improved chemotherapeutic agents to potentially treat colorectal cancer, including, but not limited to, products in development from Bristol-Myers Squibb Company, Pfizer, Inc., GlaxoSmithKline plc, Antigenics, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Cell Therapeutics, Inc., Neopharm Inc. (acquired by Insys Therapeutics, Inc.), Meditech Research Ltd, Alchemia Limited, and Enzon Pharmaceuticals, Inc.", "type": 2, "words": ["<tag1>", "In", "addition,", "there", "are", "a", "number", "of", "drugs", "in", "various", "stages", "of", "preclinical", "and", "clinical", "development", "from", "companies", "exploring", "cancer", "therapies", "or", "improved", "chemotherapeutic", "agents", "to", "potentially", "treat", "colorectal", "cancer,", "including,", "but", "not", "limited", "to,", "products", "in", "development", "from", "Bristol-Myers", "Squibb", "Company,", "Pfizer,", "Inc.,", "GlaxoSmithKline", "plc,", "Antigenics,", "Inc.,", "F.", "Hoffmann-La", "Roche", "Ltd,", "Novartis", "AG,", "Cell", "Therapeutics,", "Inc.,", "Neopharm", "Inc.,", "Meditech", "Research", "Ltd,", "Alchemia", "Limited,", "and", "Enzon", "Pharmaceuticals,", "Inc.", "<tag2>", "In", "addition,", "there", "are", "a", "number", "of", "drugs", "in", "various", "stages", "of", "preclinical", "and", "clinical", "development", "from", "companies", "exploring", "cancer", "therapies", "or", "improved", "chemotherapeutic", "agents", "to", "potentially", "treat", "colorectal", "cancer,", "including,", "but", "not", "limited", "to,", "products", "in", "development", "from", "Bristol-Myers", "Squibb", "Company,", "Pfizer,", "Inc.,", "GlaxoSmithKline", "plc,", "Antigenics,", "Inc.,", "F.", "Hoffmann-La", "Roche", "Ltd.,", "Novartis", "AG,", "Cell", "Therapeutics,", "Inc.,", "Neopharm", "Inc.", "(acquired", "by", "Insys", "Therapeutics,", "Inc.),", "Meditech", "Research", "Ltd,", "Alchemia", "Limited,", "and", "Enzon", "Pharmaceuticals,", "Inc.", "<tag3>"], "wordsA": ["In", "addition,", "there", "are", "a", "number", "of", "drugs", "in", "various", "stages", "of", "preclinical", "and", "clinical", "development", "from", "companies", "exploring", "cancer", "therapies", "or", "improved", "chemotherapeutic", "agents", "to", "potentially", "treat", "colorectal", "cancer,", "including,", "but", "not", "limited", "to,", "products", "in", "development", "from", "Bristol-Myers", "Squibb", "Company,", "Pfizer,", "Inc.,", "GlaxoSmithKline", "plc,", "Antigenics,", "Inc.,", "F.", "Hoffmann-La", "Roche", "Ltd,", "Novartis", "AG,", "Cell", "Therapeutics,", "Inc.,", "Neopharm", "Inc.,", "Meditech", "Research", "Ltd,", "Alchemia", "Limited,", "and", "Enzon", "Pharmaceuticals,", "Inc."], "wordsB": ["In", "addition,", "there", "are", "a", "number", "of", "drugs", "in", "various", "stages", "of", "preclinical", "and", "clinical", "development", "from", "companies", "exploring", "cancer", "therapies", "or", "improved", "chemotherapeutic", "agents", "to", "potentially", "treat", "colorectal", "cancer,", "including,", "but", "not", "limited", "to,", "products", "in", "development", "from", "Bristol-Myers", "Squibb", "Company,", "Pfizer,", "Inc.,", "GlaxoSmithKline", "plc,", "Antigenics,", "Inc.,", "F.", "Hoffmann-La", "Roche", "Ltd.,", "Novartis", "AG,", "Cell", "Therapeutics,", "Inc.,", "Neopharm", "Inc.", "(acquired", "by", "Insys", "Therapeutics,", "Inc.),", "Meditech", "Research", "Ltd,", "Alchemia", "Limited,", "and", "Enzon", "Pharmaceuticals,", "Inc."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p50_s0", "idA": "906709_14_item1a_p49_s14", "sentA": "The relationships that our key managers have cultivated within our industry make us particularly dependent upon their continued employment with us.", "sentB": "within our industry make us particularly dependent upon their continued employment with us.", "type": 2, "words": ["<tag1>", "The", "relationships", "that", "our", "key", "managers", "have", "cultivated", "within", "our", "industry", "make", "us", "particularly", "dependent", "upon", "their", "continued", "employment", "with", "us.", "<tag2>", "within", "our", "industry", "make", "us", "particularly", "dependent", "upon", "their", "continued", "employment", "with", "us.", "<tag3>"], "wordsA": ["The", "relationships", "that", "our", "key", "managers", "have", "cultivated", "within", "our", "industry", "make", "us", "particularly", "dependent", "upon", "their", "continued", "employment", "with", "us."], "wordsB": ["within", "our", "industry", "make", "us", "particularly", "dependent", "upon", "their", "continued", "employment", "with", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p29_s3", "idA": "906709_14_item1a_p49_s15", "sentA": "We are also dependent on the continued services of our technical personnel because of the highly technical nature of our products and the regulatory approval process.", "sentB": "We are also regularly involved in opposition proceedings at the European Patent Office where third parties seek to invalidate or limit the scope of our allowed European patents applications covering (among other things) our drugs and platform technologies.", "type": 2, "words": ["<tag1>", "We", "are", "also", "dependent", "on", "the", "continued", "services", "of", "our", "technical", "personnel", "because", "of", "the", "highly", "technical", "nature", "of", "our", "products", "and", "the", "regulatory", "approval", "process.", "<tag2>", "We", "are", "also", "regularly", "involved", "in", "opposition", "proceedings", "at", "the", "European", "Patent", "Office", "where", "third", "parties", "seek", "to", "invalidate", "or", "limit", "the", "scope", "of", "our", "allowed", "European", "patents", "applications", "covering", "(among", "other", "things)", "our", "drugs", "and", "platform", "technologies.", "<tag3>"], "wordsA": ["We", "are", "also", "dependent", "on", "the", "continued", "services", "of", "our", "technical", "personnel", "because", "of", "the", "highly", "technical", "nature", "of", "our", "products", "and", "the", "regulatory", "approval", "process."], "wordsB": ["We", "are", "also", "regularly", "involved", "in", "opposition", "proceedings", "at", "the", "European", "Patent", "Office", "where", "third", "parties", "seek", "to", "invalidate", "or", "limit", "the", "scope", "of", "our", "allowed", "European", "patents", "applications", "covering", "(among", "other", "things)", "our", "drugs", "and", "platform", "technologies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p29_s0", "idA": "906709_14_item1a_p50_s3", "sentA": "Many of the organizations with which we compete for qualified personnel have greater resources than we have.", "sentB": "PEGylated Factor VIII which we have exclusively licensed to Baxter.", "type": 2, "words": ["<tag1>", "Many", "of", "the", "organizations", "with", "which", "we", "compete", "for", "qualified", "personnel", "have", "greater", "resources", "than", "we", "have.", "<tag2>", "PEGylated", "Factor", "VIII", "which", "we", "have", "exclusively", "licensed", "to", "Baxter.", "<tag3>"], "wordsA": ["Many", "of", "the", "organizations", "with", "which", "we", "compete", "for", "qualified", "personnel", "have", "greater", "resources", "than", "we", "have."], "wordsB": ["PEGylated", "Factor", "VIII", "which", "we", "have", "exclusively", "licensed", "to", "Baxter."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p51_s6", "idA": "906709_14_item1a_p52_s5", "sentA": "During the year ended December 31, 2013, based on closing prices on The NASDAQ Global Select Market, our stock price ranged from $13.96 to $7.54 per share.", "sentB": "During the year ended December 31, 2014, based on closing prices on The NASDAQ Global Select Market, our stock price ranged from $10.53 to $17.05 per share.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2013,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$13.96", "to", "$7.54", "per", "share.", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2014,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$10.53", "to", "$17.05", "per", "share.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2013,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$13.96", "to", "$7.54", "per", "share."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2014,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$10.53", "to", "$17.05", "per", "share."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p52_s0", "idA": "906709_14_item1a_p52_s6", "sentA": "We expect our stock price to remain volatile.", "sentB": "At times, our stock price has been volatile even in the absence of significant news or developments.", "type": 2, "words": ["<tag1>", "We", "expect", "our", "stock", "price", "to", "remain", "volatile.", "<tag2>", "At", "times,", "our", "stock", "price", "has", "been", "volatile", "even", "in", "the", "absence", "of", "significant", "news", "or", "developments.", "<tag3>"], "wordsA": ["We", "expect", "our", "stock", "price", "to", "remain", "volatile."], "wordsB": ["At", "times,", "our", "stock", "price", "has", "been", "volatile", "even", "in", "the", "absence", "of", "significant", "news", "or", "developments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p51_s8", "idA": "906709_14_item1a_p52_s7", "sentA": "A variety of factors may have a significant effect on the market price of our common stock, including:", "sentB": "A variety of factors may have a significant effect on the market price of our common stock, including the risks described in this section titled Risk Factors and the following:", "type": 2, "words": ["<tag1>", "A", "variety", "of", "factors", "may", "have", "a", "significant", "effect", "on", "the", "market", "price", "of", "our", "common", "stock,", "including:", "<tag2>", "A", "variety", "of", "factors", "may", "have", "a", "significant", "effect", "on", "the", "market", "price", "of", "our", "common", "stock,", "including", "the", "risks", "described", "in", "this", "section", "titled", "Risk", "Factors", "and", "the", "following:", "<tag3>"], "wordsA": ["A", "variety", "of", "factors", "may", "have", "a", "significant", "effect", "on", "the", "market", "price", "of", "our", "common", "stock,", "including:"], "wordsB": ["A", "variety", "of", "factors", "may", "have", "a", "significant", "effect", "on", "the", "market", "price", "of", "our", "common", "stock,", "including", "the", "risks", "described", "in", "this", "section", "titled", "Risk", "Factors", "and", "the", "following:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p55_s1", "idA": "906709_14_item1a_p54_s1", "sentA": "In addition, the indenture governing the senior secured notes contains a financial maintenance covenant requiring us to maintain a $25.0 million segregated cash reserve account until July 1, 2015 to be applied to interest payments on the notes in the event of a default, subject to certain conditions.", "sentB": "In addition, the indenture governing the senior secured notes contains a financial maintenance covenant requiring us to maintain a $25.0 million segregated cash reserve account until July 1, 2015 to be applied to interest payments on the senior secured notes in the event of a default, subject to certain conditions.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "indenture", "governing", "the", "senior", "secured", "notes", "contains", "a", "financial", "maintenance", "covenant", "requiring", "us", "to", "maintain", "a", "$25.0", "million", "segregated", "cash", "reserve", "account", "until", "July", "1,", "2015", "to", "be", "applied", "to", "interest", "payments", "on", "the", "notes", "in", "the", "event", "of", "a", "default,", "subject", "to", "certain", "conditions.", "<tag2>", "In", "addition,", "the", "indenture", "governing", "the", "senior", "secured", "notes", "contains", "a", "financial", "maintenance", "covenant", "requiring", "us", "to", "maintain", "a", "$25.0", "million", "segregated", "cash", "reserve", "account", "until", "July", "1,", "2015", "to", "be", "applied", "to", "interest", "payments", "on", "the", "senior", "secured", "notes", "in", "the", "event", "of", "a", "default,", "subject", "to", "certain", "conditions.", "<tag3>"], "wordsA": ["In", "addition,", "the", "indenture", "governing", "the", "senior", "secured", "notes", "contains", "a", "financial", "maintenance", "covenant", "requiring", "us", "to", "maintain", "a", "$25.0", "million", "segregated", "cash", "reserve", "account", "until", "July", "1,", "2015", "to", "be", "applied", "to", "interest", "payments", "on", "the", "notes", "in", "the", "event", "of", "a", "default,", "subject", "to", "certain", "conditions."], "wordsB": ["In", "addition,", "the", "indenture", "governing", "the", "senior", "secured", "notes", "contains", "a", "financial", "maintenance", "covenant", "requiring", "us", "to", "maintain", "a", "$25.0", "million", "segregated", "cash", "reserve", "account", "until", "July", "1,", "2015", "to", "be", "applied", "to", "interest", "payments", "on", "the", "senior", "secured", "notes", "in", "the", "event", "of", "a", "default,", "subject", "to", "certain", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p12_s1", "idA": "906709_14_item1a_p5_s0", "sentA": "We amended our license agreement with AstraZeneca to enter into a risk sharing arrangement in the event that pre-approval or post-approval cardiovascular safety studies are required by the FDA for naloxegol.", "sentB": "For example, on January 23, 2015, we filed a lawsuit against Allergan and MAP seeking economic damages related to a dispute over the economic sharing provisions of our license agreement with MAP.", "type": 2, "words": ["<tag1>", "We", "amended", "our", "license", "agreement", "with", "AstraZeneca", "to", "enter", "into", "a", "risk", "sharing", "arrangement", "in", "the", "event", "that", "pre-approval", "or", "post-approval", "cardiovascular", "safety", "studies", "are", "required", "by", "the", "FDA", "for", "naloxegol.", "<tag2>", "For", "example,", "on", "January", "23,", "2015,", "we", "filed", "a", "lawsuit", "against", "Allergan", "and", "MAP", "seeking", "economic", "damages", "related", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "license", "agreement", "with", "MAP.", "<tag3>"], "wordsA": ["We", "amended", "our", "license", "agreement", "with", "AstraZeneca", "to", "enter", "into", "a", "risk", "sharing", "arrangement", "in", "the", "event", "that", "pre-approval", "or", "post-approval", "cardiovascular", "safety", "studies", "are", "required", "by", "the", "FDA", "for", "naloxegol."], "wordsB": ["For", "example,", "on", "January", "23,", "2015,", "we", "filed", "a", "lawsuit", "against", "Allergan", "and", "MAP", "seeking", "economic", "damages", "related", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "license", "agreement", "with", "MAP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p2_s11", "idA": "906709_14_item1a_p5_s6", "sentA": "A number of companies have suffered significant unforeseen failures in late stage clinical studies due to factors such as inconclusive efficacy or safety, even after achieving positive results in earlier clinical studies that were satisfactory both to them and to reviewing government health authorities.", "sentB": "A number of companies have suffered significant unforeseen failures in late stage (i.e. Phase 3) clinical studies due to factors such as inconclusive efficacy or safety, even after achieving positive results in earlier clinical studies that were satisfactory both to them and to reviewing government health authorities.", "type": 2, "words": ["<tag1>", "A", "number", "of", "companies", "have", "suffered", "significant", "unforeseen", "failures", "in", "late", "stage", "clinical", "studies", "due", "to", "factors", "such", "as", "inconclusive", "efficacy", "or", "safety,", "even", "after", "achieving", "positive", "results", "in", "earlier", "clinical", "studies", "that", "were", "satisfactory", "both", "to", "them", "and", "to", "reviewing", "government", "health", "authorities.", "<tag2>", "A", "number", "of", "companies", "have", "suffered", "significant", "unforeseen", "failures", "in", "late", "stage", "(i.e.", "Phase", "3)", "clinical", "studies", "due", "to", "factors", "such", "as", "inconclusive", "efficacy", "or", "safety,", "even", "after", "achieving", "positive", "results", "in", "earlier", "clinical", "studies", "that", "were", "satisfactory", "both", "to", "them", "and", "to", "reviewing", "government", "health", "authorities.", "<tag3>"], "wordsA": ["A", "number", "of", "companies", "have", "suffered", "significant", "unforeseen", "failures", "in", "late", "stage", "clinical", "studies", "due", "to", "factors", "such", "as", "inconclusive", "efficacy", "or", "safety,", "even", "after", "achieving", "positive", "results", "in", "earlier", "clinical", "studies", "that", "were", "satisfactory", "both", "to", "them", "and", "to", "reviewing", "government", "health", "authorities."], "wordsB": ["A", "number", "of", "companies", "have", "suffered", "significant", "unforeseen", "failures", "in", "late", "stage", "(i.e.", "Phase", "3)", "clinical", "studies", "due", "to", "factors", "such", "as", "inconclusive", "efficacy", "or", "safety,", "even", "after", "achieving", "positive", "results", "in", "earlier", "clinical", "studies", "that", "were", "satisfactory", "both", "to", "them", "and", "to", "reviewing", "government", "health", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p2_s12", "idA": "906709_14_item1a_p5_s7", "sentA": "While etirinotecan pegol, Amikacin Inhale, and BAX 855 have each demonstrated positive results from earlier clinical studies, there is a substantial risk that Phase 3 clinical study outcomes for these drug candidates from larger patient populations will not demonstrate positive efficacy, safety or other clinical outcomes sufficient to support regulatory filings and achieve regulatory approval.", "sentB": "While etirinotecan pegol and Amikacin Inhale have each demonstrated positive results from earlier clinical studies, there is a substantial risk that Phase 3 clinical study outcomes for these drug candidates from larger patient populations will not demonstrate positive efficacy, safety or other clinical outcomes sufficient to support regulatory filings and achieve regulatory approval.", "type": 2, "words": ["<tag1>", "While", "etirinotecan", "pegol,", "Amikacin", "Inhale,", "and", "BAX", "855", "have", "each", "demonstrated", "positive", "results", "from", "earlier", "clinical", "studies,", "there", "is", "a", "substantial", "risk", "that", "Phase", "3", "clinical", "study", "outcomes", "for", "these", "drug", "candidates", "from", "larger", "patient", "populations", "will", "not", "demonstrate", "positive", "efficacy,", "safety", "or", "other", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "filings", "and", "achieve", "regulatory", "approval.", "<tag2>", "While", "etirinotecan", "pegol", "and", "Amikacin", "Inhale", "have", "each", "demonstrated", "positive", "results", "from", "earlier", "clinical", "studies,", "there", "is", "a", "substantial", "risk", "that", "Phase", "3", "clinical", "study", "outcomes", "for", "these", "drug", "candidates", "from", "larger", "patient", "populations", "will", "not", "demonstrate", "positive", "efficacy,", "safety", "or", "other", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "filings", "and", "achieve", "regulatory", "approval.", "<tag3>"], "wordsA": ["While", "etirinotecan", "pegol,", "Amikacin", "Inhale,", "and", "BAX", "855", "have", "each", "demonstrated", "positive", "results", "from", "earlier", "clinical", "studies,", "there", "is", "a", "substantial", "risk", "that", "Phase", "3", "clinical", "study", "outcomes", "for", "these", "drug", "candidates", "from", "larger", "patient", "populations", "will", "not", "demonstrate", "positive", "efficacy,", "safety", "or", "other", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "filings", "and", "achieve", "regulatory", "approval."], "wordsB": ["While", "etirinotecan", "pegol", "and", "Amikacin", "Inhale", "have", "each", "demonstrated", "positive", "results", "from", "earlier", "clinical", "studies,", "there", "is", "a", "substantial", "risk", "that", "Phase", "3", "clinical", "study", "outcomes", "for", "these", "drug", "candidates", "from", "larger", "patient", "populations", "will", "not", "demonstrate", "positive", "efficacy,", "safety", "or", "other", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "filings", "and", "achieve", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p10_s1", "idA": "906709_14_item1a_p7_s1", "sentA": "We are a party to certain significant agreements, including an asset purchase agreement with Novartis pursuant to which we sold a significant portion of our pulmonary business at the end of 2008, the worldwide exclusive license agreement with AstraZeneca related to the further development and commercialization of naloxegol, and the purchase and sale agreement with RPI Finance Trust (RPI) related to the sale of our royalty interests in UCB s CIMZIA and Roche s MIRCERA that we completed in February 2012.", "sentB": "We are a party to certain significant agreements, including an asset purchase agreement with Novartis pursuant to which we sold a significant portion of our pulmonary business at the end of 2008, the worldwide exclusive license agreement with AstraZeneca related to the further development and commercialization of MOVANTIK TM , and the purchase and sale agreement with RPI Finance Trust (RPI) related to the sale of our royalty interests in UCB s CIMZIA and Roche s MIRCERA that we completed in February 2012.", "type": 2, "words": ["<tag1>", "We", "are", "a", "party", "to", "certain", "significant", "agreements,", "including", "an", "asset", "purchase", "agreement", "with", "Novartis", "pursuant", "to", "which", "we", "sold", "a", "significant", "portion", "of", "our", "pulmonary", "business", "at", "the", "end", "of", "2008,", "the", "worldwide", "exclusive", "license", "agreement", "with", "AstraZeneca", "related", "to", "the", "further", "development", "and", "commercialization", "of", "naloxegol,", "and", "the", "purchase", "and", "sale", "agreement", "with", "RPI", "Finance", "Trust", "(RPI)", "related", "to", "the", "sale", "of", "our", "royalty", "interests", "in", "UCB", "s", "CIMZIA", "and", "Roche", "s", "MIRCERA", "that", "we", "completed", "in", "February", "2012.", "<tag2>", "We", "are", "a", "party", "to", "certain", "significant", "agreements,", "including", "an", "asset", "purchase", "agreement", "with", "Novartis", "pursuant", "to", "which", "we", "sold", "a", "significant", "portion", "of", "our", "pulmonary", "business", "at", "the", "end", "of", "2008,", "the", "worldwide", "exclusive", "license", "agreement", "with", "AstraZeneca", "related", "to", "the", "further", "development", "and", "commercialization", "of", "MOVANTIK", "TM", ",", "and", "the", "purchase", "and", "sale", "agreement", "with", "RPI", "Finance", "Trust", "(RPI)", "related", "to", "the", "sale", "of", "our", "royalty", "interests", "in", "UCB", "s", "CIMZIA", "and", "Roche", "s", "MIRCERA", "that", "we", "completed", "in", "February", "2012.", "<tag3>"], "wordsA": ["We", "are", "a", "party", "to", "certain", "significant", "agreements,", "including", "an", "asset", "purchase", "agreement", "with", "Novartis", "pursuant", "to", "which", "we", "sold", "a", "significant", "portion", "of", "our", "pulmonary", "business", "at", "the", "end", "of", "2008,", "the", "worldwide", "exclusive", "license", "agreement", "with", "AstraZeneca", "related", "to", "the", "further", "development", "and", "commercialization", "of", "naloxegol,", "and", "the", "purchase", "and", "sale", "agreement", "with", "RPI", "Finance", "Trust", "(RPI)", "related", "to", "the", "sale", "of", "our", "royalty", "interests", "in", "UCB", "s", "CIMZIA", "and", "Roche", "s", "MIRCERA", "that", "we", "completed", "in", "February", "2012."], "wordsB": ["We", "are", "a", "party", "to", "certain", "significant", "agreements,", "including", "an", "asset", "purchase", "agreement", "with", "Novartis", "pursuant", "to", "which", "we", "sold", "a", "significant", "portion", "of", "our", "pulmonary", "business", "at", "the", "end", "of", "2008,", "the", "worldwide", "exclusive", "license", "agreement", "with", "AstraZeneca", "related", "to", "the", "further", "development", "and", "commercialization", "of", "MOVANTIK", "TM", ",", "and", "the", "purchase", "and", "sale", "agreement", "with", "RPI", "Finance", "Trust", "(RPI)", "related", "to", "the", "sale", "of", "our", "royalty", "interests", "in", "UCB", "s", "CIMZIA", "and", "Roche", "s", "MIRCERA", "that", "we", "completed", "in", "February", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p11_s0", "idA": "906709_14_item1a_p7_s3", "sentA": "If we breach any of our agreements with Novartis, AstraZeneca, RPI or any third party agreements impacted by these complex transactions, such a breach could result in substantial future liability and harm our financial condition.", "sentB": "If we breach any of our agreements with Novartis, AstraZeneca, RPI or any other third party agreements, it could subject us to substantial liabilities and harm our financial condition.", "type": 2, "words": ["<tag1>", "If", "we", "breach", "any", "of", "our", "agreements", "with", "Novartis,", "AstraZeneca,", "RPI", "or", "any", "third", "party", "agreements", "impacted", "by", "these", "complex", "transactions,", "such", "a", "breach", "could", "result", "in", "substantial", "future", "liability", "and", "harm", "our", "financial", "condition.", "<tag2>", "If", "we", "breach", "any", "of", "our", "agreements", "with", "Novartis,", "AstraZeneca,", "RPI", "or", "any", "other", "third", "party", "agreements,", "it", "could", "subject", "us", "to", "substantial", "liabilities", "and", "harm", "our", "financial", "condition.", "<tag3>"], "wordsA": ["If", "we", "breach", "any", "of", "our", "agreements", "with", "Novartis,", "AstraZeneca,", "RPI", "or", "any", "third", "party", "agreements", "impacted", "by", "these", "complex", "transactions,", "such", "a", "breach", "could", "result", "in", "substantial", "future", "liability", "and", "harm", "our", "financial", "condition."], "wordsB": ["If", "we", "breach", "any", "of", "our", "agreements", "with", "Novartis,", "AstraZeneca,", "RPI", "or", "any", "other", "third", "party", "agreements,", "it", "could", "subject", "us", "to", "substantial", "liabilities", "and", "harm", "our", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p15_s5", "idA": "906709_14_item1a_p9_s1", "sentA": "If we do not receive substantial milestone payments from our existing collaboration agreements, execute new high value collaborations or other arrangements, or are unable to raise additional capital in one or more financing transactions, we would be unable to continue our current level of investment in research and development.", "sentB": "If we do not receive substantial milestone or royalty payments from our existing collaboration agreements, execute new high value collaborations or other arrangements, or are unable to raise additional capital in one or more financing transactions, we would be unable to continue our current level of investment in research and development.", "type": 2, "words": ["<tag1>", "If", "we", "do", "not", "receive", "substantial", "milestone", "payments", "from", "our", "existing", "collaboration", "agreements,", "execute", "new", "high", "value", "collaborations", "or", "other", "arrangements,", "or", "are", "unable", "to", "raise", "additional", "capital", "in", "one", "or", "more", "financing", "transactions,", "we", "would", "be", "unable", "to", "continue", "our", "current", "level", "of", "investment", "in", "research", "and", "development.", "<tag2>", "If", "we", "do", "not", "receive", "substantial", "milestone", "or", "royalty", "payments", "from", "our", "existing", "collaboration", "agreements,", "execute", "new", "high", "value", "collaborations", "or", "other", "arrangements,", "or", "are", "unable", "to", "raise", "additional", "capital", "in", "one", "or", "more", "financing", "transactions,", "we", "would", "be", "unable", "to", "continue", "our", "current", "level", "of", "investment", "in", "research", "and", "development.", "<tag3>"], "wordsA": ["If", "we", "do", "not", "receive", "substantial", "milestone", "payments", "from", "our", "existing", "collaboration", "agreements,", "execute", "new", "high", "value", "collaborations", "or", "other", "arrangements,", "or", "are", "unable", "to", "raise", "additional", "capital", "in", "one", "or", "more", "financing", "transactions,", "we", "would", "be", "unable", "to", "continue", "our", "current", "level", "of", "investment", "in", "research", "and", "development."], "wordsB": ["If", "we", "do", "not", "receive", "substantial", "milestone", "or", "royalty", "payments", "from", "our", "existing", "collaboration", "agreements,", "execute", "new", "high", "value", "collaborations", "or", "other", "arrangements,", "or", "are", "unable", "to", "raise", "additional", "capital", "in", "one", "or", "more", "financing", "transactions,", "we", "would", "be", "unable", "to", "continue", "our", "current", "level", "of", "investment", "in", "research", "and", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item1a_p15_s7", "idA": "906709_14_item1a_p9_s3", "sentA": "The indebtedness includes approximately $125.0 million in senior secured notes due July 2017, but excludes our long-term liability relating to the sale of future royalties.", "sentB": "The indebtedness includes approximately $125.0 million in senior secured notes due July 2017, but excludes our long-term liability relating to the sale of future royalties as this royalty obligation liability will not be settled in cash.", "type": 2, "words": ["<tag1>", "The", "indebtedness", "includes", "approximately", "$125.0", "million", "in", "senior", "secured", "notes", "due", "July", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties.", "<tag2>", "The", "indebtedness", "includes", "approximately", "$125.0", "million", "in", "senior", "secured", "notes", "due", "July", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties", "as", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash.", "<tag3>"], "wordsA": ["The", "indebtedness", "includes", "approximately", "$125.0", "million", "in", "senior", "secured", "notes", "due", "July", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties."], "wordsB": ["The", "indebtedness", "includes", "approximately", "$125.0", "million", "in", "senior", "secured", "notes", "due", "July", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties", "as", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p1_s0", "idA": "906709_15_item1a_p0_s0", "sentA": "we think could cause our actual results to differ materially from expected and historical results and our forward-looking statements.", "sentB": "These are factors that, individually or in the aggregate, we think could cause our actual results to differ materially from expected and historical results and our forward-looking statements.", "type": 2, "words": ["<tag1>", "we", "think", "could", "cause", "our", "actual", "results", "to", "differ", "materially", "from", "expected", "and", "historical", "results", "and", "our", "forward-looking", "statements.", "<tag2>", "These", "are", "factors", "that,", "individually", "or", "in", "the", "aggregate,", "we", "think", "could", "cause", "our", "actual", "results", "to", "differ", "materially", "from", "expected", "and", "historical", "results", "and", "our", "forward-looking", "statements.", "<tag3>"], "wordsA": ["we", "think", "could", "cause", "our", "actual", "results", "to", "differ", "materially", "from", "expected", "and", "historical", "results", "and", "our", "forward-looking", "statements."], "wordsB": ["These", "are", "factors", "that,", "individually", "or", "in", "the", "aggregate,", "we", "think", "could", "cause", "our", "actual", "results", "to", "differ", "materially", "from", "expected", "and", "historical", "results", "and", "our", "forward-looking", "statements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p12_s1", "idA": "906709_15_item1a_p12_s1", "sentA": "For example, on January 23, 2015, we filed a lawsuit against Allergan and MAP seeking economic damages related to a dispute over the economic sharing provisions of our license agreement with MAP.", "sentB": "For example, in 2015 we filed a lawsuit against Allergan and MAP seeking economic damages related to a dispute over the economic sharing provisions of our license agreement with MAP.", "type": 2, "words": ["<tag1>", "For", "example,", "on", "January", "23,", "2015,", "we", "filed", "a", "lawsuit", "against", "Allergan", "and", "MAP", "seeking", "economic", "damages", "related", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "license", "agreement", "with", "MAP.", "<tag2>", "For", "example,", "in", "2015", "we", "filed", "a", "lawsuit", "against", "Allergan", "and", "MAP", "seeking", "economic", "damages", "related", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "license", "agreement", "with", "MAP.", "<tag3>"], "wordsA": ["For", "example,", "on", "January", "23,", "2015,", "we", "filed", "a", "lawsuit", "against", "Allergan", "and", "MAP", "seeking", "economic", "damages", "related", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "license", "agreement", "with", "MAP."], "wordsB": ["For", "example,", "in", "2015", "we", "filed", "a", "lawsuit", "against", "Allergan", "and", "MAP", "seeking", "economic", "damages", "related", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "license", "agreement", "with", "MAP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p14_s0", "idA": "906709_15_item1a_p13_s0", "sentA": "Drug candidates must undergo rigorous animal and human testing and an extensive review process for safety and efficacy by the FDA and equivalent foreign government health authorities.", "sentB": "Drug candidates must undergo rigorous animal and human testing and an extensive review process for safety and efficacy by the FDA and equivalent foreign regulatory authorities.", "type": 2, "words": ["<tag1>", "Drug", "candidates", "must", "undergo", "rigorous", "animal", "and", "human", "testing", "and", "an", "extensive", "review", "process", "for", "safety", "and", "efficacy", "by", "the", "FDA", "and", "equivalent", "foreign", "government", "health", "authorities.", "<tag2>", "Drug", "candidates", "must", "undergo", "rigorous", "animal", "and", "human", "testing", "and", "an", "extensive", "review", "process", "for", "safety", "and", "efficacy", "by", "the", "FDA", "and", "equivalent", "foreign", "regulatory", "authorities.", "<tag3>"], "wordsA": ["Drug", "candidates", "must", "undergo", "rigorous", "animal", "and", "human", "testing", "and", "an", "extensive", "review", "process", "for", "safety", "and", "efficacy", "by", "the", "FDA", "and", "equivalent", "foreign", "government", "health", "authorities."], "wordsB": ["Drug", "candidates", "must", "undergo", "rigorous", "animal", "and", "human", "testing", "and", "an", "extensive", "review", "process", "for", "safety", "and", "efficacy", "by", "the", "FDA", "and", "equivalent", "foreign", "regulatory", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p14_s2", "idA": "906709_15_item1a_p13_s2", "sentA": "The FDA and other U.S. and foreign health authorities have substantial discretion, at any phase of development, to terminate clinical studies, require additional clinical development or other testing, delay or withhold registration and marketing approval and mandate product withdrawals, including recalls.", "sentB": "The FDA and other U.S. and foreign regulatory authorities have substantial discretion, at any phase of development, to terminate clinical studies, require additional clinical development or other testing, delay or withhold registration and marketing approval and mandate product withdrawals, including recalls.", "type": 2, "words": ["<tag1>", "The", "FDA", "and", "other", "U.S.", "and", "foreign", "health", "authorities", "have", "substantial", "discretion,", "at", "any", "phase", "of", "development,", "to", "terminate", "clinical", "studies,", "require", "additional", "clinical", "development", "or", "other", "testing,", "delay", "or", "withhold", "registration", "and", "marketing", "approval", "and", "mandate", "product", "withdrawals,", "including", "recalls.", "<tag2>", "The", "FDA", "and", "other", "U.S.", "and", "foreign", "regulatory", "authorities", "have", "substantial", "discretion,", "at", "any", "phase", "of", "development,", "to", "terminate", "clinical", "studies,", "require", "additional", "clinical", "development", "or", "other", "testing,", "delay", "or", "withhold", "registration", "and", "marketing", "approval", "and", "mandate", "product", "withdrawals,", "including", "recalls.", "<tag3>"], "wordsA": ["The", "FDA", "and", "other", "U.S.", "and", "foreign", "health", "authorities", "have", "substantial", "discretion,", "at", "any", "phase", "of", "development,", "to", "terminate", "clinical", "studies,", "require", "additional", "clinical", "development", "or", "other", "testing,", "delay", "or", "withhold", "registration", "and", "marketing", "approval", "and", "mandate", "product", "withdrawals,", "including", "recalls."], "wordsB": ["The", "FDA", "and", "other", "U.S.", "and", "foreign", "regulatory", "authorities", "have", "substantial", "discretion,", "at", "any", "phase", "of", "development,", "to", "terminate", "clinical", "studies,", "require", "additional", "clinical", "development", "or", "other", "testing,", "delay", "or", "withhold", "registration", "and", "marketing", "approval", "and", "mandate", "product", "withdrawals,", "including", "recalls."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p14_s4", "idA": "906709_15_item1a_p13_s3", "sentA": "Further, health authorities have the discretion to analyze data using their own methodologies that may differ from those used by us or our partners which could lead such authorities to arrive at different conclusions regarding the safety or efficacy of a drug candidate.", "sentB": "Further, regulatory authorities have the discretion to analyze data using their own methodologies that may differ from those used by us or our partners which could lead such authorities to arrive at different conclusions regarding the safety or efficacy of a drug candidate.", "type": 2, "words": ["<tag1>", "Further,", "health", "authorities", "have", "the", "discretion", "to", "analyze", "data", "using", "their", "own", "methodologies", "that", "may", "differ", "from", "those", "used", "by", "us", "or", "our", "partners", "which", "could", "lead", "such", "authorities", "to", "arrive", "at", "different", "conclusions", "regarding", "the", "safety", "or", "efficacy", "of", "a", "drug", "candidate.", "<tag2>", "Further,", "regulatory", "authorities", "have", "the", "discretion", "to", "analyze", "data", "using", "their", "own", "methodologies", "that", "may", "differ", "from", "those", "used", "by", "us", "or", "our", "partners", "which", "could", "lead", "such", "authorities", "to", "arrive", "at", "different", "conclusions", "regarding", "the", "safety", "or", "efficacy", "of", "a", "drug", "candidate.", "<tag3>"], "wordsA": ["Further,", "health", "authorities", "have", "the", "discretion", "to", "analyze", "data", "using", "their", "own", "methodologies", "that", "may", "differ", "from", "those", "used", "by", "us", "or", "our", "partners", "which", "could", "lead", "such", "authorities", "to", "arrive", "at", "different", "conclusions", "regarding", "the", "safety", "or", "efficacy", "of", "a", "drug", "candidate."], "wordsB": ["Further,", "regulatory", "authorities", "have", "the", "discretion", "to", "analyze", "data", "using", "their", "own", "methodologies", "that", "may", "differ", "from", "those", "used", "by", "us", "or", "our", "partners", "which", "could", "lead", "such", "authorities", "to", "arrive", "at", "different", "conclusions", "regarding", "the", "safety", "or", "efficacy", "of", "a", "drug", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p14_s5", "idA": "906709_15_item1a_p14_s0", "sentA": "undesirable side effects caused by our drug candidates could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restricted label or the delay or denial of regulatory approval by regulatory authorities.", "sentB": "In addition, undesirable side effects caused by our drug candidates could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restricted label or the delay or denial of regulatory approval by regulatory authorities.", "type": 2, "words": ["<tag1>", "undesirable", "side", "effects", "caused", "by", "our", "drug", "candidates", "could", "cause", "us", "or", "regulatory", "authorities", "to", "interrupt,", "delay", "or", "halt", "clinical", "trials", "and", "could", "result", "in", "a", "more", "restricted", "label", "or", "the", "delay", "or", "denial", "of", "regulatory", "approval", "by", "regulatory", "authorities.", "<tag2>", "In", "addition,", "undesirable", "side", "effects", "caused", "by", "our", "drug", "candidates", "could", "cause", "us", "or", "regulatory", "authorities", "to", "interrupt,", "delay", "or", "halt", "clinical", "trials", "and", "could", "result", "in", "a", "more", "restricted", "label", "or", "the", "delay", "or", "denial", "of", "regulatory", "approval", "by", "regulatory", "authorities.", "<tag3>"], "wordsA": ["undesirable", "side", "effects", "caused", "by", "our", "drug", "candidates", "could", "cause", "us", "or", "regulatory", "authorities", "to", "interrupt,", "delay", "or", "halt", "clinical", "trials", "and", "could", "result", "in", "a", "more", "restricted", "label", "or", "the", "delay", "or", "denial", "of", "regulatory", "approval", "by", "regulatory", "authorities."], "wordsB": ["In", "addition,", "undesirable", "side", "effects", "caused", "by", "our", "drug", "candidates", "could", "cause", "us", "or", "regulatory", "authorities", "to", "interrupt,", "delay", "or", "halt", "clinical", "trials", "and", "could", "result", "in", "a", "more", "restricted", "label", "or", "the", "delay", "or", "denial", "of", "regulatory", "approval", "by", "regulatory", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p15_s6", "idA": "906709_15_item1a_p15_s6", "sentA": "As of December 31, 2014, we had cash and investments in marketable securities valued at approximately $262.8 million, of which $25.0 million was restricted in relation to our 12.0% senior secured notes, and indebtedness of approximately $151.8 million.", "sentB": "As of December 31, 2015, we had cash and investments in marketable securities valued at approximately $308.9 million.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2014,", "we", "had", "cash", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$262.8", "million,", "of", "which", "$25.0", "million", "was", "restricted", "in", "relation", "to", "our", "12.0%", "senior", "secured", "notes,", "and", "indebtedness", "of", "approximately", "$151.8", "million.", "<tag2>", "As", "of", "December", "31,", "2015,", "we", "had", "cash", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$308.9", "million.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2014,", "we", "had", "cash", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$262.8", "million,", "of", "which", "$25.0", "million", "was", "restricted", "in", "relation", "to", "our", "12.0%", "senior", "secured", "notes,", "and", "indebtedness", "of", "approximately", "$151.8", "million."], "wordsB": ["As", "of", "December", "31,", "2015,", "we", "had", "cash", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$308.9", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p15_s7", "idA": "906709_15_item1a_p15_s6", "sentA": "As of December 31, 2014, we had cash and investments in marketable securities valued at approximately $262.8 million, of which $25.0 million was restricted in relation to our 12.0% senior secured notes, and indebtedness of approximately $151.8 million.", "sentB": "Also, as of December 31, 2015, we had $255.8 million in debt, including $250.0 million in principal of senior secured notes and $5.8 million of capital lease obligations.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2014,", "we", "had", "cash", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$262.8", "million,", "of", "which", "$25.0", "million", "was", "restricted", "in", "relation", "to", "our", "12.0%", "senior", "secured", "notes,", "and", "indebtedness", "of", "approximately", "$151.8", "million.", "<tag2>", "Also,", "as", "of", "December", "31,", "2015,", "we", "had", "$255.8", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.8", "million", "of", "capital", "lease", "obligations.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2014,", "we", "had", "cash", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$262.8", "million,", "of", "which", "$25.0", "million", "was", "restricted", "in", "relation", "to", "our", "12.0%", "senior", "secured", "notes,", "and", "indebtedness", "of", "approximately", "$151.8", "million."], "wordsB": ["Also,", "as", "of", "December", "31,", "2015,", "we", "had", "$255.8", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.8", "million", "of", "capital", "lease", "obligations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p56_s2", "idA": "906709_15_item1a_p15_s7", "sentA": "The indebtedness includes approximately $125.0 million in senior secured notes due July 2017, but excludes our long-term liability relating to the sale of future royalties as this royalty obligation liability will not be settled in cash.", "sentB": "On October 5, 2015, we issued $250.0 million in aggregate principal amount of 7.75% senior secured notes due October 2020.", "type": 2, "words": ["<tag1>", "The", "indebtedness", "includes", "approximately", "$125.0", "million", "in", "senior", "secured", "notes", "due", "July", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties", "as", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash.", "<tag2>", "On", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020.", "<tag3>"], "wordsA": ["The", "indebtedness", "includes", "approximately", "$125.0", "million", "in", "senior", "secured", "notes", "due", "July", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties", "as", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash."], "wordsB": ["On", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p17_s0", "idA": "906709_15_item1a_p17_s0", "sentA": "A significant multi-year capital commitment is required to advance our drug candidates through the various stages of research and development in order to generate sufficient data to enable high value collaboration partnerships with significant upfront payments or to successfully achieve regulatory approval.", "sentB": "A significant multi-year capital commitment is required to advance our drug candidates through the various stages of research and development in order to generate suffic ient data to enable high value collaboration partnerships with significant upfront payments or to successfully achieve regulatory approval.", "type": 2, "words": ["<tag1>", "A", "significant", "multi-year", "capital", "commitment", "is", "required", "to", "advance", "our", "drug", "candidates", "through", "the", "various", "stages", "of", "research", "and", "development", "in", "order", "to", "generate", "sufficient", "data", "to", "enable", "high", "value", "collaboration", "partnerships", "with", "significant", "upfront", "payments", "or", "to", "successfully", "achieve", "regulatory", "approval.", "<tag2>", "A", "significant", "multi-year", "capital", "commitment", "is", "required", "to", "advance", "our", "drug", "candidates", "through", "the", "various", "stages", "of", "research", "and", "development", "in", "order", "to", "generate", "suffic", "ient", "data", "to", "enable", "high", "value", "collaboration", "partnerships", "with", "significant", "upfront", "payments", "or", "to", "successfully", "achieve", "regulatory", "approval.", "<tag3>"], "wordsA": ["A", "significant", "multi-year", "capital", "commitment", "is", "required", "to", "advance", "our", "drug", "candidates", "through", "the", "various", "stages", "of", "research", "and", "development", "in", "order", "to", "generate", "sufficient", "data", "to", "enable", "high", "value", "collaboration", "partnerships", "with", "significant", "upfront", "payments", "or", "to", "successfully", "achieve", "regulatory", "approval."], "wordsB": ["A", "significant", "multi-year", "capital", "commitment", "is", "required", "to", "advance", "our", "drug", "candidates", "through", "the", "various", "stages", "of", "research", "and", "development", "in", "order", "to", "generate", "suffic", "ient", "data", "to", "enable", "high", "value", "collaboration", "partnerships", "with", "significant", "upfront", "payments", "or", "to", "successfully", "achieve", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p17_s2", "idA": "906709_15_item1a_p17_s2", "sentA": "If sufficient capital is not available to us or is not available on commercially reasonable terms, it could require us to delay or reduce one or more of our research and development programs.", "sentB": "If sufficient capital is not available to us or is not available on commercially reasonable terms, it could require us to delay or reduce one or more of o ur research and development programs.", "type": 2, "words": ["<tag1>", "If", "sufficient", "capital", "is", "not", "available", "to", "us", "or", "is", "not", "available", "on", "commercially", "reasonable", "terms,", "it", "could", "require", "us", "to", "delay", "or", "reduce", "one", "or", "more", "of", "our", "research", "and", "development", "programs.", "<tag2>", "If", "sufficient", "capital", "is", "not", "available", "to", "us", "or", "is", "not", "available", "on", "commercially", "reasonable", "terms,", "it", "could", "require", "us", "to", "delay", "or", "reduce", "one", "or", "more", "of", "o", "ur", "research", "and", "development", "programs.", "<tag3>"], "wordsA": ["If", "sufficient", "capital", "is", "not", "available", "to", "us", "or", "is", "not", "available", "on", "commercially", "reasonable", "terms,", "it", "could", "require", "us", "to", "delay", "or", "reduce", "one", "or", "more", "of", "our", "research", "and", "development", "programs."], "wordsB": ["If", "sufficient", "capital", "is", "not", "available", "to", "us", "or", "is", "not", "available", "on", "commercially", "reasonable", "terms,", "it", "could", "require", "us", "to", "delay", "or", "reduce", "one", "or", "more", "of", "o", "ur", "research", "and", "development", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p21_s0", "idA": "906709_15_item1a_p19_s2", "sentA": "Interim data are also subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available.", "sentB": "patient enrollment continues and more patient data become available.", "type": 2, "words": ["<tag1>", "Interim", "data", "are", "also", "subject", "to", "the", "risk", "that", "one", "or", "more", "of", "the", "clinical", "outcomes", "may", "materially", "change", "as", "patient", "enrollment", "continues", "and", "more", "patient", "data", "become", "available.", "<tag2>", "patient", "enrollment", "continues", "and", "more", "patient", "data", "become", "available.", "<tag3>"], "wordsA": ["Interim", "data", "are", "also", "subject", "to", "the", "risk", "that", "one", "or", "more", "of", "the", "clinical", "outcomes", "may", "materially", "change", "as", "patient", "enrollment", "continues", "and", "more", "patient", "data", "become", "available."], "wordsB": ["patient", "enrollment", "continues", "and", "more", "patient", "data", "become", "available."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p0_s0", "idA": "906709_15_item1a_p1_s0", "sentA": "you should not consider this section to be a complete discussion of all potential risks or uncertainties that may substantially impact our business.", "sentB": "We are providing the following cautionary discussion of risk factors, uncertainties and assumptions that we believe are relevant to our business.", "type": 2, "words": ["<tag1>", "you", "should", "not", "consider", "this", "section", "to", "be", "a", "complete", "discussion", "of", "all", "potential", "risks", "or", "uncertainties", "that", "may", "substantially", "impact", "our", "business.", "<tag2>", "We", "are", "providing", "the", "following", "cautionary", "discussion", "of", "risk", "factors,", "uncertainties", "and", "assumptions", "that", "we", "believe", "are", "relevant", "to", "our", "business.", "<tag3>"], "wordsA": ["you", "should", "not", "consider", "this", "section", "to", "be", "a", "complete", "discussion", "of", "all", "potential", "risks", "or", "uncertainties", "that", "may", "substantially", "impact", "our", "business."], "wordsB": ["We", "are", "providing", "the", "following", "cautionary", "discussion", "of", "risk", "factors,", "uncertainties", "and", "assumptions", "that", "we", "believe", "are", "relevant", "to", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p1_s3", "idA": "906709_15_item1a_p1_s0", "sentA": "you should not consider this section to be a complete discussion of all potential risks or uncertainties that may substantially impact our business.", "sentB": "Consequently, you should not consider this section to be a complete discussion of all potential risks or uncertainties that may substantially impact our business.", "type": 2, "words": ["<tag1>", "you", "should", "not", "consider", "this", "section", "to", "be", "a", "complete", "discussion", "of", "all", "potential", "risks", "or", "uncertainties", "that", "may", "substantially", "impact", "our", "business.", "<tag2>", "Consequently,", "you", "should", "not", "consider", "this", "section", "to", "be", "a", "complete", "discussion", "of", "all", "potential", "risks", "or", "uncertainties", "that", "may", "substantially", "impact", "our", "business.", "<tag3>"], "wordsA": ["you", "should", "not", "consider", "this", "section", "to", "be", "a", "complete", "discussion", "of", "all", "potential", "risks", "or", "uncertainties", "that", "may", "substantially", "impact", "our", "business."], "wordsB": ["Consequently,", "you", "should", "not", "consider", "this", "section", "to", "be", "a", "complete", "discussion", "of", "all", "potential", "risks", "or", "uncertainties", "that", "may", "substantially", "impact", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p3_s0", "idA": "906709_15_item1a_p20_s1", "sentA": "We or our partners may experience delays in clinical trials of drug candidates.", "sentB": "The results from preclinical testing or early clinical trials of a product candidate may not predict the results that will be obtained in later phase clinical trials of the product candidate.", "type": 2, "words": ["<tag1>", "We", "or", "our", "partners", "may", "experience", "delays", "in", "clinical", "trials", "of", "drug", "candidates.", "<tag2>", "The", "results", "from", "preclinical", "testing", "or", "early", "clinical", "trials", "of", "a", "product", "candidate", "may", "not", "predict", "the", "results", "that", "will", "be", "obtained", "in", "later", "phase", "clinical", "trials", "of", "the", "product", "candidate.", "<tag3>"], "wordsA": ["We", "or", "our", "partners", "may", "experience", "delays", "in", "clinical", "trials", "of", "drug", "candidates."], "wordsB": ["The", "results", "from", "preclinical", "testing", "or", "early", "clinical", "trials", "of", "a", "product", "candidate", "may", "not", "predict", "the", "results", "that", "will", "be", "obtained", "in", "later", "phase", "clinical", "trials", "of", "the", "product", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p21_s5", "idA": "906709_15_item1a_p20_s2", "sentA": "We currently have ongoing Phase 3 studies for etirinotecan pegol in patients with metastatic breast cancer and NKTR-181 in patients with chronic lower back pain.", "sentB": "We currently have ongoing clinical studies for NKTR-181 in patients with chronic lower back pain and initiated a Phase 1/2 clinical study for NKTR-214 in December 2015.", "type": 2, "words": ["<tag1>", "We", "currently", "have", "ongoing", "Phase", "3", "studies", "for", "etirinotecan", "pegol", "in", "patients", "with", "metastatic", "breast", "cancer", "and", "NKTR-181", "in", "patients", "with", "chronic", "lower", "back", "pain.", "<tag2>", "We", "currently", "have", "ongoing", "clinical", "studies", "for", "NKTR-181", "in", "patients", "with", "chronic", "lower", "back", "pain", "and", "initiated", "a", "Phase", "1/2", "clinical", "study", "for", "NKTR-214", "in", "December", "2015.", "<tag3>"], "wordsA": ["We", "currently", "have", "ongoing", "Phase", "3", "studies", "for", "etirinotecan", "pegol", "in", "patients", "with", "metastatic", "breast", "cancer", "and", "NKTR-181", "in", "patients", "with", "chronic", "lower", "back", "pain."], "wordsB": ["We", "currently", "have", "ongoing", "clinical", "studies", "for", "NKTR-181", "in", "patients", "with", "chronic", "lower", "back", "pain", "and", "initiated", "a", "Phase", "1/2", "clinical", "study", "for", "NKTR-214", "in", "December", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p21_s6", "idA": "906709_15_item1a_p20_s3", "sentA": "In addition, our collaboration partners have several ongoing Phase 3 clinical programs including Baxter for BAX 855, Bayer for Amikacin Inhale and CIPRO Inhale, and Ophthotech for Fovista .", "sentB": "In addition, our collaboration partners have several ongoing Phase 3 clinical programs including Baxalta for ADYNOVATE TM (previously referred to as BAX 855), Bayer for Amikacin Inhale and CIPRO Inhale, and Ophthotech for Fovista .", "type": 2, "words": ["<tag1>", "In", "addition,", "our", "collaboration", "partners", "have", "several", "ongoing", "Phase", "3", "clinical", "programs", "including", "Baxter", "for", "BAX", "855,", "Bayer", "for", "Amikacin", "Inhale", "and", "CIPRO", "Inhale,", "and", "Ophthotech", "for", "Fovista", ".", "<tag2>", "In", "addition,", "our", "collaboration", "partners", "have", "several", "ongoing", "Phase", "3", "clinical", "programs", "including", "Baxalta", "for", "ADYNOVATE", "TM", "(previously", "referred", "to", "as", "BAX", "855),", "Bayer", "for", "Amikacin", "Inhale", "and", "CIPRO", "Inhale,", "and", "Ophthotech", "for", "Fovista", ".", "<tag3>"], "wordsA": ["In", "addition,", "our", "collaboration", "partners", "have", "several", "ongoing", "Phase", "3", "clinical", "programs", "including", "Baxter", "for", "BAX", "855,", "Bayer", "for", "Amikacin", "Inhale", "and", "CIPRO", "Inhale,", "and", "Ophthotech", "for", "Fovista", "."], "wordsB": ["In", "addition,", "our", "collaboration", "partners", "have", "several", "ongoing", "Phase", "3", "clinical", "programs", "including", "Baxalta", "for", "ADYNOVATE", "TM", "(previously", "referred", "to", "as", "BAX", "855),", "Bayer", "for", "Amikacin", "Inhale", "and", "CIPRO", "Inhale,", "and", "Ophthotech", "for", "Fovista", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p21_s8", "idA": "906709_15_item1a_p20_s5", "sentA": "Our clinical trials for any of our product candidates could be delayed for a variety of reasons, including:", "sentB": "Clinical trials for any of our product candidates could be delayed for a variety of reasons, including:", "type": 2, "words": ["<tag1>", "Our", "clinical", "trials", "for", "any", "of", "our", "product", "candidates", "could", "be", "delayed", "for", "a", "variety", "of", "reasons,", "including:", "<tag2>", "Clinical", "trials", "for", "any", "of", "our", "product", "candidates", "could", "be", "delayed", "for", "a", "variety", "of", "reasons,", "including:", "<tag3>"], "wordsA": ["Our", "clinical", "trials", "for", "any", "of", "our", "product", "candidates", "could", "be", "delayed", "for", "a", "variety", "of", "reasons,", "including:"], "wordsB": ["Clinical", "trials", "for", "any", "of", "our", "product", "candidates", "could", "be", "delayed", "for", "a", "variety", "of", "reasons,", "including:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p22_s0", "idA": "906709_15_item1a_p21_s0", "sentA": "changes in health authorities policies or guidance applicable to our drug candidates.", "sentB": "changes in regulatory authorities policies or guidance applicable to our drug candidates.", "type": 2, "words": ["<tag1>", "changes", "in", "health", "authorities", "policies", "or", "guidance", "applicable", "to", "our", "drug", "candidates.", "<tag2>", "changes", "in", "regulatory", "authorities", "policies", "or", "guidance", "applicable", "to", "our", "drug", "candidates.", "<tag3>"], "wordsA": ["changes", "in", "health", "authorities", "policies", "or", "guidance", "applicable", "to", "our", "drug", "candidates."], "wordsB": ["changes", "in", "regulatory", "authorities", "policies", "or", "guidance", "applicable", "to", "our", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p24_s5", "idA": "906709_15_item1a_p22_s5", "sentA": "If a license is not available on commercially reasonable terms or at all, we may be prevented from developing and selling the drug, which could significantly harm our business, results of operations, and financial condition.", "sentB": "If a license is not available on commercially reasonable terms or at all, we may be prevented from developing and commercializing the drug, which could significantly harm our business, results of operations, and financial condition.", "type": 2, "words": ["<tag1>", "If", "a", "license", "is", "not", "available", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "we", "may", "be", "prevented", "from", "developing", "and", "selling", "the", "drug,", "which", "could", "significantly", "harm", "our", "business,", "results", "of", "operations,", "and", "financial", "condition.", "<tag2>", "If", "a", "license", "is", "not", "available", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "we", "may", "be", "prevented", "from", "developing", "and", "commercializing", "the", "drug,", "which", "could", "significantly", "harm", "our", "business,", "results", "of", "operations,", "and", "financial", "condition.", "<tag3>"], "wordsA": ["If", "a", "license", "is", "not", "available", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "we", "may", "be", "prevented", "from", "developing", "and", "selling", "the", "drug,", "which", "could", "significantly", "harm", "our", "business,", "results", "of", "operations,", "and", "financial", "condition."], "wordsB": ["If", "a", "license", "is", "not", "available", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "we", "may", "be", "prevented", "from", "developing", "and", "commercializing", "the", "drug,", "which", "could", "significantly", "harm", "our", "business,", "results", "of", "operations,", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p25_s5", "idA": "906709_15_item1a_p24_s5", "sentA": "Further, our competitors may be able to circumvent and otherwise design around our patents.", "sentB": "Further, o ur competitors may be able to circumvent and otherwise design around our patents.", "type": 2, "words": ["<tag1>", "Further,", "our", "competitors", "may", "be", "able", "to", "circumvent", "and", "otherwise", "design", "around", "our", "patents.", "<tag2>", "Further,", "o", "ur", "competitors", "may", "be", "able", "to", "circumvent", "and", "otherwise", "design", "around", "our", "patents.", "<tag3>"], "wordsA": ["Further,", "our", "competitors", "may", "be", "able", "to", "circumvent", "and", "otherwise", "design", "around", "our", "patents."], "wordsB": ["Further,", "o", "ur", "competitors", "may", "be", "able", "to", "circumvent", "and", "otherwise", "design", "around", "our", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p26_s0", "idA": "906709_15_item1a_p24_s6", "sentA": "Even if a patent is issued and enforceable, because development and commercialization of pharmaceutical products can be subject to substantial delays, patents may expire early and provide only a short period of protection, if any, following the commercialization of products encompassed by our patents.", "sentB": "substantial delays, patents may expire earl y and provide only a short period of protection, if any, following the commercialization of products encompassed by our patents.", "type": 2, "words": ["<tag1>", "Even", "if", "a", "patent", "is", "issued", "and", "enforceable,", "because", "development", "and", "commercialization", "of", "pharmaceutical", "products", "can", "be", "subject", "to", "substantial", "delays,", "patents", "may", "expire", "early", "and", "provide", "only", "a", "short", "period", "of", "protection,", "if", "any,", "following", "the", "commercialization", "of", "products", "encompassed", "by", "our", "patents.", "<tag2>", "substantial", "delays,", "patents", "may", "expire", "earl", "y", "and", "provide", "only", "a", "short", "period", "of", "protection,", "if", "any,", "following", "the", "commercialization", "of", "products", "encompassed", "by", "our", "patents.", "<tag3>"], "wordsA": ["Even", "if", "a", "patent", "is", "issued", "and", "enforceable,", "because", "development", "and", "commercialization", "of", "pharmaceutical", "products", "can", "be", "subject", "to", "substantial", "delays,", "patents", "may", "expire", "early", "and", "provide", "only", "a", "short", "period", "of", "protection,", "if", "any,", "following", "the", "commercialization", "of", "products", "encompassed", "by", "our", "patents."], "wordsB": ["substantial", "delays,", "patents", "may", "expire", "earl", "y", "and", "provide", "only", "a", "short", "period", "of", "protection,", "if", "any,", "following", "the", "commercialization", "of", "products", "encompassed", "by", "our", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p30_s4", "idA": "906709_15_item1a_p24_s7", "sentA": "We may have to participate in interference proceedings declared by the U.S. Patent and Trademark Office, which could result in a loss of the patent and/or substantial cost to us.", "sentB": "We are also aware of an inter partes review petition that was filed with the U.S. Patent and Trademark Office by Neptune Generics, which is an affiliate of Gerchen Keller Capital.", "type": 2, "words": ["<tag1>", "We", "may", "have", "to", "participate", "in", "interference", "proceedings", "declared", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "which", "could", "result", "in", "a", "loss", "of", "the", "patent", "and/or", "substantial", "cost", "to", "us.", "<tag2>", "We", "are", "also", "aware", "of", "an", "inter", "partes", "review", "petition", "that", "was", "filed", "with", "the", "U.S.", "Patent", "and", "Trademark", "Office", "by", "Neptune", "Generics,", "which", "is", "an", "affiliate", "of", "Gerchen", "Keller", "Capital.", "<tag3>"], "wordsA": ["We", "may", "have", "to", "participate", "in", "interference", "proceedings", "declared", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "which", "could", "result", "in", "a", "loss", "of", "the", "patent", "and/or", "substantial", "cost", "to", "us."], "wordsB": ["We", "are", "also", "aware", "of", "an", "inter", "partes", "review", "petition", "that", "was", "filed", "with", "the", "U.S.", "Patent", "and", "Trademark", "Office", "by", "Neptune", "Generics,", "which", "is", "an", "affiliate", "of", "Gerchen", "Keller", "Capital."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p28_s6", "idA": "906709_15_item1a_p26_s6", "sentA": "The third party often bases its assertions on a claim that its patents cover our technology platform or drug candidates or that we have misappropriated its confidential or proprietary information.", "sentB": "A third party often bases its assertions on a claim that its patents cover our technology platform or drug candidates or that we have misappropriated its confidential or proprietary information.", "type": 2, "words": ["<tag1>", "The", "third", "party", "often", "bases", "its", "assertions", "on", "a", "claim", "that", "its", "patents", "cover", "our", "technology", "platform", "or", "drug", "candidates", "or", "that", "we", "have", "misappropriated", "its", "confidential", "or", "proprietary", "information.", "<tag2>", "A", "third", "party", "often", "bases", "its", "assertions", "on", "a", "claim", "that", "its", "patents", "cover", "our", "technology", "platform", "or", "drug", "candidates", "or", "that", "we", "have", "misappropriated", "its", "confidential", "or", "proprietary", "information.", "<tag3>"], "wordsA": ["The", "third", "party", "often", "bases", "its", "assertions", "on", "a", "claim", "that", "its", "patents", "cover", "our", "technology", "platform", "or", "drug", "candidates", "or", "that", "we", "have", "misappropriated", "its", "confidential", "or", "proprietary", "information."], "wordsB": ["A", "third", "party", "often", "bases", "its", "assertions", "on", "a", "claim", "that", "its", "patents", "cover", "our", "technology", "platform", "or", "drug", "candidates", "or", "that", "we", "have", "misappropriated", "its", "confidential", "or", "proprietary", "information."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p29_s5", "idA": "906709_15_item1a_p28_s2", "sentA": "In December 2013, we entered into a litigation settlement with the Research Foundation of the State University of New York (SUNY) pursuant to which we agree to the payment of a total of $12.0 million in future installments and certain other terms and conditions in exchange for the full release of certain breach of contract claims by SUNY.", "sentB": "In December 2013, we entered into a litigation settlement with the Research Foundation of the State University of New York (SUNY) pursuant to which we agreed to pay $12.0 million and certain other terms and conditions in exchange for the full release of certain breach of contract claims by SUNY.", "type": 2, "words": ["<tag1>", "In", "December", "2013,", "we", "entered", "into", "a", "litigation", "settlement", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "pursuant", "to", "which", "we", "agree", "to", "the", "payment", "of", "a", "total", "of", "$12.0", "million", "in", "future", "installments", "and", "certain", "other", "terms", "and", "conditions", "in", "exchange", "for", "the", "full", "release", "of", "certain", "breach", "of", "contract", "claims", "by", "SUNY.", "<tag2>", "In", "December", "2013,", "we", "entered", "into", "a", "litigation", "settlement", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "pursuant", "to", "which", "we", "agreed", "to", "pay", "$12.0", "million", "and", "certain", "other", "terms", "and", "conditions", "in", "exchange", "for", "the", "full", "release", "of", "certain", "breach", "of", "contract", "claims", "by", "SUNY.", "<tag3>"], "wordsA": ["In", "December", "2013,", "we", "entered", "into", "a", "litigation", "settlement", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "pursuant", "to", "which", "we", "agree", "to", "the", "payment", "of", "a", "total", "of", "$12.0", "million", "in", "future", "installments", "and", "certain", "other", "terms", "and", "conditions", "in", "exchange", "for", "the", "full", "release", "of", "certain", "breach", "of", "contract", "claims", "by", "SUNY."], "wordsB": ["In", "December", "2013,", "we", "entered", "into", "a", "litigation", "settlement", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "pursuant", "to", "which", "we", "agreed", "to", "pay", "$12.0", "million", "and", "certain", "other", "terms", "and", "conditions", "in", "exchange", "for", "the", "full", "release", "of", "certain", "breach", "of", "contract", "claims", "by", "SUNY."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p30_s0", "idA": "906709_15_item1a_p29_s0", "sentA": "PEGylated Factor VIII which we have exclusively licensed to Baxter.", "sentB": "PEGylated Factor VIII which we have exclusively licensed to Baxalta.", "type": 2, "words": ["<tag1>", "PEGylated", "Factor", "VIII", "which", "we", "have", "exclusively", "licensed", "to", "Baxter.", "<tag2>", "PEGylated", "Factor", "VIII", "which", "we", "have", "exclusively", "licensed", "to", "Baxalta.", "<tag3>"], "wordsA": ["PEGylated", "Factor", "VIII", "which", "we", "have", "exclusively", "licensed", "to", "Baxter."], "wordsB": ["PEGylated", "Factor", "VIII", "which", "we", "have", "exclusively", "licensed", "to", "Baxalta."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p31_s5", "idA": "906709_15_item1a_p29_s11", "sentA": "The results of these inspections could result in costly manufacturing changes or facility or capital equipment upgrades to satisfy the FDA that our manufacturing and quality control procedures are in substantial compliance with cGMP.", "sentB": "Regulatory inspections could result in costly manufacturing changes or facility or capital equipment upgrades to satisfy the FDA that our manufacturing and quality control procedures are in substantial compliance with cGMP.", "type": 2, "words": ["<tag1>", "The", "results", "of", "these", "inspections", "could", "result", "in", "costly", "manufacturing", "changes", "or", "facility", "or", "capital", "equipment", "upgrades", "to", "satisfy", "the", "FDA", "that", "our", "manufacturing", "and", "quality", "control", "procedures", "are", "in", "substantial", "compliance", "with", "cGMP.", "<tag2>", "Regulatory", "inspections", "could", "result", "in", "costly", "manufacturing", "changes", "or", "facility", "or", "capital", "equipment", "upgrades", "to", "satisfy", "the", "FDA", "that", "our", "manufacturing", "and", "quality", "control", "procedures", "are", "in", "substantial", "compliance", "with", "cGMP.", "<tag3>"], "wordsA": ["The", "results", "of", "these", "inspections", "could", "result", "in", "costly", "manufacturing", "changes", "or", "facility", "or", "capital", "equipment", "upgrades", "to", "satisfy", "the", "FDA", "that", "our", "manufacturing", "and", "quality", "control", "procedures", "are", "in", "substantial", "compliance", "with", "cGMP."], "wordsB": ["Regulatory", "inspections", "could", "result", "in", "costly", "manufacturing", "changes", "or", "facility", "or", "capital", "equipment", "upgrades", "to", "satisfy", "the", "FDA", "that", "our", "manufacturing", "and", "quality", "control", "procedures", "are", "in", "substantial", "compliance", "with", "cGMP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p31_s6", "idA": "906709_15_item1a_p29_s12", "sentA": "Manufacturing delays, for us or our contract manufacturers, pending resolution of regulatory deficiencies or suspensions would have a material adverse effect on our business, results of operations and financial condition.", "sentB": "Manufacturing delays, for us or our contract manufacturers, pending resolution of regulatory deficiencies or suspensions could have a material adverse effect on our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "Manufacturing", "delays,", "for", "us", "or", "our", "contract", "manufacturers,", "pending", "resolution", "of", "regulatory", "deficiencies", "or", "suspensions", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Manufacturing", "delays,", "for", "us", "or", "our", "contract", "manufacturers,", "pending", "resolution", "of", "regulatory", "deficiencies", "or", "suspensions", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["Manufacturing", "delays,", "for", "us", "or", "our", "contract", "manufacturers,", "pending", "resolution", "of", "regulatory", "deficiencies", "or", "suspensions", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Manufacturing", "delays,", "for", "us", "or", "our", "contract", "manufacturers,", "pending", "resolution", "of", "regulatory", "deficiencies", "or", "suspensions", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p30_s6", "idA": "906709_15_item1a_p29_s2", "sentA": "We believe that Bayer s claim to an ownership interest in these patent filings is without merit and are vigorously defending sole and exclusive ownership rights to this intellectual property.", "sentB": "We believe this petition is without merit and AstraZeneca and Nektar will vigorously defend the validity of this patent.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "Bayer", "s", "claim", "to", "an", "ownership", "interest", "in", "these", "patent", "filings", "is", "without", "merit", "and", "are", "vigorously", "defending", "sole", "and", "exclusive", "ownership", "rights", "to", "this", "intellectual", "property.", "<tag2>", "We", "believe", "this", "petition", "is", "without", "merit", "and", "AstraZeneca", "and", "Nektar", "will", "vigorously", "defend", "the", "validity", "of", "this", "patent.", "<tag3>"], "wordsA": ["We", "believe", "that", "Bayer", "s", "claim", "to", "an", "ownership", "interest", "in", "these", "patent", "filings", "is", "without", "merit", "and", "are", "vigorously", "defending", "sole", "and", "exclusive", "ownership", "rights", "to", "this", "intellectual", "property."], "wordsB": ["We", "believe", "this", "petition", "is", "without", "merit", "and", "AstraZeneca", "and", "Nektar", "will", "vigorously", "defend", "the", "validity", "of", "this", "patent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p30_s3", "idA": "906709_15_item1a_p29_s3", "sentA": "We are also regularly involved in opposition proceedings at the European Patent Office where third parties seek to invalidate or limit the scope of our allowed European patents applications covering (among other things) our drugs and platform technologies.", "sentB": "We are also regularly involved in opposition proceedings at the European Patent Office where third parties seek to invalidate or limit the scope of our allowed European patent applications covering (among other things) our drugs and platform technologies.", "type": 2, "words": ["<tag1>", "We", "are", "also", "regularly", "involved", "in", "opposition", "proceedings", "at", "the", "European", "Patent", "Office", "where", "third", "parties", "seek", "to", "invalidate", "or", "limit", "the", "scope", "of", "our", "allowed", "European", "patents", "applications", "covering", "(among", "other", "things)", "our", "drugs", "and", "platform", "technologies.", "<tag2>", "We", "are", "also", "regularly", "involved", "in", "opposition", "proceedings", "at", "the", "European", "Patent", "Office", "where", "third", "parties", "seek", "to", "invalidate", "or", "limit", "the", "scope", "of", "our", "allowed", "European", "patent", "applications", "covering", "(among", "other", "things)", "our", "drugs", "and", "platform", "technologies.", "<tag3>"], "wordsA": ["We", "are", "also", "regularly", "involved", "in", "opposition", "proceedings", "at", "the", "European", "Patent", "Office", "where", "third", "parties", "seek", "to", "invalidate", "or", "limit", "the", "scope", "of", "our", "allowed", "European", "patents", "applications", "covering", "(among", "other", "things)", "our", "drugs", "and", "platform", "technologies."], "wordsB": ["We", "are", "also", "regularly", "involved", "in", "opposition", "proceedings", "at", "the", "European", "Patent", "Office", "where", "third", "parties", "seek", "to", "invalidate", "or", "limit", "the", "scope", "of", "our", "allowed", "European", "patent", "applications", "covering", "(among", "other", "things)", "our", "drugs", "and", "platform", "technologies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p31_s0", "idA": "906709_15_item1a_p29_s6", "sentA": "Our manufacturing operations and those of our contract manufacturers are subject to laws and other governmental regulatory requirements, which, if not met, would have a material adverse effect on our business, results of operations and financial condition.", "sentB": "Our manufacturing operations and those of our contract manufacturers are subject to laws and other governmental regulatory requirements, which, if not met, would have a material adverse effect on our business, results of operations and financial condi tion.", "type": 2, "words": ["<tag1>", "Our", "manufacturing", "operations", "and", "those", "of", "our", "contract", "manufacturers", "are", "subject", "to", "laws", "and", "other", "governmental", "regulatory", "requirements,", "which,", "if", "not", "met,", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Our", "manufacturing", "operations", "and", "those", "of", "our", "contract", "manufacturers", "are", "subject", "to", "laws", "and", "other", "governmental", "regulatory", "requirements,", "which,", "if", "not", "met,", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condi", "tion.", "<tag3>"], "wordsA": ["Our", "manufacturing", "operations", "and", "those", "of", "our", "contract", "manufacturers", "are", "subject", "to", "laws", "and", "other", "governmental", "regulatory", "requirements,", "which,", "if", "not", "met,", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Our", "manufacturing", "operations", "and", "those", "of", "our", "contract", "manufacturers", "are", "subject", "to", "laws", "and", "other", "governmental", "regulatory", "requirements,", "which,", "if", "not", "met,", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condi", "tion."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p2_s10", "idA": "906709_15_item1a_p2_s10", "sentA": "Even with success in previously completed clinical trials, the risk of clinical failure for any drug candidate remains high prior to regulatory approval.", "sentB": "The risk of clinical failure for any drug candidate remains high prior to regulatory approval.", "type": 2, "words": ["<tag1>", "Even", "with", "success", "in", "previously", "completed", "clinical", "trials,", "the", "risk", "of", "clinical", "failure", "for", "any", "drug", "candidate", "remains", "high", "prior", "to", "regulatory", "approval.", "<tag2>", "The", "risk", "of", "clinical", "failure", "for", "any", "drug", "candidate", "remains", "high", "prior", "to", "regulatory", "approval.", "<tag3>"], "wordsA": ["Even", "with", "success", "in", "previously", "completed", "clinical", "trials,", "the", "risk", "of", "clinical", "failure", "for", "any", "drug", "candidate", "remains", "high", "prior", "to", "regulatory", "approval."], "wordsB": ["The", "risk", "of", "clinical", "failure", "for", "any", "drug", "candidate", "remains", "high", "prior", "to", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p2_s11", "idA": "906709_15_item1a_p2_s11", "sentA": "A number of companies have suffered significant unforeseen failures in late stage (i.e. Phase 3) clinical studies due to factors such as inconclusive efficacy or safety, even after achieving positive results in earlier clinical studies that were satisfactory both to them and to reviewing government health authorities.", "sentB": "A number of companies have suffered significant unforeseen failures in clinical studies due to factors such as inconclusive efficacy or safety, even after achieving preclinical proof-of-concept or positive results from earlier clinical studies that were satisfactory both to them and to reviewing regulatory authorities.", "type": 2, "words": ["<tag1>", "A", "number", "of", "companies", "have", "suffered", "significant", "unforeseen", "failures", "in", "late", "stage", "(i.e.", "Phase", "3)", "clinical", "studies", "due", "to", "factors", "such", "as", "inconclusive", "efficacy", "or", "safety,", "even", "after", "achieving", "positive", "results", "in", "earlier", "clinical", "studies", "that", "were", "satisfactory", "both", "to", "them", "and", "to", "reviewing", "government", "health", "authorities.", "<tag2>", "A", "number", "of", "companies", "have", "suffered", "significant", "unforeseen", "failures", "in", "clinical", "studies", "due", "to", "factors", "such", "as", "inconclusive", "efficacy", "or", "safety,", "even", "after", "achieving", "preclinical", "proof-of-concept", "or", "positive", "results", "from", "earlier", "clinical", "studies", "that", "were", "satisfactory", "both", "to", "them", "and", "to", "reviewing", "regulatory", "authorities.", "<tag3>"], "wordsA": ["A", "number", "of", "companies", "have", "suffered", "significant", "unforeseen", "failures", "in", "late", "stage", "(i.e.", "Phase", "3)", "clinical", "studies", "due", "to", "factors", "such", "as", "inconclusive", "efficacy", "or", "safety,", "even", "after", "achieving", "positive", "results", "in", "earlier", "clinical", "studies", "that", "were", "satisfactory", "both", "to", "them", "and", "to", "reviewing", "government", "health", "authorities."], "wordsB": ["A", "number", "of", "companies", "have", "suffered", "significant", "unforeseen", "failures", "in", "clinical", "studies", "due", "to", "factors", "such", "as", "inconclusive", "efficacy", "or", "safety,", "even", "after", "achieving", "preclinical", "proof-of-concept", "or", "positive", "results", "from", "earlier", "clinical", "studies", "that", "were", "satisfactory", "both", "to", "them", "and", "to", "reviewing", "regulatory", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p8_s0", "idA": "906709_15_item1a_p2_s12", "sentA": "While etirinotecan pegol and Amikacin Inhale have each demonstrated positive results from earlier clinical studies, there is a substantial risk that Phase 3 clinical study outcomes for these drug candidates from larger patient populations will not demonstrate positive efficacy, safety or other clinical outcomes sufficient to support regulatory filings and achieve regulatory approval.", "sentB": "If the approved drugs fail to achieve commercial success or the drugs in development fail to have positive late stage clinical outcomes sufficient to support regulatory approval in major markets, it could significantly impair our access to capital necessary to fund our research and development efforts for our proprietary drug candidates.", "type": 2, "words": ["<tag1>", "While", "etirinotecan", "pegol", "and", "Amikacin", "Inhale", "have", "each", "demonstrated", "positive", "results", "from", "earlier", "clinical", "studies,", "there", "is", "a", "substantial", "risk", "that", "Phase", "3", "clinical", "study", "outcomes", "for", "these", "drug", "candidates", "from", "larger", "patient", "populations", "will", "not", "demonstrate", "positive", "efficacy,", "safety", "or", "other", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "filings", "and", "achieve", "regulatory", "approval.", "<tag2>", "If", "the", "approved", "drugs", "fail", "to", "achieve", "commercial", "success", "or", "the", "drugs", "in", "development", "fail", "to", "have", "positive", "late", "stage", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "approval", "in", "major", "markets,", "it", "could", "significantly", "impair", "our", "access", "to", "capital", "necessary", "to", "fund", "our", "research", "and", "development", "efforts", "for", "our", "proprietary", "drug", "candidates.", "<tag3>"], "wordsA": ["While", "etirinotecan", "pegol", "and", "Amikacin", "Inhale", "have", "each", "demonstrated", "positive", "results", "from", "earlier", "clinical", "studies,", "there", "is", "a", "substantial", "risk", "that", "Phase", "3", "clinical", "study", "outcomes", "for", "these", "drug", "candidates", "from", "larger", "patient", "populations", "will", "not", "demonstrate", "positive", "efficacy,", "safety", "or", "other", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "filings", "and", "achieve", "regulatory", "approval."], "wordsB": ["If", "the", "approved", "drugs", "fail", "to", "achieve", "commercial", "success", "or", "the", "drugs", "in", "development", "fail", "to", "have", "positive", "late", "stage", "clinical", "outcomes", "sufficient", "to", "support", "regulatory", "approval", "in", "major", "markets,", "it", "could", "significantly", "impair", "our", "access", "to", "capital", "necessary", "to", "fund", "our", "research", "and", "development", "efforts", "for", "our", "proprietary", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p2_s12", "idA": "906709_15_item1a_p2_s13", "sentA": "Phase 3 clinical study outcomes remain very unpredictable and it is possible that one or more of these Phase 3 clinical studies could fail at any time due to efficacy, safety or other important clinical findings or regulatory requirements.", "sentB": "Clinical study outcomes remain very unpredictable and it is possible that one or more of our clinical studies could fail at any time due to efficacy, safety or other important clinical findings or regulatory requirements.", "type": 2, "words": ["<tag1>", "Phase", "3", "clinical", "study", "outcomes", "remain", "very", "unpredictable", "and", "it", "is", "possible", "that", "one", "or", "more", "of", "these", "Phase", "3", "clinical", "studies", "could", "fail", "at", "any", "time", "due", "to", "efficacy,", "safety", "or", "other", "important", "clinical", "findings", "or", "regulatory", "requirements.", "<tag2>", "Clinical", "study", "outcomes", "remain", "very", "unpredictable", "and", "it", "is", "possible", "that", "one", "or", "more", "of", "our", "clinical", "studies", "could", "fail", "at", "any", "time", "due", "to", "efficacy,", "safety", "or", "other", "important", "clinical", "findings", "or", "regulatory", "requirements.", "<tag3>"], "wordsA": ["Phase", "3", "clinical", "study", "outcomes", "remain", "very", "unpredictable", "and", "it", "is", "possible", "that", "one", "or", "more", "of", "these", "Phase", "3", "clinical", "studies", "could", "fail", "at", "any", "time", "due", "to", "efficacy,", "safety", "or", "other", "important", "clinical", "findings", "or", "regulatory", "requirements."], "wordsB": ["Clinical", "study", "outcomes", "remain", "very", "unpredictable", "and", "it", "is", "possible", "that", "one", "or", "more", "of", "our", "clinical", "studies", "could", "fail", "at", "any", "time", "due", "to", "efficacy,", "safety", "or", "other", "important", "clinical", "findings", "or", "regulatory", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p3_s3", "idA": "906709_15_item1a_p2_s14", "sentA": "If one or more of these drug candidates fail in Phase 3 clinical studies, it would have a material adverse effect on our business, financial condition and results of operations.", "sentB": "If one or more of our drug candidates fail in clinical studies, it could have a material adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "If", "one", "or", "more", "of", "these", "drug", "candidates", "fail", "in", "Phase", "3", "clinical", "studies,", "it", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "If", "one", "or", "more", "of", "our", "drug", "candidates", "fail", "in", "clinical", "studies,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["If", "one", "or", "more", "of", "these", "drug", "candidates", "fail", "in", "Phase", "3", "clinical", "studies,", "it", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["If", "one", "or", "more", "of", "our", "drug", "candidates", "fail", "in", "clinical", "studies,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p2_s2", "idA": "906709_15_item1a_p2_s2", "sentA": "Preclinical testing and clinical studies are long, expensive and highly uncertain processes.", "sentB": "Preclinical testing and clinical studies are long, expensive, difficult to design and implement and highly uncertain as to outcome.", "type": 2, "words": ["<tag1>", "Preclinical", "testing", "and", "clinical", "studies", "are", "long,", "expensive", "and", "highly", "uncertain", "processes.", "<tag2>", "Preclinical", "testing", "and", "clinical", "studies", "are", "long,", "expensive,", "difficult", "to", "design", "and", "implement", "and", "highly", "uncertain", "as", "to", "outcome.", "<tag3>"], "wordsA": ["Preclinical", "testing", "and", "clinical", "studies", "are", "long,", "expensive", "and", "highly", "uncertain", "processes."], "wordsB": ["Preclinical", "testing", "and", "clinical", "studies", "are", "long,", "expensive,", "difficult", "to", "design", "and", "implement", "and", "highly", "uncertain", "as", "to", "outcome."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p2_s3", "idA": "906709_15_item1a_p2_s3", "sentA": "It will take us, or our collaborative partners, several years to complete clinical studies.", "sentB": "It will take us, or our collaborative partners, many years to conduct extensive preclinical tests and clinical trials to demonstrate the safety and efficacy in humans of our product candidates.", "type": 2, "words": ["<tag1>", "It", "will", "take", "us,", "or", "our", "collaborative", "partners,", "several", "years", "to", "complete", "clinical", "studies.", "<tag2>", "It", "will", "take", "us,", "or", "our", "collaborative", "partners,", "many", "years", "to", "conduct", "extensive", "preclinical", "tests", "and", "clinical", "trials", "to", "demonstrate", "the", "safety", "and", "efficacy", "in", "humans", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["It", "will", "take", "us,", "or", "our", "collaborative", "partners,", "several", "years", "to", "complete", "clinical", "studies."], "wordsB": ["It", "will", "take", "us,", "or", "our", "collaborative", "partners,", "many", "years", "to", "conduct", "extensive", "preclinical", "tests", "and", "clinical", "trials", "to", "demonstrate", "the", "safety", "and", "efficacy", "in", "humans", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p2_s7", "idA": "906709_15_item1a_p2_s7", "sentA": "The risk of failure increases for our drug candidates that are based on new technologies, such as the application of our advanced polymer conjugate technology to etirinotecan pegol, NKTR-181, NKTR-171, NKTR-214 and other drug candidates currently in discovery research or preclinical development.", "sentB": "The risk of failure increases for our drug candidates that are based on new technologies, such as the application of our advanced polymer conjugate technology to NKTR-102, NKTR-181, NKTR-214 and other drug candidates currently in discovery research or preclinical development.", "type": 2, "words": ["<tag1>", "The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "etirinotecan", "pegol,", "NKTR-181,", "NKTR-171,", "NKTR-214", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development.", "<tag2>", "The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "NKTR-102,", "NKTR-181,", "NKTR-214", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development.", "<tag3>"], "wordsA": ["The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "etirinotecan", "pegol,", "NKTR-181,", "NKTR-171,", "NKTR-214", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development."], "wordsB": ["The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "NKTR-102,", "NKTR-181,", "NKTR-214", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p2_s8", "idA": "906709_15_item1a_p2_s8", "sentA": "For example, while we recently started a Phase 3 clinical program for NKTR-181 which we believe employs the most appropriate clinical trial design, we were unable to identify a single cause for the Phase 2 study for NKTR-181 not meeting its primary efficacy endpoint, and therefore there is increased risk in effectively designing a Phase 3 clinical program for NKTR-181.", "sentB": "For example, while we believe our NKTR-181 Phase 3 clinical program employs the most appropriate clinical trial design, we were unable to identify a single cause for the Phase 2 study for NKTR-181 not meeting its primary efficacy endpoint, and therefore there is increased risk in effectively designing a Phase 3 clinical program for NKTR-181.", "type": 2, "words": ["<tag1>", "For", "example,", "while", "we", "recently", "started", "a", "Phase", "3", "clinical", "program", "for", "NKTR-181", "which", "we", "believe", "employs", "the", "most", "appropriate", "clinical", "trial", "design,", "we", "were", "unable", "to", "identify", "a", "single", "cause", "for", "the", "Phase", "2", "study", "for", "NKTR-181", "not", "meeting", "its", "primary", "efficacy", "endpoint,", "and", "therefore", "there", "is", "increased", "risk", "in", "effectively", "designing", "a", "Phase", "3", "clinical", "program", "for", "NKTR-181.", "<tag2>", "For", "example,", "while", "we", "believe", "our", "NKTR-181", "Phase", "3", "clinical", "program", "employs", "the", "most", "appropriate", "clinical", "trial", "design,", "we", "were", "unable", "to", "identify", "a", "single", "cause", "for", "the", "Phase", "2", "study", "for", "NKTR-181", "not", "meeting", "its", "primary", "efficacy", "endpoint,", "and", "therefore", "there", "is", "increased", "risk", "in", "effectively", "designing", "a", "Phase", "3", "clinical", "program", "for", "NKTR-181.", "<tag3>"], "wordsA": ["For", "example,", "while", "we", "recently", "started", "a", "Phase", "3", "clinical", "program", "for", "NKTR-181", "which", "we", "believe", "employs", "the", "most", "appropriate", "clinical", "trial", "design,", "we", "were", "unable", "to", "identify", "a", "single", "cause", "for", "the", "Phase", "2", "study", "for", "NKTR-181", "not", "meeting", "its", "primary", "efficacy", "endpoint,", "and", "therefore", "there", "is", "increased", "risk", "in", "effectively", "designing", "a", "Phase", "3", "clinical", "program", "for", "NKTR-181."], "wordsB": ["For", "example,", "while", "we", "believe", "our", "NKTR-181", "Phase", "3", "clinical", "program", "employs", "the", "most", "appropriate", "clinical", "trial", "design,", "we", "were", "unable", "to", "identify", "a", "single", "cause", "for", "the", "Phase", "2", "study", "for", "NKTR-181", "not", "meeting", "its", "primary", "efficacy", "endpoint,", "and", "therefore", "there", "is", "increased", "risk", "in", "effectively", "designing", "a", "Phase", "3", "clinical", "program", "for", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p36_s4", "idA": "906709_15_item1a_p35_s0", "sentA": "Our revenue is exclusively derived from our collaboration agreements, which can result in significant fluctuation in our revenue from period to period, and our past revenue is therefore not necessarily indicative of our future revenue.", "sentB": "Our past revenue generated from collaboration agreements is not necessarily indicative of our future revenue.", "type": 2, "words": ["<tag1>", "Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "which", "can", "result", "in", "significant", "fluctuation", "in", "our", "revenue", "from", "period", "to", "period,", "and", "our", "past", "revenue", "is", "therefore", "not", "necessarily", "indicative", "of", "our", "future", "revenue.", "<tag2>", "Our", "past", "revenue", "generated", "from", "collaboration", "agreements", "is", "not", "necessarily", "indicative", "of", "our", "future", "revenue.", "<tag3>"], "wordsA": ["Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "which", "can", "result", "in", "significant", "fluctuation", "in", "our", "revenue", "from", "period", "to", "period,", "and", "our", "past", "revenue", "is", "therefore", "not", "necessarily", "indicative", "of", "our", "future", "revenue."], "wordsB": ["Our", "past", "revenue", "generated", "from", "collaboration", "agreements", "is", "not", "necessarily", "indicative", "of", "our", "future", "revenue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p36_s1", "idA": "906709_15_item1a_p35_s1", "sentA": "Our revenue is exclusively derived from our collaboration agreements, from which we receive contract research payments, milestone payments based on clinical progress, regulatory progress or net sales achievements, royalties and manufacturing revenue.", "sentB": "Our revenue is exclusively derived from our collaboration agreements, from which we receive upfront fees, contract research payments, milestone and other contingent payments based on clinical progress, regulatory progress or net sales achievements, royalties and manufacturing revenue.", "type": 2, "words": ["<tag1>", "Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "from", "which", "we", "receive", "contract", "research", "payments,", "milestone", "payments", "based", "on", "clinical", "progress,", "regulatory", "progress", "or", "net", "sales", "achievements,", "royalties", "and", "manufacturing", "revenue.", "<tag2>", "Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "from", "which", "we", "receive", "upfront", "fees,", "contract", "research", "payments,", "milestone", "and", "other", "contingent", "payments", "based", "on", "clinical", "progress,", "regulatory", "progress", "or", "net", "sales", "achievements,", "royalties", "and", "manufacturing", "revenue.", "<tag3>"], "wordsA": ["Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "from", "which", "we", "receive", "contract", "research", "payments,", "milestone", "payments", "based", "on", "clinical", "progress,", "regulatory", "progress", "or", "net", "sales", "achievements,", "royalties", "and", "manufacturing", "revenue."], "wordsB": ["Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "from", "which", "we", "receive", "upfront", "fees,", "contract", "research", "payments,", "milestone", "and", "other", "contingent", "payments", "based", "on", "clinical", "progress,", "regulatory", "progress", "or", "net", "sales", "achievements,", "royalties", "and", "manufacturing", "revenue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p36_s2", "idA": "906709_15_item1a_p35_s2", "sentA": "Significant variations in the timing of receipt of cash payments and our recognition of revenue can result from significant milestone payments based on the execution of new collaboration agreements, the timing of clinical outcomes, regulatory approval, commercial launch and the achievement of certain annual sales thresholds.", "sentB": "Significant variations in the timing of receipt of cash payments and our recognition of revenue can result from significant payments based on the execution of new collaboration agreements, the timing of clinical outcomes, regulatory approval, commercial launch or the achievement of certain annual sales thresholds.", "type": 2, "words": ["<tag1>", "Significant", "variations", "in", "the", "timing", "of", "receipt", "of", "cash", "payments", "and", "our", "recognition", "of", "revenue", "can", "result", "from", "significant", "milestone", "payments", "based", "on", "the", "execution", "of", "new", "collaboration", "agreements,", "the", "timing", "of", "clinical", "outcomes,", "regulatory", "approval,", "commercial", "launch", "and", "the", "achievement", "of", "certain", "annual", "sales", "thresholds.", "<tag2>", "Significant", "variations", "in", "the", "timing", "of", "receipt", "of", "cash", "payments", "and", "our", "recognition", "of", "revenue", "can", "result", "from", "significant", "payments", "based", "on", "the", "execution", "of", "new", "collaboration", "agreements,", "the", "timing", "of", "clinical", "outcomes,", "regulatory", "approval,", "commercial", "launch", "or", "the", "achievement", "of", "certain", "annual", "sales", "thresholds.", "<tag3>"], "wordsA": ["Significant", "variations", "in", "the", "timing", "of", "receipt", "of", "cash", "payments", "and", "our", "recognition", "of", "revenue", "can", "result", "from", "significant", "milestone", "payments", "based", "on", "the", "execution", "of", "new", "collaboration", "agreements,", "the", "timing", "of", "clinical", "outcomes,", "regulatory", "approval,", "commercial", "launch", "and", "the", "achievement", "of", "certain", "annual", "sales", "thresholds."], "wordsB": ["Significant", "variations", "in", "the", "timing", "of", "receipt", "of", "cash", "payments", "and", "our", "recognition", "of", "revenue", "can", "result", "from", "significant", "payments", "based", "on", "the", "execution", "of", "new", "collaboration", "agreements,", "the", "timing", "of", "clinical", "outcomes,", "regulatory", "approval,", "commercial", "launch", "or", "the", "achievement", "of", "certain", "annual", "sales", "thresholds."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p36_s5", "idA": "906709_15_item1a_p36_s0", "sentA": "If any of our existing or future collaboration partners fails to develop, obtain regulatory approval for, manufacture or ultimately commercialize any product candidate under our collaboration agreement, our business, financial condition, results of operations and prospectus could be materially and adversely affected.", "sentB": "If any of our existing or future collaboration partners fails to develop, obtain regulatory approval for, manufacture or ultimately commercialize any product candidate under our collaboration agreement, our business, financial condition, and results of operations could be materially and adversely affected.", "type": 2, "words": ["<tag1>", "If", "any", "of", "our", "existing", "or", "future", "collaboration", "partners", "fails", "to", "develop,", "obtain", "regulatory", "approval", "for,", "manufacture", "or", "ultimately", "commercialize", "any", "product", "candidate", "under", "our", "collaboration", "agreement,", "our", "business,", "financial", "condition,", "results", "of", "operations", "and", "prospectus", "could", "be", "materially", "and", "adversely", "affected.", "<tag2>", "If", "any", "of", "our", "existing", "or", "future", "collaboration", "partners", "fails", "to", "develop,", "obtain", "regulatory", "approval", "for,", "manufacture", "or", "ultimately", "commercialize", "any", "product", "candidate", "under", "our", "collaboration", "agreement,", "our", "business,", "financial", "condition,", "and", "results", "of", "operations", "could", "be", "materially", "and", "adversely", "affected.", "<tag3>"], "wordsA": ["If", "any", "of", "our", "existing", "or", "future", "collaboration", "partners", "fails", "to", "develop,", "obtain", "regulatory", "approval", "for,", "manufacture", "or", "ultimately", "commercialize", "any", "product", "candidate", "under", "our", "collaboration", "agreement,", "our", "business,", "financial", "condition,", "results", "of", "operations", "and", "prospectus", "could", "be", "materially", "and", "adversely", "affected."], "wordsB": ["If", "any", "of", "our", "existing", "or", "future", "collaboration", "partners", "fails", "to", "develop,", "obtain", "regulatory", "approval", "for,", "manufacture", "or", "ultimately", "commercialize", "any", "product", "candidate", "under", "our", "collaboration", "agreement,", "our", "business,", "financial", "condition,", "and", "results", "of", "operations", "could", "be", "materially", "and", "adversely", "affected."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p36_s6", "idA": "906709_15_item1a_p36_s1", "sentA": "If we are unable either to create sales, marketing and distribution capabilities or to enter into agreements with third parties to perform these functions, we will be unable to commercialize our products successfully.", "sentB": "If we are unable either to create sales, marketing and distribution capabilities or to enter into agreements with third parties to perform these functions, we will be unable to commercialize our product candidates successfully.", "type": 2, "words": ["<tag1>", "If", "we", "are", "unable", "either", "to", "create", "sales,", "marketing", "and", "distribution", "capabilities", "or", "to", "enter", "into", "agreements", "with", "third", "parties", "to", "perform", "these", "functions,", "we", "will", "be", "unable", "to", "commercialize", "our", "products", "successfully.", "<tag2>", "If", "we", "are", "unable", "either", "to", "create", "sales,", "marketing", "and", "distribution", "capabilities", "or", "to", "enter", "into", "agreements", "with", "third", "parties", "to", "perform", "these", "functions,", "we", "will", "be", "unable", "to", "commercialize", "our", "product", "candidates", "successfully.", "<tag3>"], "wordsA": ["If", "we", "are", "unable", "either", "to", "create", "sales,", "marketing", "and", "distribution", "capabilities", "or", "to", "enter", "into", "agreements", "with", "third", "parties", "to", "perform", "these", "functions,", "we", "will", "be", "unable", "to", "commercialize", "our", "products", "successfully."], "wordsB": ["If", "we", "are", "unable", "either", "to", "create", "sales,", "marketing", "and", "distribution", "capabilities", "or", "to", "enter", "into", "agreements", "with", "third", "parties", "to", "perform", "these", "functions,", "we", "will", "be", "unable", "to", "commercialize", "our", "product", "candidates", "successfully."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p38_s2", "idA": "906709_15_item1a_p37_s3", "sentA": "To the extent that we enter into co-promotion or other arrangements, any revenue we receive will depend upon the efforts of third parties, which may not be successful and are only partially in our control important examples of this risk include MOVANTIK partnered with AstraZeneca and BAX 855 partnered with Baxter.", "sentB": "To the extent that we enter into co-promotion or other arrangements, any revenue we receive will depend upon the efforts of third parties, which may not be successful and over which we have little or no control important examples of this risk include MOVANTIK partnered with AstraZeneca and ADYNOVATE TM (previously referred to as BAX 855) partnered with Baxalta.", "type": 2, "words": ["<tag1>", "To", "the", "extent", "that", "we", "enter", "into", "co-promotion", "or", "other", "arrangements,", "any", "revenue", "we", "receive", "will", "depend", "upon", "the", "efforts", "of", "third", "parties,", "which", "may", "not", "be", "successful", "and", "are", "only", "partially", "in", "our", "control", "important", "examples", "of", "this", "risk", "include", "MOVANTIK", "partnered", "with", "AstraZeneca", "and", "BAX", "855", "partnered", "with", "Baxter.", "<tag2>", "To", "the", "extent", "that", "we", "enter", "into", "co-promotion", "or", "other", "arrangements,", "any", "revenue", "we", "receive", "will", "depend", "upon", "the", "efforts", "of", "third", "parties,", "which", "may", "not", "be", "successful", "and", "over", "which", "we", "have", "little", "or", "no", "control", "important", "examples", "of", "this", "risk", "include", "MOVANTIK", "partnered", "with", "AstraZeneca", "and", "ADYNOVATE", "TM", "(previously", "referred", "to", "as", "BAX", "855)", "partnered", "with", "Baxalta.", "<tag3>"], "wordsA": ["To", "the", "extent", "that", "we", "enter", "into", "co-promotion", "or", "other", "arrangements,", "any", "revenue", "we", "receive", "will", "depend", "upon", "the", "efforts", "of", "third", "parties,", "which", "may", "not", "be", "successful", "and", "are", "only", "partially", "in", "our", "control", "important", "examples", "of", "this", "risk", "include", "MOVANTIK", "partnered", "with", "AstraZeneca", "and", "BAX", "855", "partnered", "with", "Baxter."], "wordsB": ["To", "the", "extent", "that", "we", "enter", "into", "co-promotion", "or", "other", "arrangements,", "any", "revenue", "we", "receive", "will", "depend", "upon", "the", "efforts", "of", "third", "parties,", "which", "may", "not", "be", "successful", "and", "over", "which", "we", "have", "little", "or", "no", "control", "important", "examples", "of", "this", "risk", "include", "MOVANTIK", "partnered", "with", "AstraZeneca", "and", "ADYNOVATE", "TM", "(previously", "referred", "to", "as", "BAX", "855)", "partnered", "with", "Baxalta."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p38_s5", "idA": "906709_15_item1a_p37_s6", "sentA": "We often face very limited supply of a critical raw material that can only be obtained from a single, or a limited number of, suppliers, which could cause production delays, clinical trial delays, substantial lost revenue opportunity or contract liability to third parties.", "sentB": "We often face very limited supply of a critical raw material that can only be obtained from a single, or a limited number of, suppliers, which could cause production delays, clinical trial delays, substantial lost revenue opportunities or contract liabilities to third parties.", "type": 2, "words": ["<tag1>", "We", "often", "face", "very", "limited", "supply", "of", "a", "critical", "raw", "material", "that", "can", "only", "be", "obtained", "from", "a", "single,", "or", "a", "limited", "number", "of,", "suppliers,", "which", "could", "cause", "production", "delays,", "clinical", "trial", "delays,", "substantial", "lost", "revenue", "opportunity", "or", "contract", "liability", "to", "third", "parties.", "<tag2>", "We", "often", "face", "very", "limited", "supply", "of", "a", "critical", "raw", "material", "that", "can", "only", "be", "obtained", "from", "a", "single,", "or", "a", "limited", "number", "of,", "suppliers,", "which", "could", "cause", "production", "delays,", "clinical", "trial", "delays,", "substantial", "lost", "revenue", "opportunities", "or", "contract", "liabilities", "to", "third", "parties.", "<tag3>"], "wordsA": ["We", "often", "face", "very", "limited", "supply", "of", "a", "critical", "raw", "material", "that", "can", "only", "be", "obtained", "from", "a", "single,", "or", "a", "limited", "number", "of,", "suppliers,", "which", "could", "cause", "production", "delays,", "clinical", "trial", "delays,", "substantial", "lost", "revenue", "opportunity", "or", "contract", "liability", "to", "third", "parties."], "wordsB": ["We", "often", "face", "very", "limited", "supply", "of", "a", "critical", "raw", "material", "that", "can", "only", "be", "obtained", "from", "a", "single,", "or", "a", "limited", "number", "of,", "suppliers,", "which", "could", "cause", "production", "delays,", "clinical", "trial", "delays,", "substantial", "lost", "revenue", "opportunities", "or", "contract", "liabilities", "to", "third", "parties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p39_s0", "idA": "906709_15_item1a_p38_s0", "sentA": "We rely on trade secret protection and other unpatented proprietary rights for important proprietary technologies, and any loss of such rights could harm our business, results of operations and financial condition.", "sentB": "We rely on trade secret protection and other unpatented proprietary r ights for important proprietary technologies, and any loss of such rights could harm our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "r", "ights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "r", "ights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p39_s6", "idA": "906709_15_item1a_p38_s6", "sentA": "For the year ended December 31, 2014, we reported a net loss of $53.9 million.", "sentB": "For the year ended December 31, 2015, we reported a net loss of $81.2 million.", "type": 2, "words": ["<tag1>", "For", "the", "year", "ended", "December", "31,", "2014,", "we", "reported", "a", "net", "loss", "of", "$53.9", "million.", "<tag2>", "For", "the", "year", "ended", "December", "31,", "2015,", "we", "reported", "a", "net", "loss", "of", "$81.2", "million.", "<tag3>"], "wordsA": ["For", "the", "year", "ended", "December", "31,", "2014,", "we", "reported", "a", "net", "loss", "of", "$53.9", "million."], "wordsB": ["For", "the", "year", "ended", "December", "31,", "2015,", "we", "reported", "a", "net", "loss", "of", "$81.2", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p40_s0", "idA": "906709_15_item1a_p39_s0", "sentA": "If and when we achieve profitability depends upon a number of factors, including the timing and recognition of milestone payments and royalties received, the timing of revenue under our collaboration agreements, the amount of investments we make in our proprietary product candidates and the regulatory approval and market success of our product candidates.", "sentB": "If and when we achieve profitability depends upon a number of factors, including the timing and recognition of milestone and other contingent payments and royalties received, the timing of revenue under our collaboration agreements, the amount of investments we make in our proprietary product candidates and the regulatory approval and market success of our product candidates.", "type": 2, "words": ["<tag1>", "If", "and", "when", "we", "achieve", "profitability", "depends", "upon", "a", "number", "of", "factors,", "including", "the", "timing", "and", "recognition", "of", "milestone", "payments", "and", "royalties", "received,", "the", "timing", "of", "revenue", "under", "our", "collaboration", "agreements,", "the", "amount", "of", "investments", "we", "make", "in", "our", "proprietary", "product", "candidates", "and", "the", "regulatory", "approval", "and", "market", "success", "of", "our", "product", "candidates.", "<tag2>", "If", "and", "when", "we", "achieve", "profitability", "depends", "upon", "a", "number", "of", "factors,", "including", "the", "timing", "and", "recognition", "of", "milestone", "and", "other", "contingent", "payments", "and", "royalties", "received,", "the", "timing", "of", "revenue", "under", "our", "collaboration", "agreements,", "the", "amount", "of", "investments", "we", "make", "in", "our", "proprietary", "product", "candidates", "and", "the", "regulatory", "approval", "and", "market", "success", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["If", "and", "when", "we", "achieve", "profitability", "depends", "upon", "a", "number", "of", "factors,", "including", "the", "timing", "and", "recognition", "of", "milestone", "payments", "and", "royalties", "received,", "the", "timing", "of", "revenue", "under", "our", "collaboration", "agreements,", "the", "amount", "of", "investments", "we", "make", "in", "our", "proprietary", "product", "candidates", "and", "the", "regulatory", "approval", "and", "market", "success", "of", "our", "product", "candidates."], "wordsB": ["If", "and", "when", "we", "achieve", "profitability", "depends", "upon", "a", "number", "of", "factors,", "including", "the", "timing", "and", "recognition", "of", "milestone", "and", "other", "contingent", "payments", "and", "royalties", "received,", "the", "timing", "of", "revenue", "under", "our", "collaboration", "agreements,", "the", "amount", "of", "investments", "we", "make", "in", "our", "proprietary", "product", "candidates", "and", "the", "regulatory", "approval", "and", "market", "success", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p3_s5", "idA": "906709_15_item1a_p3_s0", "sentA": "When we sign a collaborative development agreement or license agreement to develop a drug candidate with a pharmaceutical or biotechnology company, the pharmaceutical or biotechnology company is generally expected to:", "sentB": "Under our collaboration agreements with various pharmaceutical or biotechnology companies, our collaboration partner is generally solely responsible for:", "type": 2, "words": ["<tag1>", "When", "we", "sign", "a", "collaborative", "development", "agreement", "or", "license", "agreement", "to", "develop", "a", "drug", "candidate", "with", "a", "pharmaceutical", "or", "biotechnology", "company,", "the", "pharmaceutical", "or", "biotechnology", "company", "is", "generally", "expected", "to:", "<tag2>", "Under", "our", "collaboration", "agreements", "with", "various", "pharmaceutical", "or", "biotechnology", "companies,", "our", "collaboration", "partner", "is", "generally", "solely", "responsible", "for:", "<tag3>"], "wordsA": ["When", "we", "sign", "a", "collaborative", "development", "agreement", "or", "license", "agreement", "to", "develop", "a", "drug", "candidate", "with", "a", "pharmaceutical", "or", "biotechnology", "company,", "the", "pharmaceutical", "or", "biotechnology", "company", "is", "generally", "expected", "to:"], "wordsB": ["Under", "our", "collaboration", "agreements", "with", "various", "pharmaceutical", "or", "biotechnology", "companies,", "our", "collaboration", "partner", "is", "generally", "solely", "responsible", "for:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p19_s2", "idA": "906709_15_item1a_p41_s1", "sentA": "We depend on independent clinical investigators, contract research organizations and other third-party service providers to conduct clinical trials for our proprietary product candidates.", "sentB": "We also depend on our relationships with other companies for sales and marketing performance and the commercialization of product candidates.", "type": 2, "words": ["<tag1>", "We", "depend", "on", "independent", "clinical", "investigators,", "contract", "research", "organizations", "and", "other", "third-party", "service", "providers", "to", "conduct", "clinical", "trials", "for", "our", "proprietary", "product", "candidates.", "<tag2>", "We", "also", "depend", "on", "our", "relationships", "with", "other", "companies", "for", "sales", "and", "marketing", "performance", "and", "the", "commercialization", "of", "product", "candidates.", "<tag3>"], "wordsA": ["We", "depend", "on", "independent", "clinical", "investigators,", "contract", "research", "organizations", "and", "other", "third-party", "service", "providers", "to", "conduct", "clinical", "trials", "for", "our", "proprietary", "product", "candidates."], "wordsB": ["We", "also", "depend", "on", "our", "relationships", "with", "other", "companies", "for", "sales", "and", "marketing", "performance", "and", "the", "commercialization", "of", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p43_s6", "idA": "906709_15_item1a_p41_s6", "sentA": "The early termination of any of our clinical trial arrangements, the failure of third parties to comply with the regulations and requirements governing clinical trials or our reliance on results of trials that we have not directly conducted or monitored could hinder or delay the development, approval and commercialization of our product candidates and would adversely affect our business, results of operations and financial condition.", "sentB": "The early termination of any of our clinical trial arrangements, the failure of third parties to comply with the regulations and requirements governing clinical trials or the failure of third parties to properly conduct our clinical trials could hinder or delay the development, approval and commercialization of our product candidates and would adversely affect our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "The", "early", "termination", "of", "any", "of", "our", "clinical", "trial", "arrangements,", "the", "failure", "of", "third", "parties", "to", "comply", "with", "the", "regulations", "and", "requirements", "governing", "clinical", "trials", "or", "our", "reliance", "on", "results", "of", "trials", "that", "we", "have", "not", "directly", "conducted", "or", "monitored", "could", "hinder", "or", "delay", "the", "development,", "approval", "and", "commercialization", "of", "our", "product", "candidates", "and", "would", "adversely", "affect", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "The", "early", "termination", "of", "any", "of", "our", "clinical", "trial", "arrangements,", "the", "failure", "of", "third", "parties", "to", "comply", "with", "the", "regulations", "and", "requirements", "governing", "clinical", "trials", "or", "the", "failure", "of", "third", "parties", "to", "properly", "conduct", "our", "clinical", "trials", "could", "hinder", "or", "delay", "the", "development,", "approval", "and", "commercialization", "of", "our", "product", "candidates", "and", "would", "adversely", "affect", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["The", "early", "termination", "of", "any", "of", "our", "clinical", "trial", "arrangements,", "the", "failure", "of", "third", "parties", "to", "comply", "with", "the", "regulations", "and", "requirements", "governing", "clinical", "trials", "or", "our", "reliance", "on", "results", "of", "trials", "that", "we", "have", "not", "directly", "conducted", "or", "monitored", "could", "hinder", "or", "delay", "the", "development,", "approval", "and", "commercialization", "of", "our", "product", "candidates", "and", "would", "adversely", "affect", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["The", "early", "termination", "of", "any", "of", "our", "clinical", "trial", "arrangements,", "the", "failure", "of", "third", "parties", "to", "comply", "with", "the", "regulations", "and", "requirements", "governing", "clinical", "trials", "or", "the", "failure", "of", "third", "parties", "to", "properly", "conduct", "our", "clinical", "trials", "could", "hinder", "or", "delay", "the", "development,", "approval", "and", "commercialization", "of", "our", "product", "candidates", "and", "would", "adversely", "affect", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p44_s1", "idA": "906709_15_item1a_p42_s1", "sentA": "Competitors of our PEGylation and polymer conjugate chemistry technologies include Biogen Idec Inc., Savient Pharmaceuticals, Inc., Dr. Reddy s Laboratories Ltd., Enzon Pharmaceuticals, Inc., SunBio Corporation, Mountain View Pharmaceuticals, Inc., Novo Nordisk A/S (formerly assets held by Neose Technologies, Inc.), and NOF Corporation.", "sentB": "Competitors of our PEGylation and polymer conjugate chemistry technologies include Biogen Inc., Savient Pharmaceuticals, Inc., Dr. Reddy s Laboratories Ltd., SunBio Corporation, Mountain View Pharmaceuticals, Inc., Novo Nordisk A/S (formerly assets held by Neose Technologies, Inc.), and NOF Corporation.", "type": 2, "words": ["<tag1>", "Competitors", "of", "our", "PEGylation", "and", "polymer", "conjugate", "chemistry", "technologies", "include", "Biogen", "Idec", "Inc.,", "Savient", "Pharmaceuticals,", "Inc.,", "Dr.", "Reddy", "s", "Laboratories", "Ltd.,", "Enzon", "Pharmaceuticals,", "Inc.,", "SunBio", "Corporation,", "Mountain", "View", "Pharmaceuticals,", "Inc.,", "Novo", "Nordisk", "A/S", "(formerly", "assets", "held", "by", "Neose", "Technologies,", "Inc.),", "and", "NOF", "Corporation.", "<tag2>", "Competitors", "of", "our", "PEGylation", "and", "polymer", "conjugate", "chemistry", "technologies", "include", "Biogen", "Inc.,", "Savient", "Pharmaceuticals,", "Inc.,", "Dr.", "Reddy", "s", "Laboratories", "Ltd.,", "SunBio", "Corporation,", "Mountain", "View", "Pharmaceuticals,", "Inc.,", "Novo", "Nordisk", "A/S", "(formerly", "assets", "held", "by", "Neose", "Technologies,", "Inc.),", "and", "NOF", "Corporation.", "<tag3>"], "wordsA": ["Competitors", "of", "our", "PEGylation", "and", "polymer", "conjugate", "chemistry", "technologies", "include", "Biogen", "Idec", "Inc.,", "Savient", "Pharmaceuticals,", "Inc.,", "Dr.", "Reddy", "s", "Laboratories", "Ltd.,", "Enzon", "Pharmaceuticals,", "Inc.,", "SunBio", "Corporation,", "Mountain", "View", "Pharmaceuticals,", "Inc.,", "Novo", "Nordisk", "A/S", "(formerly", "assets", "held", "by", "Neose", "Technologies,", "Inc.),", "and", "NOF", "Corporation."], "wordsB": ["Competitors", "of", "our", "PEGylation", "and", "polymer", "conjugate", "chemistry", "technologies", "include", "Biogen", "Inc.,", "Savient", "Pharmaceuticals,", "Inc.,", "Dr.", "Reddy", "s", "Laboratories", "Ltd.,", "SunBio", "Corporation,", "Mountain", "View", "Pharmaceuticals,", "Inc.,", "Novo", "Nordisk", "A/S", "(formerly", "assets", "held", "by", "Neose", "Technologies,", "Inc.),", "and", "NOF", "Corporation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p45_s0", "idA": "906709_15_item1a_p43_s0", "sentA": "There are several competitors for our proprietary product candidates currently in development.", "sentB": "There are many competitors for our proprietary product candidates currently in development.", "type": 2, "words": ["<tag1>", "There", "are", "several", "competitors", "for", "our", "proprietary", "product", "candidates", "currently", "in", "development.", "<tag2>", "There", "are", "many", "competitors", "for", "our", "proprietary", "product", "candidates", "currently", "in", "development.", "<tag3>"], "wordsA": ["There", "are", "several", "competitors", "for", "our", "proprietary", "product", "candidates", "currently", "in", "development."], "wordsB": ["There", "are", "many", "competitors", "for", "our", "proprietary", "product", "candidates", "currently", "in", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p47_s0", "idA": "906709_15_item1a_p45_s0", "sentA": "In addition, there are a number of companies developing potential products which are in various stages of clinical development and are being evaluated for the treatment of OIC and OBD in different patient populations, including Cubist Pharmaceuticals, Inc., Progenics Pharmaceuticals, Inc. in collaboration with Salix Pharmaceuticals, Ltd., Mundipharma Int.", "sentB": "In addition, there are a number of companies developing potential products which are in various stages of clinical development and are being evaluated for the treatment of OIC and OBD in different patient populations, including Merck Co., Inc., Progenics Pharmaceuticals, Inc. in collaboration with Salix Pharmaceuticals, Ltd., Mundipharma Int.", "type": 2, "words": ["<tag1>", "In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Cubist", "Pharmaceuticals,", "Inc.,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Mundipharma", "Int.", "<tag2>", "In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Merck", "Co.,", "Inc.,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Mundipharma", "Int.", "<tag3>"], "wordsA": ["In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Cubist", "Pharmaceuticals,", "Inc.,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Mundipharma", "Int."], "wordsB": ["In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Merck", "Co.,", "Inc.,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Mundipharma", "Int."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p47_s1", "idA": "906709_15_item1a_p45_s1", "sentA": "Limited, Sucampo Pharmaceuticals, Inc., Develco Pharma GmbH, Alkermes, Inc., GlaxoSmithKline plc, Theravance, Inc., and Takeda Pharmaceutical Company Limited.", "sentB": "Limited, Sucampo Pharmaceuticals, Inc., Develco Pharma GmbH, Alkermes plc, GlaxoSmithKline plc, Theravance, Inc., and Takeda Pharmaceutical Company Limited.", "type": 2, "words": ["<tag1>", "Limited,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Develco", "Pharma", "GmbH,", "Alkermes,", "Inc.,", "GlaxoSmithKline", "plc,", "Theravance,", "Inc.,", "and", "Takeda", "Pharmaceutical", "Company", "Limited.", "<tag2>", "Limited,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Develco", "Pharma", "GmbH,", "Alkermes", "plc,", "GlaxoSmithKline", "plc,", "Theravance,", "Inc.,", "and", "Takeda", "Pharmaceutical", "Company", "Limited.", "<tag3>"], "wordsA": ["Limited,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Develco", "Pharma", "GmbH,", "Alkermes,", "Inc.,", "GlaxoSmithKline", "plc,", "Theravance,", "Inc.,", "and", "Takeda", "Pharmaceutical", "Company", "Limited."], "wordsB": ["Limited,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Develco", "Pharma", "GmbH,", "Alkermes", "plc,", "GlaxoSmithKline", "plc,", "Theravance,", "Inc.,", "and", "Takeda", "Pharmaceutical", "Company", "Limited."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p48_s1", "idA": "906709_15_item1a_p46_s0", "sentA": "For etirinotecan pegol, there are a number of chemotherapies and cancer therapies approved today and in various stages of clinical development for breast and ovarian cancers, including, but not limited to: Abraxane (paclitaxel protein-bound particles for injectable suspension (albumin bound)), Xeloda (capecitabine), Afinitor (everolimus), Doxil (doxorubicin HCl), Ellence (epirubicin), Gemzar (gemcitabine), Halaven (eribulin), Herceptin (trastuzumab), Hycamtin (topotecan), Ibrance (palbociclib), Ixempra (ixabepilone), Navelbine (vinolrebine), Iniparib, Paraplatin (carboplatin), Taxol (paclitaxel) and Taxotere (docetaxel).", "sentB": "For NKTR-102 there are a number of chemotherapies and cancer therapies approved today and in various stages of clinical development for breast cancer, including, but not limited to: Abraxane (paclitaxel protein-bound particles for injectable suspension (albumin bound)), Xeloda (capecitabine), Afinitor (everolimus), Doxil (doxorubicin HCl), Ellence (epirubicin), Gemzar (gemcitabine), Halaven (eribulin), Herceptin (trastuzumab), Hycamtin (topotecan), Ibrance (palbociclib), Ixempra (ixabepilone), Navelbine (vinolrebine), Iniparib, Paraplatin (carboplatin), Taxol (paclitaxel) and Taxotere (docetaxel).", "type": 2, "words": ["<tag1>", "For", "etirinotecan", "pegol,", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "and", "ovarian", "cancers,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Xeloda", "(capecitabine),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ibrance", "(palbociclib),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel).", "<tag2>", "For", "NKTR-102", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "cancer,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Xeloda", "(capecitabine),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ibrance", "(palbociclib),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel).", "<tag3>"], "wordsA": ["For", "etirinotecan", "pegol,", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "and", "ovarian", "cancers,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Xeloda", "(capecitabine),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ibrance", "(palbociclib),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel)."], "wordsB": ["For", "NKTR-102", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "cancer,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Xeloda", "(capecitabine),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ibrance", "(palbociclib),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p48_s2", "idA": "906709_15_item1a_p46_s1", "sentA": "Major pharmaceutical or biotechnology companies with approved drugs or drugs in development for these cancers include, but are not limited to, Bristol-Meyers Squibb Company, Eli Lilly Co., Roche, GlaxoSmithKline plc, Johnson and Johnson, Pfizer, Inc.", "sentB": "Major pharmaceutical or biotechnology companies with approved drugs or drugs in development for breast cancers include, but are not limited to, Bristol-Meyers Squibb Company, Eli Lilly Co., Roche, GlaxoSmithKline plc, Johnson and Johnson, Pfizer Inc., Eisai Inc., and Sanofi Aventis S.A.", "type": 2, "words": ["<tag1>", "Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "these", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Meyers", "Squibb", "Company,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer,", "Inc.", "<tag2>", "Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "breast", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Meyers", "Squibb", "Company,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer", "Inc.,", "Eisai", "Inc.,", "and", "Sanofi", "Aventis", "S.A.", "<tag3>"], "wordsA": ["Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "these", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Meyers", "Squibb", "Company,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer,", "Inc."], "wordsB": ["Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "breast", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Meyers", "Squibb", "Company,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer", "Inc.,", "Eisai", "Inc.,", "and", "Sanofi", "Aventis", "S.A."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p50_s0", "idA": "906709_15_item1a_p48_s3", "sentA": "As a result, our competitors may succeed in developing competing technologies, obtaining regulatory approval or gaining market acceptance for products before we do.", "sentB": "may succeed in developing competing technologies, obtaining regulatory approval or gaining market acceptance for products before we do.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "our", "competitors", "may", "succeed", "in", "developing", "competing", "technologies,", "obtaining", "regulatory", "approval", "or", "gaining", "market", "acceptance", "for", "products", "before", "we", "do.", "<tag2>", "may", "succeed", "in", "developing", "competing", "technologies,", "obtaining", "regulatory", "approval", "or", "gaining", "market", "acceptance", "for", "products", "before", "we", "do.", "<tag3>"], "wordsA": ["As", "a", "result,", "our", "competitors", "may", "succeed", "in", "developing", "competing", "technologies,", "obtaining", "regulatory", "approval", "or", "gaining", "market", "acceptance", "for", "products", "before", "we", "do."], "wordsB": ["may", "succeed", "in", "developing", "competing", "technologies,", "obtaining", "regulatory", "approval", "or", "gaining", "market", "acceptance", "for", "products", "before", "we", "do."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p51_s7", "idA": "906709_15_item1a_p49_s7", "sentA": "Our decision to bear a majority or all of the clinical development costs of etirinotecan pegol substantially increases our future capital requirements.", "sentB": "If we make a decision to bear a majority or all of the clinical development costs of NKTR-102 this will substantially increase our future capital requirements.", "type": 2, "words": ["<tag1>", "Our", "decision", "to", "bear", "a", "majority", "or", "all", "of", "the", "clinical", "development", "costs", "of", "etirinotecan", "pegol", "substantially", "increases", "our", "future", "capital", "requirements.", "<tag2>", "If", "we", "make", "a", "decision", "to", "bear", "a", "majority", "or", "all", "of", "the", "clinical", "development", "costs", "of", "NKTR-102", "this", "will", "substantially", "increase", "our", "future", "capital", "requirements.", "<tag3>"], "wordsA": ["Our", "decision", "to", "bear", "a", "majority", "or", "all", "of", "the", "clinical", "development", "costs", "of", "etirinotecan", "pegol", "substantially", "increases", "our", "future", "capital", "requirements."], "wordsB": ["If", "we", "make", "a", "decision", "to", "bear", "a", "majority", "or", "all", "of", "the", "clinical", "development", "costs", "of", "NKTR-102", "this", "will", "substantially", "increase", "our", "future", "capital", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p4_s0", "idA": "906709_15_item1a_p4_s0", "sentA": "market and sell the drugs when and if they are approved.", "sentB": "marketing and selling the drugs when and if they are approved.", "type": 2, "words": ["<tag1>", "market", "and", "sell", "the", "drugs", "when", "and", "if", "they", "are", "approved.", "<tag2>", "marketing", "and", "selling", "the", "drugs", "when", "and", "if", "they", "are", "approved.", "<tag3>"], "wordsA": ["market", "and", "sell", "the", "drugs", "when", "and", "if", "they", "are", "approved."], "wordsB": ["marketing", "and", "selling", "the", "drugs", "when", "and", "if", "they", "are", "approved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p51_s14", "idA": "906709_15_item1a_p50_s0", "sentA": "within our industry make us particularly dependent upon their continued employment with us.", "sentB": "The relationships that our key managers have cultivated within our industry make us particularly dependent upon their continued employment with us.", "type": 2, "words": ["<tag1>", "within", "our", "industry", "make", "us", "particularly", "dependent", "upon", "their", "continued", "employment", "with", "us.", "<tag2>", "The", "relationships", "that", "our", "key", "managers", "have", "cultivated", "within", "our", "industry", "make", "us", "particularly", "dependent", "upon", "their", "continued", "employment", "with", "us.", "<tag3>"], "wordsA": ["within", "our", "industry", "make", "us", "particularly", "dependent", "upon", "their", "continued", "employment", "with", "us."], "wordsB": ["The", "relationships", "that", "our", "key", "managers", "have", "cultivated", "within", "our", "industry", "make", "us", "particularly", "dependent", "upon", "their", "continued", "employment", "with", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p54_s5", "idA": "906709_15_item1a_p51_s6", "sentA": "During the year ended December 31, 2014, based on closing prices on The NASDAQ Global Select Market, our stock price ranged from $10.53 to $17.05 per share.", "sentB": "During the year ended December 31, 2015, based on closing prices on The NASDAQ Global Select Market, our stock price ranged from $9.50 to $17.41 per share.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2014,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$10.53", "to", "$17.05", "per", "share.", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2015,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$9.50", "to", "$17.41", "per", "share.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2014,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$10.53", "to", "$17.05", "per", "share."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2015,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$9.50", "to", "$17.41", "per", "share."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p56_s1", "idA": "906709_15_item1a_p54_s0", "sentA": "The indenture governing the senior secured notes imposes significant operating and financial restrictions on us and our subsidiaries that may prevent us from pursuing certain business opportunities and restrict our ability to operate our business.", "sentB": "The indenture governing our 7.75% senior secured notes imposes significant operating and financial restrictions on us and our subsidiaries that may prevent us from pursuing certain business opportunities and restrict our ability to operate our business.", "type": 2, "words": ["<tag1>", "The", "indenture", "governing", "the", "senior", "secured", "notes", "imposes", "significant", "operating", "and", "financial", "restrictions", "on", "us", "and", "our", "subsidiaries", "that", "may", "prevent", "us", "from", "pursuing", "certain", "business", "opportunities", "and", "restrict", "our", "ability", "to", "operate", "our", "business.", "<tag2>", "The", "indenture", "governing", "our", "7.75%", "senior", "secured", "notes", "imposes", "significant", "operating", "and", "financial", "restrictions", "on", "us", "and", "our", "subsidiaries", "that", "may", "prevent", "us", "from", "pursuing", "certain", "business", "opportunities", "and", "restrict", "our", "ability", "to", "operate", "our", "business.", "<tag3>"], "wordsA": ["The", "indenture", "governing", "the", "senior", "secured", "notes", "imposes", "significant", "operating", "and", "financial", "restrictions", "on", "us", "and", "our", "subsidiaries", "that", "may", "prevent", "us", "from", "pursuing", "certain", "business", "opportunities", "and", "restrict", "our", "ability", "to", "operate", "our", "business."], "wordsB": ["The", "indenture", "governing", "our", "7.75%", "senior", "secured", "notes", "imposes", "significant", "operating", "and", "financial", "restrictions", "on", "us", "and", "our", "subsidiaries", "that", "may", "prevent", "us", "from", "pursuing", "certain", "business", "opportunities", "and", "restrict", "our", "ability", "to", "operate", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p57_s0", "idA": "906709_15_item1a_p54_s1", "sentA": "The indenture governing the senior secured notes contains covenants that restrict our and our subsidiaries ability to take various actions, such as:", "sentB": "The indenture governing the senior secured notes contains covenants that restrict our and our subsidiaries ability to take various actions, including, among other things:", "type": 2, "words": ["<tag1>", "The", "indenture", "governing", "the", "senior", "secured", "notes", "contains", "covenants", "that", "restrict", "our", "and", "our", "subsidiaries", "ability", "to", "take", "various", "actions,", "such", "as:", "<tag2>", "The", "indenture", "governing", "the", "senior", "secured", "notes", "contains", "covenants", "that", "restrict", "our", "and", "our", "subsidiaries", "ability", "to", "take", "various", "actions,", "including,", "among", "other", "things:", "<tag3>"], "wordsA": ["The", "indenture", "governing", "the", "senior", "secured", "notes", "contains", "covenants", "that", "restrict", "our", "and", "our", "subsidiaries", "ability", "to", "take", "various", "actions,", "such", "as:"], "wordsB": ["The", "indenture", "governing", "the", "senior", "secured", "notes", "contains", "covenants", "that", "restrict", "our", "and", "our", "subsidiaries", "ability", "to", "take", "various", "actions,", "including,", "among", "other", "things:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p58_s0", "idA": "906709_15_item1a_p55_s0", "sentA": "consummate a merger, consolidation, reorganization or business combination, or sell, assign, transfer, lease or otherwise dispose of all or substantially all of our assets.", "sentB": "consummate a merger, consolidation, reorganization or business combination, sell, lease, convey or otherwise dispose of all or substantially all of our assets or other change of control transaction.", "type": 2, "words": ["<tag1>", "consummate", "a", "merger,", "consolidation,", "reorganization", "or", "business", "combination,", "or", "sell,", "assign,", "transfer,", "lease", "or", "otherwise", "dispose", "of", "all", "or", "substantially", "all", "of", "our", "assets.", "<tag2>", "consummate", "a", "merger,", "consolidation,", "reorganization", "or", "business", "combination,", "sell,", "lease,", "convey", "or", "otherwise", "dispose", "of", "all", "or", "substantially", "all", "of", "our", "assets", "or", "other", "change", "of", "control", "transaction.", "<tag3>"], "wordsA": ["consummate", "a", "merger,", "consolidation,", "reorganization", "or", "business", "combination,", "or", "sell,", "assign,", "transfer,", "lease", "or", "otherwise", "dispose", "of", "all", "or", "substantially", "all", "of", "our", "assets."], "wordsB": ["consummate", "a", "merger,", "consolidation,", "reorganization", "or", "business", "combination,", "sell,", "lease,", "convey", "or", "otherwise", "dispose", "of", "all", "or", "substantially", "all", "of", "our", "assets", "or", "other", "change", "of", "control", "transaction."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p59_s0", "idA": "906709_15_item1a_p55_s2", "sentA": "This indenture also requires us not to permit, thereafter and through the quarter ending June 30, 2017, the aggregate balance of our unrestricted cash and cash equivalents at the end of any two consecutive fiscal quarters to be less than $25.0 million, subject to certain conditions.", "sentB": "This indenture also requires us to maintain a minimum cash balance of $60.0 million.", "type": 2, "words": ["<tag1>", "This", "indenture", "also", "requires", "us", "not", "to", "permit,", "thereafter", "and", "through", "the", "quarter", "ending", "June", "30,", "2017,", "the", "aggregate", "balance", "of", "our", "unrestricted", "cash", "and", "cash", "equivalents", "at", "the", "end", "of", "any", "two", "consecutive", "fiscal", "quarters", "to", "be", "less", "than", "$25.0", "million,", "subject", "to", "certain", "conditions.", "<tag2>", "This", "indenture", "also", "requires", "us", "to", "maintain", "a", "minimum", "cash", "balance", "of", "$60.0", "million.", "<tag3>"], "wordsA": ["This", "indenture", "also", "requires", "us", "not", "to", "permit,", "thereafter", "and", "through", "the", "quarter", "ending", "June", "30,", "2017,", "the", "aggregate", "balance", "of", "our", "unrestricted", "cash", "and", "cash", "equivalents", "at", "the", "end", "of", "any", "two", "consecutive", "fiscal", "quarters", "to", "be", "less", "than", "$25.0", "million,", "subject", "to", "certain", "conditions."], "wordsB": ["This", "indenture", "also", "requires", "us", "to", "maintain", "a", "minimum", "cash", "balance", "of", "$60.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p61_s2", "idA": "906709_15_item1a_p55_s4", "sentA": "Our failure to comply with our debt-related obligations could result in an event of default under our other indebtedness and the acceleration of our other indebtedness, in whole or in part, could result in an event of default under the indenture governing the senior secured notes.", "sentB": "Our failure to comply with our obligations could result in an event of default under our other indebtedness and the acceleration of our other indebtedness, in whole or in part, could result in an event of default under the indenture governing the senior secured notes.", "type": 2, "words": ["<tag1>", "Our", "failure", "to", "comply", "with", "our", "debt-related", "obligations", "could", "result", "in", "an", "event", "of", "default", "under", "our", "other", "indebtedness", "and", "the", "acceleration", "of", "our", "other", "indebtedness,", "in", "whole", "or", "in", "part,", "could", "result", "in", "an", "event", "of", "default", "under", "the", "indenture", "governing", "the", "senior", "secured", "notes.", "<tag2>", "Our", "failure", "to", "comply", "with", "our", "obligations", "could", "result", "in", "an", "event", "of", "default", "under", "our", "other", "indebtedness", "and", "the", "acceleration", "of", "our", "other", "indebtedness,", "in", "whole", "or", "in", "part,", "could", "result", "in", "an", "event", "of", "default", "under", "the", "indenture", "governing", "the", "senior", "secured", "notes.", "<tag3>"], "wordsA": ["Our", "failure", "to", "comply", "with", "our", "debt-related", "obligations", "could", "result", "in", "an", "event", "of", "default", "under", "our", "other", "indebtedness", "and", "the", "acceleration", "of", "our", "other", "indebtedness,", "in", "whole", "or", "in", "part,", "could", "result", "in", "an", "event", "of", "default", "under", "the", "indenture", "governing", "the", "senior", "secured", "notes."], "wordsB": ["Our", "failure", "to", "comply", "with", "our", "obligations", "could", "result", "in", "an", "event", "of", "default", "under", "our", "other", "indebtedness", "and", "the", "acceleration", "of", "our", "other", "indebtedness,", "in", "whole", "or", "in", "part,", "could", "result", "in", "an", "event", "of", "default", "under", "the", "indenture", "governing", "the", "senior", "secured", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p7_s0", "idA": "906709_15_item1a_p6_s1", "sentA": "Given these risks, the success of our current and future collaboration partnerships is highly unpredictable and can have a substantial negative or positive impact on our business in particular, we expect the commercial outcomes of MOVANTIK , and if approved, BAX 855, to have a particularly significant impact on our near to mid- term financial results and financial condition.", "sentB": "Given these risks, the success of our current and future collaboration partnerships is highly unpredictable and can have a substantial negative or positive impact on our business in particular, we expect the commercial outcomes of MOVANTIK and ADYNOVATE TM (previously referred to as BAX 855) to have a particularly significant impact on our near to mid- term financial results and financial condition.", "type": 2, "words": ["<tag1>", "Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business", "in", "particular,", "we", "expect", "the", "commercial", "outcomes", "of", "MOVANTIK", ",", "and", "if", "approved,", "BAX", "855,", "to", "have", "a", "particularly", "significant", "impact", "on", "our", "near", "to", "mid-", "term", "financial", "results", "and", "financial", "condition.", "<tag2>", "Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business", "in", "particular,", "we", "expect", "the", "commercial", "outcomes", "of", "MOVANTIK", "and", "ADYNOVATE", "TM", "(previously", "referred", "to", "as", "BAX", "855)", "to", "have", "a", "particularly", "significant", "impact", "on", "our", "near", "to", "mid-", "term", "financial", "results", "and", "financial", "condition.", "<tag3>"], "wordsA": ["Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business", "in", "particular,", "we", "expect", "the", "commercial", "outcomes", "of", "MOVANTIK", ",", "and", "if", "approved,", "BAX", "855,", "to", "have", "a", "particularly", "significant", "impact", "on", "our", "near", "to", "mid-", "term", "financial", "results", "and", "financial", "condition."], "wordsB": ["Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business", "in", "particular,", "we", "expect", "the", "commercial", "outcomes", "of", "MOVANTIK", "and", "ADYNOVATE", "TM", "(previously", "referred", "to", "as", "BAX", "855)", "to", "have", "a", "particularly", "significant", "impact", "on", "our", "near", "to", "mid-", "term", "financial", "results", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p19_s3", "idA": "906709_15_item1a_p7_s1", "sentA": "If the market size for a new drug is significantly smaller than we anticipate, it could significantly and negatively impact our revenue, results of operations and financial condition.", "sentB": "Poor performance by these companies, or disputes with these companies, could negatively impact our revenue and financial condition.", "type": 2, "words": ["<tag1>", "If", "the", "market", "size", "for", "a", "new", "drug", "is", "significantly", "smaller", "than", "we", "anticipate,", "it", "could", "significantly", "and", "negatively", "impact", "our", "revenue,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Poor", "performance", "by", "these", "companies,", "or", "disputes", "with", "these", "companies,", "could", "negatively", "impact", "our", "revenue", "and", "financial", "condition.", "<tag3>"], "wordsA": ["If", "the", "market", "size", "for", "a", "new", "drug", "is", "significantly", "smaller", "than", "we", "anticipate,", "it", "could", "significantly", "and", "negatively", "impact", "our", "revenue,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Poor", "performance", "by", "these", "companies,", "or", "disputes", "with", "these", "companies,", "could", "negatively", "impact", "our", "revenue", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item1a_p19_s0", "idA": "906709_15_item1a_p8_s0", "sentA": "It is very difficult to estimate the commercial potential of product candidates due to important factors such as safety and efficacy compared to other available treatments, including potential generic drug alternatives with similar efficacy profiles, changing standards of care, third party payer reimbursement standards, patient and physician preferences, drug scheduling status, the availability of competitive alternatives that may emerge either during the long drug development process or after commercial introduction, and the availability of generic versions of our successful product candidates following approval by government health authorities based on the expiration of regulatory exclusivity or our inability to prevent generic versions from coming to market by asserting our patents.", "sentB": "It is very difficult to estimate the commercial potential of product candidates due to important factors such as safety and efficacy compared to other available treatments, including potential generic drug alternatives with similar efficacy profiles, changing standards of care, third party payer reimbursement standards, patient and physician preferences, drug scheduling status, the availability of competitive alternatives that may emerge either during the long drug development process or after commercial introduction, and the availability of generic versions of our product candidates following approval by regulatory authorities based on the expiration of regulatory exclusivity or our inability to prevent generic versions from coming to market by asserting our patents.", "type": 2, "words": ["<tag1>", "It", "is", "very", "difficult", "to", "estimate", "the", "commercial", "potential", "of", "product", "candidates", "due", "to", "important", "factors", "such", "as", "safety", "and", "efficacy", "compared", "to", "other", "available", "treatments,", "including", "potential", "generic", "drug", "alternatives", "with", "similar", "efficacy", "profiles,", "changing", "standards", "of", "care,", "third", "party", "payer", "reimbursement", "standards,", "patient", "and", "physician", "preferences,", "drug", "scheduling", "status,", "the", "availability", "of", "competitive", "alternatives", "that", "may", "emerge", "either", "during", "the", "long", "drug", "development", "process", "or", "after", "commercial", "introduction,", "and", "the", "availability", "of", "generic", "versions", "of", "our", "successful", "product", "candidates", "following", "approval", "by", "government", "health", "authorities", "based", "on", "the", "expiration", "of", "regulatory", "exclusivity", "or", "our", "inability", "to", "prevent", "generic", "versions", "from", "coming", "to", "market", "by", "asserting", "our", "patents.", "<tag2>", "It", "is", "very", "difficult", "to", "estimate", "the", "commercial", "potential", "of", "product", "candidates", "due", "to", "important", "factors", "such", "as", "safety", "and", "efficacy", "compared", "to", "other", "available", "treatments,", "including", "potential", "generic", "drug", "alternatives", "with", "similar", "efficacy", "profiles,", "changing", "standards", "of", "care,", "third", "party", "payer", "reimbursement", "standards,", "patient", "and", "physician", "preferences,", "drug", "scheduling", "status,", "the", "availability", "of", "competitive", "alternatives", "that", "may", "emerge", "either", "during", "the", "long", "drug", "development", "process", "or", "after", "commercial", "introduction,", "and", "the", "availability", "of", "generic", "versions", "of", "our", "product", "candidates", "following", "approval", "by", "regulatory", "authorities", "based", "on", "the", "expiration", "of", "regulatory", "exclusivity", "or", "our", "inability", "to", "prevent", "generic", "versions", "from", "coming", "to", "market", "by", "asserting", "our", "patents.", "<tag3>"], "wordsA": ["It", "is", "very", "difficult", "to", "estimate", "the", "commercial", "potential", "of", "product", "candidates", "due", "to", "important", "factors", "such", "as", "safety", "and", "efficacy", "compared", "to", "other", "available", "treatments,", "including", "potential", "generic", "drug", "alternatives", "with", "similar", "efficacy", "profiles,", "changing", "standards", "of", "care,", "third", "party", "payer", "reimbursement", "standards,", "patient", "and", "physician", "preferences,", "drug", "scheduling", "status,", "the", "availability", "of", "competitive", "alternatives", "that", "may", "emerge", "either", "during", "the", "long", "drug", "development", "process", "or", "after", "commercial", "introduction,", "and", "the", "availability", "of", "generic", "versions", "of", "our", "successful", "product", "candidates", "following", "approval", "by", "government", "health", "authorities", "based", "on", "the", "expiration", "of", "regulatory", "exclusivity", "or", "our", "inability", "to", "prevent", "generic", "versions", "from", "coming", "to", "market", "by", "asserting", "our", "patents."], "wordsB": ["It", "is", "very", "difficult", "to", "estimate", "the", "commercial", "potential", "of", "product", "candidates", "due", "to", "important", "factors", "such", "as", "safety", "and", "efficacy", "compared", "to", "other", "available", "treatments,", "including", "potential", "generic", "drug", "alternatives", "with", "similar", "efficacy", "profiles,", "changing", "standards", "of", "care,", "third", "party", "payer", "reimbursement", "standards,", "patient", "and", "physician", "preferences,", "drug", "scheduling", "status,", "the", "availability", "of", "competitive", "alternatives", "that", "may", "emerge", "either", "during", "the", "long", "drug", "development", "process", "or", "after", "commercial", "introduction,", "and", "the", "availability", "of", "generic", "versions", "of", "our", "product", "candidates", "following", "approval", "by", "regulatory", "authorities", "based", "on", "the", "expiration", "of", "regulatory", "exclusivity", "or", "our", "inability", "to", "prevent", "generic", "versions", "from", "coming", "to", "market", "by", "asserting", "our", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p10_s0", "idA": "906709_16_item1a_p10_s1", "sentA": "Each of these agreements contains complex representations and warranties, covenants and indemnification obligations.", "sentB": "We are a party to numerous significant collaboration agreements and other strategic transaction agreements (e.g., financings and asset divestitures) that contain complex representations and warranties, covenants and indemnification obligations.", "type": 2, "words": ["<tag1>", "Each", "of", "these", "agreements", "contains", "complex", "representations", "and", "warranties,", "covenants", "and", "indemnification", "obligations.", "<tag2>", "We", "are", "a", "party", "to", "numerous", "significant", "collaboration", "agreements", "and", "other", "strategic", "transaction", "agreements", "(e.g.,", "financings", "and", "asset", "divestitures)", "that", "contain", "complex", "representations", "and", "warranties,", "covenants", "and", "indemnification", "obligations.", "<tag3>"], "wordsA": ["Each", "of", "these", "agreements", "contains", "complex", "representations", "and", "warranties,", "covenants", "and", "indemnification", "obligations."], "wordsB": ["We", "are", "a", "party", "to", "numerous", "significant", "collaboration", "agreements", "and", "other", "strategic", "transaction", "agreements", "(e.g.,", "financings", "and", "asset", "divestitures)", "that", "contain", "complex", "representations", "and", "warranties,", "covenants", "and", "indemnification", "obligations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p10_s1", "idA": "906709_16_item1a_p11_s0", "sentA": "If we breach any of our agreements with Novartis, AstraZeneca, RPI or any other third party agreements, it could subject us to substantial liabilities and harm our financial condition.", "sentB": "If we are found to have materially breached such agreements, it could subject us to substantial liabilities and harm our financial condition.", "type": 2, "words": ["<tag1>", "If", "we", "breach", "any", "of", "our", "agreements", "with", "Novartis,", "AstraZeneca,", "RPI", "or", "any", "other", "third", "party", "agreements,", "it", "could", "subject", "us", "to", "substantial", "liabilities", "and", "harm", "our", "financial", "condition.", "<tag2>", "If", "we", "are", "found", "to", "have", "materially", "breached", "such", "agreements,", "it", "could", "subject", "us", "to", "substantial", "liabilities", "and", "harm", "our", "financial", "condition.", "<tag3>"], "wordsA": ["If", "we", "breach", "any", "of", "our", "agreements", "with", "Novartis,", "AstraZeneca,", "RPI", "or", "any", "other", "third", "party", "agreements,", "it", "could", "subject", "us", "to", "substantial", "liabilities", "and", "harm", "our", "financial", "condition."], "wordsB": ["If", "we", "are", "found", "to", "have", "materially", "breached", "such", "agreements,", "it", "could", "subject", "us", "to", "substantial", "liabilities", "and", "harm", "our", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p11_s0", "idA": "906709_16_item1a_p12_s0", "sentA": "From time to time, we have informal dispute resolution discussions with third parties regarding the appropriate interpretation of the complex commercial terms contained in our agreements.", "sentB": "From time to time, we are involved in litigation matters involving the interpretation and application of complex terms and conditions of our agreements.", "type": 2, "words": ["<tag1>", "From", "time", "to", "time,", "we", "have", "informal", "dispute", "resolution", "discussions", "with", "third", "parties", "regarding", "the", "appropriate", "interpretation", "of", "the", "complex", "commercial", "terms", "contained", "in", "our", "agreements.", "<tag2>", "From", "time", "to", "time,", "we", "are", "involved", "in", "litigation", "matters", "involving", "the", "interpretation", "and", "application", "of", "complex", "terms", "and", "conditions", "of", "our", "agreements.", "<tag3>"], "wordsA": ["From", "time", "to", "time,", "we", "have", "informal", "dispute", "resolution", "discussions", "with", "third", "parties", "regarding", "the", "appropriate", "interpretation", "of", "the", "complex", "commercial", "terms", "contained", "in", "our", "agreements."], "wordsB": ["From", "time", "to", "time,", "we", "are", "involved", "in", "litigation", "matters", "involving", "the", "interpretation", "and", "application", "of", "complex", "terms", "and", "conditions", "of", "our", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p11_s1", "idA": "906709_16_item1a_p12_s1", "sentA": "For example, in 2015 we filed a lawsuit against Allergan and MAP seeking economic damages related to a dispute over the economic sharing provisions of our license agreement with MAP.", "sentB": "For example, in February 2015 we filed a claim against Allergan and MAP seeking monetary damages re lated to a dispute over the economic sharing provisions of our collaboration agreement with MAP.", "type": 2, "words": ["<tag1>", "For", "example,", "in", "2015", "we", "filed", "a", "lawsuit", "against", "Allergan", "and", "MAP", "seeking", "economic", "damages", "related", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "license", "agreement", "with", "MAP.", "<tag2>", "For", "example,", "in", "February", "2015", "we", "filed", "a", "claim", "against", "Allergan", "and", "MAP", "seeking", "monetary", "damages", "re", "lated", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "collaboration", "agreement", "with", "MAP.", "<tag3>"], "wordsA": ["For", "example,", "in", "2015", "we", "filed", "a", "lawsuit", "against", "Allergan", "and", "MAP", "seeking", "economic", "damages", "related", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "license", "agreement", "with", "MAP."], "wordsB": ["For", "example,", "in", "February", "2015", "we", "filed", "a", "claim", "against", "Allergan", "and", "MAP", "seeking", "monetary", "damages", "re", "lated", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "collaboration", "agreement", "with", "MAP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p43_s5", "idA": "906709_16_item1a_p12_s1", "sentA": "For example, in 2015 we filed a lawsuit against Allergan and MAP seeking economic damages related to a dispute over the economic sharing provisions of our license agreement with MAP.", "sentB": "For example, President Trump has indicated support for possible new measures related to drug pricing.", "type": 2, "words": ["<tag1>", "For", "example,", "in", "2015", "we", "filed", "a", "lawsuit", "against", "Allergan", "and", "MAP", "seeking", "economic", "damages", "related", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "license", "agreement", "with", "MAP.", "<tag2>", "For", "example,", "President", "Trump", "has", "indicated", "support", "for", "possible", "new", "measures", "related", "to", "drug", "pricing.", "<tag3>"], "wordsA": ["For", "example,", "in", "2015", "we", "filed", "a", "lawsuit", "against", "Allergan", "and", "MAP", "seeking", "economic", "damages", "related", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "license", "agreement", "with", "MAP."], "wordsB": ["For", "example,", "President", "Trump", "has", "indicated", "support", "for", "possible", "new", "measures", "related", "to", "drug", "pricing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p13_s1", "idA": "906709_16_item1a_p12_s2", "sentA": "One or more disputes may arise or escalate in the future regarding our collaboration agreements, transaction documents, or third-party license agreements that may ultimately result in costly litigation and unfavorable interpretation of contract terms, which would have a material adverse effect on our business, financial condition and results of operations.", "sentB": "One or more disputes may arise or escalate in the future regarding our collaboration agreements, transaction documents, or thi rd-party license agreements that may ultimately result in costly litigation and unfavorable interpretation of contract terms, which would have a material adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "One", "or", "more", "disputes", "may", "arise", "or", "escalate", "in", "the", "future", "regarding", "our", "collaboration", "agreements,", "transaction", "documents,", "or", "third-party", "license", "agreements", "that", "may", "ultimately", "result", "in", "costly", "litigation", "and", "unfavorable", "interpretation", "of", "contract", "terms,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "One", "or", "more", "disputes", "may", "arise", "or", "escalate", "in", "the", "future", "regarding", "our", "collaboration", "agreements,", "transaction", "documents,", "or", "thi", "rd-party", "license", "agreements", "that", "may", "ultimately", "result", "in", "costly", "litigation", "and", "unfavorable", "interpretation", "of", "contract", "terms,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["One", "or", "more", "disputes", "may", "arise", "or", "escalate", "in", "the", "future", "regarding", "our", "collaboration", "agreements,", "transaction", "documents,", "or", "third-party", "license", "agreements", "that", "may", "ultimately", "result", "in", "costly", "litigation", "and", "unfavorable", "interpretation", "of", "contract", "terms,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["One", "or", "more", "disputes", "may", "arise", "or", "escalate", "in", "the", "future", "regarding", "our", "collaboration", "agreements,", "transaction", "documents,", "or", "thi", "rd-party", "license", "agreements", "that", "may", "ultimately", "result", "in", "costly", "litigation", "and", "unfavorable", "interpretation", "of", "contract", "terms,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p14_s6", "idA": "906709_16_item1a_p14_s6", "sentA": "For example, AstraZeneca will be conducting a post-marketing, observational epidemiological study comparing MOVANTIK TM to other treatments of OIC in patients with chronic, non-cancer pain and the results of this study could at some point in the future negatively impact the labeling, regulatory status, and commercial potential of MOVANTIK TM .", "sentB": "For example, AstraZeneca will be conducting a post-marketing, observational epidemiological study comparing MOVANTIK to other treatments of OIC in patients with chronic, non-cancer pain and the results of this study could at some point in the future negatively impact the labeling, regulatory status, and commercial potential of MOVANTIK .", "type": 2, "words": ["<tag1>", "For", "example,", "AstraZeneca", "will", "be", "conducting", "a", "post-marketing,", "observational", "epidemiological", "study", "comparing", "MOVANTIK", "TM", "to", "other", "treatments", "of", "OIC", "in", "patients", "with", "chronic,", "non-cancer", "pain", "and", "the", "results", "of", "this", "study", "could", "at", "some", "point", "in", "the", "future", "negatively", "impact", "the", "labeling,", "regulatory", "status,", "and", "commercial", "potential", "of", "MOVANTIK", "TM", ".", "<tag2>", "For", "example,", "AstraZeneca", "will", "be", "conducting", "a", "post-marketing,", "observational", "epidemiological", "study", "comparing", "MOVANTIK", "to", "other", "treatments", "of", "OIC", "in", "patients", "with", "chronic,", "non-cancer", "pain", "and", "the", "results", "of", "this", "study", "could", "at", "some", "point", "in", "the", "future", "negatively", "impact", "the", "labeling,", "regulatory", "status,", "and", "commercial", "potential", "of", "MOVANTIK", ".", "<tag3>"], "wordsA": ["For", "example,", "AstraZeneca", "will", "be", "conducting", "a", "post-marketing,", "observational", "epidemiological", "study", "comparing", "MOVANTIK", "TM", "to", "other", "treatments", "of", "OIC", "in", "patients", "with", "chronic,", "non-cancer", "pain", "and", "the", "results", "of", "this", "study", "could", "at", "some", "point", "in", "the", "future", "negatively", "impact", "the", "labeling,", "regulatory", "status,", "and", "commercial", "potential", "of", "MOVANTIK", "TM", "."], "wordsB": ["For", "example,", "AstraZeneca", "will", "be", "conducting", "a", "post-marketing,", "observational", "epidemiological", "study", "comparing", "MOVANTIK", "to", "other", "treatments", "of", "OIC", "in", "patients", "with", "chronic,", "non-cancer", "pain", "and", "the", "results", "of", "this", "study", "could", "at", "some", "point", "in", "the", "future", "negatively", "impact", "the", "labeling,", "regulatory", "status,", "and", "commercial", "potential", "of", "MOVANTIK", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p15_s6", "idA": "906709_16_item1a_p15_s6", "sentA": "As of December 31, 2015, we had cash and investments in marketable securities valued at approximately $308.9 million.", "sentB": "As of December 31, 2016, we had cash and investments in marketable securities valued at approximately $389.1 million.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2015,", "we", "had", "cash", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$308.9", "million.", "<tag2>", "As", "of", "December", "31,", "2016,", "we", "had", "cash", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$389.1", "million.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2015,", "we", "had", "cash", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$308.9", "million."], "wordsB": ["As", "of", "December", "31,", "2016,", "we", "had", "cash", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$389.1", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p15_s7", "idA": "906709_16_item1a_p15_s7", "sentA": "Also, as of December 31, 2015, we had $255.8 million in debt, including $250.0 million in principal of senior secured notes and $5.8 million of capital lease obligations.", "sentB": "Also, as of December 31, 2016, we had $255.1 million in debt, including $250.0 million in principal of senior secured notes and $5.1 million of capital lease obligations.", "type": 2, "words": ["<tag1>", "Also,", "as", "of", "December", "31,", "2015,", "we", "had", "$255.8", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.8", "million", "of", "capital", "lease", "obligations.", "<tag2>", "Also,", "as", "of", "December", "31,", "2016,", "we", "had", "$255.1", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.1", "million", "of", "capital", "lease", "obligations.", "<tag3>"], "wordsA": ["Also,", "as", "of", "December", "31,", "2015,", "we", "had", "$255.8", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.8", "million", "of", "capital", "lease", "obligations."], "wordsB": ["Also,", "as", "of", "December", "31,", "2016,", "we", "had", "$255.1", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.1", "million", "of", "capital", "lease", "obligations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p17_s0", "idA": "906709_16_item1a_p17_s0", "sentA": "A significant multi-year capital commitment is required to advance our drug candidates through the various stages of research and development in order to generate suffic ient data to enable high value collaboration partnerships with significant upfront payments or to successfully achieve regulatory approval.", "sentB": "A significant multi-year capital commitment is required to advance our drug candidates through the various stages of research and development in order to generate sufficient data to enable high value collaboration partnerships with significant upfront payments or to successfully achieve regulatory approval.", "type": 2, "words": ["<tag1>", "A", "significant", "multi-year", "capital", "commitment", "is", "required", "to", "advance", "our", "drug", "candidates", "through", "the", "various", "stages", "of", "research", "and", "development", "in", "order", "to", "generate", "suffic", "ient", "data", "to", "enable", "high", "value", "collaboration", "partnerships", "with", "significant", "upfront", "payments", "or", "to", "successfully", "achieve", "regulatory", "approval.", "<tag2>", "A", "significant", "multi-year", "capital", "commitment", "is", "required", "to", "advance", "our", "drug", "candidates", "through", "the", "various", "stages", "of", "research", "and", "development", "in", "order", "to", "generate", "sufficient", "data", "to", "enable", "high", "value", "collaboration", "partnerships", "with", "significant", "upfront", "payments", "or", "to", "successfully", "achieve", "regulatory", "approval.", "<tag3>"], "wordsA": ["A", "significant", "multi-year", "capital", "commitment", "is", "required", "to", "advance", "our", "drug", "candidates", "through", "the", "various", "stages", "of", "research", "and", "development", "in", "order", "to", "generate", "suffic", "ient", "data", "to", "enable", "high", "value", "collaboration", "partnerships", "with", "significant", "upfront", "payments", "or", "to", "successfully", "achieve", "regulatory", "approval."], "wordsB": ["A", "significant", "multi-year", "capital", "commitment", "is", "required", "to", "advance", "our", "drug", "candidates", "through", "the", "various", "stages", "of", "research", "and", "development", "in", "order", "to", "generate", "sufficient", "data", "to", "enable", "high", "value", "collaboration", "partnerships", "with", "significant", "upfront", "payments", "or", "to", "successfully", "achieve", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p17_s2", "idA": "906709_16_item1a_p17_s2", "sentA": "If sufficient capital is not available to us or is not available on commercially reasonable terms, it could require us to delay or reduce one or more of o ur research and development programs.", "sentB": "If sufficient capital is not available to us or is not available on commercially reasonable terms, it could require us to delay or reduce one or more of our research and development programs.", "type": 2, "words": ["<tag1>", "If", "sufficient", "capital", "is", "not", "available", "to", "us", "or", "is", "not", "available", "on", "commercially", "reasonable", "terms,", "it", "could", "require", "us", "to", "delay", "or", "reduce", "one", "or", "more", "of", "o", "ur", "research", "and", "development", "programs.", "<tag2>", "If", "sufficient", "capital", "is", "not", "available", "to", "us", "or", "is", "not", "available", "on", "commercially", "reasonable", "terms,", "it", "could", "require", "us", "to", "delay", "or", "reduce", "one", "or", "more", "of", "our", "research", "and", "development", "programs.", "<tag3>"], "wordsA": ["If", "sufficient", "capital", "is", "not", "available", "to", "us", "or", "is", "not", "available", "on", "commercially", "reasonable", "terms,", "it", "could", "require", "us", "to", "delay", "or", "reduce", "one", "or", "more", "of", "o", "ur", "research", "and", "development", "programs."], "wordsB": ["If", "sufficient", "capital", "is", "not", "available", "to", "us", "or", "is", "not", "available", "on", "commercially", "reasonable", "terms,", "it", "could", "require", "us", "to", "delay", "or", "reduce", "one", "or", "more", "of", "our", "research", "and", "development", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p20_s0", "idA": "906709_16_item1a_p19_s7", "sentA": "If we are unable to find suitable partners or negotiate collaboration arrangements with favorable commercial terms with respect to our existing and future drug candidates or the licensing of our intellectual property, or if any arrangements we negotiate, or have negotiated, are terminated, it could have a material adverse effect on our business, financial condition and results of operations.", "sentB": "terms with respect to our exis ting and future drug candidates or the licensing of our intellectual property, or if any arrangements we negotiate, or have negotiated, are terminated, it could have a material adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "If", "we", "are", "unable", "to", "find", "suitable", "partners", "or", "negotiate", "collaboration", "arrangements", "with", "favorable", "commercial", "terms", "with", "respect", "to", "our", "existing", "and", "future", "drug", "candidates", "or", "the", "licensing", "of", "our", "intellectual", "property,", "or", "if", "any", "arrangements", "we", "negotiate,", "or", "have", "negotiated,", "are", "terminated,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "terms", "with", "respect", "to", "our", "exis", "ting", "and", "future", "drug", "candidates", "or", "the", "licensing", "of", "our", "intellectual", "property,", "or", "if", "any", "arrangements", "we", "negotiate,", "or", "have", "negotiated,", "are", "terminated,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["If", "we", "are", "unable", "to", "find", "suitable", "partners", "or", "negotiate", "collaboration", "arrangements", "with", "favorable", "commercial", "terms", "with", "respect", "to", "our", "existing", "and", "future", "drug", "candidates", "or", "the", "licensing", "of", "our", "intellectual", "property,", "or", "if", "any", "arrangements", "we", "negotiate,", "or", "have", "negotiated,", "are", "terminated,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["terms", "with", "respect", "to", "our", "exis", "ting", "and", "future", "drug", "candidates", "or", "the", "licensing", "of", "our", "intellectual", "property,", "or", "if", "any", "arrangements", "we", "negotiate,", "or", "have", "negotiated,", "are", "terminated,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p21_s2", "idA": "906709_16_item1a_p21_s0", "sentA": "patient enrollment continues and more patient data become available.", "sentB": "Interim data are also subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available.", "type": 2, "words": ["<tag1>", "patient", "enrollment", "continues", "and", "more", "patient", "data", "become", "available.", "<tag2>", "Interim", "data", "are", "also", "subject", "to", "the", "risk", "that", "one", "or", "more", "of", "the", "clinical", "outcomes", "may", "materially", "change", "as", "patient", "enrollment", "continues", "and", "more", "patient", "data", "become", "available.", "<tag3>"], "wordsA": ["patient", "enrollment", "continues", "and", "more", "patient", "data", "become", "available."], "wordsB": ["Interim", "data", "are", "also", "subject", "to", "the", "risk", "that", "one", "or", "more", "of", "the", "clinical", "outcomes", "may", "materially", "change", "as", "patient", "enrollment", "continues", "and", "more", "patient", "data", "become", "available."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p21_s8", "idA": "906709_16_item1a_p21_s6", "sentA": "In addition, our collaboration partners have several ongoing Phase 3 clinical programs including Baxalta for ADYNOVATE TM (previously referred to as BAX 855), Bayer for Amikacin Inhale and CIPRO Inhale, and Ophthotech for Fovista .", "sentB": "In addition, our collaboration partners have several ongoing Phase 3 clinical programs including Baxalta for ADYNOVATE (previously referred to as BAX 855) in the EU, Bayer for Amikacin Inhale and CIPRO Inhale, and Ophthotech for Fovista .", "type": 2, "words": ["<tag1>", "In", "addition,", "our", "collaboration", "partners", "have", "several", "ongoing", "Phase", "3", "clinical", "programs", "including", "Baxalta", "for", "ADYNOVATE", "TM", "(previously", "referred", "to", "as", "BAX", "855),", "Bayer", "for", "Amikacin", "Inhale", "and", "CIPRO", "Inhale,", "and", "Ophthotech", "for", "Fovista", ".", "<tag2>", "In", "addition,", "our", "collaboration", "partners", "have", "several", "ongoing", "Phase", "3", "clinical", "programs", "including", "Baxalta", "for", "ADYNOVATE", "(previously", "referred", "to", "as", "BAX", "855)", "in", "the", "EU,", "Bayer", "for", "Amikacin", "Inhale", "and", "CIPRO", "Inhale,", "and", "Ophthotech", "for", "Fovista", ".", "<tag3>"], "wordsA": ["In", "addition,", "our", "collaboration", "partners", "have", "several", "ongoing", "Phase", "3", "clinical", "programs", "including", "Baxalta", "for", "ADYNOVATE", "TM", "(previously", "referred", "to", "as", "BAX", "855),", "Bayer", "for", "Amikacin", "Inhale", "and", "CIPRO", "Inhale,", "and", "Ophthotech", "for", "Fovista", "."], "wordsB": ["In", "addition,", "our", "collaboration", "partners", "have", "several", "ongoing", "Phase", "3", "clinical", "programs", "including", "Baxalta", "for", "ADYNOVATE", "(previously", "referred", "to", "as", "BAX", "855)", "in", "the", "EU,", "Bayer", "for", "Amikacin", "Inhale", "and", "CIPRO", "Inhale,", "and", "Ophthotech", "for", "Fovista", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p54_s3", "idA": "906709_16_item1a_p21_s8", "sentA": "Clinical trials for any of our product candidates could be delayed for a variety of reasons, including:", "sentB": "For instance, the loss of preclinical data or data from any future clinical trial involving our product candidates could result in delays in our development and regulatory filing efforts and significantly increase our costs.", "type": 2, "words": ["<tag1>", "Clinical", "trials", "for", "any", "of", "our", "product", "candidates", "could", "be", "delayed", "for", "a", "variety", "of", "reasons,", "including:", "<tag2>", "For", "instance,", "the", "loss", "of", "preclinical", "data", "or", "data", "from", "any", "future", "clinical", "trial", "involving", "our", "product", "candidates", "could", "result", "in", "delays", "in", "our", "development", "and", "regulatory", "filing", "efforts", "and", "significantly", "increase", "our", "costs.", "<tag3>"], "wordsA": ["Clinical", "trials", "for", "any", "of", "our", "product", "candidates", "could", "be", "delayed", "for", "a", "variety", "of", "reasons,", "including:"], "wordsB": ["For", "instance,", "the", "loss", "of", "preclinical", "data", "or", "data", "from", "any", "future", "clinical", "trial", "involving", "our", "product", "candidates", "could", "result", "in", "delays", "in", "our", "development", "and", "regulatory", "filing", "efforts", "and", "significantly", "increase", "our", "costs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p54_s4", "idA": "906709_16_item1a_p21_s8", "sentA": "Clinical trials for any of our product candidates could be delayed for a variety of reasons, including:", "sentB": "To the extent that any disruption or security breach were to result in a loss of, or damage to, our data, or inappropriate disclosure of confidential or proprietary information of our company or clinical patients, we could incur liability and the development of our product candidates could be delayed.", "type": 2, "words": ["<tag1>", "Clinical", "trials", "for", "any", "of", "our", "product", "candidates", "could", "be", "delayed", "for", "a", "variety", "of", "reasons,", "including:", "<tag2>", "To", "the", "extent", "that", "any", "disruption", "or", "security", "breach", "were", "to", "result", "in", "a", "loss", "of,", "or", "damage", "to,", "our", "data,", "or", "inappropriate", "disclosure", "of", "confidential", "or", "proprietary", "information", "of", "our", "company", "or", "clinical", "patients,", "we", "could", "incur", "liability", "and", "the", "development", "of", "our", "product", "candidates", "could", "be", "delayed.", "<tag3>"], "wordsA": ["Clinical", "trials", "for", "any", "of", "our", "product", "candidates", "could", "be", "delayed", "for", "a", "variety", "of", "reasons,", "including:"], "wordsB": ["To", "the", "extent", "that", "any", "disruption", "or", "security", "breach", "were", "to", "result", "in", "a", "loss", "of,", "or", "damage", "to,", "our", "data,", "or", "inappropriate", "disclosure", "of", "confidential", "or", "proprietary", "information", "of", "our", "company", "or", "clinical", "patients,", "we", "could", "incur", "liability", "and", "the", "development", "of", "our", "product", "candidates", "could", "be", "delayed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p26_s5", "idA": "906709_16_item1a_p25_s5", "sentA": "Further, o ur competitors may be able to circumvent and otherwise design around our patents.", "sentB": "Further, our competitors may be able to circumvent and otherwise design around our patents.", "type": 2, "words": ["<tag1>", "Further,", "o", "ur", "competitors", "may", "be", "able", "to", "circumvent", "and", "otherwise", "design", "around", "our", "patents.", "<tag2>", "Further,", "our", "competitors", "may", "be", "able", "to", "circumvent", "and", "otherwise", "design", "around", "our", "patents.", "<tag3>"], "wordsA": ["Further,", "o", "ur", "competitors", "may", "be", "able", "to", "circumvent", "and", "otherwise", "design", "around", "our", "patents."], "wordsB": ["Further,", "our", "competitors", "may", "be", "able", "to", "circumvent", "and", "otherwise", "design", "around", "our", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p26_s6", "idA": "906709_16_item1a_p26_s0", "sentA": "substantial delays, patents may expire earl y and provide only a short period of protection, if any, following the commercialization of products encompassed by our patents.", "sentB": "Even if a patent is issued and enforceable, because development and commercialization of pharmaceutical products can be subject to substantial delays, patents may expire early and provide only a short period of protection, if any, following the commercialization of products encompassed by our patents.", "type": 2, "words": ["<tag1>", "substantial", "delays,", "patents", "may", "expire", "earl", "y", "and", "provide", "only", "a", "short", "period", "of", "protection,", "if", "any,", "following", "the", "commercialization", "of", "products", "encompassed", "by", "our", "patents.", "<tag2>", "Even", "if", "a", "patent", "is", "issued", "and", "enforceable,", "because", "development", "and", "commercialization", "of", "pharmaceutical", "products", "can", "be", "subject", "to", "substantial", "delays,", "patents", "may", "expire", "early", "and", "provide", "only", "a", "short", "period", "of", "protection,", "if", "any,", "following", "the", "commercialization", "of", "products", "encompassed", "by", "our", "patents.", "<tag3>"], "wordsA": ["substantial", "delays,", "patents", "may", "expire", "earl", "y", "and", "provide", "only", "a", "short", "period", "of", "protection,", "if", "any,", "following", "the", "commercialization", "of", "products", "encompassed", "by", "our", "patents."], "wordsB": ["Even", "if", "a", "patent", "is", "issued", "and", "enforceable,", "because", "development", "and", "commercialization", "of", "pharmaceutical", "products", "can", "be", "subject", "to", "substantial", "delays,", "patents", "may", "expire", "early", "and", "provide", "only", "a", "short", "period", "of", "protection,", "if", "any,", "following", "the", "commercialization", "of", "products", "encompassed", "by", "our", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p54_s0", "idA": "906709_16_item1a_p26_s1", "sentA": "We may have to participate in interference proceedings declared by the U.S. Patent and Trademark Office, which could result in a loss of the patent and/or substantial cost to us.", "sentB": "Our internal computer systems, or those of our CROs or other contractors or consultants, may fail or suffer security breaches, which could result in a material disruption of our product development programs or the theft of our confidential information or patient confidential information.", "type": 2, "words": ["<tag1>", "We", "may", "have", "to", "participate", "in", "interference", "proceedings", "declared", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "which", "could", "result", "in", "a", "loss", "of", "the", "patent", "and/or", "substantial", "cost", "to", "us.", "<tag2>", "Our", "internal", "computer", "systems,", "or", "those", "of", "our", "CROs", "or", "other", "contractors", "or", "consultants,", "may", "fail", "or", "suffer", "security", "breaches,", "which", "could", "result", "in", "a", "material", "disruption", "of", "our", "product", "development", "programs", "or", "the", "theft", "of", "our", "confidential", "information", "or", "patient", "confidential", "information.", "<tag3>"], "wordsA": ["We", "may", "have", "to", "participate", "in", "interference", "proceedings", "declared", "by", "the", "U.S.", "Patent", "and", "Trademark", "Office,", "which", "could", "result", "in", "a", "loss", "of", "the", "patent", "and/or", "substantial", "cost", "to", "us."], "wordsB": ["Our", "internal", "computer", "systems,", "or", "those", "of", "our", "CROs", "or", "other", "contractors", "or", "consultants,", "may", "fail", "or", "suffer", "security", "breaches,", "which", "could", "result", "in", "a", "material", "disruption", "of", "our", "product", "development", "programs", "or", "the", "theft", "of", "our", "confidential", "information", "or", "patient", "confidential", "information."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p31_s3", "idA": "906709_16_item1a_p29_s1", "sentA": "If a third party obtains injunctive or other equitable relief against us or our partners, they could effectively prevent us, or our partners, from developing or commercializing, or deriving revenue from, certain drugs or drug candidates in the U.S. and abroad.", "sentB": "In addition, Bayer has filed a claim in the U.S. against Baxalta and Nektar in which Bayer alleges ADYNOVATE infringes a Bayer patent.", "type": 2, "words": ["<tag1>", "If", "a", "third", "party", "obtains", "injunctive", "or", "other", "equitable", "relief", "against", "us", "or", "our", "partners,", "they", "could", "effectively", "prevent", "us,", "or", "our", "partners,", "from", "developing", "or", "commercializing,", "or", "deriving", "revenue", "from,", "certain", "drugs", "or", "drug", "candidates", "in", "the", "U.S.", "and", "abroad.", "<tag2>", "In", "addition,", "Bayer", "has", "filed", "a", "claim", "in", "the", "U.S.", "against", "Baxalta", "and", "Nektar", "in", "which", "Bayer", "alleges", "ADYNOVATE", "infringes", "a", "Bayer", "patent.", "<tag3>"], "wordsA": ["If", "a", "third", "party", "obtains", "injunctive", "or", "other", "equitable", "relief", "against", "us", "or", "our", "partners,", "they", "could", "effectively", "prevent", "us,", "or", "our", "partners,", "from", "developing", "or", "commercializing,", "or", "deriving", "revenue", "from,", "certain", "drugs", "or", "drug", "candidates", "in", "the", "U.S.", "and", "abroad."], "wordsB": ["In", "addition,", "Bayer", "has", "filed", "a", "claim", "in", "the", "U.S.", "against", "Baxalta", "and", "Nektar", "in", "which", "Bayer", "alleges", "ADYNOVATE", "infringes", "a", "Bayer", "patent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p13_s0", "idA": "906709_16_item1a_p29_s5", "sentA": "In December 2013, we entered into a litigation settlement with the Research Foundation of the State University of New York (SUNY) pursuant to which we agreed to pay $12.0 million and certain other terms and conditions in exchange for the full release of certain breach of contract claims by SUNY.", "sentB": "In 2013, we settled a breach of contract litigation matter with the Research Foundation of the State University of New York (SUNY) pursuant to which we paid an aggregate of $12.0 million.", "type": 2, "words": ["<tag1>", "In", "December", "2013,", "we", "entered", "into", "a", "litigation", "settlement", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "pursuant", "to", "which", "we", "agreed", "to", "pay", "$12.0", "million", "and", "certain", "other", "terms", "and", "conditions", "in", "exchange", "for", "the", "full", "release", "of", "certain", "breach", "of", "contract", "claims", "by", "SUNY.", "<tag2>", "In", "2013,", "we", "settled", "a", "breach", "of", "contract", "litigation", "matter", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "pursuant", "to", "which", "we", "paid", "an", "aggregate", "of", "$12.0", "million.", "<tag3>"], "wordsA": ["In", "December", "2013,", "we", "entered", "into", "a", "litigation", "settlement", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "pursuant", "to", "which", "we", "agreed", "to", "pay", "$12.0", "million", "and", "certain", "other", "terms", "and", "conditions", "in", "exchange", "for", "the", "full", "release", "of", "certain", "breach", "of", "contract", "claims", "by", "SUNY."], "wordsB": ["In", "2013,", "we", "settled", "a", "breach", "of", "contract", "litigation", "matter", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "(SUNY)", "pursuant", "to", "which", "we", "paid", "an", "aggregate", "of", "$12.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p30_s0", "idA": "906709_16_item1a_p29_s6", "sentA": "In addition, from time to time, we are involved in legal proceedings where we or other third parties are enforcing or seeking intellectual property rights, invalidating or limiting patent rights that have already been allowed or issued, or otherwise asserting proprietary rights through one or more potential legal remedies.", "sentB": "We are involved in legal proceedings where we or other third parties are enforcing or seeking intellectual property rights, invalidating or limiting patent rights that have already been allowed or issued, or otherwise asserting proprietary rights through one or more potential legal remedies.", "type": 2, "words": ["<tag1>", "In", "addition,", "from", "time", "to", "time,", "we", "are", "involved", "in", "legal", "proceedings", "where", "we", "or", "other", "third", "parties", "are", "enforcing", "or", "seeking", "intellectual", "property", "rights,", "invalidating", "or", "limiting", "patent", "rights", "that", "have", "already", "been", "allowed", "or", "issued,", "or", "otherwise", "asserting", "proprietary", "rights", "through", "one", "or", "more", "potential", "legal", "remedies.", "<tag2>", "We", "are", "involved", "in", "legal", "proceedings", "where", "we", "or", "other", "third", "parties", "are", "enforcing", "or", "seeking", "intellectual", "property", "rights,", "invalidating", "or", "limiting", "patent", "rights", "that", "have", "already", "been", "allowed", "or", "issued,", "or", "otherwise", "asserting", "proprietary", "rights", "through", "one", "or", "more", "potential", "legal", "remedies.", "<tag3>"], "wordsA": ["In", "addition,", "from", "time", "to", "time,", "we", "are", "involved", "in", "legal", "proceedings", "where", "we", "or", "other", "third", "parties", "are", "enforcing", "or", "seeking", "intellectual", "property", "rights,", "invalidating", "or", "limiting", "patent", "rights", "that", "have", "already", "been", "allowed", "or", "issued,", "or", "otherwise", "asserting", "proprietary", "rights", "through", "one", "or", "more", "potential", "legal", "remedies."], "wordsB": ["We", "are", "involved", "in", "legal", "proceedings", "where", "we", "or", "other", "third", "parties", "are", "enforcing", "or", "seeking", "intellectual", "property", "rights,", "invalidating", "or", "limiting", "patent", "rights", "that", "have", "already", "been", "allowed", "or", "issued,", "or", "otherwise", "asserting", "proprietary", "rights", "through", "one", "or", "more", "potential", "legal", "remedies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p2_s7", "idA": "906709_16_item1a_p2_s7", "sentA": "The risk of failure increases for our drug candidates that are based on new technologies, such as the application of our advanced polymer conjugate technology to NKTR-102, NKTR-181, NKTR-214 and other drug candidates currently in discovery research or preclinical development.", "sentB": "The risk of failure increases for our drug candidates that are based on new technologies, such as the application of our advanced polymer conjugate technology to ONZEALD TM , NKTR-181, NKTR-214 and other drug candidates currently in discovery research or preclinical development.", "type": 2, "words": ["<tag1>", "The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "NKTR-102,", "NKTR-181,", "NKTR-214", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development.", "<tag2>", "The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "ONZEALD", "TM", ",", "NKTR-181,", "NKTR-214", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development.", "<tag3>"], "wordsA": ["The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "NKTR-102,", "NKTR-181,", "NKTR-214", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development."], "wordsB": ["The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "ONZEALD", "TM", ",", "NKTR-181,", "NKTR-214", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p54_s2", "idA": "906709_16_item1a_p2_s9", "sentA": "The failure of one or more of our drug candidates could have a material adverse effect on our business, financial condition and results of operations.", "sentB": "Such events could cause interruptions of our operations.", "type": 2, "words": ["<tag1>", "The", "failure", "of", "one", "or", "more", "of", "our", "drug", "candidates", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "Such", "events", "could", "cause", "interruptions", "of", "our", "operations.", "<tag3>"], "wordsA": ["The", "failure", "of", "one", "or", "more", "of", "our", "drug", "candidates", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["Such", "events", "could", "cause", "interruptions", "of", "our", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p32_s0", "idA": "906709_16_item1a_p30_s8", "sentA": "Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could delay our research and development efforts or result in financial implications either in terms of seeking license arrangements or payment of damages or royalties.", "sentB": "patent litigation or other proceedings could delay our research and development efforts or result in financial implications either in terms of seeking license arrangements or payment of damages or royalties.", "type": 2, "words": ["<tag1>", "Uncertainties", "resulting", "from", "the", "initiation", "and", "continuation", "of", "patent", "litigation", "or", "other", "proceedings", "could", "delay", "our", "research", "and", "development", "efforts", "or", "result", "in", "financial", "implications", "either", "in", "terms", "of", "seeking", "license", "arrangements", "or", "payment", "of", "damages", "or", "royalties.", "<tag2>", "patent", "litigation", "or", "other", "proceedings", "could", "delay", "our", "research", "and", "development", "efforts", "or", "result", "in", "financial", "implications", "either", "in", "terms", "of", "seeking", "license", "arrangements", "or", "payment", "of", "damages", "or", "royalties.", "<tag3>"], "wordsA": ["Uncertainties", "resulting", "from", "the", "initiation", "and", "continuation", "of", "patent", "litigation", "or", "other", "proceedings", "could", "delay", "our", "research", "and", "development", "efforts", "or", "result", "in", "financial", "implications", "either", "in", "terms", "of", "seeking", "license", "arrangements", "or", "payment", "of", "damages", "or", "royalties."], "wordsB": ["patent", "litigation", "or", "other", "proceedings", "could", "delay", "our", "research", "and", "development", "efforts", "or", "result", "in", "financial", "implications", "either", "in", "terms", "of", "seeking", "license", "arrangements", "or", "payment", "of", "damages", "or", "royalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p32_s1", "idA": "906709_16_item1a_p31_s0", "sentA": "Our manufacturing operations and those of our contract manufacturers are subject to laws and other governmental regulatory requirements, which, if not met, would have a material adverse effect on our business, results of operations and financial condi tion.", "sentB": "Our manufacturing operations and those of our contract manufacturers are subject to laws and other governmental regulatory requirements, which, if not met, would have a material adverse effect on our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "Our", "manufacturing", "operations", "and", "those", "of", "our", "contract", "manufacturers", "are", "subject", "to", "laws", "and", "other", "governmental", "regulatory", "requirements,", "which,", "if", "not", "met,", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condi", "tion.", "<tag2>", "Our", "manufacturing", "operations", "and", "those", "of", "our", "contract", "manufacturers", "are", "subject", "to", "laws", "and", "other", "governmental", "regulatory", "requirements,", "which,", "if", "not", "met,", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["Our", "manufacturing", "operations", "and", "those", "of", "our", "contract", "manufacturers", "are", "subject", "to", "laws", "and", "other", "governmental", "regulatory", "requirements,", "which,", "if", "not", "met,", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condi", "tion."], "wordsB": ["Our", "manufacturing", "operations", "and", "those", "of", "our", "contract", "manufacturers", "are", "subject", "to", "laws", "and", "other", "governmental", "regulatory", "requirements,", "which,", "if", "not", "met,", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p54_s1", "idA": "906709_16_item1a_p31_s0", "sentA": "Our manufacturing operations and those of our contract manufacturers are subject to laws and other governmental regulatory requirements, which, if not met, would have a material adverse effect on our business, results of operations and financial condi tion.", "sentB": "Despite the implementation of security measures, our internal computer systems and those of our CROs and other contractors and consultants are vulnerable to damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures.", "type": 2, "words": ["<tag1>", "Our", "manufacturing", "operations", "and", "those", "of", "our", "contract", "manufacturers", "are", "subject", "to", "laws", "and", "other", "governmental", "regulatory", "requirements,", "which,", "if", "not", "met,", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condi", "tion.", "<tag2>", "Despite", "the", "implementation", "of", "security", "measures,", "our", "internal", "computer", "systems", "and", "those", "of", "our", "CROs", "and", "other", "contractors", "and", "consultants", "are", "vulnerable", "to", "damage", "from", "computer", "viruses,", "unauthorized", "access,", "natural", "disasters,", "terrorism,", "war", "and", "telecommunication", "and", "electrical", "failures.", "<tag3>"], "wordsA": ["Our", "manufacturing", "operations", "and", "those", "of", "our", "contract", "manufacturers", "are", "subject", "to", "laws", "and", "other", "governmental", "regulatory", "requirements,", "which,", "if", "not", "met,", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condi", "tion."], "wordsB": ["Despite", "the", "implementation", "of", "security", "measures,", "our", "internal", "computer", "systems", "and", "those", "of", "our", "CROs", "and", "other", "contractors", "and", "consultants", "are", "vulnerable", "to", "damage", "from", "computer", "viruses,", "unauthorized", "access,", "natural", "disasters,", "terrorism,", "war", "and", "telecommunication", "and", "electrical", "failures."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p37_s0", "idA": "906709_16_item1a_p36_s0", "sentA": "Our revenue is exclusively derived from our collaboration agreements, which can result in significant fluctuation in our revenue from period to period, and our past revenue is therefore not necessarily indicative of our future revenue.", "sentB": "Our revenue is exclusively derived from our collaboration agreements, which can result in significant fluctuation in our revenue from period to period, and our past revenue is theref ore not necessarily indicative of our future revenue.", "type": 2, "words": ["<tag1>", "Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "which", "can", "result", "in", "significant", "fluctuation", "in", "our", "revenue", "from", "period", "to", "period,", "and", "our", "past", "revenue", "is", "therefore", "not", "necessarily", "indicative", "of", "our", "future", "revenue.", "<tag2>", "Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "which", "can", "result", "in", "significant", "fluctuation", "in", "our", "revenue", "from", "period", "to", "period,", "and", "our", "past", "revenue", "is", "theref", "ore", "not", "necessarily", "indicative", "of", "our", "future", "revenue.", "<tag3>"], "wordsA": ["Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "which", "can", "result", "in", "significant", "fluctuation", "in", "our", "revenue", "from", "period", "to", "period,", "and", "our", "past", "revenue", "is", "therefore", "not", "necessarily", "indicative", "of", "our", "future", "revenue."], "wordsB": ["Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "which", "can", "result", "in", "significant", "fluctuation", "in", "our", "revenue", "from", "period", "to", "period,", "and", "our", "past", "revenue", "is", "theref", "ore", "not", "necessarily", "indicative", "of", "our", "future", "revenue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p39_s2", "idA": "906709_16_item1a_p38_s2", "sentA": "To the extent that we enter into co-promotion or other arrangements, any revenue we receive will depend upon the efforts of third parties, which may not be successful and over which we have little or no control important examples of this risk include MOVANTIK partnered with AstraZeneca and ADYNOVATE TM (previously referred to as BAX 855) partnered with Baxalta.", "sentB": "To the extent that we enter into co-promotion or other arrangements, any revenue we receive will depend upon the efforts of third parties, which may not be successful and over which we have little or no control important examples of this risk include MOVANTIK partnered with AstraZeneca and ADYNOVATE (previously referred to as BAX 855) partnered with Baxalta.", "type": 2, "words": ["<tag1>", "To", "the", "extent", "that", "we", "enter", "into", "co-promotion", "or", "other", "arrangements,", "any", "revenue", "we", "receive", "will", "depend", "upon", "the", "efforts", "of", "third", "parties,", "which", "may", "not", "be", "successful", "and", "over", "which", "we", "have", "little", "or", "no", "control", "important", "examples", "of", "this", "risk", "include", "MOVANTIK", "partnered", "with", "AstraZeneca", "and", "ADYNOVATE", "TM", "(previously", "referred", "to", "as", "BAX", "855)", "partnered", "with", "Baxalta.", "<tag2>", "To", "the", "extent", "that", "we", "enter", "into", "co-promotion", "or", "other", "arrangements,", "any", "revenue", "we", "receive", "will", "depend", "upon", "the", "efforts", "of", "third", "parties,", "which", "may", "not", "be", "successful", "and", "over", "which", "we", "have", "little", "or", "no", "control", "important", "examples", "of", "this", "risk", "include", "MOVANTIK", "partnered", "with", "AstraZeneca", "and", "ADYNOVATE", "(previously", "referred", "to", "as", "BAX", "855)", "partnered", "with", "Baxalta.", "<tag3>"], "wordsA": ["To", "the", "extent", "that", "we", "enter", "into", "co-promotion", "or", "other", "arrangements,", "any", "revenue", "we", "receive", "will", "depend", "upon", "the", "efforts", "of", "third", "parties,", "which", "may", "not", "be", "successful", "and", "over", "which", "we", "have", "little", "or", "no", "control", "important", "examples", "of", "this", "risk", "include", "MOVANTIK", "partnered", "with", "AstraZeneca", "and", "ADYNOVATE", "TM", "(previously", "referred", "to", "as", "BAX", "855)", "partnered", "with", "Baxalta."], "wordsB": ["To", "the", "extent", "that", "we", "enter", "into", "co-promotion", "or", "other", "arrangements,", "any", "revenue", "we", "receive", "will", "depend", "upon", "the", "efforts", "of", "third", "parties,", "which", "may", "not", "be", "successful", "and", "over", "which", "we", "have", "little", "or", "no", "control", "important", "examples", "of", "this", "risk", "include", "MOVANTIK", "partnered", "with", "AstraZeneca", "and", "ADYNOVATE", "(previously", "referred", "to", "as", "BAX", "855)", "partnered", "with", "Baxalta."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p39_s6", "idA": "906709_16_item1a_p38_s6", "sentA": "For example, there are only a limited number of qualified suppliers, and in some cases single source suppliers, for the raw materials included in our PEGylation and advanced polymer conjugate drug formulations.", "sentB": "For example, there are only a limited number of qualified suppliers, and in some cases single source suppliers, for the raw materials included in our advanced polymer conjugate drug formulations.", "type": 2, "words": ["<tag1>", "For", "example,", "there", "are", "only", "a", "limited", "number", "of", "qualified", "suppliers,", "and", "in", "some", "cases", "single", "source", "suppliers,", "for", "the", "raw", "materials", "included", "in", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "drug", "formulations.", "<tag2>", "For", "example,", "there", "are", "only", "a", "limited", "number", "of", "qualified", "suppliers,", "and", "in", "some", "cases", "single", "source", "suppliers,", "for", "the", "raw", "materials", "included", "in", "our", "advanced", "polymer", "conjugate", "drug", "formulations.", "<tag3>"], "wordsA": ["For", "example,", "there", "are", "only", "a", "limited", "number", "of", "qualified", "suppliers,", "and", "in", "some", "cases", "single", "source", "suppliers,", "for", "the", "raw", "materials", "included", "in", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "drug", "formulations."], "wordsB": ["For", "example,", "there", "are", "only", "a", "limited", "number", "of", "qualified", "suppliers,", "and", "in", "some", "cases", "single", "source", "suppliers,", "for", "the", "raw", "materials", "included", "in", "our", "advanced", "polymer", "conjugate", "drug", "formulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p40_s0", "idA": "906709_16_item1a_p39_s0", "sentA": "We rely on trade secret protection and other unpatented proprietary r ights for important proprietary technologies, and any loss of such rights could harm our business, results of operations and financial condition.", "sentB": "We rely on trade secret protection and other unpatented proprietary rights for important proprietary technologies, and any loss of such rights could harm our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "r", "ights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "r", "ights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["We", "rely", "on", "trade", "secret", "protection", "and", "other", "unpatented", "proprietary", "rights", "for", "important", "proprietary", "technologies,", "and", "any", "loss", "of", "such", "rights", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p40_s6", "idA": "906709_16_item1a_p39_s6", "sentA": "For the year ended December 31, 2015, we reported a net loss of $81.2 million.", "sentB": "For the year ended December 31, 2016, we reported a net loss of $153.5 million.", "type": 2, "words": ["<tag1>", "For", "the", "year", "ended", "December", "31,", "2015,", "we", "reported", "a", "net", "loss", "of", "$81.2", "million.", "<tag2>", "For", "the", "year", "ended", "December", "31,", "2016,", "we", "reported", "a", "net", "loss", "of", "$153.5", "million.", "<tag3>"], "wordsA": ["For", "the", "year", "ended", "December", "31,", "2015,", "we", "reported", "a", "net", "loss", "of", "$81.2", "million."], "wordsB": ["For", "the", "year", "ended", "December", "31,", "2016,", "we", "reported", "a", "net", "loss", "of", "$153.5", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p44_s0", "idA": "906709_16_item1a_p42_s5", "sentA": "A government or third-party payer decision not to approve pricing for, or provide adequate coverage and reimbursements of, our products would limit market acceptance of such products.", "sentB": "New government legislation or regulations related to pricing or a government or third-party payer decision not to approve pricing for, or provide adequate coverage and reimbursements of, our products hold the potential to severely limit market opportunities of such products.", "type": 2, "words": ["<tag1>", "A", "government", "or", "third-party", "payer", "decision", "not", "to", "approve", "pricing", "for,", "or", "provide", "adequate", "coverage", "and", "reimbursements", "of,", "our", "products", "would", "limit", "market", "acceptance", "of", "such", "products.", "<tag2>", "New", "government", "legislation", "or", "regulations", "related", "to", "pricing", "or", "a", "government", "or", "third-party", "payer", "decision", "not", "to", "approve", "pricing", "for,", "or", "provide", "adequate", "coverage", "and", "reimbursements", "of,", "our", "products", "hold", "the", "potential", "to", "severely", "limit", "market", "opportunities", "of", "such", "products.", "<tag3>"], "wordsA": ["A", "government", "or", "third-party", "payer", "decision", "not", "to", "approve", "pricing", "for,", "or", "provide", "adequate", "coverage", "and", "reimbursements", "of,", "our", "products", "would", "limit", "market", "acceptance", "of", "such", "products."], "wordsB": ["New", "government", "legislation", "or", "regulations", "related", "to", "pricing", "or", "a", "government", "or", "third-party", "payer", "decision", "not", "to", "approve", "pricing", "for,", "or", "provide", "adequate", "coverage", "and", "reimbursements", "of,", "our", "products", "hold", "the", "potential", "to", "severely", "limit", "market", "opportunities", "of", "such", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p45_s0", "idA": "906709_16_item1a_p43_s0", "sentA": "We depend on third parties to conduct the clinical trials for our proprietary product candidates and any failure of those parties to fulfill their obligations could harm our development and commercialization plans.", "sentB": "We depend on third parties to conduct the clinical trials for our proprietary product candidates and any failure of those parties to fulfill their obl igations could harm our development and commercialization plans.", "type": 2, "words": ["<tag1>", "We", "depend", "on", "third", "parties", "to", "conduct", "the", "clinical", "trials", "for", "our", "proprietary", "product", "candidates", "and", "any", "failure", "of", "those", "parties", "to", "fulfill", "their", "obligations", "could", "harm", "our", "development", "and", "commercialization", "plans.", "<tag2>", "We", "depend", "on", "third", "parties", "to", "conduct", "the", "clinical", "trials", "for", "our", "proprietary", "product", "candidates", "and", "any", "failure", "of", "those", "parties", "to", "fulfill", "their", "obl", "igations", "could", "harm", "our", "development", "and", "commercialization", "plans.", "<tag3>"], "wordsA": ["We", "depend", "on", "third", "parties", "to", "conduct", "the", "clinical", "trials", "for", "our", "proprietary", "product", "candidates", "and", "any", "failure", "of", "those", "parties", "to", "fulfill", "their", "obligations", "could", "harm", "our", "development", "and", "commercialization", "plans."], "wordsB": ["We", "depend", "on", "third", "parties", "to", "conduct", "the", "clinical", "trials", "for", "our", "proprietary", "product", "candidates", "and", "any", "failure", "of", "those", "parties", "to", "fulfill", "their", "obl", "igations", "could", "harm", "our", "development", "and", "commercialization", "plans."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p46_s0", "idA": "906709_16_item1a_p44_s0", "sentA": "Our PEGylation and advanced polymer conjugate chemistry platforms and our partnered and proprietary products and product candidates compete with various pharmaceutical and biotechnology companies.", "sentB": "Our advanced polymer conjugate chemistry platforms and our partnered and proprietary products and product candidates compete with various pharmaceutical and biotechnology companies.", "type": 2, "words": ["<tag1>", "Our", "PEGylation", "and", "advanced", "polymer", "conjugate", "chemistry", "platforms", "and", "our", "partnered", "and", "proprietary", "products", "and", "product", "candidates", "compete", "with", "various", "pharmaceutical", "and", "biotechnology", "companies.", "<tag2>", "Our", "advanced", "polymer", "conjugate", "chemistry", "platforms", "and", "our", "partnered", "and", "proprietary", "products", "and", "product", "candidates", "compete", "with", "various", "pharmaceutical", "and", "biotechnology", "companies.", "<tag3>"], "wordsA": ["Our", "PEGylation", "and", "advanced", "polymer", "conjugate", "chemistry", "platforms", "and", "our", "partnered", "and", "proprietary", "products", "and", "product", "candidates", "compete", "with", "various", "pharmaceutical", "and", "biotechnology", "companies."], "wordsB": ["Our", "advanced", "polymer", "conjugate", "chemistry", "platforms", "and", "our", "partnered", "and", "proprietary", "products", "and", "product", "candidates", "compete", "with", "various", "pharmaceutical", "and", "biotechnology", "companies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p46_s1", "idA": "906709_16_item1a_p44_s1", "sentA": "Competitors of our PEGylation and polymer conjugate chemistry technologies include Biogen Inc., Savient Pharmaceuticals, Inc., Dr. Reddy s Laboratories Ltd., SunBio Corporation, Mountain View Pharmaceuticals, Inc., Novo Nordisk A/S (formerly assets held by Neose Technologies, Inc.), and NOF Corporation.", "sentB": "Competitors of our polymer conjugate chemistry technologies include Biogen Inc., Savient Pharmaceuticals, Inc., Dr. Reddy s Laboratories Ltd., SunBio Corporation, Mountain View Pharmaceuticals, Inc., Novo Nordisk A/S (formerly assets held by Neose Technologies, Inc.), and NOF Corporation.", "type": 2, "words": ["<tag1>", "Competitors", "of", "our", "PEGylation", "and", "polymer", "conjugate", "chemistry", "technologies", "include", "Biogen", "Inc.,", "Savient", "Pharmaceuticals,", "Inc.,", "Dr.", "Reddy", "s", "Laboratories", "Ltd.,", "SunBio", "Corporation,", "Mountain", "View", "Pharmaceuticals,", "Inc.,", "Novo", "Nordisk", "A/S", "(formerly", "assets", "held", "by", "Neose", "Technologies,", "Inc.),", "and", "NOF", "Corporation.", "<tag2>", "Competitors", "of", "our", "polymer", "conjugate", "chemistry", "technologies", "include", "Biogen", "Inc.,", "Savient", "Pharmaceuticals,", "Inc.,", "Dr.", "Reddy", "s", "Laboratories", "Ltd.,", "SunBio", "Corporation,", "Mountain", "View", "Pharmaceuticals,", "Inc.,", "Novo", "Nordisk", "A/S", "(formerly", "assets", "held", "by", "Neose", "Technologies,", "Inc.),", "and", "NOF", "Corporation.", "<tag3>"], "wordsA": ["Competitors", "of", "our", "PEGylation", "and", "polymer", "conjugate", "chemistry", "technologies", "include", "Biogen", "Inc.,", "Savient", "Pharmaceuticals,", "Inc.,", "Dr.", "Reddy", "s", "Laboratories", "Ltd.,", "SunBio", "Corporation,", "Mountain", "View", "Pharmaceuticals,", "Inc.,", "Novo", "Nordisk", "A/S", "(formerly", "assets", "held", "by", "Neose", "Technologies,", "Inc.),", "and", "NOF", "Corporation."], "wordsB": ["Competitors", "of", "our", "polymer", "conjugate", "chemistry", "technologies", "include", "Biogen", "Inc.,", "Savient", "Pharmaceuticals,", "Inc.,", "Dr.", "Reddy", "s", "Laboratories", "Ltd.,", "SunBio", "Corporation,", "Mountain", "View", "Pharmaceuticals,", "Inc.,", "Novo", "Nordisk", "A/S", "(formerly", "assets", "held", "by", "Neose", "Technologies,", "Inc.),", "and", "NOF", "Corporation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p46_s2", "idA": "906709_16_item1a_p44_s2", "sentA": "Several other chemical, biotechnology and pharmaceutical companies may also be developing PEGylation technologies or technologies that have similar impact on target drug molecules.", "sentB": "Several other chemical, biotechnology and pharmaceutical companies may also be developing polymer conjugation technologies or technologies that have similar impact on target drug molecules.", "type": 2, "words": ["<tag1>", "Several", "other", "chemical,", "biotechnology", "and", "pharmaceutical", "companies", "may", "also", "be", "developing", "PEGylation", "technologies", "or", "technologies", "that", "have", "similar", "impact", "on", "target", "drug", "molecules.", "<tag2>", "Several", "other", "chemical,", "biotechnology", "and", "pharmaceutical", "companies", "may", "also", "be", "developing", "polymer", "conjugation", "technologies", "or", "technologies", "that", "have", "similar", "impact", "on", "target", "drug", "molecules.", "<tag3>"], "wordsA": ["Several", "other", "chemical,", "biotechnology", "and", "pharmaceutical", "companies", "may", "also", "be", "developing", "PEGylation", "technologies", "or", "technologies", "that", "have", "similar", "impact", "on", "target", "drug", "molecules."], "wordsB": ["Several", "other", "chemical,", "biotechnology", "and", "pharmaceutical", "companies", "may", "also", "be", "developing", "polymer", "conjugation", "technologies", "or", "technologies", "that", "have", "similar", "impact", "on", "target", "drug", "molecules."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p48_s1", "idA": "906709_16_item1a_p46_s1", "sentA": "Subcutaneous Injection, oral Amitizia (lubiprostone), and oral and rectal over-the-counter laxatives and stool softeners such as docusate sodium, senna and milk of magnesia.", "sentB": "For MOVANTIK , there are currently several alternative therapies used to address opioid-induced constipation (OIC) and opioid-induced bowel dysfunction (OBD), including RELISTOR Subcutaneous Injection (methylnaltrexone bromide), oral therapy Amitizia (lubiprostone), and oral and rectal over-the-counter laxatives and stool softeners such as docusate sodium, senna and milk of magnesia.", "type": 2, "words": ["<tag1>", "Subcutaneous", "Injection,", "oral", "Amitizia", "(lubiprostone),", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia.", "<tag2>", "For", "MOVANTIK", ",", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "RELISTOR", "Subcutaneous", "Injection", "(methylnaltrexone", "bromide),", "oral", "therapy", "Amitizia", "(lubiprostone),", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia.", "<tag3>"], "wordsA": ["Subcutaneous", "Injection,", "oral", "Amitizia", "(lubiprostone),", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia."], "wordsB": ["For", "MOVANTIK", ",", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "RELISTOR", "Subcutaneous", "Injection", "(methylnaltrexone", "bromide),", "oral", "therapy", "Amitizia", "(lubiprostone),", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p48_s2", "idA": "906709_16_item1a_p47_s0", "sentA": "In addition, there are a number of companies developing potential products which are in various stages of clinical development and are being evaluated for the treatment of OIC and OBD in different patient populations, including Merck Co., Inc., Progenics Pharmaceuticals, Inc. in collaboration with Salix Pharmaceuticals, Ltd., Mundipharma Int.", "sentB": "In addition, there are a number of companies developing potential products which are in various stages of clinical development and are being evaluated for the treatment of OIC and OBD in different patient populations, including Merck Co., Inc., Progenics Pharmaceuticals, Inc. in collaboration with Salix Pharmaceuticals, Ltd., Purdue Pharma L.P. in collaboration with Shionogi Co., Ltd., Mundipharma Int.", "type": 2, "words": ["<tag1>", "In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Merck", "Co.,", "Inc.,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Mundipharma", "Int.", "<tag2>", "In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Merck", "Co.,", "Inc.,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Purdue", "Pharma", "L.P.", "in", "collaboration", "with", "Shionogi", "Co.,", "Ltd.,", "Mundipharma", "Int.", "<tag3>"], "wordsA": ["In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Merck", "Co.,", "Inc.,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Mundipharma", "Int."], "wordsB": ["In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Merck", "Co.,", "Inc.,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Purdue", "Pharma", "L.P.", "in", "collaboration", "with", "Shionogi", "Co.,", "Ltd.,", "Mundipharma", "Int."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p49_s1", "idA": "906709_16_item1a_p47_s1", "sentA": "Limited, Sucampo Pharmaceuticals, Inc., Develco Pharma GmbH, Alkermes plc, GlaxoSmithKline plc, Theravance, Inc., and Takeda Pharmaceutical Company Limited.", "sentB": "Potential competitors include Acura Pharmaceuticals, Inc., Cara Therapeutics, Inc., Collegium Pharmaceutical, Inc., Egalet Ltd, Elite Pharmaceuticals, Inc., Endo Health Solutions Inc., KemPharm, Inc., Pfizer, Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Ltd.", "type": 2, "words": ["<tag1>", "Limited,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Develco", "Pharma", "GmbH,", "Alkermes", "plc,", "GlaxoSmithKline", "plc,", "Theravance,", "Inc.,", "and", "Takeda", "Pharmaceutical", "Company", "Limited.", "<tag2>", "Potential", "competitors", "include", "Acura", "Pharmaceuticals,", "Inc.,", "Cara", "Therapeutics,", "Inc.,", "Collegium", "Pharmaceutical,", "Inc.,", "Egalet", "Ltd,", "Elite", "Pharmaceuticals,", "Inc.,", "Endo", "Health", "Solutions", "Inc.,", "KemPharm,", "Inc.,", "Pfizer,", "Inc.,", "Purdue", "Pharma", "L.P.,", "and", "Teva", "Pharmaceutical", "Industries", "Ltd.", "<tag3>"], "wordsA": ["Limited,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Develco", "Pharma", "GmbH,", "Alkermes", "plc,", "GlaxoSmithKline", "plc,", "Theravance,", "Inc.,", "and", "Takeda", "Pharmaceutical", "Company", "Limited."], "wordsB": ["Potential", "competitors", "include", "Acura", "Pharmaceuticals,", "Inc.,", "Cara", "Therapeutics,", "Inc.,", "Collegium", "Pharmaceutical,", "Inc.,", "Egalet", "Ltd,", "Elite", "Pharmaceuticals,", "Inc.,", "Endo", "Health", "Solutions", "Inc.,", "KemPharm,", "Inc.,", "Pfizer,", "Inc.,", "Purdue", "Pharma", "L.P.,", "and", "Teva", "Pharmaceutical", "Industries", "Ltd."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p48_s4", "idA": "906709_16_item1a_p47_s2", "sentA": "For ADYNOVATE TM , on June 6, 2014, the FDA approved Biogen Idec s ELOCTATE for the control and prevention of bleeding episodes, perioperative (surgical) management and routine prophylaxis in adults and children with Hemophilia A, and Bayer Healthcare and Novo Nordisk have ongoing Phase 3 clinical development programs for longer acting Factor VIII proteins based on pegylation technology approaches.", "sentB": "For ADYNOVATE , on June 6, 2014, the FDA approved Biogen Idec s ELOCTATE for the control and prevention of bleeding episodes, perioperative (surgical) management and routine prophylaxis in adults and children with Hemophilia A, and Bayer Healthcare and Novo Nordisk have ongoing Phase 3 clinical development programs for longer acting Factor VIII proteins based on polymer conjugation technology approaches.", "type": 2, "words": ["<tag1>", "For", "ADYNOVATE", "TM", ",", "on", "June", "6,", "2014,", "the", "FDA", "approved", "Biogen", "Idec", "s", "ELOCTATE", "for", "the", "control", "and", "prevention", "of", "bleeding", "episodes,", "perioperative", "(surgical)", "management", "and", "routine", "prophylaxis", "in", "adults", "and", "children", "with", "Hemophilia", "A,", "and", "Bayer", "Healthcare", "and", "Novo", "Nordisk", "have", "ongoing", "Phase", "3", "clinical", "development", "programs", "for", "longer", "acting", "Factor", "VIII", "proteins", "based", "on", "pegylation", "technology", "approaches.", "<tag2>", "For", "ADYNOVATE", ",", "on", "June", "6,", "2014,", "the", "FDA", "approved", "Biogen", "Idec", "s", "ELOCTATE", "for", "the", "control", "and", "prevention", "of", "bleeding", "episodes,", "perioperative", "(surgical)", "management", "and", "routine", "prophylaxis", "in", "adults", "and", "children", "with", "Hemophilia", "A,", "and", "Bayer", "Healthcare", "and", "Novo", "Nordisk", "have", "ongoing", "Phase", "3", "clinical", "development", "programs", "for", "longer", "acting", "Factor", "VIII", "proteins", "based", "on", "polymer", "conjugation", "technology", "approaches.", "<tag3>"], "wordsA": ["For", "ADYNOVATE", "TM", ",", "on", "June", "6,", "2014,", "the", "FDA", "approved", "Biogen", "Idec", "s", "ELOCTATE", "for", "the", "control", "and", "prevention", "of", "bleeding", "episodes,", "perioperative", "(surgical)", "management", "and", "routine", "prophylaxis", "in", "adults", "and", "children", "with", "Hemophilia", "A,", "and", "Bayer", "Healthcare", "and", "Novo", "Nordisk", "have", "ongoing", "Phase", "3", "clinical", "development", "programs", "for", "longer", "acting", "Factor", "VIII", "proteins", "based", "on", "pegylation", "technology", "approaches."], "wordsB": ["For", "ADYNOVATE", ",", "on", "June", "6,", "2014,", "the", "FDA", "approved", "Biogen", "Idec", "s", "ELOCTATE", "for", "the", "control", "and", "prevention", "of", "bleeding", "episodes,", "perioperative", "(surgical)", "management", "and", "routine", "prophylaxis", "in", "adults", "and", "children", "with", "Hemophilia", "A,", "and", "Bayer", "Healthcare", "and", "Novo", "Nordisk", "have", "ongoing", "Phase", "3", "clinical", "development", "programs", "for", "longer", "acting", "Factor", "VIII", "proteins", "based", "on", "polymer", "conjugation", "technology", "approaches."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p50_s0", "idA": "906709_16_item1a_p48_s1", "sentA": "For NKTR-102 there are a number of chemotherapies and cancer therapies approved today and in various stages of clinical development for breast cancer, including, but not limited to: Abraxane (paclitaxel protein-bound particles for injectable suspension (albumin bound)), Xeloda (capecitabine), Afinitor (everolimus), Doxil (doxorubicin HCl), Ellence (epirubicin), Gemzar (gemcitabine), Halaven (eribulin), Herceptin (trastuzumab), Hycamtin (topotecan), Ibrance (palbociclib), Ixempra (ixabepilone), Navelbine (vinolrebine), Iniparib, Paraplatin (carboplatin), Taxol (paclitaxel) and Taxotere (docetaxel).", "sentB": "For ONZEALD TM there are a number of chemotherapies and cancer therapies approved today and in various stages of clinical development for breast cancer, including, but not limited to: Abraxane (paclitaxel protein-bound particles for injectable suspension (albumin bound)), Xeloda (capecitabine), Afinitor (everolimus), Doxil (doxorubicin HCl), Ellence (epirubicin), Gemzar (gemcitabine), Halaven (eribulin), Herceptin (trastuzumab), Hycamtin (topotecan), Ibrance (palbociclib), Ixempra (ixabepilone), Navelbine (vinolrebine), Iniparib, Paraplatin (carboplatin), Taxol (paclitaxel) and Taxotere (docetaxel).", "type": 2, "words": ["<tag1>", "For", "NKTR-102", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "cancer,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Xeloda", "(capecitabine),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ibrance", "(palbociclib),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel).", "<tag2>", "For", "ONZEALD", "TM", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "cancer,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Xeloda", "(capecitabine),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ibrance", "(palbociclib),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel).", "<tag3>"], "wordsA": ["For", "NKTR-102", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "cancer,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Xeloda", "(capecitabine),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ibrance", "(palbociclib),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel)."], "wordsB": ["For", "ONZEALD", "TM", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "cancer,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Xeloda", "(capecitabine),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ibrance", "(palbociclib),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p50_s1", "idA": "906709_16_item1a_p48_s2", "sentA": "Major pharmaceutical or biotechnology companies with approved drugs or drugs in development for breast cancers include, but are not limited to, Bristol-Meyers Squibb Company, Eli Lilly Co., Roche, GlaxoSmithKline plc, Johnson and Johnson, Pfizer Inc., Eisai Inc., and Sanofi Aventis S.A.", "sentB": "Major pharmaceutical or biotechnology companies with approved drugs or drugs in development for breast cancers include, but are not limited to, Bristol-Myers Squibb Company, Eli Lilly Co., Roche, GlaxoSmithKline plc, Johnson and Johnson, Pfizer Inc., Eisai Inc., and Sanofi Aventis S.A.", "type": 2, "words": ["<tag1>", "Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "breast", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Meyers", "Squibb", "Company,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer", "Inc.,", "Eisai", "Inc.,", "and", "Sanofi", "Aventis", "S.A.", "<tag2>", "Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "breast", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Myers", "Squibb", "Company,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer", "Inc.,", "Eisai", "Inc.,", "and", "Sanofi", "Aventis", "S.A.", "<tag3>"], "wordsA": ["Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "breast", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Meyers", "Squibb", "Company,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer", "Inc.,", "Eisai", "Inc.,", "and", "Sanofi", "Aventis", "S.A."], "wordsB": ["Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "breast", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Myers", "Squibb", "Company,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer", "Inc.,", "Eisai", "Inc.,", "and", "Sanofi", "Aventis", "S.A."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p52_s0", "idA": "906709_16_item1a_p49_s5", "sentA": "We face competition from these companies not just in product development but also in areas such as recruiting employees, acquiring technologies that might enhance our ability to commercialize products, establishing relationships with certain research and academic institutions, enrolling patients in clinical trials and seeking program partnerships and collaborations with larger pharmaceutical companies.", "sentB": "companies not just in product development but also in areas such as recruiting employees, acquiring technologies that might enhance our ability to commercialize products, establishing relation ships with certain research and academic institutions, enrolling patients in clinical trials and seeking program partnerships and collaborations with larger pharmaceutical companies.", "type": 2, "words": ["<tag1>", "We", "face", "competition", "from", "these", "companies", "not", "just", "in", "product", "development", "but", "also", "in", "areas", "such", "as", "recruiting", "employees,", "acquiring", "technologies", "that", "might", "enhance", "our", "ability", "to", "commercialize", "products,", "establishing", "relationships", "with", "certain", "research", "and", "academic", "institutions,", "enrolling", "patients", "in", "clinical", "trials", "and", "seeking", "program", "partnerships", "and", "collaborations", "with", "larger", "pharmaceutical", "companies.", "<tag2>", "companies", "not", "just", "in", "product", "development", "but", "also", "in", "areas", "such", "as", "recruiting", "employees,", "acquiring", "technologies", "that", "might", "enhance", "our", "ability", "to", "commercialize", "products,", "establishing", "relation", "ships", "with", "certain", "research", "and", "academic", "institutions,", "enrolling", "patients", "in", "clinical", "trials", "and", "seeking", "program", "partnerships", "and", "collaborations", "with", "larger", "pharmaceutical", "companies.", "<tag3>"], "wordsA": ["We", "face", "competition", "from", "these", "companies", "not", "just", "in", "product", "development", "but", "also", "in", "areas", "such", "as", "recruiting", "employees,", "acquiring", "technologies", "that", "might", "enhance", "our", "ability", "to", "commercialize", "products,", "establishing", "relationships", "with", "certain", "research", "and", "academic", "institutions,", "enrolling", "patients", "in", "clinical", "trials", "and", "seeking", "program", "partnerships", "and", "collaborations", "with", "larger", "pharmaceutical", "companies."], "wordsB": ["companies", "not", "just", "in", "product", "development", "but", "also", "in", "areas", "such", "as", "recruiting", "employees,", "acquiring", "technologies", "that", "might", "enhance", "our", "ability", "to", "commercialize", "products,", "establishing", "relation", "ships", "with", "certain", "research", "and", "academic", "institutions,", "enrolling", "patients", "in", "clinical", "trials", "and", "seeking", "program", "partnerships", "and", "collaborations", "with", "larger", "pharmaceutical", "companies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p52_s1", "idA": "906709_16_item1a_p50_s0", "sentA": "may succeed in developing competing technologies, obtaining regulatory approval or gaining market acceptance for products before we do.", "sentB": "As a result, our competitors may succeed in developing competing technolo gies, obtaining regulatory approval or gaining market acceptance for products before we do.", "type": 2, "words": ["<tag1>", "may", "succeed", "in", "developing", "competing", "technologies,", "obtaining", "regulatory", "approval", "or", "gaining", "market", "acceptance", "for", "products", "before", "we", "do.", "<tag2>", "As", "a", "result,", "our", "competitors", "may", "succeed", "in", "developing", "competing", "technolo", "gies,", "obtaining", "regulatory", "approval", "or", "gaining", "market", "acceptance", "for", "products", "before", "we", "do.", "<tag3>"], "wordsA": ["may", "succeed", "in", "developing", "competing", "technologies,", "obtaining", "regulatory", "approval", "or", "gaining", "market", "acceptance", "for", "products", "before", "we", "do."], "wordsB": ["As", "a", "result,", "our", "competitors", "may", "succeed", "in", "developing", "competing", "technolo", "gies,", "obtaining", "regulatory", "approval", "or", "gaining", "market", "acceptance", "for", "products", "before", "we", "do."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p23_s1", "idA": "906709_16_item1a_p51_s11", "sentA": "We are dependent on our management team and key technical personnel, and the loss of any key manager or employee may impair our ability to develop our products effectively and may harm our business, operating results and financial condition.", "sentB": "Clinical study delays could also shorten any periods during which our products have patent protection and may allow our competitors to bring products to market before we do, which could impair our ability to successfully commercialize our product candidates and may harm our business and results of operations.", "type": 2, "words": ["<tag1>", "We", "are", "dependent", "on", "our", "management", "team", "and", "key", "technical", "personnel,", "and", "the", "loss", "of", "any", "key", "manager", "or", "employee", "may", "impair", "our", "ability", "to", "develop", "our", "products", "effectively", "and", "may", "harm", "our", "business,", "operating", "results", "and", "financial", "condition.", "<tag2>", "Clinical", "study", "delays", "could", "also", "shorten", "any", "periods", "during", "which", "our", "products", "have", "patent", "protection", "and", "may", "allow", "our", "competitors", "to", "bring", "products", "to", "market", "before", "we", "do,", "which", "could", "impair", "our", "ability", "to", "successfully", "commercialize", "our", "product", "candidates", "and", "may", "harm", "our", "business", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["We", "are", "dependent", "on", "our", "management", "team", "and", "key", "technical", "personnel,", "and", "the", "loss", "of", "any", "key", "manager", "or", "employee", "may", "impair", "our", "ability", "to", "develop", "our", "products", "effectively", "and", "may", "harm", "our", "business,", "operating", "results", "and", "financial", "condition."], "wordsB": ["Clinical", "study", "delays", "could", "also", "shorten", "any", "periods", "during", "which", "our", "products", "have", "patent", "protection", "and", "may", "allow", "our", "competitors", "to", "bring", "products", "to", "market", "before", "we", "do,", "which", "could", "impair", "our", "ability", "to", "successfully", "commercialize", "our", "product", "candidates", "and", "may", "harm", "our", "business", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p55_s0", "idA": "906709_16_item1a_p51_s22", "sentA": "Because competition for skilled personnel in our industry is intense, companies such as ours sometimes experience high attrition rates with regard to their skilled employees.", "sentB": "competition for skilled personnel in our industry is intense, companies such as ours sometimes experience high attrition rates with regard to their skilled employees.", "type": 2, "words": ["<tag1>", "Because", "competition", "for", "skilled", "personnel", "in", "our", "industry", "is", "intense,", "companies", "such", "as", "ours", "sometimes", "experience", "high", "attrition", "rates", "with", "regard", "to", "their", "skilled", "employees.", "<tag2>", "competition", "for", "skilled", "personnel", "in", "our", "industry", "is", "intense,", "companies", "such", "as", "ours", "sometimes", "experience", "high", "attrition", "rates", "with", "regard", "to", "their", "skilled", "employees.", "<tag3>"], "wordsA": ["Because", "competition", "for", "skilled", "personnel", "in", "our", "industry", "is", "intense,", "companies", "such", "as", "ours", "sometimes", "experience", "high", "attrition", "rates", "with", "regard", "to", "their", "skilled", "employees."], "wordsB": ["competition", "for", "skilled", "personnel", "in", "our", "industry", "is", "intense,", "companies", "such", "as", "ours", "sometimes", "experience", "high", "attrition", "rates", "with", "regard", "to", "their", "skilled", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p56_s0", "idA": "906709_16_item1a_p51_s24", "sentA": "Our equity incentive plan and employee benefit plans may not be effective in motivating or retaining our employees or attracting new employees, and significant volatility in the price of our stock may adversely affect our ability to attract or retain qualified personnel.", "sentB": "Our equity incentive plan and employee benefit plans may not be effective in motivating or retaining our employees or attracting new employees, and significant volatility in the pri ce of our stock may adversely affect our ability to attract or retain qualified personnel.", "type": 2, "words": ["<tag1>", "Our", "equity", "incentive", "plan", "and", "employee", "benefit", "plans", "may", "not", "be", "effective", "in", "motivating", "or", "retaining", "our", "employees", "or", "attracting", "new", "employees,", "and", "significant", "volatility", "in", "the", "price", "of", "our", "stock", "may", "adversely", "affect", "our", "ability", "to", "attract", "or", "retain", "qualified", "personnel.", "<tag2>", "Our", "equity", "incentive", "plan", "and", "employee", "benefit", "plans", "may", "not", "be", "effective", "in", "motivating", "or", "retaining", "our", "employees", "or", "attracting", "new", "employees,", "and", "significant", "volatility", "in", "the", "pri", "ce", "of", "our", "stock", "may", "adversely", "affect", "our", "ability", "to", "attract", "or", "retain", "qualified", "personnel.", "<tag3>"], "wordsA": ["Our", "equity", "incentive", "plan", "and", "employee", "benefit", "plans", "may", "not", "be", "effective", "in", "motivating", "or", "retaining", "our", "employees", "or", "attracting", "new", "employees,", "and", "significant", "volatility", "in", "the", "price", "of", "our", "stock", "may", "adversely", "affect", "our", "ability", "to", "attract", "or", "retain", "qualified", "personnel."], "wordsB": ["Our", "equity", "incentive", "plan", "and", "employee", "benefit", "plans", "may", "not", "be", "effective", "in", "motivating", "or", "retaining", "our", "employees", "or", "attracting", "new", "employees,", "and", "significant", "volatility", "in", "the", "pri", "ce", "of", "our", "stock", "may", "adversely", "affect", "our", "ability", "to", "attract", "or", "retain", "qualified", "personnel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p56_s4", "idA": "906709_16_item1a_p52_s2", "sentA": "In addition, we own facilities for the manufacture of products using our PEGylation and advanced polymer conjugate technologies in Huntsville, Alabama and own and lease offices in Hyderabad, India.", "sentB": "In addition, we own facilities for the manufacture of products using our advanced polymer conjugate technologies in Huntsville, Alabama and own and lease offices in Hyderabad, India.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "own", "facilities", "for", "the", "manufacture", "of", "products", "using", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technologies", "in", "Huntsville,", "Alabama", "and", "own", "and", "lease", "offices", "in", "Hyderabad,", "India.", "<tag2>", "In", "addition,", "we", "own", "facilities", "for", "the", "manufacture", "of", "products", "using", "our", "advanced", "polymer", "conjugate", "technologies", "in", "Huntsville,", "Alabama", "and", "own", "and", "lease", "offices", "in", "Hyderabad,", "India.", "<tag3>"], "wordsA": ["In", "addition,", "we", "own", "facilities", "for", "the", "manufacture", "of", "products", "using", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technologies", "in", "Huntsville,", "Alabama", "and", "own", "and", "lease", "offices", "in", "Hyderabad,", "India."], "wordsB": ["In", "addition,", "we", "own", "facilities", "for", "the", "manufacture", "of", "products", "using", "our", "advanced", "polymer", "conjugate", "technologies", "in", "Huntsville,", "Alabama", "and", "own", "and", "lease", "offices", "in", "Hyderabad,", "India."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p59_s1", "idA": "906709_16_item1a_p54_s5", "sentA": "During the year ended December 31, 2015, based on closing prices on The NASDAQ Global Select Market, our stock price ranged from $9.50 to $17.41 per share.", "sentB": "During the year ended December 31, 2016, based on closing prices on The NASDAQ Global Select Market, the closing price of our common stock ranged from $11.00 to $19.68 per share.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2015,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$9.50", "to", "$17.41", "per", "share.", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2016,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "the", "closing", "price", "of", "our", "common", "stock", "ranged", "from", "$11.00", "to", "$19.68", "per", "share.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2015,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "our", "stock", "price", "ranged", "from", "$9.50", "to", "$17.41", "per", "share."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2016,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "the", "closing", "price", "of", "our", "common", "stock", "ranged", "from", "$11.00", "to", "$19.68", "per", "share."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p67_s0", "idA": "906709_16_item1a_p61_s1", "sentA": "Our ability to comply with these covenants will likely be affected by many factors, including events beyond our control, and we may not satisfy those requirements.", "sentB": "ability to comply with these covenants will likely be affected by many factors, including even ts beyond our control, and we may not satisfy those requirements.", "type": 2, "words": ["<tag1>", "Our", "ability", "to", "comply", "with", "these", "covenants", "will", "likely", "be", "affected", "by", "many", "factors,", "including", "events", "beyond", "our", "control,", "and", "we", "may", "not", "satisfy", "those", "requirements.", "<tag2>", "ability", "to", "comply", "with", "these", "covenants", "will", "likely", "be", "affected", "by", "many", "factors,", "including", "even", "ts", "beyond", "our", "control,", "and", "we", "may", "not", "satisfy", "those", "requirements.", "<tag3>"], "wordsA": ["Our", "ability", "to", "comply", "with", "these", "covenants", "will", "likely", "be", "affected", "by", "many", "factors,", "including", "events", "beyond", "our", "control,", "and", "we", "may", "not", "satisfy", "those", "requirements."], "wordsB": ["ability", "to", "comply", "with", "these", "covenants", "will", "likely", "be", "affected", "by", "many", "factors,", "including", "even", "ts", "beyond", "our", "control,", "and", "we", "may", "not", "satisfy", "those", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item1a_p7_s0", "idA": "906709_16_item1a_p7_s0", "sentA": "Given these risks, the success of our current and future collaboration partnerships is highly unpredictable and can have a substantial negative or positive impact on our business in particular, we expect the commercial outcomes of MOVANTIK and ADYNOVATE TM (previously referred to as BAX 855) to have a particularly significant impact on our near to mid- term financial results and financial condition.", "sentB": "Given these risks, the success of our current and future collaboration partnerships is highly unpredictable and can have a substantial negative or positive impact on our business in particular, we expect the commercial outcomes of MOVANTIK , MOVENTIG and ADYNOVATE (previously referred to as BAX 855) to have a particularly significant impact on our near to mid- term financial results and financial condition.", "type": 2, "words": ["<tag1>", "Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business", "in", "particular,", "we", "expect", "the", "commercial", "outcomes", "of", "MOVANTIK", "and", "ADYNOVATE", "TM", "(previously", "referred", "to", "as", "BAX", "855)", "to", "have", "a", "particularly", "significant", "impact", "on", "our", "near", "to", "mid-", "term", "financial", "results", "and", "financial", "condition.", "<tag2>", "Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business", "in", "particular,", "we", "expect", "the", "commercial", "outcomes", "of", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "(previously", "referred", "to", "as", "BAX", "855)", "to", "have", "a", "particularly", "significant", "impact", "on", "our", "near", "to", "mid-", "term", "financial", "results", "and", "financial", "condition.", "<tag3>"], "wordsA": ["Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business", "in", "particular,", "we", "expect", "the", "commercial", "outcomes", "of", "MOVANTIK", "and", "ADYNOVATE", "TM", "(previously", "referred", "to", "as", "BAX", "855)", "to", "have", "a", "particularly", "significant", "impact", "on", "our", "near", "to", "mid-", "term", "financial", "results", "and", "financial", "condition."], "wordsB": ["Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business", "in", "particular,", "we", "expect", "the", "commercial", "outcomes", "of", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "(previously", "referred", "to", "as", "BAX", "855)", "to", "have", "a", "particularly", "significant", "impact", "on", "our", "near", "to", "mid-", "term", "financial", "results", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p13_s1", "idA": "906709_17_item1a_p11_s1", "sentA": "For example, in February 2015 we filed a claim against Allergan and MAP seeking monetary damages re lated to a dispute over the economic sharing provisions of our collaboration agreement with MAP.", "sentB": "For example, in February 2015, we filed a claim against Allergan and MAP seeking monetary damages related to a dispute over the economic sharing provisions of our collaboration agreement with MAP.", "type": 2, "words": ["<tag1>", "For", "example,", "in", "February", "2015", "we", "filed", "a", "claim", "against", "Allergan", "and", "MAP", "seeking", "monetary", "damages", "re", "lated", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "collaboration", "agreement", "with", "MAP.", "<tag2>", "For", "example,", "in", "February", "2015,", "we", "filed", "a", "claim", "against", "Allergan", "and", "MAP", "seeking", "monetary", "damages", "related", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "collaboration", "agreement", "with", "MAP.", "<tag3>"], "wordsA": ["For", "example,", "in", "February", "2015", "we", "filed", "a", "claim", "against", "Allergan", "and", "MAP", "seeking", "monetary", "damages", "re", "lated", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "collaboration", "agreement", "with", "MAP."], "wordsB": ["For", "example,", "in", "February", "2015,", "we", "filed", "a", "claim", "against", "Allergan", "and", "MAP", "seeking", "monetary", "damages", "related", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "collaboration", "agreement", "with", "MAP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p18_s3", "idA": "906709_17_item1a_p11_s1", "sentA": "For example, in February 2015 we filed a claim against Allergan and MAP seeking monetary damages re lated to a dispute over the economic sharing provisions of our collaboration agreement with MAP.", "sentB": "In addition, as described above and in Note 14 to our Consolidated Financial Statements, in February 2018, we entered into a collaboration agreement with BMS under which BMS agreed to pay us a non-refundable upfront cash payment of $1.0 billion and a share purchase agreement under which BMS agreed to purchase $850.0 million of shares of our common stock.", "type": 2, "words": ["<tag1>", "For", "example,", "in", "February", "2015", "we", "filed", "a", "claim", "against", "Allergan", "and", "MAP", "seeking", "monetary", "damages", "re", "lated", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "collaboration", "agreement", "with", "MAP.", "<tag2>", "In", "addition,", "as", "described", "above", "and", "in", "Note", "14", "to", "our", "Consolidated", "Financial", "Statements,", "in", "February", "2018,", "we", "entered", "into", "a", "collaboration", "agreement", "with", "BMS", "under", "which", "BMS", "agreed", "to", "pay", "us", "a", "non-refundable", "upfront", "cash", "payment", "of", "$1.0", "billion", "and", "a", "share", "purchase", "agreement", "under", "which", "BMS", "agreed", "to", "purchase", "$850.0", "million", "of", "shares", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["For", "example,", "in", "February", "2015", "we", "filed", "a", "claim", "against", "Allergan", "and", "MAP", "seeking", "monetary", "damages", "re", "lated", "to", "a", "dispute", "over", "the", "economic", "sharing", "provisions", "of", "our", "collaboration", "agreement", "with", "MAP."], "wordsB": ["In", "addition,", "as", "described", "above", "and", "in", "Note", "14", "to", "our", "Consolidated", "Financial", "Statements,", "in", "February", "2018,", "we", "entered", "into", "a", "collaboration", "agreement", "with", "BMS", "under", "which", "BMS", "agreed", "to", "pay", "us", "a", "non-refundable", "upfront", "cash", "payment", "of", "$1.0", "billion", "and", "a", "share", "purchase", "agreement", "under", "which", "BMS", "agreed", "to", "purchase", "$850.0", "million", "of", "shares", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p14_s0", "idA": "906709_17_item1a_p12_s0", "sentA": "On August 14, 2015, Enzon, Inc. filed a breach of contract claim for alleged unpaid licensing fees.", "sentB": "On August 14, 2015, Enzon, Inc. filed a breach of contract claim for alleged unpaid licensing fees (the Enzon Litigation ).", "type": 2, "words": ["<tag1>", "On", "August", "14,", "2015,", "Enzon,", "Inc.", "filed", "a", "breach", "of", "contract", "claim", "for", "alleged", "unpaid", "licensing", "fees.", "<tag2>", "On", "August", "14,", "2015,", "Enzon,", "Inc.", "filed", "a", "breach", "of", "contract", "claim", "for", "alleged", "unpaid", "licensing", "fees", "(the", "Enzon", "Litigation", ").", "<tag3>"], "wordsA": ["On", "August", "14,", "2015,", "Enzon,", "Inc.", "filed", "a", "breach", "of", "contract", "claim", "for", "alleged", "unpaid", "licensing", "fees."], "wordsB": ["On", "August", "14,", "2015,", "Enzon,", "Inc.", "filed", "a", "breach", "of", "contract", "claim", "for", "alleged", "unpaid", "licensing", "fees", "(the", "Enzon", "Litigation", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p15_s1", "idA": "906709_17_item1a_p13_s1", "sentA": "One or more disputes may arise or escalate in the future regarding our collaboration agreements, transaction documents, or thi rd-party license agreements that may ultimately result in costly litigation and unfavorable interpretation of contract terms, which would have a material adverse effect on our business, financial condition and results of operations.", "sentB": "One or more disputes may arise or escalate in the future regarding our collaboration agreements, transaction documents, or third-party license agreements that may ultimately result in costly litigation and unfavorable interpretation of contract terms, which would have a material adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "One", "or", "more", "disputes", "may", "arise", "or", "escalate", "in", "the", "future", "regarding", "our", "collaboration", "agreements,", "transaction", "documents,", "or", "thi", "rd-party", "license", "agreements", "that", "may", "ultimately", "result", "in", "costly", "litigation", "and", "unfavorable", "interpretation", "of", "contract", "terms,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "One", "or", "more", "disputes", "may", "arise", "or", "escalate", "in", "the", "future", "regarding", "our", "collaboration", "agreements,", "transaction", "documents,", "or", "third-party", "license", "agreements", "that", "may", "ultimately", "result", "in", "costly", "litigation", "and", "unfavorable", "interpretation", "of", "contract", "terms,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["One", "or", "more", "disputes", "may", "arise", "or", "escalate", "in", "the", "future", "regarding", "our", "collaboration", "agreements,", "transaction", "documents,", "or", "thi", "rd-party", "license", "agreements", "that", "may", "ultimately", "result", "in", "costly", "litigation", "and", "unfavorable", "interpretation", "of", "contract", "terms,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["One", "or", "more", "disputes", "may", "arise", "or", "escalate", "in", "the", "future", "regarding", "our", "collaboration", "agreements,", "transaction", "documents,", "or", "third-party", "license", "agreements", "that", "may", "ultimately", "result", "in", "costly", "litigation", "and", "unfavorable", "interpretation", "of", "contract", "terms,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p45_s0", "idA": "906709_17_item1a_p13_s1", "sentA": "One or more disputes may arise or escalate in the future regarding our collaboration agreements, transaction documents, or thi rd-party license agreements that may ultimately result in costly litigation and unfavorable interpretation of contract terms, which would have a material adverse effect on our business, financial condition and results of operations.", "sentB": "The application of the Accounting Standards Codification (ASC) 606, Revenue Recognition - Revenue from Contracts with Customers , which will apply beginning in the first quarter of 2018, may have a material impact on revenue recognition under our collaboration agreements.", "type": 2, "words": ["<tag1>", "One", "or", "more", "disputes", "may", "arise", "or", "escalate", "in", "the", "future", "regarding", "our", "collaboration", "agreements,", "transaction", "documents,", "or", "thi", "rd-party", "license", "agreements", "that", "may", "ultimately", "result", "in", "costly", "litigation", "and", "unfavorable", "interpretation", "of", "contract", "terms,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "The", "application", "of", "the", "Accounting", "Standards", "Codification", "(ASC)", "606,", "Revenue", "Recognition", "-", "Revenue", "from", "Contracts", "with", "Customers", ",", "which", "will", "apply", "beginning", "in", "the", "first", "quarter", "of", "2018,", "may", "have", "a", "material", "impact", "on", "revenue", "recognition", "under", "our", "collaboration", "agreements.", "<tag3>"], "wordsA": ["One", "or", "more", "disputes", "may", "arise", "or", "escalate", "in", "the", "future", "regarding", "our", "collaboration", "agreements,", "transaction", "documents,", "or", "thi", "rd-party", "license", "agreements", "that", "may", "ultimately", "result", "in", "costly", "litigation", "and", "unfavorable", "interpretation", "of", "contract", "terms,", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["The", "application", "of", "the", "Accounting", "Standards", "Codification", "(ASC)", "606,", "Revenue", "Recognition", "-", "Revenue", "from", "Contracts", "with", "Customers", ",", "which", "will", "apply", "beginning", "in", "the", "first", "quarter", "of", "2018,", "may", "have", "a", "material", "impact", "on", "revenue", "recognition", "under", "our", "collaboration", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p16_s3", "idA": "906709_17_item1a_p14_s3", "sentA": "For example, while data from certain pre-specified subgroups in the BEACON study was positive, the study did not achieve statistical significance for its primary endpoint and the FDA and European Medicines Agency rarely approve drugs on the basis of studies that do not achieve statistical significance on the primary endpoint.", "sentB": "For example, while data from certain pre-specified subgroups in our BEACON study for etirinotecan pegol (NKTR-102) in 2015 was positive, the study did not achieve statistical significance for its primary endpoint and the FDA and European Medicines Agency rarely approve drugs on the basis of studies that do not achieve statistical significance on the primary endpoint.", "type": 2, "words": ["<tag1>", "For", "example,", "while", "data", "from", "certain", "pre-specified", "subgroups", "in", "the", "BEACON", "study", "was", "positive,", "the", "study", "did", "not", "achieve", "statistical", "significance", "for", "its", "primary", "endpoint", "and", "the", "FDA", "and", "European", "Medicines", "Agency", "rarely", "approve", "drugs", "on", "the", "basis", "of", "studies", "that", "do", "not", "achieve", "statistical", "significance", "on", "the", "primary", "endpoint.", "<tag2>", "For", "example,", "while", "data", "from", "certain", "pre-specified", "subgroups", "in", "our", "BEACON", "study", "for", "etirinotecan", "pegol", "(NKTR-102)", "in", "2015", "was", "positive,", "the", "study", "did", "not", "achieve", "statistical", "significance", "for", "its", "primary", "endpoint", "and", "the", "FDA", "and", "European", "Medicines", "Agency", "rarely", "approve", "drugs", "on", "the", "basis", "of", "studies", "that", "do", "not", "achieve", "statistical", "significance", "on", "the", "primary", "endpoint.", "<tag3>"], "wordsA": ["For", "example,", "while", "data", "from", "certain", "pre-specified", "subgroups", "in", "the", "BEACON", "study", "was", "positive,", "the", "study", "did", "not", "achieve", "statistical", "significance", "for", "its", "primary", "endpoint", "and", "the", "FDA", "and", "European", "Medicines", "Agency", "rarely", "approve", "drugs", "on", "the", "basis", "of", "studies", "that", "do", "not", "achieve", "statistical", "significance", "on", "the", "primary", "endpoint."], "wordsB": ["For", "example,", "while", "data", "from", "certain", "pre-specified", "subgroups", "in", "our", "BEACON", "study", "for", "etirinotecan", "pegol", "(NKTR-102)", "in", "2015", "was", "positive,", "the", "study", "did", "not", "achieve", "statistical", "significance", "for", "its", "primary", "endpoint", "and", "the", "FDA", "and", "European", "Medicines", "Agency", "rarely", "approve", "drugs", "on", "the", "basis", "of", "studies", "that", "do", "not", "achieve", "statistical", "significance", "on", "the", "primary", "endpoint."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p18_s2", "idA": "906709_17_item1a_p15_s6", "sentA": "As of December 31, 2016, we had cash and investments in marketable securities valued at approximately $389.1 million.", "sentB": "As of December 31, 2017, we had cash and investments in marketable securities valued at approximately $353.2 million and had debt of $250.0 million in principal of senior secured notes.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2016,", "we", "had", "cash", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$389.1", "million.", "<tag2>", "As", "of", "December", "31,", "2017,", "we", "had", "cash", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$353.2", "million", "and", "had", "debt", "of", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2016,", "we", "had", "cash", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$389.1", "million."], "wordsB": ["As", "of", "December", "31,", "2017,", "we", "had", "cash", "and", "investments", "in", "marketable", "securities", "valued", "at", "approximately", "$353.2", "million", "and", "had", "debt", "of", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p22_s0", "idA": "906709_17_item1a_p18_s0", "sentA": "The commercial potential of a drug candidate in development is difficult to predict.", "sentB": "The comm ercial potential of a drug candidate in development is difficult to predict.", "type": 2, "words": ["<tag1>", "The", "commercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict.", "<tag2>", "The", "comm", "ercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["The", "commercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict."], "wordsB": ["The", "comm", "ercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p22_s1", "idA": "906709_17_item1a_p18_s1", "sentA": "If the market size for a new drug is significantly smaller than we anticipate, it could significantly and negatively impact our revenue, results of operations and financial condition.", "sentB": "If the market size for a new drug is significantly smaller than we anticipate, it could significantly and negatively impact our revenue, results of operations and financial condit ion.", "type": 2, "words": ["<tag1>", "If", "the", "market", "size", "for", "a", "new", "drug", "is", "significantly", "smaller", "than", "we", "anticipate,", "it", "could", "significantly", "and", "negatively", "impact", "our", "revenue,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "If", "the", "market", "size", "for", "a", "new", "drug", "is", "significantly", "smaller", "than", "we", "anticipate,", "it", "could", "significantly", "and", "negatively", "impact", "our", "revenue,", "results", "of", "operations", "and", "financial", "condit", "ion.", "<tag3>"], "wordsA": ["If", "the", "market", "size", "for", "a", "new", "drug", "is", "significantly", "smaller", "than", "we", "anticipate,", "it", "could", "significantly", "and", "negatively", "impact", "our", "revenue,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["If", "the", "market", "size", "for", "a", "new", "drug", "is", "significantly", "smaller", "than", "we", "anticipate,", "it", "could", "significantly", "and", "negatively", "impact", "our", "revenue,", "results", "of", "operations", "and", "financial", "condit", "ion."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p23_s8", "idA": "906709_17_item1a_p20_s0", "sentA": "terms with respect to our exis ting and future drug candidates or the licensing of our intellectual property, or if any arrangements we negotiate, or have negotiated, are terminated, it could have a material adverse effect on our business, financial condition and results of operations.", "sentB": "If we are unable to find suitable partners or negotiate collaboration arrangements with favorable commercial terms with respect to our existing and future drug candidates or the licensing of our intellectual property, or if any arrangements we negotiate, or have negotiated, are terminated, it could have a material adverse effect on our business, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "terms", "with", "respect", "to", "our", "exis", "ting", "and", "future", "drug", "candidates", "or", "the", "licensing", "of", "our", "intellectual", "property,", "or", "if", "any", "arrangements", "we", "negotiate,", "or", "have", "negotiated,", "are", "terminated,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "If", "we", "are", "unable", "to", "find", "suitable", "partners", "or", "negotiate", "collaboration", "arrangements", "with", "favorable", "commercial", "terms", "with", "respect", "to", "our", "existing", "and", "future", "drug", "candidates", "or", "the", "licensing", "of", "our", "intellectual", "property,", "or", "if", "any", "arrangements", "we", "negotiate,", "or", "have", "negotiated,", "are", "terminated,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["terms", "with", "respect", "to", "our", "exis", "ting", "and", "future", "drug", "candidates", "or", "the", "licensing", "of", "our", "intellectual", "property,", "or", "if", "any", "arrangements", "we", "negotiate,", "or", "have", "negotiated,", "are", "terminated,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["If", "we", "are", "unable", "to", "find", "suitable", "partners", "or", "negotiate", "collaboration", "arrangements", "with", "favorable", "commercial", "terms", "with", "respect", "to", "our", "existing", "and", "future", "drug", "candidates", "or", "the", "licensing", "of", "our", "intellectual", "property,", "or", "if", "any", "arrangements", "we", "negotiate,", "or", "have", "negotiated,", "are", "terminated,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p2_s1", "idA": "906709_17_item1a_p21_s2", "sentA": "Interim data are also subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available.", "sentB": "Accordingly, there is a very meaningful risk that NKTR-214 will not succeed in one or more clinical trials sufficient to support one or more regulatory approvals.", "type": 2, "words": ["<tag1>", "Interim", "data", "are", "also", "subject", "to", "the", "risk", "that", "one", "or", "more", "of", "the", "clinical", "outcomes", "may", "materially", "change", "as", "patient", "enrollment", "continues", "and", "more", "patient", "data", "become", "available.", "<tag2>", "Accordingly,", "there", "is", "a", "very", "meaningful", "risk", "that", "NKTR-214", "will", "not", "succeed", "in", "one", "or", "more", "clinical", "trials", "sufficient", "to", "support", "one", "or", "more", "regulatory", "approvals.", "<tag3>"], "wordsA": ["Interim", "data", "are", "also", "subject", "to", "the", "risk", "that", "one", "or", "more", "of", "the", "clinical", "outcomes", "may", "materially", "change", "as", "patient", "enrollment", "continues", "and", "more", "patient", "data", "become", "available."], "wordsB": ["Accordingly,", "there", "is", "a", "very", "meaningful", "risk", "that", "NKTR-214", "will", "not", "succeed", "in", "one", "or", "more", "clinical", "trials", "sufficient", "to", "support", "one", "or", "more", "regulatory", "approvals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p1_s7", "idA": "906709_17_item1a_p21_s4", "sentA": "Material adverse changes in the final data could significantly harm our business prospects.", "sentB": "We are executing a broad development program for NKTR-214 and clinical and regulatory outcomes for NKTR-214, if not successful, will significantly harm our business.", "type": 2, "words": ["<tag1>", "Material", "adverse", "changes", "in", "the", "final", "data", "could", "significantly", "harm", "our", "business", "prospects.", "<tag2>", "We", "are", "executing", "a", "broad", "development", "program", "for", "NKTR-214", "and", "clinical", "and", "regulatory", "outcomes", "for", "NKTR-214,", "if", "not", "successful,", "will", "significantly", "harm", "our", "business.", "<tag3>"], "wordsA": ["Material", "adverse", "changes", "in", "the", "final", "data", "could", "significantly", "harm", "our", "business", "prospects."], "wordsB": ["We", "are", "executing", "a", "broad", "development", "program", "for", "NKTR-214", "and", "clinical", "and", "regulatory", "outcomes", "for", "NKTR-214,", "if", "not", "successful,", "will", "significantly", "harm", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p28_s1", "idA": "906709_17_item1a_p26_s1", "sentA": "We own more than 215 U.S. and 750 foreign patents and a number of pending patent applications that cover various aspects of our technologies.", "sentB": "We own more than 250 U.S. and 800 foreign patents and have a number of pending patent applications that cover various aspects of our technologies.", "type": 2, "words": ["<tag1>", "We", "own", "more", "than", "215", "U.S.", "and", "750", "foreign", "patents", "and", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies.", "<tag2>", "We", "own", "more", "than", "250", "U.S.", "and", "800", "foreign", "patents", "and", "have", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies.", "<tag3>"], "wordsA": ["We", "own", "more", "than", "215", "U.S.", "and", "750", "foreign", "patents", "and", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies."], "wordsB": ["We", "own", "more", "than", "250", "U.S.", "and", "800", "foreign", "patents", "and", "have", "a", "number", "of", "pending", "patent", "applications", "that", "cover", "various", "aspects", "of", "our", "technologies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p16_s5", "idA": "906709_17_item1a_p28_s1", "sentA": "In addition, there is no guarantee that we will be the first to file a patent application directed to an invention.", "sentB": "In particular, regulations concerning and controlling the access to opioid-based pharmaceuticals are strict and there is no guarantee which scheduling category will apply to NKTR-181 if regulatory approval is achieved.", "type": 2, "words": ["<tag1>", "In", "addition,", "there", "is", "no", "guarantee", "that", "we", "will", "be", "the", "first", "to", "file", "a", "patent", "application", "directed", "to", "an", "invention.", "<tag2>", "In", "particular,", "regulations", "concerning", "and", "controlling", "the", "access", "to", "opioid-based", "pharmaceuticals", "are", "strict", "and", "there", "is", "no", "guarantee", "which", "scheduling", "category", "will", "apply", "to", "NKTR-181", "if", "regulatory", "approval", "is", "achieved.", "<tag3>"], "wordsA": ["In", "addition,", "there", "is", "no", "guarantee", "that", "we", "will", "be", "the", "first", "to", "file", "a", "patent", "application", "directed", "to", "an", "invention."], "wordsB": ["In", "particular,", "regulations", "concerning", "and", "controlling", "the", "access", "to", "opioid-based", "pharmaceuticals", "are", "strict", "and", "there", "is", "no", "guarantee", "which", "scheduling", "category", "will", "apply", "to", "NKTR-181", "if", "regulatory", "approval", "is", "achieved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p23_s1", "idA": "906709_17_item1a_p28_s1", "sentA": "In addition, there is no guarantee that we will be the first to file a patent application directed to an invention.", "sentB": "In particular, regulations concerning and controlling the access to opioid-based pharmaceuticals are strict and there is no guarantee which scheduling category will apply to NKTR-181 if regulatory approval is achieved.", "type": 2, "words": ["<tag1>", "In", "addition,", "there", "is", "no", "guarantee", "that", "we", "will", "be", "the", "first", "to", "file", "a", "patent", "application", "directed", "to", "an", "invention.", "<tag2>", "In", "particular,", "regulations", "concerning", "and", "controlling", "the", "access", "to", "opioid-based", "pharmaceuticals", "are", "strict", "and", "there", "is", "no", "guarantee", "which", "scheduling", "category", "will", "apply", "to", "NKTR-181", "if", "regulatory", "approval", "is", "achieved.", "<tag3>"], "wordsA": ["In", "addition,", "there", "is", "no", "guarantee", "that", "we", "will", "be", "the", "first", "to", "file", "a", "patent", "application", "directed", "to", "an", "invention."], "wordsB": ["In", "particular,", "regulations", "concerning", "and", "controlling", "the", "access", "to", "opioid-based", "pharmaceuticals", "are", "strict", "and", "there", "is", "no", "guarantee", "which", "scheduling", "category", "will", "apply", "to", "NKTR-181", "if", "regulatory", "approval", "is", "achieved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p31_s0", "idA": "906709_17_item1a_p28_s3", "sentA": "In those instances where we seek an intellectual property license from another, we may not be able to obtain the license on a commercially reasonable basis, if at all, thereby raising concerns on our ability to freely commercialize our technologies or products.", "sentB": "In those instances where we seek an intellectual property license from another, we may not be able to obtain the license on a commercially reasonable basis, if at all, thereby raising concerns on our abilit y to freely commercialize our technologies or products.", "type": 2, "words": ["<tag1>", "In", "those", "instances", "where", "we", "seek", "an", "intellectual", "property", "license", "from", "another,", "we", "may", "not", "be", "able", "to", "obtain", "the", "license", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all,", "thereby", "raising", "concerns", "on", "our", "ability", "to", "freely", "commercialize", "our", "technologies", "or", "products.", "<tag2>", "In", "those", "instances", "where", "we", "seek", "an", "intellectual", "property", "license", "from", "another,", "we", "may", "not", "be", "able", "to", "obtain", "the", "license", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all,", "thereby", "raising", "concerns", "on", "our", "abilit", "y", "to", "freely", "commercialize", "our", "technologies", "or", "products.", "<tag3>"], "wordsA": ["In", "those", "instances", "where", "we", "seek", "an", "intellectual", "property", "license", "from", "another,", "we", "may", "not", "be", "able", "to", "obtain", "the", "license", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all,", "thereby", "raising", "concerns", "on", "our", "ability", "to", "freely", "commercialize", "our", "technologies", "or", "products."], "wordsB": ["In", "those", "instances", "where", "we", "seek", "an", "intellectual", "property", "license", "from", "another,", "we", "may", "not", "be", "able", "to", "obtain", "the", "license", "on", "a", "commercially", "reasonable", "basis,", "if", "at", "all,", "thereby", "raising", "concerns", "on", "our", "abilit", "y", "to", "freely", "commercialize", "our", "technologies", "or", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p3_s0", "idA": "906709_17_item1a_p2_s0", "sentA": "Risks Related to Our Business Drug development is a long and inherently uncertain process with a high risk of failure at every stage of development.", "sentB": "Drug development is a long and inherently uncertain process with a high risk of failure at every stage of development.", "type": 2, "words": ["<tag1>", "Risks", "Related", "to", "Our", "Business", "Drug", "development", "is", "a", "long", "and", "inherently", "uncertain", "process", "with", "a", "high", "risk", "of", "failure", "at", "every", "stage", "of", "development.", "<tag2>", "Drug", "development", "is", "a", "long", "and", "inherently", "uncertain", "process", "with", "a", "high", "risk", "of", "failure", "at", "every", "stage", "of", "development.", "<tag3>"], "wordsA": ["Risks", "Related", "to", "Our", "Business", "Drug", "development", "is", "a", "long", "and", "inherently", "uncertain", "process", "with", "a", "high", "risk", "of", "failure", "at", "every", "stage", "of", "development."], "wordsB": ["Drug", "development", "is", "a", "long", "and", "inherently", "uncertain", "process", "with", "a", "high", "risk", "of", "failure", "at", "every", "stage", "of", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p36_s0", "idA": "906709_17_item1a_p2_s10", "sentA": "The risk of clinical failure for any drug candidate remains high prior to regulatory approval.", "sentB": "Healthcare providers, physicians and third-party payors play a primary role in the recommendation and prescription of any drug candidates for which we obtain marketing approval.", "type": 2, "words": ["<tag1>", "The", "risk", "of", "clinical", "failure", "for", "any", "drug", "candidate", "remains", "high", "prior", "to", "regulatory", "approval.", "<tag2>", "Healthcare", "providers,", "physicians", "and", "third-party", "payors", "play", "a", "primary", "role", "in", "the", "recommendation", "and", "prescription", "of", "any", "drug", "candidates", "for", "which", "we", "obtain", "marketing", "approval.", "<tag3>"], "wordsA": ["The", "risk", "of", "clinical", "failure", "for", "any", "drug", "candidate", "remains", "high", "prior", "to", "regulatory", "approval."], "wordsB": ["Healthcare", "providers,", "physicians", "and", "third-party", "payors", "play", "a", "primary", "role", "in", "the", "recommendation", "and", "prescription", "of", "any", "drug", "candidates", "for", "which", "we", "obtain", "marketing", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p3_s7", "idA": "906709_17_item1a_p2_s7", "sentA": "The risk of failure increases for our drug candidates that are based on new technologies, such as the application of our advanced polymer conjugate technology to ONZEALD TM , NKTR-181, NKTR-214 and other drug candidates currently in discovery research or preclinical development.", "sentB": "The risk of failure increases for our drug candidates that are based on new technologies, such as the application of our advanced polymer conjugate technology to ONZEALD TM , NKTR-181, NKTR-214, NKTR-358, NKTR-262, NKTR-255, and other drug candidates currently in discovery research or preclinical development.", "type": 2, "words": ["<tag1>", "The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "ONZEALD", "TM", ",", "NKTR-181,", "NKTR-214", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development.", "<tag2>", "The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "ONZEALD", "TM", ",", "NKTR-181,", "NKTR-214,", "NKTR-358,", "NKTR-262,", "NKTR-255,", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development.", "<tag3>"], "wordsA": ["The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "ONZEALD", "TM", ",", "NKTR-181,", "NKTR-214", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development."], "wordsB": ["The", "risk", "of", "failure", "increases", "for", "our", "drug", "candidates", "that", "are", "based", "on", "new", "technologies,", "such", "as", "the", "application", "of", "our", "advanced", "polymer", "conjugate", "technology", "to", "ONZEALD", "TM", ",", "NKTR-181,", "NKTR-214,", "NKTR-358,", "NKTR-262,", "NKTR-255,", "and", "other", "drug", "candidates", "currently", "in", "discovery", "research", "or", "preclinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p33_s1", "idA": "906709_17_item1a_p31_s0", "sentA": "PEGylated Factor VIII which we have exclusively licensed to Baxalta.", "sentB": "For example, we are currently involved in a German litigation proceeding whereby Bayer is seeking co-ownership rights in certain of our patent filings pending at the European Patent Office covering, among other things, PEGylated Factor VIII which we have exclusively licensed to Baxalta.", "type": 2, "words": ["<tag1>", "PEGylated", "Factor", "VIII", "which", "we", "have", "exclusively", "licensed", "to", "Baxalta.", "<tag2>", "For", "example,", "we", "are", "currently", "involved", "in", "a", "German", "litigation", "proceeding", "whereby", "Bayer", "is", "seeking", "co-ownership", "rights", "in", "certain", "of", "our", "patent", "filings", "pending", "at", "the", "European", "Patent", "Office", "covering,", "among", "other", "things,", "PEGylated", "Factor", "VIII", "which", "we", "have", "exclusively", "licensed", "to", "Baxalta.", "<tag3>"], "wordsA": ["PEGylated", "Factor", "VIII", "which", "we", "have", "exclusively", "licensed", "to", "Baxalta."], "wordsB": ["For", "example,", "we", "are", "currently", "involved", "in", "a", "German", "litigation", "proceeding", "whereby", "Bayer", "is", "seeking", "co-ownership", "rights", "in", "certain", "of", "our", "patent", "filings", "pending", "at", "the", "European", "Patent", "Office", "covering,", "among", "other", "things,", "PEGylated", "Factor", "VIII", "which", "we", "have", "exclusively", "licensed", "to", "Baxalta."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p34_s0", "idA": "906709_17_item1a_p31_s0", "sentA": "PEGylated Factor VIII which we have exclusively licensed to Baxalta.", "sentB": "As part of its intellectual property litigation strategy relating to PEGylated Factor VIII products, Nektar has also filed claims against Bayer.", "type": 2, "words": ["<tag1>", "PEGylated", "Factor", "VIII", "which", "we", "have", "exclusively", "licensed", "to", "Baxalta.", "<tag2>", "As", "part", "of", "its", "intellectual", "property", "litigation", "strategy", "relating", "to", "PEGylated", "Factor", "VIII", "products,", "Nektar", "has", "also", "filed", "claims", "against", "Bayer.", "<tag3>"], "wordsA": ["PEGylated", "Factor", "VIII", "which", "we", "have", "exclusively", "licensed", "to", "Baxalta."], "wordsB": ["As", "part", "of", "its", "intellectual", "property", "litigation", "strategy", "relating", "to", "PEGylated", "Factor", "VIII", "products,", "Nektar", "has", "also", "filed", "claims", "against", "Bayer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p33_s2", "idA": "906709_17_item1a_p31_s1", "sentA": "The subject matter of our patent filings in this proceeding relates to Bayer s investigational PEGylated recombinant Factor VIII compound.", "sentB": "The subject matter of our patent filings in this proceeding relates to Bayer s PEGylated recombinant Factor VIII compound, BAY 94-9027.", "type": 2, "words": ["<tag1>", "The", "subject", "matter", "of", "our", "patent", "filings", "in", "this", "proceeding", "relates", "to", "Bayer", "s", "investigational", "PEGylated", "recombinant", "Factor", "VIII", "compound.", "<tag2>", "The", "subject", "matter", "of", "our", "patent", "filings", "in", "this", "proceeding", "relates", "to", "Bayer", "s", "PEGylated", "recombinant", "Factor", "VIII", "compound,", "BAY", "94-9027.", "<tag3>"], "wordsA": ["The", "subject", "matter", "of", "our", "patent", "filings", "in", "this", "proceeding", "relates", "to", "Bayer", "s", "investigational", "PEGylated", "recombinant", "Factor", "VIII", "compound."], "wordsB": ["The", "subject", "matter", "of", "our", "patent", "filings", "in", "this", "proceeding", "relates", "to", "Bayer", "s", "PEGylated", "recombinant", "Factor", "VIII", "compound,", "BAY", "94-9027."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p33_s4", "idA": "906709_17_item1a_p31_s3", "sentA": "In addition, Bayer has filed a claim in the U.S. against Baxalta and Nektar in which Bayer alleges ADYNOVATE infringes a Bayer patent.", "sentB": "In addition, Bayer has filed claims in the U.S. against Baxalta and Nektar.", "type": 2, "words": ["<tag1>", "In", "addition,", "Bayer", "has", "filed", "a", "claim", "in", "the", "U.S.", "against", "Baxalta", "and", "Nektar", "in", "which", "Bayer", "alleges", "ADYNOVATE", "infringes", "a", "Bayer", "patent.", "<tag2>", "In", "addition,", "Bayer", "has", "filed", "claims", "in", "the", "U.S.", "against", "Baxalta", "and", "Nektar.", "<tag3>"], "wordsA": ["In", "addition,", "Bayer", "has", "filed", "a", "claim", "in", "the", "U.S.", "against", "Baxalta", "and", "Nektar", "in", "which", "Bayer", "alleges", "ADYNOVATE", "infringes", "a", "Bayer", "patent."], "wordsB": ["In", "addition,", "Bayer", "has", "filed", "claims", "in", "the", "U.S.", "against", "Baxalta", "and", "Nektar."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p33_s5", "idA": "906709_17_item1a_p31_s3", "sentA": "In addition, Bayer has filed a claim in the U.S. against Baxalta and Nektar in which Bayer alleges ADYNOVATE infringes a Bayer patent.", "sentB": "In one U.S. proceeding, Bayer alleges ADYNOVATE infringes a Bayer patent.", "type": 2, "words": ["<tag1>", "In", "addition,", "Bayer", "has", "filed", "a", "claim", "in", "the", "U.S.", "against", "Baxalta", "and", "Nektar", "in", "which", "Bayer", "alleges", "ADYNOVATE", "infringes", "a", "Bayer", "patent.", "<tag2>", "In", "one", "U.S.", "proceeding,", "Bayer", "alleges", "ADYNOVATE", "infringes", "a", "Bayer", "patent.", "<tag3>"], "wordsA": ["In", "addition,", "Bayer", "has", "filed", "a", "claim", "in", "the", "U.S.", "against", "Baxalta", "and", "Nektar", "in", "which", "Bayer", "alleges", "ADYNOVATE", "infringes", "a", "Bayer", "patent."], "wordsB": ["In", "one", "U.S.", "proceeding,", "Bayer", "alleges", "ADYNOVATE", "infringes", "a", "Bayer", "patent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p38_s3", "idA": "906709_17_item1a_p31_s5", "sentA": "The cost to us in initiating or defending any litigation or other proceeding, even if resolved in our favor, could be substantial, and litigation would divert our management s attention.", "sentB": "Any action against us for an alleged or suspected violation could cause us to incur significant legal expenses and could divert our management s attention from the operation of our business, even if our defense is successful.", "type": 2, "words": ["<tag1>", "The", "cost", "to", "us", "in", "initiating", "or", "defending", "any", "litigation", "or", "other", "proceeding,", "even", "if", "resolved", "in", "our", "favor,", "could", "be", "substantial,", "and", "litigation", "would", "divert", "our", "management", "s", "attention.", "<tag2>", "Any", "action", "against", "us", "for", "an", "alleged", "or", "suspected", "violation", "could", "cause", "us", "to", "incur", "significant", "legal", "expenses", "and", "could", "divert", "our", "management", "s", "attention", "from", "the", "operation", "of", "our", "business,", "even", "if", "our", "defense", "is", "successful.", "<tag3>"], "wordsA": ["The", "cost", "to", "us", "in", "initiating", "or", "defending", "any", "litigation", "or", "other", "proceeding,", "even", "if", "resolved", "in", "our", "favor,", "could", "be", "substantial,", "and", "litigation", "would", "divert", "our", "management", "s", "attention."], "wordsB": ["Any", "action", "against", "us", "for", "an", "alleged", "or", "suspected", "violation", "could", "cause", "us", "to", "incur", "significant", "legal", "expenses", "and", "could", "divert", "our", "management", "s", "attention", "from", "the", "operation", "of", "our", "business,", "even", "if", "our", "defense", "is", "successful."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p34_s3", "idA": "906709_17_item1a_p32_s0", "sentA": "patent litigation or other proceedings could delay our research and development efforts or result in financial implications either in terms of seeking license arrangements or payment of damages or royalties.", "sentB": "Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could delay our research and development efforts or result in financial implications either in terms of seeking license arrangements or payment of damages or royalties.", "type": 2, "words": ["<tag1>", "patent", "litigation", "or", "other", "proceedings", "could", "delay", "our", "research", "and", "development", "efforts", "or", "result", "in", "financial", "implications", "either", "in", "terms", "of", "seeking", "license", "arrangements", "or", "payment", "of", "damages", "or", "royalties.", "<tag2>", "Uncertainties", "resulting", "from", "the", "initiation", "and", "continuation", "of", "patent", "litigation", "or", "other", "proceedings", "could", "delay", "our", "research", "and", "development", "efforts", "or", "result", "in", "financial", "implications", "either", "in", "terms", "of", "seeking", "license", "arrangements", "or", "payment", "of", "damages", "or", "royalties.", "<tag3>"], "wordsA": ["patent", "litigation", "or", "other", "proceedings", "could", "delay", "our", "research", "and", "development", "efforts", "or", "result", "in", "financial", "implications", "either", "in", "terms", "of", "seeking", "license", "arrangements", "or", "payment", "of", "damages", "or", "royalties."], "wordsB": ["Uncertainties", "resulting", "from", "the", "initiation", "and", "continuation", "of", "patent", "litigation", "or", "other", "proceedings", "could", "delay", "our", "research", "and", "development", "efforts", "or", "result", "in", "financial", "implications", "either", "in", "terms", "of", "seeking", "license", "arrangements", "or", "payment", "of", "damages", "or", "royalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p38_s0", "idA": "906709_17_item1a_p32_s5", "sentA": "Failure to comply with applicable laws and regulations may also result in sanctions being imposed on us, including fines, injunctions, civil penalties, failure of regulatory authorities to grant marketing approval of our products, delays, suspension or withdrawal of approvals, license revocation, seizures, administrative detention, or recalls of products, operating restrictions and criminal prosecutions, any of which could harm our business.", "sentB": "Ensuring that our future business arrangements with third-parties comply with applicable healthcare laws and regulations could involve substantial costs.", "type": 2, "words": ["<tag1>", "Failure", "to", "comply", "with", "applicable", "laws", "and", "regulations", "may", "also", "result", "in", "sanctions", "being", "imposed", "on", "us,", "including", "fines,", "injunctions,", "civil", "penalties,", "failure", "of", "regulatory", "authorities", "to", "grant", "marketing", "approval", "of", "our", "products,", "delays,", "suspension", "or", "withdrawal", "of", "approvals,", "license", "revocation,", "seizures,", "administrative", "detention,", "or", "recalls", "of", "products,", "operating", "restrictions", "and", "criminal", "prosecutions,", "any", "of", "which", "could", "harm", "our", "business.", "<tag2>", "Ensuring", "that", "our", "future", "business", "arrangements", "with", "third-parties", "comply", "with", "applicable", "healthcare", "laws", "and", "regulations", "could", "involve", "substantial", "costs.", "<tag3>"], "wordsA": ["Failure", "to", "comply", "with", "applicable", "laws", "and", "regulations", "may", "also", "result", "in", "sanctions", "being", "imposed", "on", "us,", "including", "fines,", "injunctions,", "civil", "penalties,", "failure", "of", "regulatory", "authorities", "to", "grant", "marketing", "approval", "of", "our", "products,", "delays,", "suspension", "or", "withdrawal", "of", "approvals,", "license", "revocation,", "seizures,", "administrative", "detention,", "or", "recalls", "of", "products,", "operating", "restrictions", "and", "criminal", "prosecutions,", "any", "of", "which", "could", "harm", "our", "business."], "wordsB": ["Ensuring", "that", "our", "future", "business", "arrangements", "with", "third-parties", "comply", "with", "applicable", "healthcare", "laws", "and", "regulations", "could", "involve", "substantial", "costs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p38_s4", "idA": "906709_17_item1a_p32_s5", "sentA": "Failure to comply with applicable laws and regulations may also result in sanctions being imposed on us, including fines, injunctions, civil penalties, failure of regulatory authorities to grant marketing approval of our products, delays, suspension or withdrawal of approvals, license revocation, seizures, administrative detention, or recalls of products, operating restrictions and criminal prosecutions, any of which could harm our business.", "sentB": "In addition, achieving and sustaining compliance with applicable laws and regulations may be costly to us in terms of money, time and resources.", "type": 2, "words": ["<tag1>", "Failure", "to", "comply", "with", "applicable", "laws", "and", "regulations", "may", "also", "result", "in", "sanctions", "being", "imposed", "on", "us,", "including", "fines,", "injunctions,", "civil", "penalties,", "failure", "of", "regulatory", "authorities", "to", "grant", "marketing", "approval", "of", "our", "products,", "delays,", "suspension", "or", "withdrawal", "of", "approvals,", "license", "revocation,", "seizures,", "administrative", "detention,", "or", "recalls", "of", "products,", "operating", "restrictions", "and", "criminal", "prosecutions,", "any", "of", "which", "could", "harm", "our", "business.", "<tag2>", "In", "addition,", "achieving", "and", "sustaining", "compliance", "with", "applicable", "laws", "and", "regulations", "may", "be", "costly", "to", "us", "in", "terms", "of", "money,", "time", "and", "resources.", "<tag3>"], "wordsA": ["Failure", "to", "comply", "with", "applicable", "laws", "and", "regulations", "may", "also", "result", "in", "sanctions", "being", "imposed", "on", "us,", "including", "fines,", "injunctions,", "civil", "penalties,", "failure", "of", "regulatory", "authorities", "to", "grant", "marketing", "approval", "of", "our", "products,", "delays,", "suspension", "or", "withdrawal", "of", "approvals,", "license", "revocation,", "seizures,", "administrative", "detention,", "or", "recalls", "of", "products,", "operating", "restrictions", "and", "criminal", "prosecutions,", "any", "of", "which", "could", "harm", "our", "business."], "wordsB": ["In", "addition,", "achieving", "and", "sustaining", "compliance", "with", "applicable", "laws", "and", "regulations", "may", "be", "costly", "to", "us", "in", "terms", "of", "money,", "time", "and", "resources."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p39_s0", "idA": "906709_17_item1a_p32_s9", "sentA": "If we or our contract manufacturers are not able to manufacture and supply sufficient drug quantities meeting applicable quality standards required to support large clinical studies or commercial manufacturing in a timely manner, it could delay our or our collaboration partners clinical studies or result in a breach of our contractual obligations, which could in turn reduce the potential commercial sales of our or our collaboration partners products.", "sentB": "commercial sales of our or our collaboration partners products.", "type": 2, "words": ["<tag1>", "If", "we", "or", "our", "contract", "manufacturers", "are", "not", "able", "to", "manufacture", "and", "supply", "sufficient", "drug", "quantities", "meeting", "applicable", "quality", "standards", "required", "to", "support", "large", "clinical", "studies", "or", "commercial", "manufacturing", "in", "a", "timely", "manner,", "it", "could", "delay", "our", "or", "our", "collaboration", "partners", "clinical", "studies", "or", "result", "in", "a", "breach", "of", "our", "contractual", "obligations,", "which", "could", "in", "turn", "reduce", "the", "potential", "commercial", "sales", "of", "our", "or", "our", "collaboration", "partners", "products.", "<tag2>", "commercial", "sales", "of", "our", "or", "our", "collaboration", "partners", "products.", "<tag3>"], "wordsA": ["If", "we", "or", "our", "contract", "manufacturers", "are", "not", "able", "to", "manufacture", "and", "supply", "sufficient", "drug", "quantities", "meeting", "applicable", "quality", "standards", "required", "to", "support", "large", "clinical", "studies", "or", "commercial", "manufacturing", "in", "a", "timely", "manner,", "it", "could", "delay", "our", "or", "our", "collaboration", "partners", "clinical", "studies", "or", "result", "in", "a", "breach", "of", "our", "contractual", "obligations,", "which", "could", "in", "turn", "reduce", "the", "potential", "commercial", "sales", "of", "our", "or", "our", "collaboration", "partners", "products."], "wordsB": ["commercial", "sales", "of", "our", "or", "our", "collaboration", "partners", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p41_s0", "idA": "906709_17_item1a_p34_s0", "sentA": "Pharmaceutical manufacturing of drugs and devices involves significant risks and uncertainties related to the demonstration of adequate stability, sufficient purification of the drug substance and drug product, the identification and elimination of impurities, optimal formulations, process and analytical methods validations, device performance and challenges in controlling for all of these variables.", "sentB": "Pharmaceutical manufacturing of drugs and devices involves significant risks and uncertainties related to the demonstratio n of adequate stability, sufficient purification of the drug substance and drug product, the identification and elimination of impurities, optimal formulations, process and analytical methods validations, device performance and challenges in controlling fo r all of these variables.", "type": 2, "words": ["<tag1>", "Pharmaceutical", "manufacturing", "of", "drugs", "and", "devices", "involves", "significant", "risks", "and", "uncertainties", "related", "to", "the", "demonstration", "of", "adequate", "stability,", "sufficient", "purification", "of", "the", "drug", "substance", "and", "drug", "product,", "the", "identification", "and", "elimination", "of", "impurities,", "optimal", "formulations,", "process", "and", "analytical", "methods", "validations,", "device", "performance", "and", "challenges", "in", "controlling", "for", "all", "of", "these", "variables.", "<tag2>", "Pharmaceutical", "manufacturing", "of", "drugs", "and", "devices", "involves", "significant", "risks", "and", "uncertainties", "related", "to", "the", "demonstratio", "n", "of", "adequate", "stability,", "sufficient", "purification", "of", "the", "drug", "substance", "and", "drug", "product,", "the", "identification", "and", "elimination", "of", "impurities,", "optimal", "formulations,", "process", "and", "analytical", "methods", "validations,", "device", "performance", "and", "challenges", "in", "controlling", "fo", "r", "all", "of", "these", "variables.", "<tag3>"], "wordsA": ["Pharmaceutical", "manufacturing", "of", "drugs", "and", "devices", "involves", "significant", "risks", "and", "uncertainties", "related", "to", "the", "demonstration", "of", "adequate", "stability,", "sufficient", "purification", "of", "the", "drug", "substance", "and", "drug", "product,", "the", "identification", "and", "elimination", "of", "impurities,", "optimal", "formulations,", "process", "and", "analytical", "methods", "validations,", "device", "performance", "and", "challenges", "in", "controlling", "for", "all", "of", "these", "variables."], "wordsB": ["Pharmaceutical", "manufacturing", "of", "drugs", "and", "devices", "involves", "significant", "risks", "and", "uncertainties", "related", "to", "the", "demonstratio", "n", "of", "adequate", "stability,", "sufficient", "purification", "of", "the", "drug", "substance", "and", "drug", "product,", "the", "identification", "and", "elimination", "of", "impurities,", "optimal", "formulations,", "process", "and", "analytical", "methods", "validations,", "device", "performance", "and", "challenges", "in", "controlling", "fo", "r", "all", "of", "these", "variables."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p41_s1", "idA": "906709_17_item1a_p34_s1", "sentA": "We have faced and may in the future face significant difficulties, delays and unexpected expenses as we validate third party contract manufacturers required for drug and device supply to support our clinical studies and the clinical studies and products of our collaboration partners.", "sentB": "We have faced and may in the future face significant difficulties, delays and unexpected expenses as we validate third party contract manufacturers required for drug and device supply to support our clinical studies and the clinic al studies and products of our collaboration partners.", "type": 2, "words": ["<tag1>", "We", "have", "faced", "and", "may", "in", "the", "future", "face", "significant", "difficulties,", "delays", "and", "unexpected", "expenses", "as", "we", "validate", "third", "party", "contract", "manufacturers", "required", "for", "drug", "and", "device", "supply", "to", "support", "our", "clinical", "studies", "and", "the", "clinical", "studies", "and", "products", "of", "our", "collaboration", "partners.", "<tag2>", "We", "have", "faced", "and", "may", "in", "the", "future", "face", "significant", "difficulties,", "delays", "and", "unexpected", "expenses", "as", "we", "validate", "third", "party", "contract", "manufacturers", "required", "for", "drug", "and", "device", "supply", "to", "support", "our", "clinical", "studies", "and", "the", "clinic", "al", "studies", "and", "products", "of", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["We", "have", "faced", "and", "may", "in", "the", "future", "face", "significant", "difficulties,", "delays", "and", "unexpected", "expenses", "as", "we", "validate", "third", "party", "contract", "manufacturers", "required", "for", "drug", "and", "device", "supply", "to", "support", "our", "clinical", "studies", "and", "the", "clinical", "studies", "and", "products", "of", "our", "collaboration", "partners."], "wordsB": ["We", "have", "faced", "and", "may", "in", "the", "future", "face", "significant", "difficulties,", "delays", "and", "unexpected", "expenses", "as", "we", "validate", "third", "party", "contract", "manufacturers", "required", "for", "drug", "and", "device", "supply", "to", "support", "our", "clinical", "studies", "and", "the", "clinic", "al", "studies", "and", "products", "of", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p41_s2", "idA": "906709_17_item1a_p34_s2", "sentA": "Failure by us or our contract manufacturers to supply drug product or devices in sufficient quantities that meet all applicable quality requirements could result in supply shortages for our clinical studies or the clinical studies and commercial activities of our collaboration partners.", "sentB": "Failure by us or our contract manufacturers to supply drug product or devices in sufficient quantities that meet all applicable quality requirements could result in supply shortages for our clinical st udies or the clinical studies and commercial activities of our collaboration partners.", "type": 2, "words": ["<tag1>", "Failure", "by", "us", "or", "our", "contract", "manufacturers", "to", "supply", "drug", "product", "or", "devices", "in", "sufficient", "quantities", "that", "meet", "all", "applicable", "quality", "requirements", "could", "result", "in", "supply", "shortages", "for", "our", "clinical", "studies", "or", "the", "clinical", "studies", "and", "commercial", "activities", "of", "our", "collaboration", "partners.", "<tag2>", "Failure", "by", "us", "or", "our", "contract", "manufacturers", "to", "supply", "drug", "product", "or", "devices", "in", "sufficient", "quantities", "that", "meet", "all", "applicable", "quality", "requirements", "could", "result", "in", "supply", "shortages", "for", "our", "clinical", "st", "udies", "or", "the", "clinical", "studies", "and", "commercial", "activities", "of", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["Failure", "by", "us", "or", "our", "contract", "manufacturers", "to", "supply", "drug", "product", "or", "devices", "in", "sufficient", "quantities", "that", "meet", "all", "applicable", "quality", "requirements", "could", "result", "in", "supply", "shortages", "for", "our", "clinical", "studies", "or", "the", "clinical", "studies", "and", "commercial", "activities", "of", "our", "collaboration", "partners."], "wordsB": ["Failure", "by", "us", "or", "our", "contract", "manufacturers", "to", "supply", "drug", "product", "or", "devices", "in", "sufficient", "quantities", "that", "meet", "all", "applicable", "quality", "requirements", "could", "result", "in", "supply", "shortages", "for", "our", "clinical", "st", "udies", "or", "the", "clinical", "studies", "and", "commercial", "activities", "of", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p41_s3", "idA": "906709_17_item1a_p34_s3", "sentA": "Such failures could significantly and materially delay clinical trials and regulatory submissions or result in reduced sales, any of which could significantly harm our business prospects, results of operations and financial condition.", "sentB": "Such failures could significantly and materially delay clinical trials and regulatory submissions or result in reduced sales, any of which could significantly harm our b usiness prospects, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "Such", "failures", "could", "significantly", "and", "materially", "delay", "clinical", "trials", "and", "regulatory", "submissions", "or", "result", "in", "reduced", "sales,", "any", "of", "which", "could", "significantly", "harm", "our", "business", "prospects,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Such", "failures", "could", "significantly", "and", "materially", "delay", "clinical", "trials", "and", "regulatory", "submissions", "or", "result", "in", "reduced", "sales,", "any", "of", "which", "could", "significantly", "harm", "our", "b", "usiness", "prospects,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["Such", "failures", "could", "significantly", "and", "materially", "delay", "clinical", "trials", "and", "regulatory", "submissions", "or", "result", "in", "reduced", "sales,", "any", "of", "which", "could", "significantly", "harm", "our", "business", "prospects,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Such", "failures", "could", "significantly", "and", "materially", "delay", "clinical", "trials", "and", "regulatory", "submissions", "or", "result", "in", "reduced", "sales,", "any", "of", "which", "could", "significantly", "harm", "our", "b", "usiness", "prospects,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p43_s1", "idA": "906709_17_item1a_p36_s2", "sentA": "Drug/device combination products are particularly complex, expensive and time-consuming to develop due to the number of variables involved in the final product design, including ease of patient and doctor use, maintenance of clinical efficacy, reliability and cost of manufacturing, regulatory approval requirements and standards and other important factors.", "sentB": "Drug and device combination products are particularly complex, expensive and time-consuming to develop due to the number of variables involved in the final product design, including ease of patient and doctor use, maintenance of clinical efficacy, reliability and cost of manufacturing, regulatory approval requirements and standards and other important factors.", "type": 2, "words": ["<tag1>", "Drug/device", "combination", "products", "are", "particularly", "complex,", "expensive", "and", "time-consuming", "to", "develop", "due", "to", "the", "number", "of", "variables", "involved", "in", "the", "final", "product", "design,", "including", "ease", "of", "patient", "and", "doctor", "use,", "maintenance", "of", "clinical", "efficacy,", "reliability", "and", "cost", "of", "manufacturing,", "regulatory", "approval", "requirements", "and", "standards", "and", "other", "important", "factors.", "<tag2>", "Drug", "and", "device", "combination", "products", "are", "particularly", "complex,", "expensive", "and", "time-consuming", "to", "develop", "due", "to", "the", "number", "of", "variables", "involved", "in", "the", "final", "product", "design,", "including", "ease", "of", "patient", "and", "doctor", "use,", "maintenance", "of", "clinical", "efficacy,", "reliability", "and", "cost", "of", "manufacturing,", "regulatory", "approval", "requirements", "and", "standards", "and", "other", "important", "factors.", "<tag3>"], "wordsA": ["Drug/device", "combination", "products", "are", "particularly", "complex,", "expensive", "and", "time-consuming", "to", "develop", "due", "to", "the", "number", "of", "variables", "involved", "in", "the", "final", "product", "design,", "including", "ease", "of", "patient", "and", "doctor", "use,", "maintenance", "of", "clinical", "efficacy,", "reliability", "and", "cost", "of", "manufacturing,", "regulatory", "approval", "requirements", "and", "standards", "and", "other", "important", "factors."], "wordsB": ["Drug", "and", "device", "combination", "products", "are", "particularly", "complex,", "expensive", "and", "time-consuming", "to", "develop", "due", "to", "the", "number", "of", "variables", "involved", "in", "the", "final", "product", "design,", "including", "ease", "of", "patient", "and", "doctor", "use,", "maintenance", "of", "clinical", "efficacy,", "reliability", "and", "cost", "of", "manufacturing,", "regulatory", "approval", "requirements", "and", "standards", "and", "other", "important", "factors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p44_s4", "idA": "906709_17_item1a_p37_s0", "sentA": "Our revenue is exclusively derived from our collaboration agreements, which can result in significant fluctuation in our revenue from period to period, and our past revenue is theref ore not necessarily indicative of our future revenue.", "sentB": "Our revenue is exclusively derived from our collaboration agreements, which can result in significant fluctuation in our revenue from period to period, and our past revenue is therefore not necessarily indicative of our future revenue.", "type": 2, "words": ["<tag1>", "Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "which", "can", "result", "in", "significant", "fluctuation", "in", "our", "revenue", "from", "period", "to", "period,", "and", "our", "past", "revenue", "is", "theref", "ore", "not", "necessarily", "indicative", "of", "our", "future", "revenue.", "<tag2>", "Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "which", "can", "result", "in", "significant", "fluctuation", "in", "our", "revenue", "from", "period", "to", "period,", "and", "our", "past", "revenue", "is", "therefore", "not", "necessarily", "indicative", "of", "our", "future", "revenue.", "<tag3>"], "wordsA": ["Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "which", "can", "result", "in", "significant", "fluctuation", "in", "our", "revenue", "from", "period", "to", "period,", "and", "our", "past", "revenue", "is", "theref", "ore", "not", "necessarily", "indicative", "of", "our", "future", "revenue."], "wordsB": ["Our", "revenue", "is", "exclusively", "derived", "from", "our", "collaboration", "agreements,", "which", "can", "result", "in", "significant", "fluctuation", "in", "our", "revenue", "from", "period", "to", "period,", "and", "our", "past", "revenue", "is", "therefore", "not", "necessarily", "indicative", "of", "our", "future", "revenue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p47_s0", "idA": "906709_17_item1a_p37_s6", "sentA": "If we are unable either to create sales, marketing and distribution capabilities or to enter into agreements with third parties to perform these functions, we will be unable to commercialize our product candidates successfully.", "sentB": "If we are unable either to create sales, marketing and distribution capabilitie s or to enter into agreements with third parties to perform these functions, we will be unable to commercialize our product candidates successfully.", "type": 2, "words": ["<tag1>", "If", "we", "are", "unable", "either", "to", "create", "sales,", "marketing", "and", "distribution", "capabilities", "or", "to", "enter", "into", "agreements", "with", "third", "parties", "to", "perform", "these", "functions,", "we", "will", "be", "unable", "to", "commercialize", "our", "product", "candidates", "successfully.", "<tag2>", "If", "we", "are", "unable", "either", "to", "create", "sales,", "marketing", "and", "distribution", "capabilitie", "s", "or", "to", "enter", "into", "agreements", "with", "third", "parties", "to", "perform", "these", "functions,", "we", "will", "be", "unable", "to", "commercialize", "our", "product", "candidates", "successfully.", "<tag3>"], "wordsA": ["If", "we", "are", "unable", "either", "to", "create", "sales,", "marketing", "and", "distribution", "capabilities", "or", "to", "enter", "into", "agreements", "with", "third", "parties", "to", "perform", "these", "functions,", "we", "will", "be", "unable", "to", "commercialize", "our", "product", "candidates", "successfully."], "wordsB": ["If", "we", "are", "unable", "either", "to", "create", "sales,", "marketing", "and", "distribution", "capabilitie", "s", "or", "to", "enter", "into", "agreements", "with", "third", "parties", "to", "perform", "these", "functions,", "we", "will", "be", "unable", "to", "commercialize", "our", "product", "candidates", "successfully."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p44_s2", "idA": "906709_17_item1a_p39_s6", "sentA": "For example, there are only a limited number of qualified suppliers, and in some cases single source suppliers, for the raw materials included in our advanced polymer conjugate drug formulations.", "sentB": "For example, there are only a limited number of qualified suppliers, and in some cases single source suppliers, for the raw materials included in our PEGylation and advanced polymer conjugate drug formulations.", "type": 2, "words": ["<tag1>", "For", "example,", "there", "are", "only", "a", "limited", "number", "of", "qualified", "suppliers,", "and", "in", "some", "cases", "single", "source", "suppliers,", "for", "the", "raw", "materials", "included", "in", "our", "advanced", "polymer", "conjugate", "drug", "formulations.", "<tag2>", "For", "example,", "there", "are", "only", "a", "limited", "number", "of", "qualified", "suppliers,", "and", "in", "some", "cases", "single", "source", "suppliers,", "for", "the", "raw", "materials", "included", "in", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "drug", "formulations.", "<tag3>"], "wordsA": ["For", "example,", "there", "are", "only", "a", "limited", "number", "of", "qualified", "suppliers,", "and", "in", "some", "cases", "single", "source", "suppliers,", "for", "the", "raw", "materials", "included", "in", "our", "advanced", "polymer", "conjugate", "drug", "formulations."], "wordsB": ["For", "example,", "there", "are", "only", "a", "limited", "number", "of", "qualified", "suppliers,", "and", "in", "some", "cases", "single", "source", "suppliers,", "for", "the", "raw", "materials", "included", "in", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "drug", "formulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p5_s0", "idA": "906709_17_item1a_p3_s1", "sentA": "We, the FDA, IRB, an independent ethics committee, or other applicable regulatory authorities may suspend clinical trials of a product candidate at any time for various reasons, including a belief that subjects participating in such trials are being exposed to unacceptable health risks or adverse side effects.", "sentB": "We, the FDA, an independent Institutional Review Board (IRB), an independent ethics committee, or other applicable regulatory authorities may suspend clinical trials of a product candidate at any time for various reasons, including a belief that subjects participating in such trials are being exposed to unacceptable health risks or adverse side effects.", "type": 2, "words": ["<tag1>", "We,", "the", "FDA,", "IRB,", "an", "independent", "ethics", "committee,", "or", "other", "applicable", "regulatory", "authorities", "may", "suspend", "clinical", "trials", "of", "a", "product", "candidate", "at", "any", "time", "for", "various", "reasons,", "including", "a", "belief", "that", "subjects", "participating", "in", "such", "trials", "are", "being", "exposed", "to", "unacceptable", "health", "risks", "or", "adverse", "side", "effects.", "<tag2>", "We,", "the", "FDA,", "an", "independent", "Institutional", "Review", "Board", "(IRB),", "an", "independent", "ethics", "committee,", "or", "other", "applicable", "regulatory", "authorities", "may", "suspend", "clinical", "trials", "of", "a", "product", "candidate", "at", "any", "time", "for", "various", "reasons,", "including", "a", "belief", "that", "subjects", "participating", "in", "such", "trials", "are", "being", "exposed", "to", "unacceptable", "health", "risks", "or", "adverse", "side", "effects.", "<tag3>"], "wordsA": ["We,", "the", "FDA,", "IRB,", "an", "independent", "ethics", "committee,", "or", "other", "applicable", "regulatory", "authorities", "may", "suspend", "clinical", "trials", "of", "a", "product", "candidate", "at", "any", "time", "for", "various", "reasons,", "including", "a", "belief", "that", "subjects", "participating", "in", "such", "trials", "are", "being", "exposed", "to", "unacceptable", "health", "risks", "or", "adverse", "side", "effects."], "wordsB": ["We,", "the", "FDA,", "an", "independent", "Institutional", "Review", "Board", "(IRB),", "an", "independent", "ethics", "committee,", "or", "other", "applicable", "regulatory", "authorities", "may", "suspend", "clinical", "trials", "of", "a", "product", "candidate", "at", "any", "time", "for", "various", "reasons,", "including", "a", "belief", "that", "subjects", "participating", "in", "such", "trials", "are", "being", "exposed", "to", "unacceptable", "health", "risks", "or", "adverse", "side", "effects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p2_s3", "idA": "906709_17_item1a_p3_s3", "sentA": "If one or more of our drug candidates fail in clinical studies, it could have a material adverse effect on our business, financial condition and results of operations.", "sentB": "If one or more clinical studies of NKTR-214 are not successful, it would materially harm our market valuation, prospects, financial condition and results of operations.", "type": 2, "words": ["<tag1>", "If", "one", "or", "more", "of", "our", "drug", "candidates", "fail", "in", "clinical", "studies,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "If", "one", "or", "more", "clinical", "studies", "of", "NKTR-214", "are", "not", "successful,", "it", "would", "materially", "harm", "our", "market", "valuation,", "prospects,", "financial", "condition", "and", "results", "of", "operations.", "<tag3>"], "wordsA": ["If", "one", "or", "more", "of", "our", "drug", "candidates", "fail", "in", "clinical", "studies,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["If", "one", "or", "more", "clinical", "studies", "of", "NKTR-214", "are", "not", "successful,", "it", "would", "materially", "harm", "our", "market", "valuation,", "prospects,", "financial", "condition", "and", "results", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p6_s1", "idA": "906709_17_item1a_p3_s5", "sentA": "Under our collaboration agreements with various pharmaceutical or biotechnology companies, our collaboration partner is generally solely responsible for:", "sentB": "Under our collaboration agreements with various pharmaceutical or biotechnology companies (other than the BMS Collaboration Agreement), our collaboration partner is generally solely responsible for:", "type": 2, "words": ["<tag1>", "Under", "our", "collaboration", "agreements", "with", "various", "pharmaceutical", "or", "biotechnology", "companies,", "our", "collaboration", "partner", "is", "generally", "solely", "responsible", "for:", "<tag2>", "Under", "our", "collaboration", "agreements", "with", "various", "pharmaceutical", "or", "biotechnology", "companies", "(other", "than", "the", "BMS", "Collaboration", "Agreement),", "our", "collaboration", "partner", "is", "generally", "solely", "responsible", "for:", "<tag3>"], "wordsA": ["Under", "our", "collaboration", "agreements", "with", "various", "pharmaceutical", "or", "biotechnology", "companies,", "our", "collaboration", "partner", "is", "generally", "solely", "responsible", "for:"], "wordsB": ["Under", "our", "collaboration", "agreements", "with", "various", "pharmaceutical", "or", "biotechnology", "companies", "(other", "than", "the", "BMS", "Collaboration", "Agreement),", "our", "collaboration", "partner", "is", "generally", "solely", "responsible", "for:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p49_s10", "idA": "906709_17_item1a_p40_s6", "sentA": "For the year ended December 31, 2016, we reported a net loss of $153.5 million.", "sentB": "For the year ended December 31, 2017, we reported a net loss of $96.7 million.", "type": 2, "words": ["<tag1>", "For", "the", "year", "ended", "December", "31,", "2016,", "we", "reported", "a", "net", "loss", "of", "$153.5", "million.", "<tag2>", "For", "the", "year", "ended", "December", "31,", "2017,", "we", "reported", "a", "net", "loss", "of", "$96.7", "million.", "<tag3>"], "wordsA": ["For", "the", "year", "ended", "December", "31,", "2016,", "we", "reported", "a", "net", "loss", "of", "$153.5", "million."], "wordsB": ["For", "the", "year", "ended", "December", "31,", "2017,", "we", "reported", "a", "net", "loss", "of", "$96.7", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p52_s1", "idA": "906709_17_item1a_p43_s1", "sentA": "In both domestic and foreign markets, sales of our partnered and proprietary products that have received regulatory approval will depend in part on market acceptance among physicians and patients, pricing approvals by government authorities and the availability of payment or reimbursement from third-party payers, such as government health administration authorities, managed care providers, private health insurers and other organizations.", "sentB": "In both domestic and foreign markets, sales of our partnered and proprietary products that have received regulatory approval will depend in part on market acceptance among physicians and patients, pricing approvals by government authorities and the availability of coverage and payment or reimbursement from third-party payers, such as government programs, including Medicare and Medicaid, managed care providers, private health insurers and other organizations.", "type": 2, "words": ["<tag1>", "In", "both", "domestic", "and", "foreign", "markets,", "sales", "of", "our", "partnered", "and", "proprietary", "products", "that", "have", "received", "regulatory", "approval", "will", "depend", "in", "part", "on", "market", "acceptance", "among", "physicians", "and", "patients,", "pricing", "approvals", "by", "government", "authorities", "and", "the", "availability", "of", "payment", "or", "reimbursement", "from", "third-party", "payers,", "such", "as", "government", "health", "administration", "authorities,", "managed", "care", "providers,", "private", "health", "insurers", "and", "other", "organizations.", "<tag2>", "In", "both", "domestic", "and", "foreign", "markets,", "sales", "of", "our", "partnered", "and", "proprietary", "products", "that", "have", "received", "regulatory", "approval", "will", "depend", "in", "part", "on", "market", "acceptance", "among", "physicians", "and", "patients,", "pricing", "approvals", "by", "government", "authorities", "and", "the", "availability", "of", "coverage", "and", "payment", "or", "reimbursement", "from", "third-party", "payers,", "such", "as", "government", "programs,", "including", "Medicare", "and", "Medicaid,", "managed", "care", "providers,", "private", "health", "insurers", "and", "other", "organizations.", "<tag3>"], "wordsA": ["In", "both", "domestic", "and", "foreign", "markets,", "sales", "of", "our", "partnered", "and", "proprietary", "products", "that", "have", "received", "regulatory", "approval", "will", "depend", "in", "part", "on", "market", "acceptance", "among", "physicians", "and", "patients,", "pricing", "approvals", "by", "government", "authorities", "and", "the", "availability", "of", "payment", "or", "reimbursement", "from", "third-party", "payers,", "such", "as", "government", "health", "administration", "authorities,", "managed", "care", "providers,", "private", "health", "insurers", "and", "other", "organizations."], "wordsB": ["In", "both", "domestic", "and", "foreign", "markets,", "sales", "of", "our", "partnered", "and", "proprietary", "products", "that", "have", "received", "regulatory", "approval", "will", "depend", "in", "part", "on", "market", "acceptance", "among", "physicians", "and", "patients,", "pricing", "approvals", "by", "government", "authorities", "and", "the", "availability", "of", "coverage", "and", "payment", "or", "reimbursement", "from", "third-party", "payers,", "such", "as", "government", "programs,", "including", "Medicare", "and", "Medicaid,", "managed", "care", "providers,", "private", "health", "insurers", "and", "other", "organizations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p53_s0", "idA": "906709_17_item1a_p43_s2", "sentA": "Such third-party payers are increasingly challenging the price and cost effectiveness of medical products and services.", "sentB": "Third-party payers are increasingly challenging the price and cost effectiveness of medical products and services.", "type": 2, "words": ["<tag1>", "Such", "third-party", "payers", "are", "increasingly", "challenging", "the", "price", "and", "cost", "effectiveness", "of", "medical", "products", "and", "services.", "<tag2>", "Third-party", "payers", "are", "increasingly", "challenging", "the", "price", "and", "cost", "effectiveness", "of", "medical", "products", "and", "services.", "<tag3>"], "wordsA": ["Such", "third-party", "payers", "are", "increasingly", "challenging", "the", "price", "and", "cost", "effectiveness", "of", "medical", "products", "and", "services."], "wordsB": ["Third-party", "payers", "are", "increasingly", "challenging", "the", "price", "and", "cost", "effectiveness", "of", "medical", "products", "and", "services."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p53_s1", "idA": "906709_17_item1a_p43_s3", "sentA": "Therefore, significant uncertainty exists as to the pricing approvals for, and the payment or reimbursement status of, newly approved healthcare products.", "sentB": "Therefore, significant uncertainty exists as to the coverage and pricing approvals for, and the payment or reimbursement status of, newly approved healthcare products.", "type": 2, "words": ["<tag1>", "Therefore,", "significant", "uncertainty", "exists", "as", "to", "the", "pricing", "approvals", "for,", "and", "the", "payment", "or", "reimbursement", "status", "of,", "newly", "approved", "healthcare", "products.", "<tag2>", "Therefore,", "significant", "uncertainty", "exists", "as", "to", "the", "coverage", "and", "pricing", "approvals", "for,", "and", "the", "payment", "or", "reimbursement", "status", "of,", "newly", "approved", "healthcare", "products.", "<tag3>"], "wordsA": ["Therefore,", "significant", "uncertainty", "exists", "as", "to", "the", "pricing", "approvals", "for,", "and", "the", "payment", "or", "reimbursement", "status", "of,", "newly", "approved", "healthcare", "products."], "wordsB": ["Therefore,", "significant", "uncertainty", "exists", "as", "to", "the", "coverage", "and", "pricing", "approvals", "for,", "and", "the", "payment", "or", "reimbursement", "status", "of,", "newly", "approved", "healthcare", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p53_s2", "idA": "906709_17_item1a_p43_s4", "sentA": "Moreover, legislation and regulations affecting the pricing of pharmaceuticals may change before regulatory agencies approve our proposed products for marketing and could further limit pricing approvals for, and reimbursement of, our products from government authorities and third-party payers.", "sentB": "Moreover, legislation and regulations affecting the pricing of pharmaceuticals may change before regulatory agencies approve our proposed products for marketing and could further limit coverage or pricing approvals for, and reimbursement of, our products from government authorities and third-party payers.", "type": 2, "words": ["<tag1>", "Moreover,", "legislation", "and", "regulations", "affecting", "the", "pricing", "of", "pharmaceuticals", "may", "change", "before", "regulatory", "agencies", "approve", "our", "proposed", "products", "for", "marketing", "and", "could", "further", "limit", "pricing", "approvals", "for,", "and", "reimbursement", "of,", "our", "products", "from", "government", "authorities", "and", "third-party", "payers.", "<tag2>", "Moreover,", "legislation", "and", "regulations", "affecting", "the", "pricing", "of", "pharmaceuticals", "may", "change", "before", "regulatory", "agencies", "approve", "our", "proposed", "products", "for", "marketing", "and", "could", "further", "limit", "coverage", "or", "pricing", "approvals", "for,", "and", "reimbursement", "of,", "our", "products", "from", "government", "authorities", "and", "third-party", "payers.", "<tag3>"], "wordsA": ["Moreover,", "legislation", "and", "regulations", "affecting", "the", "pricing", "of", "pharmaceuticals", "may", "change", "before", "regulatory", "agencies", "approve", "our", "proposed", "products", "for", "marketing", "and", "could", "further", "limit", "pricing", "approvals", "for,", "and", "reimbursement", "of,", "our", "products", "from", "government", "authorities", "and", "third-party", "payers."], "wordsB": ["Moreover,", "legislation", "and", "regulations", "affecting", "the", "pricing", "of", "pharmaceuticals", "may", "change", "before", "regulatory", "agencies", "approve", "our", "proposed", "products", "for", "marketing", "and", "could", "further", "limit", "coverage", "or", "pricing", "approvals", "for,", "and", "reimbursement", "of,", "our", "products", "from", "government", "authorities", "and", "third-party", "payers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p53_s6", "idA": "906709_17_item1a_p44_s0", "sentA": "New government legislation or regulations related to pricing or a government or third-party payer decision not to approve pricing for, or provide adequate coverage and reimbursements of, our products hold the potential to severely limit market opportunities of such products.", "sentB": "New government legislation or regulations related to pricing or other fundamental changes to the healthcare delivery system as well as a government or third-party payer decision not to approve pricing for, or provide adequate coverage or reimbursement of, our products hold the potential to severely limit market opportunities of such products.", "type": 2, "words": ["<tag1>", "New", "government", "legislation", "or", "regulations", "related", "to", "pricing", "or", "a", "government", "or", "third-party", "payer", "decision", "not", "to", "approve", "pricing", "for,", "or", "provide", "adequate", "coverage", "and", "reimbursements", "of,", "our", "products", "hold", "the", "potential", "to", "severely", "limit", "market", "opportunities", "of", "such", "products.", "<tag2>", "New", "government", "legislation", "or", "regulations", "related", "to", "pricing", "or", "other", "fundamental", "changes", "to", "the", "healthcare", "delivery", "system", "as", "well", "as", "a", "government", "or", "third-party", "payer", "decision", "not", "to", "approve", "pricing", "for,", "or", "provide", "adequate", "coverage", "or", "reimbursement", "of,", "our", "products", "hold", "the", "potential", "to", "severely", "limit", "market", "opportunities", "of", "such", "products.", "<tag3>"], "wordsA": ["New", "government", "legislation", "or", "regulations", "related", "to", "pricing", "or", "a", "government", "or", "third-party", "payer", "decision", "not", "to", "approve", "pricing", "for,", "or", "provide", "adequate", "coverage", "and", "reimbursements", "of,", "our", "products", "hold", "the", "potential", "to", "severely", "limit", "market", "opportunities", "of", "such", "products."], "wordsB": ["New", "government", "legislation", "or", "regulations", "related", "to", "pricing", "or", "other", "fundamental", "changes", "to", "the", "healthcare", "delivery", "system", "as", "well", "as", "a", "government", "or", "third-party", "payer", "decision", "not", "to", "approve", "pricing", "for,", "or", "provide", "adequate", "coverage", "or", "reimbursement", "of,", "our", "products", "hold", "the", "potential", "to", "severely", "limit", "market", "opportunities", "of", "such", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p53_s7", "idA": "906709_17_item1a_p45_s0", "sentA": "We depend on third parties to conduct the clinical trials for our proprietary product candidates and any failure of those parties to fulfill their obl igations could harm our development and commercialization plans.", "sentB": "We depend on third parties to conduct the clinical trials for our proprietary product candidates and any failure of those parties to fulfill their obligations could harm our development and commercialization plans.", "type": 2, "words": ["<tag1>", "We", "depend", "on", "third", "parties", "to", "conduct", "the", "clinical", "trials", "for", "our", "proprietary", "product", "candidates", "and", "any", "failure", "of", "those", "parties", "to", "fulfill", "their", "obl", "igations", "could", "harm", "our", "development", "and", "commercialization", "plans.", "<tag2>", "We", "depend", "on", "third", "parties", "to", "conduct", "the", "clinical", "trials", "for", "our", "proprietary", "product", "candidates", "and", "any", "failure", "of", "those", "parties", "to", "fulfill", "their", "obligations", "could", "harm", "our", "development", "and", "commercialization", "plans.", "<tag3>"], "wordsA": ["We", "depend", "on", "third", "parties", "to", "conduct", "the", "clinical", "trials", "for", "our", "proprietary", "product", "candidates", "and", "any", "failure", "of", "those", "parties", "to", "fulfill", "their", "obl", "igations", "could", "harm", "our", "development", "and", "commercialization", "plans."], "wordsB": ["We", "depend", "on", "third", "parties", "to", "conduct", "the", "clinical", "trials", "for", "our", "proprietary", "product", "candidates", "and", "any", "failure", "of", "those", "parties", "to", "fulfill", "their", "obligations", "could", "harm", "our", "development", "and", "commercialization", "plans."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p55_s0", "idA": "906709_17_item1a_p47_s0", "sentA": "There are many competitors for our proprietary product candidates currently in development.", "sentB": "There are many competitors for our proprietary product candidates currently in developm ent.", "type": 2, "words": ["<tag1>", "There", "are", "many", "competitors", "for", "our", "proprietary", "product", "candidates", "currently", "in", "development.", "<tag2>", "There", "are", "many", "competitors", "for", "our", "proprietary", "product", "candidates", "currently", "in", "developm", "ent.", "<tag3>"], "wordsA": ["There", "are", "many", "competitors", "for", "our", "proprietary", "product", "candidates", "currently", "in", "development."], "wordsB": ["There", "are", "many", "competitors", "for", "our", "proprietary", "product", "candidates", "currently", "in", "developm", "ent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p56_s0", "idA": "906709_17_item1a_p48_s1", "sentA": "For MOVANTIK , there are currently several alternative therapies used to address opioid-induced constipation (OIC) and opioid-induced bowel dysfunction (OBD), including RELISTOR Subcutaneous Injection (methylnaltrexone bromide), oral therapy Amitizia (lubiprostone), and oral and rectal over-the-counter laxatives and stool softeners such as docusate sodium, senna and milk of magnesia.", "sentB": "For MOVANTIK , there are currently several alternative therapies used to address opioid-induced constipation (OIC) and opioid-induced bowel dysfunction (OBD), including Symproic (naldemedine) from Shionogi and Purdue Pharma L.P., RELISTOR Subcutaneo us Injection (methylnaltrexone bromide), oral therapy Amitizia (lubiprostone), and oral and rectal over-the-counter laxatives and stool softeners such as docusate sodium, senna and milk of magnesia.", "type": 2, "words": ["<tag1>", "For", "MOVANTIK", ",", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "RELISTOR", "Subcutaneous", "Injection", "(methylnaltrexone", "bromide),", "oral", "therapy", "Amitizia", "(lubiprostone),", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia.", "<tag2>", "For", "MOVANTIK", ",", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "Symproic", "(naldemedine)", "from", "Shionogi", "and", "Purdue", "Pharma", "L.P.,", "RELISTOR", "Subcutaneo", "us", "Injection", "(methylnaltrexone", "bromide),", "oral", "therapy", "Amitizia", "(lubiprostone),", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia.", "<tag3>"], "wordsA": ["For", "MOVANTIK", ",", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "RELISTOR", "Subcutaneous", "Injection", "(methylnaltrexone", "bromide),", "oral", "therapy", "Amitizia", "(lubiprostone),", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia."], "wordsB": ["For", "MOVANTIK", ",", "there", "are", "currently", "several", "alternative", "therapies", "used", "to", "address", "opioid-induced", "constipation", "(OIC)", "and", "opioid-induced", "bowel", "dysfunction", "(OBD),", "including", "Symproic", "(naldemedine)", "from", "Shionogi", "and", "Purdue", "Pharma", "L.P.,", "RELISTOR", "Subcutaneo", "us", "Injection", "(methylnaltrexone", "bromide),", "oral", "therapy", "Amitizia", "(lubiprostone),", "and", "oral", "and", "rectal", "over-the-counter", "laxatives", "and", "stool", "softeners", "such", "as", "docusate", "sodium,", "senna", "and", "milk", "of", "magnesia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p56_s1", "idA": "906709_17_item1a_p48_s2", "sentA": "In addition, there are a number of companies developing potential products which are in various stages of clinical development and are being evaluated for the treatment of OIC and OBD in different patient populations, including Merck Co., Inc., Progenics Pharmaceuticals, Inc. in collaboration with Salix Pharmaceuticals, Ltd., Purdue Pharma L.P. in collaboration with Shionogi Co., Ltd., Mundipharma Int.", "sentB": "In addition, there are a number of companies developing p otential products which are in various stages of clinical development and are being evaluated for the treatment of OIC and OBD in different patient populations, including Merck Co., Inc., Progenics Pharmaceuticals, Inc. in collaboration with Salix Pharma ceuticals, Ltd., Purdue Pharma L.P. in collaboration with Shionogi Co., Ltd., Mundipharma Int.", "type": 2, "words": ["<tag1>", "In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Merck", "Co.,", "Inc.,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Purdue", "Pharma", "L.P.", "in", "collaboration", "with", "Shionogi", "Co.,", "Ltd.,", "Mundipharma", "Int.", "<tag2>", "In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "p", "otential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Merck", "Co.,", "Inc.,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharma", "ceuticals,", "Ltd.,", "Purdue", "Pharma", "L.P.", "in", "collaboration", "with", "Shionogi", "Co.,", "Ltd.,", "Mundipharma", "Int.", "<tag3>"], "wordsA": ["In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Merck", "Co.,", "Inc.,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Purdue", "Pharma", "L.P.", "in", "collaboration", "with", "Shionogi", "Co.,", "Ltd.,", "Mundipharma", "Int."], "wordsB": ["In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "p", "otential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Merck", "Co.,", "Inc.,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharma", "ceuticals,", "Ltd.,", "Purdue", "Pharma", "L.P.", "in", "collaboration", "with", "Shionogi", "Co.,", "Ltd.,", "Mundipharma", "Int."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p61_s0", "idA": "906709_17_item1a_p48_s2", "sentA": "In addition, there are a number of companies developing potential products which are in various stages of clinical development and are being evaluated for the treatment of OIC and OBD in different patient populations, including Merck Co., Inc., Progenics Pharmaceuticals, Inc. in collaboration with Salix Pharmaceuticals, Ltd., Purdue Pharma L.P. in collaboration with Shionogi Co., Ltd., Mundipharma Int.", "sentB": "For NKTR 358, there are a number of compe titors in various stages of clinical development that are working on programs which are designed to correct the underlying immune system imbalance in the body due to autoimmune disease.", "type": 2, "words": ["<tag1>", "In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Merck", "Co.,", "Inc.,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Purdue", "Pharma", "L.P.", "in", "collaboration", "with", "Shionogi", "Co.,", "Ltd.,", "Mundipharma", "Int.", "<tag2>", "For", "NKTR", "358,", "there", "are", "a", "number", "of", "compe", "titors", "in", "various", "stages", "of", "clinical", "development", "that", "are", "working", "on", "programs", "which", "are", "designed", "to", "correct", "the", "underlying", "immune", "system", "imbalance", "in", "the", "body", "due", "to", "autoimmune", "disease.", "<tag3>"], "wordsA": ["In", "addition,", "there", "are", "a", "number", "of", "companies", "developing", "potential", "products", "which", "are", "in", "various", "stages", "of", "clinical", "development", "and", "are", "being", "evaluated", "for", "the", "treatment", "of", "OIC", "and", "OBD", "in", "different", "patient", "populations,", "including", "Merck", "Co.,", "Inc.,", "Progenics", "Pharmaceuticals,", "Inc.", "in", "collaboration", "with", "Salix", "Pharmaceuticals,", "Ltd.,", "Purdue", "Pharma", "L.P.", "in", "collaboration", "with", "Shionogi", "Co.,", "Ltd.,", "Mundipharma", "Int."], "wordsB": ["For", "NKTR", "358,", "there", "are", "a", "number", "of", "compe", "titors", "in", "various", "stages", "of", "clinical", "development", "that", "are", "working", "on", "programs", "which", "are", "designed", "to", "correct", "the", "underlying", "immune", "system", "imbalance", "in", "the", "body", "due", "to", "autoimmune", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p57_s0", "idA": "906709_17_item1a_p48_s4", "sentA": "For ADYNOVATE , on June 6, 2014, the FDA approved Biogen Idec s ELOCTATE for the control and prevention of bleeding episodes, perioperative (surgical) management and routine prophylaxis in adults and children with Hemophilia A, and Bayer Healthcare and Novo Nordisk have ongoing Phase 3 clinical development programs for longer acting Factor VIII proteins based on polymer conjugation technology approaches.", "sentB": "Fo r ADYNOVATE , o n June 6, 2014, the FDA approved Biogen Idec s Fc fusion protein ELOCTATE TM for the control and prevention of bleeding episodes, perioperative (surgical) management and routine prophylaxis in adults and children with Hemophilia A. Longer ac ting Factor VIII proteins based on polymer conjugation technology approaches are being pursued by Bayer Healthcare LLC (which has filed for regulatory approval in the U.S.) and Novo Nordisk (which has an ongoing Phase 3 clinical development program).", "type": 2, "words": ["<tag1>", "For", "ADYNOVATE", ",", "on", "June", "6,", "2014,", "the", "FDA", "approved", "Biogen", "Idec", "s", "ELOCTATE", "for", "the", "control", "and", "prevention", "of", "bleeding", "episodes,", "perioperative", "(surgical)", "management", "and", "routine", "prophylaxis", "in", "adults", "and", "children", "with", "Hemophilia", "A,", "and", "Bayer", "Healthcare", "and", "Novo", "Nordisk", "have", "ongoing", "Phase", "3", "clinical", "development", "programs", "for", "longer", "acting", "Factor", "VIII", "proteins", "based", "on", "polymer", "conjugation", "technology", "approaches.", "<tag2>", "Fo", "r", "ADYNOVATE", ",", "o", "n", "June", "6,", "2014,", "the", "FDA", "approved", "Biogen", "Idec", "s", "Fc", "fusion", "protein", "ELOCTATE", "TM", "for", "the", "control", "and", "prevention", "of", "bleeding", "episodes,", "perioperative", "(surgical)", "management", "and", "routine", "prophylaxis", "in", "adults", "and", "children", "with", "Hemophilia", "A.", "Longer", "ac", "ting", "Factor", "VIII", "proteins", "based", "on", "polymer", "conjugation", "technology", "approaches", "are", "being", "pursued", "by", "Bayer", "Healthcare", "LLC", "(which", "has", "filed", "for", "regulatory", "approval", "in", "the", "U.S.)", "and", "Novo", "Nordisk", "(which", "has", "an", "ongoing", "Phase", "3", "clinical", "development", "program).", "<tag3>"], "wordsA": ["For", "ADYNOVATE", ",", "on", "June", "6,", "2014,", "the", "FDA", "approved", "Biogen", "Idec", "s", "ELOCTATE", "for", "the", "control", "and", "prevention", "of", "bleeding", "episodes,", "perioperative", "(surgical)", "management", "and", "routine", "prophylaxis", "in", "adults", "and", "children", "with", "Hemophilia", "A,", "and", "Bayer", "Healthcare", "and", "Novo", "Nordisk", "have", "ongoing", "Phase", "3", "clinical", "development", "programs", "for", "longer", "acting", "Factor", "VIII", "proteins", "based", "on", "polymer", "conjugation", "technology", "approaches."], "wordsB": ["Fo", "r", "ADYNOVATE", ",", "o", "n", "June", "6,", "2014,", "the", "FDA", "approved", "Biogen", "Idec", "s", "Fc", "fusion", "protein", "ELOCTATE", "TM", "for", "the", "control", "and", "prevention", "of", "bleeding", "episodes,", "perioperative", "(surgical)", "management", "and", "routine", "prophylaxis", "in", "adults", "and", "children", "with", "Hemophilia", "A.", "Longer", "ac", "ting", "Factor", "VIII", "proteins", "based", "on", "polymer", "conjugation", "technology", "approaches", "are", "being", "pursued", "by", "Bayer", "Healthcare", "LLC", "(which", "has", "filed", "for", "regulatory", "approval", "in", "the", "U.S.)", "and", "Novo", "Nordisk", "(which", "has", "an", "ongoing", "Phase", "3", "clinical", "development", "program)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p58_s0", "idA": "906709_17_item1a_p49_s0", "sentA": "For NKTR-181, there are numerous companies developing pain therapies designed to have less abuse potential primarily through formulation technologies and techniques applied to existing pain therapies.", "sentB": "In a ddition, technologies other than those based on Fc fusion and polymer conjugation approaches (such as gene therapy) are being pursued to treat patients with Hemophilia A. For NKTR-181, t here are numerous companies developing pain therapies designed to hav e less abuse potential primarily through formulation technologies and techniques applied to existing pain therapies.", "type": 2, "words": ["<tag1>", "For", "NKTR-181,", "there", "are", "numerous", "companies", "developing", "pain", "therapies", "designed", "to", "have", "less", "abuse", "potential", "primarily", "through", "formulation", "technologies", "and", "techniques", "applied", "to", "existing", "pain", "therapies.", "<tag2>", "In", "a", "ddition,", "technologies", "other", "than", "those", "based", "on", "Fc", "fusion", "and", "polymer", "conjugation", "approaches", "(such", "as", "gene", "therapy)", "are", "being", "pursued", "to", "treat", "patients", "with", "Hemophilia", "A.", "For", "NKTR-181,", "t", "here", "are", "numerous", "companies", "developing", "pain", "therapies", "designed", "to", "hav", "e", "less", "abuse", "potential", "primarily", "through", "formulation", "technologies", "and", "techniques", "applied", "to", "existing", "pain", "therapies.", "<tag3>"], "wordsA": ["For", "NKTR-181,", "there", "are", "numerous", "companies", "developing", "pain", "therapies", "designed", "to", "have", "less", "abuse", "potential", "primarily", "through", "formulation", "technologies", "and", "techniques", "applied", "to", "existing", "pain", "therapies."], "wordsB": ["In", "a", "ddition,", "technologies", "other", "than", "those", "based", "on", "Fc", "fusion", "and", "polymer", "conjugation", "approaches", "(such", "as", "gene", "therapy)", "are", "being", "pursued", "to", "treat", "patients", "with", "Hemophilia", "A.", "For", "NKTR-181,", "t", "here", "are", "numerous", "companies", "developing", "pain", "therapies", "designed", "to", "hav", "e", "less", "abuse", "potential", "primarily", "through", "formulation", "technologies", "and", "techniques", "applied", "to", "existing", "pain", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p58_s1", "idA": "906709_17_item1a_p49_s1", "sentA": "Potential competitors include Acura Pharmaceuticals, Inc., Cara Therapeutics, Inc., Collegium Pharmaceutical, Inc., Egalet Ltd, Elite Pharmaceuticals, Inc., Endo Health Solutions Inc., KemPharm, Inc., Pfizer, Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Ltd.", "sentB": "Potential competitors include Acura Pharmaceuticals, Inc., Cara Therapeutics, Inc., Collegium Pharmaceutical, Inc., Egalet Ltd, Elite Pharm aceuticals, Inc., Endo Health Solutions Inc., KemPharm, Inc., Pfizer, Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Ltd.", "type": 2, "words": ["<tag1>", "Potential", "competitors", "include", "Acura", "Pharmaceuticals,", "Inc.,", "Cara", "Therapeutics,", "Inc.,", "Collegium", "Pharmaceutical,", "Inc.,", "Egalet", "Ltd,", "Elite", "Pharmaceuticals,", "Inc.,", "Endo", "Health", "Solutions", "Inc.,", "KemPharm,", "Inc.,", "Pfizer,", "Inc.,", "Purdue", "Pharma", "L.P.,", "and", "Teva", "Pharmaceutical", "Industries", "Ltd.", "<tag2>", "Potential", "competitors", "include", "Acura", "Pharmaceuticals,", "Inc.,", "Cara", "Therapeutics,", "Inc.,", "Collegium", "Pharmaceutical,", "Inc.,", "Egalet", "Ltd,", "Elite", "Pharm", "aceuticals,", "Inc.,", "Endo", "Health", "Solutions", "Inc.,", "KemPharm,", "Inc.,", "Pfizer,", "Inc.,", "Purdue", "Pharma", "L.P.,", "and", "Teva", "Pharmaceutical", "Industries", "Ltd.", "<tag3>"], "wordsA": ["Potential", "competitors", "include", "Acura", "Pharmaceuticals,", "Inc.,", "Cara", "Therapeutics,", "Inc.,", "Collegium", "Pharmaceutical,", "Inc.,", "Egalet", "Ltd,", "Elite", "Pharmaceuticals,", "Inc.,", "Endo", "Health", "Solutions", "Inc.,", "KemPharm,", "Inc.,", "Pfizer,", "Inc.,", "Purdue", "Pharma", "L.P.,", "and", "Teva", "Pharmaceutical", "Industries", "Ltd."], "wordsB": ["Potential", "competitors", "include", "Acura", "Pharmaceuticals,", "Inc.,", "Cara", "Therapeutics,", "Inc.,", "Collegium", "Pharmaceutical,", "Inc.,", "Egalet", "Ltd,", "Elite", "Pharm", "aceuticals,", "Inc.,", "Endo", "Health", "Solutions", "Inc.,", "KemPharm,", "Inc.,", "Pfizer,", "Inc.,", "Purdue", "Pharma", "L.P.,", "and", "Teva", "Pharmaceutical", "Industries", "Ltd."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p59_s0", "idA": "906709_17_item1a_p50_s0", "sentA": "For ONZEALD TM there are a number of chemotherapies and cancer therapies approved today and in various stages of clinical development for breast cancer, including, but not limited to: Abraxane (paclitaxel protein-bound particles for injectable suspension (albumin bound)), Xeloda (capecitabine), Afinitor (everolimus), Doxil (doxorubicin HCl), Ellence (epirubicin), Gemzar (gemcitabine), Halaven (eribulin), Herceptin (trastuzumab), Hycamtin (topotecan), Ibrance (palbociclib), Ixempra (ixabepilone), Navelbine (vinolrebine), Iniparib, Paraplatin (carboplatin), Taxol (paclitaxel) and Taxotere (docetaxel).", "sentB": "For ONZEALD TM there are a number of chemotherapies and cancer therapies approved today and in various stages of clinica l development for breast cancer, including, but not limited to: Abraxane (paclitaxel protein-bound particles for injectable suspension (albumin bound)), Xeloda (capecitabine), Afinitor (everolimus), Doxil (doxorubicin HCl), Ellence (epirubicin), Gemza r (gemcitabine), Halaven (eribulin), Herceptin (trastuzumab), Hycamtin (topotecan), Ibrance (palbociclib), Ixempra (ixabepilone), Navelbine (vinolrebine), Iniparib, Paraplatin (carboplatin), Taxol (paclitaxel) and Taxotere (docetaxel).", "type": 2, "words": ["<tag1>", "For", "ONZEALD", "TM", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "cancer,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Xeloda", "(capecitabine),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ibrance", "(palbociclib),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel).", "<tag2>", "For", "ONZEALD", "TM", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinica", "l", "development", "for", "breast", "cancer,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Xeloda", "(capecitabine),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemza", "r", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ibrance", "(palbociclib),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel).", "<tag3>"], "wordsA": ["For", "ONZEALD", "TM", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinical", "development", "for", "breast", "cancer,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Xeloda", "(capecitabine),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemzar", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ibrance", "(palbociclib),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel)."], "wordsB": ["For", "ONZEALD", "TM", "there", "are", "a", "number", "of", "chemotherapies", "and", "cancer", "therapies", "approved", "today", "and", "in", "various", "stages", "of", "clinica", "l", "development", "for", "breast", "cancer,", "including,", "but", "not", "limited", "to:", "Abraxane", "(paclitaxel", "protein-bound", "particles", "for", "injectable", "suspension", "(albumin", "bound)),", "Xeloda", "(capecitabine),", "Afinitor", "(everolimus),", "Doxil", "(doxorubicin", "HCl),", "Ellence", "(epirubicin),", "Gemza", "r", "(gemcitabine),", "Halaven", "(eribulin),", "Herceptin", "(trastuzumab),", "Hycamtin", "(topotecan),", "Ibrance", "(palbociclib),", "Ixempra", "(ixabepilone),", "Navelbine", "(vinolrebine),", "Iniparib,", "Paraplatin", "(carboplatin),", "Taxol", "(paclitaxel)", "and", "Taxotere", "(docetaxel)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p60_s0", "idA": "906709_17_item1a_p50_s1", "sentA": "Major pharmaceutical or biotechnology companies with approved drugs or drugs in development for breast cancers include, but are not limited to, Bristol-Myers Squibb Company, Eli Lilly Co., Roche, GlaxoSmithKline plc, Johnson and Johnson, Pfizer Inc., Eisai Inc., and Sanofi Aventis S.A.", "sentB": "Major phar maceutical or biotechnology companies with approved drugs or drugs in development for breast cancers include, but are not limited to, Bristol-Myers Squibb Company, Eli Lilly Co., Roche, GlaxoSmithKline plc, Johnson and Johnson, Pfizer Inc., Eisai Inc., a nd Sanofi Aventis S.A.", "type": 2, "words": ["<tag1>", "Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "breast", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Myers", "Squibb", "Company,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer", "Inc.,", "Eisai", "Inc.,", "and", "Sanofi", "Aventis", "S.A.", "<tag2>", "Major", "phar", "maceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "breast", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Myers", "Squibb", "Company,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer", "Inc.,", "Eisai", "Inc.,", "a", "nd", "Sanofi", "Aventis", "S.A.", "<tag3>"], "wordsA": ["Major", "pharmaceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "breast", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Myers", "Squibb", "Company,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer", "Inc.,", "Eisai", "Inc.,", "and", "Sanofi", "Aventis", "S.A."], "wordsB": ["Major", "phar", "maceutical", "or", "biotechnology", "companies", "with", "approved", "drugs", "or", "drugs", "in", "development", "for", "breast", "cancers", "include,", "but", "are", "not", "limited", "to,", "Bristol-Myers", "Squibb", "Company,", "Eli", "Lilly", "Co.,", "Roche,", "GlaxoSmithKline", "plc,", "Johnson", "and", "Johnson,", "Pfizer", "Inc.,", "Eisai", "Inc.,", "a", "nd", "Sanofi", "Aventis", "S.A."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p60_s1", "idA": "906709_17_item1a_p51_s0", "sentA": "There are numerous companies engaged in developing immunotherapies to be used alone, or in combination, to treat a wide range of oncology indications targeting both solid and liquid tumors.", "sentB": "For NKTR-214, there are numerous companies engaged in developing immunotherapies to be used alone, or in combination, to treat a wide range of oncology indications targeting both solid and liquid tumors.", "type": 2, "words": ["<tag1>", "There", "are", "numerous", "companies", "engaged", "in", "developing", "immunotherapies", "to", "be", "used", "alone,", "or", "in", "combination,", "to", "treat", "a", "wide", "range", "of", "oncology", "indications", "targeting", "both", "solid", "and", "liquid", "tumors.", "<tag2>", "For", "NKTR-214,", "there", "are", "numerous", "companies", "engaged", "in", "developing", "immunotherapies", "to", "be", "used", "alone,", "or", "in", "combination,", "to", "treat", "a", "wide", "range", "of", "oncology", "indications", "targeting", "both", "solid", "and", "liquid", "tumors.", "<tag3>"], "wordsA": ["There", "are", "numerous", "companies", "engaged", "in", "developing", "immunotherapies", "to", "be", "used", "alone,", "or", "in", "combination,", "to", "treat", "a", "wide", "range", "of", "oncology", "indications", "targeting", "both", "solid", "and", "liquid", "tumors."], "wordsB": ["For", "NKTR-214,", "there", "are", "numerous", "companies", "engaged", "in", "developing", "immunotherapies", "to", "be", "used", "alone,", "or", "in", "combination,", "to", "treat", "a", "wide", "range", "of", "oncology", "indications", "targeting", "both", "solid", "and", "liquid", "tumors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p61_s1", "idA": "906709_17_item1a_p51_s1", "sentA": "In particular, we expect to compete with therapies with tumor infiltrating lymphocytes, or TILS, chimeric antigen receptor-expressing T cells, or CAR-T, cytokine-based therapies, and checkpoint inhibitors.", "sentB": "In particular, we expect to compete with therapies that could be cytok ine-based therapies (Symbiotix, LLC and Tizona Therapeutics), regulatory T cell therapies (Targazyme, Inc., Juno Therapeutics and Tract Therapeutics, Inc.), or IL-2-based and toleragen-based therapies (Celgene Corporation, Amgen Inc., Tolera Therapeutics, Inc., and Caladrius BioSciences, Inc.).", "type": 2, "words": ["<tag1>", "In", "particular,", "we", "expect", "to", "compete", "with", "therapies", "with", "tumor", "infiltrating", "lymphocytes,", "or", "TILS,", "chimeric", "antigen", "receptor-expressing", "T", "cells,", "or", "CAR-T,", "cytokine-based", "therapies,", "and", "checkpoint", "inhibitors.", "<tag2>", "In", "particular,", "we", "expect", "to", "compete", "with", "therapies", "that", "could", "be", "cytok", "ine-based", "therapies", "(Symbiotix,", "LLC", "and", "Tizona", "Therapeutics),", "regulatory", "T", "cell", "therapies", "(Targazyme,", "Inc.,", "Juno", "Therapeutics", "and", "Tract", "Therapeutics,", "Inc.),", "or", "IL-2-based", "and", "toleragen-based", "therapies", "(Celgene", "Corporation,", "Amgen", "Inc.,", "Tolera", "Therapeutics,", "Inc.,", "and", "Caladrius", "BioSciences,", "Inc.).", "<tag3>"], "wordsA": ["In", "particular,", "we", "expect", "to", "compete", "with", "therapies", "with", "tumor", "infiltrating", "lymphocytes,", "or", "TILS,", "chimeric", "antigen", "receptor-expressing", "T", "cells,", "or", "CAR-T,", "cytokine-based", "therapies,", "and", "checkpoint", "inhibitors."], "wordsB": ["In", "particular,", "we", "expect", "to", "compete", "with", "therapies", "that", "could", "be", "cytok", "ine-based", "therapies", "(Symbiotix,", "LLC", "and", "Tizona", "Therapeutics),", "regulatory", "T", "cell", "therapies", "(Targazyme,", "Inc.,", "Juno", "Therapeutics", "and", "Tract", "Therapeutics,", "Inc.),", "or", "IL-2-based", "and", "toleragen-based", "therapies", "(Celgene", "Corporation,", "Amgen", "Inc.,", "Tolera", "Therapeutics,", "Inc.,", "and", "Caladrius", "BioSciences,", "Inc.)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p60_s3", "idA": "906709_17_item1a_p51_s2", "sentA": "Potential competitors in the TIL and CAR-T space include Kite Pharma/NCI, Adaptimmune LLC, Celgene Corporation, Juno Therapeutics, and Novartis, Alkermes, Altor, and Armo in the cytokine-based therapies space, and Tesaro, Macrogenics, Merck, BMS, and Roche in the checkpoint inhibitor space.", "sentB": "Potential competitors in the TIL and CAR-T space include Kite Pharma/NCI, Ada ptimmune LLC, Celgene Corporation, Juno Therapeutics, and Novartis, Alkermes, Altor, and Armo in the cytokine-based therapies space, and Tesaro, Macrogenics, Merck, BMS, and Roche in the checkpoint inhibitor space.", "type": 2, "words": ["<tag1>", "Potential", "competitors", "in", "the", "TIL", "and", "CAR-T", "space", "include", "Kite", "Pharma/NCI,", "Adaptimmune", "LLC,", "Celgene", "Corporation,", "Juno", "Therapeutics,", "and", "Novartis,", "Alkermes,", "Altor,", "and", "Armo", "in", "the", "cytokine-based", "therapies", "space,", "and", "Tesaro,", "Macrogenics,", "Merck,", "BMS,", "and", "Roche", "in", "the", "checkpoint", "inhibitor", "space.", "<tag2>", "Potential", "competitors", "in", "the", "TIL", "and", "CAR-T", "space", "include", "Kite", "Pharma/NCI,", "Ada", "ptimmune", "LLC,", "Celgene", "Corporation,", "Juno", "Therapeutics,", "and", "Novartis,", "Alkermes,", "Altor,", "and", "Armo", "in", "the", "cytokine-based", "therapies", "space,", "and", "Tesaro,", "Macrogenics,", "Merck,", "BMS,", "and", "Roche", "in", "the", "checkpoint", "inhibitor", "space.", "<tag3>"], "wordsA": ["Potential", "competitors", "in", "the", "TIL", "and", "CAR-T", "space", "include", "Kite", "Pharma/NCI,", "Adaptimmune", "LLC,", "Celgene", "Corporation,", "Juno", "Therapeutics,", "and", "Novartis,", "Alkermes,", "Altor,", "and", "Armo", "in", "the", "cytokine-based", "therapies", "space,", "and", "Tesaro,", "Macrogenics,", "Merck,", "BMS,", "and", "Roche", "in", "the", "checkpoint", "inhibitor", "space."], "wordsB": ["Potential", "competitors", "in", "the", "TIL", "and", "CAR-T", "space", "include", "Kite", "Pharma/NCI,", "Ada", "ptimmune", "LLC,", "Celgene", "Corporation,", "Juno", "Therapeutics,", "and", "Novartis,", "Alkermes,", "Altor,", "and", "Armo", "in", "the", "cytokine-based", "therapies", "space,", "and", "Tesaro,", "Macrogenics,", "Merck,", "BMS,", "and", "Roche", "in", "the", "checkpoint", "inhibitor", "space."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p1_s8", "idA": "906709_17_item1a_p51_s3", "sentA": "There can be no assurance that we or our partners will successfully develop, obtain regulatory approvals for and commercialize next-generation or new products that will successfully compete with those of our competitors.", "sentB": "Our future success is highly dependent on our ability to successfully develop, obtain regulatory approval for, and commercialize NKTR-214.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "we", "or", "our", "partners", "will", "successfully", "develop,", "obtain", "regulatory", "approvals", "for", "and", "commercialize", "next-generation", "or", "new", "products", "that", "will", "successfully", "compete", "with", "those", "of", "our", "competitors.", "<tag2>", "Our", "future", "success", "is", "highly", "dependent", "on", "our", "ability", "to", "successfully", "develop,", "obtain", "regulatory", "approval", "for,", "and", "commercialize", "NKTR-214.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "we", "or", "our", "partners", "will", "successfully", "develop,", "obtain", "regulatory", "approvals", "for", "and", "commercialize", "next-generation", "or", "new", "products", "that", "will", "successfully", "compete", "with", "those", "of", "our", "competitors."], "wordsB": ["Our", "future", "success", "is", "highly", "dependent", "on", "our", "ability", "to", "successfully", "develop,", "obtain", "regulatory", "approval", "for,", "and", "commercialize", "NKTR-214."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p27_s3", "idA": "906709_17_item1a_p51_s3", "sentA": "There can be no assurance that we or our partners will successfully develop, obtain regulatory approvals for and commercialize next-generation or new products that will successfully compete with those of our competitors.", "sentB": "There can be no assurance that we can obtain a license to any technology that we determine we need on reasonable terms, if at all, or that we could develop or otherwise obtain alternate technology.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "we", "or", "our", "partners", "will", "successfully", "develop,", "obtain", "regulatory", "approvals", "for", "and", "commercialize", "next-generation", "or", "new", "products", "that", "will", "successfully", "compete", "with", "those", "of", "our", "competitors.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "we", "can", "obtain", "a", "license", "to", "any", "technology", "that", "we", "determine", "we", "need", "on", "reasonable", "terms,", "if", "at", "all,", "or", "that", "we", "could", "develop", "or", "otherwise", "obtain", "alternate", "technology.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "we", "or", "our", "partners", "will", "successfully", "develop,", "obtain", "regulatory", "approvals", "for", "and", "commercialize", "next-generation", "or", "new", "products", "that", "will", "successfully", "compete", "with", "those", "of", "our", "competitors."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "we", "can", "obtain", "a", "license", "to", "any", "technology", "that", "we", "determine", "we", "need", "on", "reasonable", "terms,", "if", "at", "all,", "or", "that", "we", "could", "develop", "or", "otherwise", "obtain", "alternate", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p61_s4", "idA": "906709_17_item1a_p52_s0", "sentA": "companies not just in product development but also in areas such as recruiting employees, acquiring technologies that might enhance our ability to commercialize products, establishing relation ships with certain research and academic institutions, enrolling patients in clinical trials and seeking program partnerships and collaborations with larger pharmaceutical companies.", "sentB": "We face competition from these companies not just in product development but also in areas such as recruiting employees, acquiring technologies that might enhance our ability to commercialize products, establishing relationships with certain research and academic institutions, enrolling patients in clinical trials and seeking program partnerships and collaborations with larger pharmaceutical companies.", "type": 2, "words": ["<tag1>", "companies", "not", "just", "in", "product", "development", "but", "also", "in", "areas", "such", "as", "recruiting", "employees,", "acquiring", "technologies", "that", "might", "enhance", "our", "ability", "to", "commercialize", "products,", "establishing", "relation", "ships", "with", "certain", "research", "and", "academic", "institutions,", "enrolling", "patients", "in", "clinical", "trials", "and", "seeking", "program", "partnerships", "and", "collaborations", "with", "larger", "pharmaceutical", "companies.", "<tag2>", "We", "face", "competition", "from", "these", "companies", "not", "just", "in", "product", "development", "but", "also", "in", "areas", "such", "as", "recruiting", "employees,", "acquiring", "technologies", "that", "might", "enhance", "our", "ability", "to", "commercialize", "products,", "establishing", "relationships", "with", "certain", "research", "and", "academic", "institutions,", "enrolling", "patients", "in", "clinical", "trials", "and", "seeking", "program", "partnerships", "and", "collaborations", "with", "larger", "pharmaceutical", "companies.", "<tag3>"], "wordsA": ["companies", "not", "just", "in", "product", "development", "but", "also", "in", "areas", "such", "as", "recruiting", "employees,", "acquiring", "technologies", "that", "might", "enhance", "our", "ability", "to", "commercialize", "products,", "establishing", "relation", "ships", "with", "certain", "research", "and", "academic", "institutions,", "enrolling", "patients", "in", "clinical", "trials", "and", "seeking", "program", "partnerships", "and", "collaborations", "with", "larger", "pharmaceutical", "companies."], "wordsB": ["We", "face", "competition", "from", "these", "companies", "not", "just", "in", "product", "development", "but", "also", "in", "areas", "such", "as", "recruiting", "employees,", "acquiring", "technologies", "that", "might", "enhance", "our", "ability", "to", "commercialize", "products,", "establishing", "relationships", "with", "certain", "research", "and", "academic", "institutions,", "enrolling", "patients", "in", "clinical", "trials", "and", "seeking", "program", "partnerships", "and", "collaborations", "with", "larger", "pharmaceutical", "companies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p61_s5", "idA": "906709_17_item1a_p52_s1", "sentA": "As a result, our competitors may succeed in developing competing technolo gies, obtaining regulatory approval or gaining market acceptance for products before we do.", "sentB": "As a result, our competitors may succeed in developing competing technologies, obtaining regulatory approval or gaining market acceptance for products before we do.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "our", "competitors", "may", "succeed", "in", "developing", "competing", "technolo", "gies,", "obtaining", "regulatory", "approval", "or", "gaining", "market", "acceptance", "for", "products", "before", "we", "do.", "<tag2>", "As", "a", "result,", "our", "competitors", "may", "succeed", "in", "developing", "competing", "technologies,", "obtaining", "regulatory", "approval", "or", "gaining", "market", "acceptance", "for", "products", "before", "we", "do.", "<tag3>"], "wordsA": ["As", "a", "result,", "our", "competitors", "may", "succeed", "in", "developing", "competing", "technolo", "gies,", "obtaining", "regulatory", "approval", "or", "gaining", "market", "acceptance", "for", "products", "before", "we", "do."], "wordsB": ["As", "a", "result,", "our", "competitors", "may", "succeed", "in", "developing", "competing", "technologies,", "obtaining", "regulatory", "approval", "or", "gaining", "market", "acceptance", "for", "products", "before", "we", "do."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p63_s1", "idA": "906709_17_item1a_p54_s1", "sentA": "Despite the implementation of security measures, our internal computer systems and those of our CROs and other contractors and consultants are vulnerable to damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures.", "sentB": "Despite the implementation of security measures, our internal computer systems and those of our contract research organizations (CROs) and other contractors and consultants are vulnerable to damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures.", "type": 2, "words": ["<tag1>", "Despite", "the", "implementation", "of", "security", "measures,", "our", "internal", "computer", "systems", "and", "those", "of", "our", "CROs", "and", "other", "contractors", "and", "consultants", "are", "vulnerable", "to", "damage", "from", "computer", "viruses,", "unauthorized", "access,", "natural", "disasters,", "terrorism,", "war", "and", "telecommunication", "and", "electrical", "failures.", "<tag2>", "Despite", "the", "implementation", "of", "security", "measures,", "our", "internal", "computer", "systems", "and", "those", "of", "our", "contract", "research", "organizations", "(CROs)", "and", "other", "contractors", "and", "consultants", "are", "vulnerable", "to", "damage", "from", "computer", "viruses,", "unauthorized", "access,", "natural", "disasters,", "terrorism,", "war", "and", "telecommunication", "and", "electrical", "failures.", "<tag3>"], "wordsA": ["Despite", "the", "implementation", "of", "security", "measures,", "our", "internal", "computer", "systems", "and", "those", "of", "our", "CROs", "and", "other", "contractors", "and", "consultants", "are", "vulnerable", "to", "damage", "from", "computer", "viruses,", "unauthorized", "access,", "natural", "disasters,", "terrorism,", "war", "and", "telecommunication", "and", "electrical", "failures."], "wordsB": ["Despite", "the", "implementation", "of", "security", "measures,", "our", "internal", "computer", "systems", "and", "those", "of", "our", "contract", "research", "organizations", "(CROs)", "and", "other", "contractors", "and", "consultants", "are", "vulnerable", "to", "damage", "from", "computer", "viruses,", "unauthorized", "access,", "natural", "disasters,", "terrorism,", "war", "and", "telecommunication", "and", "electrical", "failures."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p1_s6", "idA": "906709_17_item1a_p54_s16", "sentA": "We are also dependent on the continued services of our technical personnel because of the highly technical nature of our products and the regulatory approval process.", "sentB": "We are highly dependent on the success of NKTR-214, our lead I-O candidate.", "type": 2, "words": ["<tag1>", "We", "are", "also", "dependent", "on", "the", "continued", "services", "of", "our", "technical", "personnel", "because", "of", "the", "highly", "technical", "nature", "of", "our", "products", "and", "the", "regulatory", "approval", "process.", "<tag2>", "We", "are", "highly", "dependent", "on", "the", "success", "of", "NKTR-214,", "our", "lead", "I-O", "candidate.", "<tag3>"], "wordsA": ["We", "are", "also", "dependent", "on", "the", "continued", "services", "of", "our", "technical", "personnel", "because", "of", "the", "highly", "technical", "nature", "of", "our", "products", "and", "the", "regulatory", "approval", "process."], "wordsB": ["We", "are", "highly", "dependent", "on", "the", "success", "of", "NKTR-214,", "our", "lead", "I-O", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p63_s4", "idA": "906709_17_item1a_p54_s4", "sentA": "To the extent that any disruption or security breach were to result in a loss of, or damage to, our data, or inappropriate disclosure of confidential or proprietary information of our company or clinical patients, we could incur liability and the development of our product candidates could be delayed.", "sentB": "To the extent that any disruption or security breach were to result in a loss of, or damage to, our data, or inappropriate disclosure of confidential or proprietary information of our company or clinical patients, we could suffer or be subject to reputational harm, monetary fines, civil suits, civil penalties or criminal sanctions and requirements to disclose the breach, and other forms of liability, and the development of our product candidates could be delayed.", "type": 2, "words": ["<tag1>", "To", "the", "extent", "that", "any", "disruption", "or", "security", "breach", "were", "to", "result", "in", "a", "loss", "of,", "or", "damage", "to,", "our", "data,", "or", "inappropriate", "disclosure", "of", "confidential", "or", "proprietary", "information", "of", "our", "company", "or", "clinical", "patients,", "we", "could", "incur", "liability", "and", "the", "development", "of", "our", "product", "candidates", "could", "be", "delayed.", "<tag2>", "To", "the", "extent", "that", "any", "disruption", "or", "security", "breach", "were", "to", "result", "in", "a", "loss", "of,", "or", "damage", "to,", "our", "data,", "or", "inappropriate", "disclosure", "of", "confidential", "or", "proprietary", "information", "of", "our", "company", "or", "clinical", "patients,", "we", "could", "suffer", "or", "be", "subject", "to", "reputational", "harm,", "monetary", "fines,", "civil", "suits,", "civil", "penalties", "or", "criminal", "sanctions", "and", "requirements", "to", "disclose", "the", "breach,", "and", "other", "forms", "of", "liability,", "and", "the", "development", "of", "our", "product", "candidates", "could", "be", "delayed.", "<tag3>"], "wordsA": ["To", "the", "extent", "that", "any", "disruption", "or", "security", "breach", "were", "to", "result", "in", "a", "loss", "of,", "or", "damage", "to,", "our", "data,", "or", "inappropriate", "disclosure", "of", "confidential", "or", "proprietary", "information", "of", "our", "company", "or", "clinical", "patients,", "we", "could", "incur", "liability", "and", "the", "development", "of", "our", "product", "candidates", "could", "be", "delayed."], "wordsB": ["To", "the", "extent", "that", "any", "disruption", "or", "security", "breach", "were", "to", "result", "in", "a", "loss", "of,", "or", "damage", "to,", "our", "data,", "or", "inappropriate", "disclosure", "of", "confidential", "or", "proprietary", "information", "of", "our", "company", "or", "clinical", "patients,", "we", "could", "suffer", "or", "be", "subject", "to", "reputational", "harm,", "monetary", "fines,", "civil", "suits,", "civil", "penalties", "or", "criminal", "sanctions", "and", "requirements", "to", "disclose", "the", "breach,", "and", "other", "forms", "of", "liability,", "and", "the", "development", "of", "our", "product", "candidates", "could", "be", "delayed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p64_s14", "idA": "906709_17_item1a_p55_s0", "sentA": "competition for skilled personnel in our industry is intense, companies such as ours sometimes experience high attrition rates with regard to their skilled employees.", "sentB": "Because competition for skilled personnel in our industry is intense, companies such as ours sometimes experience high attrition rates with regard to their skilled employees.", "type": 2, "words": ["<tag1>", "competition", "for", "skilled", "personnel", "in", "our", "industry", "is", "intense,", "companies", "such", "as", "ours", "sometimes", "experience", "high", "attrition", "rates", "with", "regard", "to", "their", "skilled", "employees.", "<tag2>", "Because", "competition", "for", "skilled", "personnel", "in", "our", "industry", "is", "intense,", "companies", "such", "as", "ours", "sometimes", "experience", "high", "attrition", "rates", "with", "regard", "to", "their", "skilled", "employees.", "<tag3>"], "wordsA": ["competition", "for", "skilled", "personnel", "in", "our", "industry", "is", "intense,", "companies", "such", "as", "ours", "sometimes", "experience", "high", "attrition", "rates", "with", "regard", "to", "their", "skilled", "employees."], "wordsB": ["Because", "competition", "for", "skilled", "personnel", "in", "our", "industry", "is", "intense,", "companies", "such", "as", "ours", "sometimes", "experience", "high", "attrition", "rates", "with", "regard", "to", "their", "skilled", "employees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p64_s16", "idA": "906709_17_item1a_p56_s0", "sentA": "Our equity incentive plan and employee benefit plans may not be effective in motivating or retaining our employees or attracting new employees, and significant volatility in the pri ce of our stock may adversely affect our ability to attract or retain qualified personnel.", "sentB": "Our equity incentive plan and employee benefit plans may not be effective in motivating or retaining our employees or attracting new employees, and significant volatility in the price of our stock may adversely affect our ability to attract or retain qualified personnel.", "type": 2, "words": ["<tag1>", "Our", "equity", "incentive", "plan", "and", "employee", "benefit", "plans", "may", "not", "be", "effective", "in", "motivating", "or", "retaining", "our", "employees", "or", "attracting", "new", "employees,", "and", "significant", "volatility", "in", "the", "pri", "ce", "of", "our", "stock", "may", "adversely", "affect", "our", "ability", "to", "attract", "or", "retain", "qualified", "personnel.", "<tag2>", "Our", "equity", "incentive", "plan", "and", "employee", "benefit", "plans", "may", "not", "be", "effective", "in", "motivating", "or", "retaining", "our", "employees", "or", "attracting", "new", "employees,", "and", "significant", "volatility", "in", "the", "price", "of", "our", "stock", "may", "adversely", "affect", "our", "ability", "to", "attract", "or", "retain", "qualified", "personnel.", "<tag3>"], "wordsA": ["Our", "equity", "incentive", "plan", "and", "employee", "benefit", "plans", "may", "not", "be", "effective", "in", "motivating", "or", "retaining", "our", "employees", "or", "attracting", "new", "employees,", "and", "significant", "volatility", "in", "the", "pri", "ce", "of", "our", "stock", "may", "adversely", "affect", "our", "ability", "to", "attract", "or", "retain", "qualified", "personnel."], "wordsB": ["Our", "equity", "incentive", "plan", "and", "employee", "benefit", "plans", "may", "not", "be", "effective", "in", "motivating", "or", "retaining", "our", "employees", "or", "attracting", "new", "employees,", "and", "significant", "volatility", "in", "the", "price", "of", "our", "stock", "may", "adversely", "affect", "our", "ability", "to", "attract", "or", "retain", "qualified", "personnel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p35_s0", "idA": "906709_17_item1a_p56_s1", "sentA": "If we fail to attract new personnel or to retain and motivate our current personnel, our business and future growth prospects could be severely harmed.", "sentB": "If we or current or future collaborators or service providers fail to comply with healthcare laws and regulations, we or they could be subject to enforcement actions and civil or criminal penalties.", "type": 2, "words": ["<tag1>", "If", "we", "fail", "to", "attract", "new", "personnel", "or", "to", "retain", "and", "motivate", "our", "current", "personnel,", "our", "business", "and", "future", "growth", "prospects", "could", "be", "severely", "harmed.", "<tag2>", "If", "we", "or", "current", "or", "future", "collaborators", "or", "service", "providers", "fail", "to", "comply", "with", "healthcare", "laws", "and", "regulations,", "we", "or", "they", "could", "be", "subject", "to", "enforcement", "actions", "and", "civil", "or", "criminal", "penalties.", "<tag3>"], "wordsA": ["If", "we", "fail", "to", "attract", "new", "personnel", "or", "to", "retain", "and", "motivate", "our", "current", "personnel,", "our", "business", "and", "future", "growth", "prospects", "could", "be", "severely", "harmed."], "wordsB": ["If", "we", "or", "current", "or", "future", "collaborators", "or", "service", "providers", "fail", "to", "comply", "with", "healthcare", "laws", "and", "regulations,", "we", "or", "they", "could", "be", "subject", "to", "enforcement", "actions", "and", "civil", "or", "criminal", "penalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p65_s0", "idA": "906709_17_item1a_p56_s6", "sentA": "In the event of an earthquake or other natural disaster, political instability, or terrorist event in any of these locations, our ability to manufacture and supply materials for drug candidates in development and our ability to meet our manufacturing obligations to our customers would be significantly disrupted and our business, results of operations and financial condition would be harmed.", "sentB": "significantly disrupted and our business, results of operations and financial condition would be harmed.", "type": 2, "words": ["<tag1>", "In", "the", "event", "of", "an", "earthquake", "or", "other", "natural", "disaster,", "political", "instability,", "or", "terrorist", "event", "in", "any", "of", "these", "locations,", "our", "ability", "to", "manufacture", "and", "supply", "materials", "for", "drug", "candidates", "in", "development", "and", "our", "ability", "to", "meet", "our", "manufacturing", "obligations", "to", "our", "customers", "would", "be", "significantly", "disrupted", "and", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "would", "be", "harmed.", "<tag2>", "significantly", "disrupted", "and", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "would", "be", "harmed.", "<tag3>"], "wordsA": ["In", "the", "event", "of", "an", "earthquake", "or", "other", "natural", "disaster,", "political", "instability,", "or", "terrorist", "event", "in", "any", "of", "these", "locations,", "our", "ability", "to", "manufacture", "and", "supply", "materials", "for", "drug", "candidates", "in", "development", "and", "our", "ability", "to", "meet", "our", "manufacturing", "obligations", "to", "our", "customers", "would", "be", "significantly", "disrupted", "and", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "would", "be", "harmed."], "wordsB": ["significantly", "disrupted", "and", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "would", "be", "harmed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p38_s1", "idA": "906709_17_item1a_p56_s7", "sentA": "Our collaborative partners may also be subject to catastrophic events, such as earthquakes, floods, hurricanes and tornadoes, any of which could harm our business, results of operations and financial condition.", "sentB": "If our operations are found to be in violation of any such requirements, we may be subject to penalties, including civil or criminal penalties, monetary damages, the curtailment or restructuring of our operations, or exclusion from participation in government contracting, healthcare reimbursement or other government programs, including Medicare and Medicaid, any of which could adversely affect financial results.", "type": 2, "words": ["<tag1>", "Our", "collaborative", "partners", "may", "also", "be", "subject", "to", "catastrophic", "events,", "such", "as", "earthquakes,", "floods,", "hurricanes", "and", "tornadoes,", "any", "of", "which", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "If", "our", "operations", "are", "found", "to", "be", "in", "violation", "of", "any", "such", "requirements,", "we", "may", "be", "subject", "to", "penalties,", "including", "civil", "or", "criminal", "penalties,", "monetary", "damages,", "the", "curtailment", "or", "restructuring", "of", "our", "operations,", "or", "exclusion", "from", "participation", "in", "government", "contracting,", "healthcare", "reimbursement", "or", "other", "government", "programs,", "including", "Medicare", "and", "Medicaid,", "any", "of", "which", "could", "adversely", "affect", "financial", "results.", "<tag3>"], "wordsA": ["Our", "collaborative", "partners", "may", "also", "be", "subject", "to", "catastrophic", "events,", "such", "as", "earthquakes,", "floods,", "hurricanes", "and", "tornadoes,", "any", "of", "which", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["If", "our", "operations", "are", "found", "to", "be", "in", "violation", "of", "any", "such", "requirements,", "we", "may", "be", "subject", "to", "penalties,", "including", "civil", "or", "criminal", "penalties,", "monetary", "damages,", "the", "curtailment", "or", "restructuring", "of", "our", "operations,", "or", "exclusion", "from", "participation", "in", "government", "contracting,", "healthcare", "reimbursement", "or", "other", "government", "programs,", "including", "Medicare", "and", "Medicaid,", "any", "of", "which", "could", "adversely", "affect", "financial", "results."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p65_s1", "idA": "906709_17_item1a_p56_s7", "sentA": "Our collaborative partners may also be subject to catastrophic events, such as earthquakes, floods, hurricanes and tornadoes, any of which could harm our business, results of operations and financial condition.", "sentB": "Our collaborative partner s may also be subject to catastrophic events, such as earthquakes, floods, hurricanes and tornadoes, any of which could harm our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "Our", "collaborative", "partners", "may", "also", "be", "subject", "to", "catastrophic", "events,", "such", "as", "earthquakes,", "floods,", "hurricanes", "and", "tornadoes,", "any", "of", "which", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Our", "collaborative", "partner", "s", "may", "also", "be", "subject", "to", "catastrophic", "events,", "such", "as", "earthquakes,", "floods,", "hurricanes", "and", "tornadoes,", "any", "of", "which", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["Our", "collaborative", "partners", "may", "also", "be", "subject", "to", "catastrophic", "events,", "such", "as", "earthquakes,", "floods,", "hurricanes", "and", "tornadoes,", "any", "of", "which", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Our", "collaborative", "partner", "s", "may", "also", "be", "subject", "to", "catastrophic", "events,", "such", "as", "earthquakes,", "floods,", "hurricanes", "and", "tornadoes,", "any", "of", "which", "could", "harm", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p65_s2", "idA": "906709_17_item1a_p56_s8", "sentA": "We have not undertaken a systematic analysis of the potential consequences to our business, results of operations and financial condition from a major earthquake or other catastrophic event, such as a fire, sustained loss of power, terrorist activity or other disaster, and do not have a recovery plan for such disasters.", "sentB": "We have not undertaken a systematic analysis of the potential conseque nces to our business, results of operations and financial condition from a major earthquake or other catastrophic event, such as a fire, sustained loss of power, terrorist activity or other disaster, and do not have a recovery plan for such disasters.", "type": 2, "words": ["<tag1>", "We", "have", "not", "undertaken", "a", "systematic", "analysis", "of", "the", "potential", "consequences", "to", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "from", "a", "major", "earthquake", "or", "other", "catastrophic", "event,", "such", "as", "a", "fire,", "sustained", "loss", "of", "power,", "terrorist", "activity", "or", "other", "disaster,", "and", "do", "not", "have", "a", "recovery", "plan", "for", "such", "disasters.", "<tag2>", "We", "have", "not", "undertaken", "a", "systematic", "analysis", "of", "the", "potential", "conseque", "nces", "to", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "from", "a", "major", "earthquake", "or", "other", "catastrophic", "event,", "such", "as", "a", "fire,", "sustained", "loss", "of", "power,", "terrorist", "activity", "or", "other", "disaster,", "and", "do", "not", "have", "a", "recovery", "plan", "for", "such", "disasters.", "<tag3>"], "wordsA": ["We", "have", "not", "undertaken", "a", "systematic", "analysis", "of", "the", "potential", "consequences", "to", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "from", "a", "major", "earthquake", "or", "other", "catastrophic", "event,", "such", "as", "a", "fire,", "sustained", "loss", "of", "power,", "terrorist", "activity", "or", "other", "disaster,", "and", "do", "not", "have", "a", "recovery", "plan", "for", "such", "disasters."], "wordsB": ["We", "have", "not", "undertaken", "a", "systematic", "analysis", "of", "the", "potential", "conseque", "nces", "to", "our", "business,", "results", "of", "operations", "and", "financial", "condition", "from", "a", "major", "earthquake", "or", "other", "catastrophic", "event,", "such", "as", "a", "fire,", "sustained", "loss", "of", "power,", "terrorist", "activity", "or", "other", "disaster,", "and", "do", "not", "have", "a", "recovery", "plan", "for", "such", "disasters."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p65_s3", "idA": "906709_17_item1a_p56_s9", "sentA": "In addition, our insurance coverage may not be sufficient to compensate us for actual losses from any interruption of our business that may occur.", "sentB": "In a ddition, our insurance coverage may not be sufficient to compensate us for actual losses from any interruption of our business that may occur.", "type": 2, "words": ["<tag1>", "In", "addition,", "our", "insurance", "coverage", "may", "not", "be", "sufficient", "to", "compensate", "us", "for", "actual", "losses", "from", "any", "interruption", "of", "our", "business", "that", "may", "occur.", "<tag2>", "In", "a", "ddition,", "our", "insurance", "coverage", "may", "not", "be", "sufficient", "to", "compensate", "us", "for", "actual", "losses", "from", "any", "interruption", "of", "our", "business", "that", "may", "occur.", "<tag3>"], "wordsA": ["In", "addition,", "our", "insurance", "coverage", "may", "not", "be", "sufficient", "to", "compensate", "us", "for", "actual", "losses", "from", "any", "interruption", "of", "our", "business", "that", "may", "occur."], "wordsB": ["In", "a", "ddition,", "our", "insurance", "coverage", "may", "not", "be", "sufficient", "to", "compensate", "us", "for", "actual", "losses", "from", "any", "interruption", "of", "our", "business", "that", "may", "occur."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p67_s5", "idA": "906709_17_item1a_p59_s1", "sentA": "During the year ended December 31, 2016, based on closing prices on The NASDAQ Global Select Market, the closing price of our common stock ranged from $11.00 to $19.68 per share.", "sentB": "During the year ended December 31, 2017, based on closing prices on The NASDAQ Global Select Market, the closing price of our common stock ranged from $11.75 to $60.50 per share.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2016,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "the", "closing", "price", "of", "our", "common", "stock", "ranged", "from", "$11.00", "to", "$19.68", "per", "share.", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2017,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "the", "closing", "price", "of", "our", "common", "stock", "ranged", "from", "$11.75", "to", "$60.50", "per", "share.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2016,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "the", "closing", "price", "of", "our", "common", "stock", "ranged", "from", "$11.00", "to", "$19.68", "per", "share."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2017,", "based", "on", "closing", "prices", "on", "The", "NASDAQ", "Global", "Select", "Market,", "the", "closing", "price", "of", "our", "common", "stock", "ranged", "from", "$11.75", "to", "$60.50", "per", "share."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p72_s0", "idA": "906709_17_item1a_p64_s0", "sentA": "This indenture also requires us to maintain a minimum cash balance of $60.0 million.", "sentB": "This indenture also requires us to maintain a minimum cash and investments in marketable securities balance of $60.0 million.", "type": 2, "words": ["<tag1>", "This", "indenture", "also", "requires", "us", "to", "maintain", "a", "minimum", "cash", "balance", "of", "$60.0", "million.", "<tag2>", "This", "indenture", "also", "requires", "us", "to", "maintain", "a", "minimum", "cash", "and", "investments", "in", "marketable", "securities", "balance", "of", "$60.0", "million.", "<tag3>"], "wordsA": ["This", "indenture", "also", "requires", "us", "to", "maintain", "a", "minimum", "cash", "balance", "of", "$60.0", "million."], "wordsB": ["This", "indenture", "also", "requires", "us", "to", "maintain", "a", "minimum", "cash", "and", "investments", "in", "marketable", "securities", "balance", "of", "$60.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p74_s1", "idA": "906709_17_item1a_p67_s0", "sentA": "ability to comply with these covenants will likely be affected by many factors, including even ts beyond our control, and we may not satisfy those requirements.", "sentB": "Our ability to comply with these covenants will likely be affected by many factors, including events beyond our control, and we may not satisfy those requirements.", "type": 2, "words": ["<tag1>", "ability", "to", "comply", "with", "these", "covenants", "will", "likely", "be", "affected", "by", "many", "factors,", "including", "even", "ts", "beyond", "our", "control,", "and", "we", "may", "not", "satisfy", "those", "requirements.", "<tag2>", "Our", "ability", "to", "comply", "with", "these", "covenants", "will", "likely", "be", "affected", "by", "many", "factors,", "including", "events", "beyond", "our", "control,", "and", "we", "may", "not", "satisfy", "those", "requirements.", "<tag3>"], "wordsA": ["ability", "to", "comply", "with", "these", "covenants", "will", "likely", "be", "affected", "by", "many", "factors,", "including", "even", "ts", "beyond", "our", "control,", "and", "we", "may", "not", "satisfy", "those", "requirements."], "wordsB": ["Our", "ability", "to", "comply", "with", "these", "covenants", "will", "likely", "be", "affected", "by", "many", "factors,", "including", "events", "beyond", "our", "control,", "and", "we", "may", "not", "satisfy", "those", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p10_s0", "idA": "906709_17_item1a_p7_s0", "sentA": "Given these risks, the success of our current and future collaboration partnerships is highly unpredictable and can have a substantial negative or positive impact on our business in particular, we expect the commercial outcomes of MOVANTIK , MOVENTIG and ADYNOVATE (previously referred to as BAX 855) to have a particularly significant impact on our near to mid- term financial results and financial condition.", "sentB": "Given these risks, the success of our current and future collaboration partnerships is highly unpredictable and can have a substantial negative or positive impact on our business.", "type": 2, "words": ["<tag1>", "Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business", "in", "particular,", "we", "expect", "the", "commercial", "outcomes", "of", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "(previously", "referred", "to", "as", "BAX", "855)", "to", "have", "a", "particularly", "significant", "impact", "on", "our", "near", "to", "mid-", "term", "financial", "results", "and", "financial", "condition.", "<tag2>", "Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business.", "<tag3>"], "wordsA": ["Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business", "in", "particular,", "we", "expect", "the", "commercial", "outcomes", "of", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "(previously", "referred", "to", "as", "BAX", "855)", "to", "have", "a", "particularly", "significant", "impact", "on", "our", "near", "to", "mid-", "term", "financial", "results", "and", "financial", "condition."], "wordsB": ["Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item1a_p2_s2", "idA": "906709_17_item1a_p7_s0", "sentA": "Given these risks, the success of our current and future collaboration partnerships is highly unpredictable and can have a substantial negative or positive impact on our business in particular, we expect the commercial outcomes of MOVANTIK , MOVENTIG and ADYNOVATE (previously referred to as BAX 855) to have a particularly significant impact on our near to mid- term financial results and financial condition.", "sentB": "To date, clinical outcomes from NKTR-214 have had a significant impact on our market valuation, financial position, and business prospects and we expect this to continue in future periods.", "type": 2, "words": ["<tag1>", "Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business", "in", "particular,", "we", "expect", "the", "commercial", "outcomes", "of", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "(previously", "referred", "to", "as", "BAX", "855)", "to", "have", "a", "particularly", "significant", "impact", "on", "our", "near", "to", "mid-", "term", "financial", "results", "and", "financial", "condition.", "<tag2>", "To", "date,", "clinical", "outcomes", "from", "NKTR-214", "have", "had", "a", "significant", "impact", "on", "our", "market", "valuation,", "financial", "position,", "and", "business", "prospects", "and", "we", "expect", "this", "to", "continue", "in", "future", "periods.", "<tag3>"], "wordsA": ["Given", "these", "risks,", "the", "success", "of", "our", "current", "and", "future", "collaboration", "partnerships", "is", "highly", "unpredictable", "and", "can", "have", "a", "substantial", "negative", "or", "positive", "impact", "on", "our", "business", "in", "particular,", "we", "expect", "the", "commercial", "outcomes", "of", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "(previously", "referred", "to", "as", "BAX", "855)", "to", "have", "a", "particularly", "significant", "impact", "on", "our", "near", "to", "mid-", "term", "financial", "results", "and", "financial", "condition."], "wordsB": ["To", "date,", "clinical", "outcomes", "from", "NKTR-214", "have", "had", "a", "significant", "impact", "on", "our", "market", "valuation,", "financial", "position,", "and", "business", "prospects", "and", "we", "expect", "this", "to", "continue", "in", "future", "periods."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
